data_2lfc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.663 0.616 . . . . 75.42 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.02 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.53 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.43 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 65.22 111.216 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 74.23 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.22 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 75.11 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 72.03 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 70.23 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.524 ' HE3' ' HA ' ' A' ' 62' ' ' THR . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 75.42 110.138 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 63.14 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.45 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 75.24 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.523 ' HH ' ' HB2' ' A' ' 14' ' ' SER . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 74.22 108.264 169.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 72.1 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.44 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 74.33 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.33 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 71.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.42 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 74.25 110.603 -176.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 74.2 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 73.32 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 71.01 111.389 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.04 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.04 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.41 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 72.24 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 75.3 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 61.55 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.44 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.24 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 75.33 110.312 -174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.52 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 62.23 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.43 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.03 112.86 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.53 110.437 -178.381 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.586 0.587 . . . . 73.13 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.41 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 64.13 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.42 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 72.44 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.44 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 74.4 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.23 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.03 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 74.15 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.524 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 73.04 110.335 170.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 74.11 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.42 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 73.31 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.13 112.106 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.51 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.23 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.44 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.11 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 64.1 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 72.14 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.32 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 72.43 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 72.24 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 75.14 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.43 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.534 ' HG2' HG21 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 74.23 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.41 111.6 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.43 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 73.5 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 74.35 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 72.43 110.669 -178.631 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.099 0.407 . . . . 72.24 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HB2' HG23 ' A' ' 94' ' ' VAL . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 65.53 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 73.23 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.21 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HE3' HG22 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.12 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.14 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 75.31 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.11 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.11 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.05 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.44 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 74.32 110.818 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.42 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.51 111.128 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.2 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.54 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.24 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 73.24 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 72.15 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 73.24 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 61.3 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.21 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.35 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.32 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 74.33 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.44 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' O ' HG21 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.44 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.05 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.24 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.44 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.13 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 64.32 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.34 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.21 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 74.3 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 63.01 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 71.34 108.891 175.191 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 119.133 -0.461 . . . . 64.03 110.527 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 71.35 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 74.02 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 135' ' ' PRO . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 72.12 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.1 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 75.54 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.42 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 73.05 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.42 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.33 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.478 HG22 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 74.24 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.23 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 73.33 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.54 109.522 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 70.21 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.11 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 74.03 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 75.41 111.163 173.148 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.53 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 75.11 111.408 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 72.44 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 75.04 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 73.34 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.53 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.12 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.42 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 74.24 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 65.31 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 60.05 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 73.45 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.43 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 74.32 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 74.04 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.1 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.45 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.14 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.41 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 74.12 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.22 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.41 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.56 HD22 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 74.31 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.43 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 73.43 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 74.43 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.3 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 74.21 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 74.32 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 71.42 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 71.14 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 72.53 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 74.55 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 73.32 111.781 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 75.31 111.617 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 73.13 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 65.23 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.33 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.54 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 63.33 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 75.45 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.02 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.03 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.33 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.4 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 75.22 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.44 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.43 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.13 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.3 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.12 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 73.11 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 64.45 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 75.22 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 70.54 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.42 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.54 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 73.44 106.251 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 74.2 111.874 -166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 74.43 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 75.51 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.45 110.669 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 71.34 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.3 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.21 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.31 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.42 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.34 110.529 -178.192 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 72.14 108.029 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HB2' HG21 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.43 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.21 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.54 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 73.52 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 73.42 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.12 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 71.22 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 113' ' ' VAL . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.24 110.868 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.33 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.23 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 73.33 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.42 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 75.01 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.01 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.13 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.31 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.24 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 71.1 109.1 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 73.24 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.51 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.51 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 73.31 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.412 ' N ' HD13 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.35 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.22 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.15 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 74.13 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.52 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.53 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 71.54 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.14 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.586 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.04 112.226 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.02 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.24 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.586 HE21 ' HA2' ' A' ' 121' ' ' GLY . 28.2 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.43 110.869 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.24 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.44 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.1 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.31 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 72.52 109.536 -172.449 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.006 -0.521 . . . . 70.23 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.43 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.01 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 73.2 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 74.12 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.04 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 74.25 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.441 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 74.43 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.33 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 71.22 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 74.34 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 75.24 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 74.4 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.13 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.32 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.23 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 71.52 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HA ' HG22 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 65.25 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 74.31 111.031 179.453 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.374 0.138 . . . . 75.33 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.01 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.21 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 74.23 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 73.23 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 72.44 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 70.43 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 73.12 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.02 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.44 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.469 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 74.24 111.597 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 75.41 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 75.15 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 75.51 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 74.53 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 74.15 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 71.21 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 74.54 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.14 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.42 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 73.04 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 70.23 111.151 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.33 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 74.21 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.3 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 73.44 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 62.34 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.51 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.5 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.21 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.417 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 73.21 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 75.44 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.23 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 70.14 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.21 110.966 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 75.22 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.435 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 72.44 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 75.31 110.078 176.405 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 46' ' ' ILE . 1.2 mptm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 74.13 109.873 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 72.34 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.04 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.31 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.4 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.43 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.44 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.24 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.14 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.402 HG23 ' HE3' ' A' ' 20' ' ' MET . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.13 110.244 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.31 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 74.32 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.22 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 73.24 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.12 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.33 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.42 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 74.0 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.5 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 74.22 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 70.22 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.01 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.14 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.508 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 64.15 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.31 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.2 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 73.42 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 70.34 111.5 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 73.32 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.04 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 73.54 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.11 110.18 176.482 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.531 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 109.8 -0.444 . . . . 75.4 109.8 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 71.25 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.52 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.01 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 72.03 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.23 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 34.24 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 70.01 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 74.22 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.3 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 73.45 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.55 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB1' HD22 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.13 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 74.42 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.34 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.531 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.11 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.472 HD13 HG23 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 72.41 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.12 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.31 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.2 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 73.12 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 75.43 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 74.13 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.24 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.534 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.13 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 74.44 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.13 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 71.41 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.447 ' O ' HG21 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.35 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.33 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.421 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.24 112.415 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.42 112.221 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.04 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.421 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.3 111.53 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 74.1 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.31 112.797 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 74.2 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 73.41 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.3 108.751 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 112.404 0.52 . . . . 72.43 112.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.04 113.828 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.12 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 75.3 110.454 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.24 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 71.12 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.34 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 72.45 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 73.13 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.31 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 72.23 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.41 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 75.13 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 73.02 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.11 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.03 109.778 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.31 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 75.24 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 73.24 109.935 174.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 74.35 112.204 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.122 -0.695 . . . . 74.03 109.122 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 74.01 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.33 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.04 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.21 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 74.23 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 74.23 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.01 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.54 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 75.22 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 73.44 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 73.01 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 74.32 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 63.43 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.543 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.55 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.53 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.44 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.32 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 64.11 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.11 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.42 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.685 ' HD2' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 75.21 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.437 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 73.34 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.43 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.5 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.51 108.102 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 75.32 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.3 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.32 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 75.11 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 74.12 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 75.14 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 74.12 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.22 111.334 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.24 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.13 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.45 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 64.53 111.354 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 74.43 111.784 171.561 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.22 111.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 72.32 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.2 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 75.45 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.52 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.53 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 72.32 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 63.14 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.11 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 75.22 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.405 HG21 ' HE3' ' A' ' 20' ' ' MET . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.01 110.478 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 75.44 112.657 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.14 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 75.23 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 74.11 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.04 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.12 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 74.24 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 73.33 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.44 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 71.34 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 74.41 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 74.12 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.4 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 54.22 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 73.43 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.499 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.24 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 72.22 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.12 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 73.35 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.24 111.182 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.537 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.51 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.42 109.532 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 . . . . . 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 74.13 106.061 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.22 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.12 108.124 172.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.32 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.53 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.24 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.45 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.3 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.51 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.14 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.41 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.23 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.52 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.33 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.35 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 63.41 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.51 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 75.31 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 75.51 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.44 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.24 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.11 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.04 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 70.05 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.14 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 74.15 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.43 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 74.55 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.53 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 74.53 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.12 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.12 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.45 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.34 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 55.43 113.539 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.34 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.23 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.33 111.907 -176.621 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 118.984 -0.532 . . . . 70.44 110.979 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.1 116.253 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.41 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.32 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 65.43 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 73.21 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 75.14 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.4 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 64.2 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 71.04 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.52 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.15 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.12 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 73.23 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.54 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.42 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 74.5 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.461 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.34 110.624 166.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 65.23 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.32 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.21 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 74.11 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.02 111.785 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 65.51 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.3 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 75.41 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.11 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 61.43 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.1 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.13 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.35 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HH ' ' HB3' ' A' ' 14' ' ' SER . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.11 109.242 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 75.41 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.55 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.41 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.14 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.43 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 73.31 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 73.4 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.526 HG13 HG13 ' A' ' 33' ' ' VAL . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.11 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 75.43 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 70.01 112.159 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 74.2 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.14 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 74.5 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.23 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.32 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.44 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.13 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 74.11 111.478 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.52 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.4 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 71.52 111.195 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 73.0 110.306 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.04 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.44 110.645 175.672 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' HD11 ' A' ' 153' ' ' LEU . 29.2 mmtp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.173 0.511 . . . . 64.43 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.54 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 74.14 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 74.43 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.43 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 65.13 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 75.52 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.31 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.22 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 73.21 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.41 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.42 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 75.02 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 75.44 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 73.12 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.22 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.51 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 72.04 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 75.15 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.34 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 74.35 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 60.15 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.23 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.35 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.579 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.22 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 74.04 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.34 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.12 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 75.0 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 74.02 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 73.13 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.52 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.31 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.44 109.791 -176.099 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 119.04 -0.505 . . . . 75.22 109.863 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.531 ' HB2' HG23 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.52 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 72.03 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 73.54 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 74.02 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 74.33 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.44 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 75.32 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.51 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.14 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.24 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 72.22 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 73.2 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 72.2 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.22 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 75.53 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.3 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.401 HG23 HD21 ' A' ' 112' ' ' LEU . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.14 109.23 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 102' ' ' ALA . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.35 110.879 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.55 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.04 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.57 ' HA ' HG21 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.13 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 73.12 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 75.23 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.42 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.34 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 73.15 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.44 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.505 ' O ' HG22 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 74.21 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 71.23 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.23 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.518 HG13 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.43 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.434 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 73.41 111.6 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.22 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.31 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 75.22 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.12 108.099 175.536 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 74.52 109.053 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.45 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.24 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 72.41 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.22 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.21 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.518 ' HG3' HG13 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.41 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.13 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 74.51 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 73.33 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.3 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.11 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 75.42 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 73.44 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 71.41 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.43 108.821 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.35 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 72.34 110.346 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.351 0.119 . . . . 75.42 111.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 75.0 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 74.13 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.14 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.34 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 65.33 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.12 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 71.15 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.52 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.34 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.43 110.767 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 72.22 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.416 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.24 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.12 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.12 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.53 109.815 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 75.52 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 75.45 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 75.32 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 112' ' ' LEU . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.22 112.911 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.52 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 74.2 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.401 HG13 HG11 ' A' ' 33' ' ' VAL . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 73.21 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 32' ' ' ILE . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.34 108.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 74.52 113.187 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.44 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 63.14 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.53 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 74.5 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 73.54 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 70.55 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.14 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.3 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 74.52 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.4 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 72.41 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 73.22 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.24 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 64.41 109.947 174.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm . . . . . 0 C--O 1.243 0.758 0 CA-C-O 122.154 0.978 . . . . 72.32 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 74.13 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 75.33 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 74.13 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 74.31 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 75.41 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 63.45 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.35 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 75.32 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.25 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.15 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.44 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.14 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 64.11 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 72.14 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.21 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.23 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.23 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 63.23 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 73.33 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 75.31 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.05 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.13 108.387 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 72.22 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.22 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.42 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.11 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.21 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.454 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 74.22 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 74.4 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 73.35 111.786 175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 75.51 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 65.05 110.649 -173.396 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 119.366 -0.35 . . . . 75.3 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.33 110.558 171.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.14 109.209 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 75.01 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 74.12 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.31 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 53.44 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 75.22 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.22 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 73.33 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 63.43 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 61.24 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 74.2 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.51 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 62.44 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 72.02 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 75.21 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.3 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.43 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG21 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 74.35 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 74.13 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.05 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.475 HG21 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.11 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.34 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 74.33 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.41 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 74.31 109.654 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 72.21 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.2 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.14 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.15 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.415 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 72.3 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.21 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.24 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 74.51 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.23 106.785 170.715 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 119.465 -0.302 . . . . 74.23 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 70.43 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 72.0 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.22 111.508 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 75.23 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 73.4 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.415 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.35 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.14 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.51 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 70.42 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.33 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 63.05 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.35 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.549 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 73.01 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.32 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 72.14 109.421 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.34 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.23 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.24 109.17 173.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.31 112.651 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 110.227 -0.286 . . . . 74.33 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.42 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 74.33 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 71.35 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.02 112.219 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.31 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.52 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 64.31 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.441 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 72.21 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 72.43 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.439 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 73.5 110.635 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 73.31 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 74.24 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 73.31 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 75.33 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.22 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 74.1 109.663 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 72.43 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.51 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.35 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 74.53 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HD3' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.4 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.11 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.45 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.03 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.33 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.44 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 74.45 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.44 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.11 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.416 ' H ' HG21 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 74.52 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 75.23 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 75.14 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 74.25 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 73.23 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 62.02 111.134 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.1 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 75.34 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.31 109.954 175.615 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.52 110.283 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 65.13 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 73.41 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.24 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.35 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 148' ' ' ILE . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.11 109.864 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.31 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.44 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.02 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.44 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 64.14 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.34 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.34 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.33 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 63.24 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 72.1 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 74.32 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.14 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.24 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.491 HD11 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.42 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.33 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.41 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.522 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.52 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD3' HD11 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 75.2 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 74.25 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 60.22 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 72.51 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.418 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 74.42 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.54 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 75.43 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.21 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 75.24 110.538 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 119.337 -0.363 . . . . 70.43 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 64.11 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.02 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 71.01 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG21 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.03 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.05 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 72.45 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 72.01 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.34 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.42 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.2 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 74.21 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 72.34 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.34 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.32 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.43 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.52 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 74.05 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.34 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 75.4 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 74.31 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 75.33 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.24 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 74.13 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.21 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 74.2 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.11 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.22 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.43 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.3 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.41 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 138' ' ' LEU . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 72.41 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.23 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.54 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.34 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.55 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 71.54 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.02 109.197 179.576 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.654 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 75.42 109.967 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.467 ' HA ' HD11 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.44 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.31 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.654 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.2 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 74.43 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.23 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 74.34 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.52 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.34 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.11 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.24 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 73.23 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 73.23 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 57' ' ' VAL . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 75.15 108.3 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.457 HG22 ' NE2' ' A' ' 151' ' ' GLN . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.2 109.487 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.51 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.457 ' NE2' HG22 ' A' ' 149' ' ' ILE . 25.1 mm-40 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.15 108.638 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 74.21 109.45 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 74.34 111.108 172.469 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 11' ' ' THR . 1.9 m . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.1 108.436 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 74.13 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 74.12 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 72.11 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.42 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.22 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.01 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.44 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.32 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.22 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 64.53 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.02 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 74.0 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 71.4 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.529 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.42 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.44 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 74.32 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 74.42 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.42 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 60.41 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.42 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.442 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 65.22 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.22 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.32 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.22 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.44 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 73.15 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.2 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 75.14 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 75.33 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.1 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.14 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.04 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 74.14 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 74.42 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 64.53 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.21 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 74.12 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 73.23 110.488 174.537 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.553 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.252 0.549 . . . . 70.2 112.435 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 71.14 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.41 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 73.05 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.458 HD21 ' HB1' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.31 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.42 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 74.12 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.4 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.41 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.52 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 63.42 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.22 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 74.41 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 75.54 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.52 111.376 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.15 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 72.34 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.21 110.397 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.35 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.13 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.31 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.23 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.12 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.14 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.42 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.31 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 74.21 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 73.12 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 73.12 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 72.34 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.52 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.41 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.22 110.6 -177.028 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.216 -0.421 . . . . 74.43 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.35 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 54.41 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 74.55 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 71.21 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 61.21 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.11 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.14 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.44 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.31 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.41 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 63.52 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 70.14 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.32 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 74.24 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.32 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 74.25 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 75.11 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.23 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.53 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.42 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.32 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.13 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.34 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.32 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.11 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.32 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 73.43 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 73.22 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 72.01 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.52 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.13 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.14 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 72.4 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.31 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.12 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.01 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.11 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.435 ' HB2' HD13 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 74.42 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.3 110.744 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 118.738 -0.648 . . . . 75.42 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.52 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.05 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.24 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.31 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HB3' HG23 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 75.55 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.21 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 71.2 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.43 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.01 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.3 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.03 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 72.02 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.41 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 73.13 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.13 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 74.34 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.13 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.456 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 74.14 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 mt . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 63.3 110.81 167.767 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 109.965 -0.383 . . . . 63.22 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.13 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.11 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 62.23 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 74.34 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 74.43 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 63.25 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.45 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 35' ' ' GLU . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 73.21 111.431 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.32 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.53 110.558 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 72.03 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 75.43 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.15 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.54 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 72.43 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.43 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 74.42 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 74.23 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.32 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.35 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.45 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 73.43 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 73.53 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 75.34 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 18' ' ' THR . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.44 109.338 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.43 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.34 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.41 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.12 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.3 111.004 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.43 ' H ' HG12 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 74.44 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.42 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 74.03 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.51 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.23 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.422 HD11 HD21 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.4 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 75.14 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.45 111.474 176.767 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.925 0.393 . . . . 75.54 111.104 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.24 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 70.44 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 73.22 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.32 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.24 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 72.01 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.32 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 72.15 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 72.02 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.24 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 74.32 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 74.42 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 72.42 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HB2' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 75.03 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.01 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.3 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 64.52 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 72.13 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.41 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.44 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.34 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.573 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 70.03 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 74.41 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.52 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.573 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.44 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.33 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HZ3' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.11 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.23 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.42 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 72.01 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 61.0 111.511 -177.467 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 73.35 106.919 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' HB2' HG21 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.24 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.14 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.23 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.31 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 74.03 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 70.41 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 71.55 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 75.12 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.42 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.41 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.43 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 65.41 111.293 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.43 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 74.02 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 74.52 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 74.42 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 74.51 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 73.31 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 74.2 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.44 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.12 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.24 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 70.22 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.3 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.33 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 74.24 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.492 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 73.44 111.39 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.12 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.465 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 75.24 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 63.43 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.24 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 138' ' ' LEU . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.32 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 72.2 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.11 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 75.42 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.33 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 73.22 111.888 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.21 108.849 176.12 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.0 t70 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 112.032 0.382 . . . . 74.2 112.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 75.4 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.11 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.02 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.44 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.41 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.4 ' HG3' HG13 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.3 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.33 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 72.42 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.22 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.42 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.44 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 74.11 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.441 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 71.2 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 71.33 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.23 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.35 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.51 109.047 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.42 107.504 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 46' ' ' ILE . 61.5 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.547 0.827 0 N-CA-C 113.066 0.765 . . . . 74.44 113.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 72.43 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.54 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 74.32 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.552 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.41 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.11 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.24 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 73.21 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 63.25 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.35 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 73.45 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.42 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 74.01 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.53 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.552 ' HH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.44 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 71.21 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.21 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 73.12 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 60.14 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 71.23 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.03 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.411 HG13 HG11 ' A' ' 33' ' ' VAL . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 70.13 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 HG11 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.43 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 70.34 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.44 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 72.14 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.1 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.34 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.15 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 75.33 111.891 -171.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.458 ' H ' HG12 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 74.0 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.41 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.23 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.1 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 65.21 110.934 173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG12 ' HB1' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.32 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 73.03 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.42 111.004 178.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.05 111.485 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.11 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 75.12 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.35 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.44 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 65.24 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.479 ' HE2' HG11 ' A' ' 66' ' ' VAL . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.22 108.884 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.24 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.42 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.43 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 72.51 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.32 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 75.34 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.54 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 74.31 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.31 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.22 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 73.12 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 74.23 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 73.43 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.44 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.52 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.2 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 74.55 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.42 111.06 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.33 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.44 111.121 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.31 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 74.11 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.456 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.42 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.32 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.15 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 75.44 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.44 111.014 -179.539 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.2 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 73.23 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.11 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 62.34 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 74.33 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.33 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 72.42 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.34 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.12 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 74.41 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.33 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.42 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 71.4 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 75.31 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.1 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 51.14 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 74.02 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 74.43 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 75.44 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.44 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.45 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.512 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 73.5 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.3 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.1 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 63.4 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 73.32 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.23 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' HG21 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.23 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.52 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.12 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 75.04 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.11 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.442 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 74.15 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 72.01 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.54 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.24 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.21 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.4 109.923 177.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 119.414 -0.327 . . . . 73.25 111.692 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.15 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.01 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 74.24 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 73.2 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 74.4 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 75.43 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.41 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 61.42 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.33 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 73.12 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 64.11 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.5 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.54 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 73.4 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.34 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 73.43 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.597 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 74.1 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.488 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt . . . . . 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 74.53 110.543 167.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.242 0.681 0 N-CA-C 108.231 -1.025 . . . . 61.45 108.231 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.588 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 72.01 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.41 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.32 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 62.23 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 73.12 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 74.31 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 71.31 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.12 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 74.24 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 71.44 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.44 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 74.14 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 74.33 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 74.21 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 HG22 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.31 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 73.13 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 74.03 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.2 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 54.25 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.42 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.515 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 74.21 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 75.21 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.42 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.12 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.23 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.12 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.4 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 65.24 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.11 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.33 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 75.32 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 74.43 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.53 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.31 111.467 -175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 62.22 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.54 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 72.14 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 75.02 110.537 175.384 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.22 109.766 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 74.01 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.22 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.13 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 72.52 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 70.14 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.492 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.42 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 74.25 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.42 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 75.22 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.2 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.45 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.13 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.33 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.13 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.13 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.05 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.21 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 73.23 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 64.24 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 75.0 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 72.42 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 70.33 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.43 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.44 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 75.33 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.32 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 73.05 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.52 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 74.21 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 72.55 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.21 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.23 108.957 177.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.758 -0.163 . . . . 74.5 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 73.43 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.43 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.23 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.53 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.14 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 70.32 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.31 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.22 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 73.24 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.03 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.14 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 70.52 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.24 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.04 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.53 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.42 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 73.23 111.384 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.1 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.31 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 73.54 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 75.02 109.156 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 55.42 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 74.04 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 75.24 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.53 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 74.23 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.444 ' O ' HG22 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 74.04 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.34 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.43 110.999 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.34 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 73.23 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.421 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 26.9 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.4 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.3 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 72.03 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.42 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.11 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 72.13 108.44 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 CA--C 1.553 1.082 0 CA-C-O 118.771 -0.633 . . . . 72.2 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.32 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 75.21 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.43 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 74.43 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.24 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 73.34 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.03 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.1 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.42 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.55 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.45 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 74.44 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.13 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.492 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 73.01 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.13 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.34 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.34 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.224 174.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.553 HG21 ' H ' ' A' ' 11' ' ' THR . 1.4 m . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.43 107.155 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.553 ' H ' HG21 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 73.04 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.32 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 61.21 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.01 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 75.51 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.44 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 74.11 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.11 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.33 111.822 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.33 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.24 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 70.45 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' ARG . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.55 109.107 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.35 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 74.52 110.659 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.45 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.31 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 73.31 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 73.52 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.1 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.52 110.525 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.24 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.53 112.928 -171.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 70.4 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.31 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.42 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.32 108.82 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 73.13 110.283 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 71.32 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.412 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.23 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.13 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.35 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 73.22 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.45 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.44 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.12 110.624 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 112.725 0.639 . . . . 61.12 112.725 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.44 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.21 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HB3' HG21 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.43 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.34 109.14 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.32 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 75.31 109.939 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 74.05 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 74.33 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 75.32 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.44 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.53 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.31 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 20' ' ' MET . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.4 112.465 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.55 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 72.14 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.12 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.31 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.02 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.14 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.4 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.12 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.31 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.3 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.01 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.43 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.21 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.52 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.31 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.21 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.53 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.21 111.046 -179.338 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.24 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.21 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 74.12 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.41 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.03 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 70.53 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.35 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 74.41 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 74.31 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 64.42 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.23 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 75.51 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.23 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.11 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 75.23 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.14 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.44 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.507 HD11 HG23 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 74.44 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.44 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.22 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 75.15 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.44 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.23 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.14 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.12 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.12 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.22 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 75.33 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.54 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.35 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.22 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.43 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.21 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 72.32 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 74.22 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.43 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.31 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.51 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 73.44 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 71.53 110.849 177.604 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 70.4 110.112 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 71.11 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.42 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 71.54 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 74.23 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 73.13 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 73.15 110.535 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 74.11 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 74.24 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.22 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 74.3 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 63.24 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 74.14 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 74.41 109.58 171.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.507 HG23 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.11 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.43 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.45 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.45 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.542 173.243 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 12' ' ' TYR . 11.4 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 109.546 -0.538 . . . . 72.24 109.546 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.562 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 71.02 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 75.5 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 64.13 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 74.23 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.32 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 75.12 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.34 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.46 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 73.34 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.34 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.538 ' HE3' HG23 ' A' ' 62' ' ' THR . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.15 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.42 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 31' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 74.11 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.54 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.01 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.15 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 55.35 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.11 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 112' ' ' LEU . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.31 110.724 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.31 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 73.14 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.33 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 72.02 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.12 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 73.34 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.21 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.41 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.41 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.41 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.519 ' H ' HG21 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.45 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.544 ' H ' HG12 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 73.42 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 74.5 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 74.2 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.24 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.41 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.42 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 74.34 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.14 110.39 -178.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.349 0.5 . . . . 74.42 112.349 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 73.21 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.44 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.14 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 74.43 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG21 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 74.44 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.23 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 74.54 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 74.55 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 75.44 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.538 HG23 ' HE3' ' A' ' 20' ' ' MET . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 73.4 111.292 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.31 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 64.51 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 73.42 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 73.25 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.14 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 71.52 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.35 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 75.03 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.15 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.24 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.54 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.41 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.13 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.44 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.33 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.587 ' HG2' HG21 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.55 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 75.41 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 74.15 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 71.05 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 73.43 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 72.55 109.949 177.14 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.215 -0.661 . . . . 75.51 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.5 ' HG2' HG21 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.4 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.11 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.32 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 64.13 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 75.41 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.04 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 71.21 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 74.21 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.34 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 54.43 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 73.04 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.42 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 73.11 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.45 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.1 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.52 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.34 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 72.33 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.55 110.722 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 75.14 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.15 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.441 HD23 ' HB1' ' A' ' 102' ' ' ALA . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.14 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.12 109.259 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.53 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 74.2 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.14 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.53 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.491 ' O ' HG22 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.15 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.12 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.44 113.383 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.02 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.3 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 121' ' ' GLY . 29.2 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.23 110.903 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.41 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.52 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 53.31 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.24 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.43 108.505 176.439 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.4 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HA ' HD13 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.44 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 75.0 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 64.11 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 135' ' ' PRO . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.34 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.33 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.4 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 72.32 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.31 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.42 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 74.43 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.23 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.429 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.42 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.477 HG12 HG21 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.44 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.427 HG12 ' HE1' ' A' ' 58' ' ' MET . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.41 108.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.41 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.32 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.43 108.499 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 75.44 111.604 -179.438 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 71.11 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 74.22 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.11 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.33 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.33 111.629 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.02 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.1 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 55.51 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.22 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.14 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 71.4 109.699 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.04 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.52 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.31 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.44 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 64.35 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 63.31 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.22 113.647 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.12 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.33 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.22 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.35 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 74.11 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 73.5 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.31 111.154 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 75.14 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.34 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 75.32 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.43 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.04 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.51 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.472 ' H ' HG12 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.02 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.44 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 74.51 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.41 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.11 109.91 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 74.25 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 HD21 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 75.23 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 75.03 110.351 174.45 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HD2' HD21 ' A' ' 47' ' ' LEU . 45.1 mmtm . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.43 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 75.22 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.43 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB3' HG22 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 75.23 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.2 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.54 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.482 ' HE1' HG12 ' A' ' 149' ' ' ILE . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.34 110.169 175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.33 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.5 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 73.42 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.22 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.45 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 73.3 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 73.3 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.32 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.42 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.52 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 75.34 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 74.41 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 72.44 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 75.01 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.51 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.43 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 70.11 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 65.22 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 73.42 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' HG21 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 75.33 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 73.55 111.354 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.04 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.23 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.42 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.21 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 75.34 109.677 178.714 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 114.196 1.184 . . . . 73.21 114.196 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 75.51 110.052 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 74.35 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.05 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.51 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 72.22 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.13 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 65.22 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 74.23 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.14 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.21 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.4 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.45 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.32 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 64.52 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 74.04 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.42 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 75.15 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.03 110.741 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 55.44 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 64.44 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 75.2 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.35 109.784 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.32 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 75.34 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.44 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.11 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.34 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 73.12 111.088 174.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 74.32 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.45 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.487 HE21 ' HA2' ' A' ' 121' ' ' GLY . 24.4 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.42 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.43 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 70.42 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.43 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.02 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.43 109.252 177.216 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 119.135 -0.46 . . . . 70.15 111.331 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.457 ' HA ' HD13 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 75.41 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.35 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.523 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.15 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 73.14 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 62.2 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.23 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 73.43 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.41 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.2 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.22 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.4 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 74.51 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.23 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.482 HG12 ' HE1' ' A' ' 58' ' ' MET . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 73.13 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 71.21 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 73.14 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.2 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 73.25 111.82 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.622 0.248 . . . . 73.2 111.416 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 73.45 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.33 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.15 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.11 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 74.2 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 74.44 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.34 110.022 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 70.43 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.4 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.23 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.43 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 71.03 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 72.32 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 71.31 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 74.4 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.12 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.497 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.31 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.14 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 74.13 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.3 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 72.34 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 71.03 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.53 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.12 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.1 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.433 ' H ' HG21 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 70.32 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 74.3 111.338 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 75.11 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' HG3' HD23 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.53 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.32 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 64.12 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.528 HG12 HD13 ' A' ' 32' ' ' ILE . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.02 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 75.21 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.14 110.988 176.598 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.362 0.601 . . . . 74.5 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 72.54 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 72.22 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.42 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 75.5 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.448 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 74.11 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.41 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 75.42 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.33 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 74.32 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.33 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 74.32 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.44 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.02 110.15 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.51 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.03 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 73.31 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 74.42 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 75.23 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 74.32 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 74.14 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.51 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 74.01 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 74.52 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.04 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.22 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.34 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 74.51 110.945 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 74.53 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.03 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 72.1 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.21 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 74.13 111.887 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 119.305 -0.378 . . . . 74.35 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.04 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 73.2 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.44 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 74.31 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 65.02 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.32 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.33 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 72.35 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.15 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 73.01 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.11 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.41 111.306 177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.42 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.14 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 63.22 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 62.23 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 75.12 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 73.4 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.44 110.744 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.14 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.34 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 75.23 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 74.44 109.045 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 73.42 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.41 113.135 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 74.0 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.55 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.33 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.31 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.32 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.02 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 138' ' ' LEU . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 73.44 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.466 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 73.13 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.21 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 71.5 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.13 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.505 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.23 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 . . . . . 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 73.14 109.84 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.23 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD13 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 71.5 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 75.31 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.22 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 135' ' ' PRO . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.35 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 72.42 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.23 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.04 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.42 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 31.22 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.02 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 74.43 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 73.44 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.448 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 75.32 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.405 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 55.41 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.44 108.984 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 74.35 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.42 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.41 109.999 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.5 HD21 HD13 ' A' ' 46' ' ' ILE . 55.5 mt . . . . . 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 65.45 110.831 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.128 0.49 . . . . 72.34 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.13 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.12 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.4 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 74.22 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.34 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.34 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 62.01 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.54 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.13 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.53 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.12 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.41 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.32 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.41 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.561 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 62.01 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 70.24 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 52.41 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 63.35 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.32 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.22 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.11 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.545 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.2 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.11 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 72.03 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.1 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.22 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.1 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 73.04 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 74.3 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.43 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.461 ' H ' HG11 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.51 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.51 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.34 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.24 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 71.13 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 73.42 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.52 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 61.54 110.405 175.764 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 112.206 0.447 . . . . 71.03 112.206 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 73.54 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 70.23 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HB3' HG21 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 75.42 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 73.21 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.43 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 62.31 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 73.2 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.12 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 74.22 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.41 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.51 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 74.5 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.24 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.31 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.31 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.43 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.22 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.21 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.414 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.13 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 64.31 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.42 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 70.21 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 75.4 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.589 HG21 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 74.34 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.33 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 71.4 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HG2' HG21 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.23 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 74.52 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 73.24 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.42 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.12 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.24 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 63.44 112.721 -173.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.45 109.698 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 62.42 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 65.31 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.51 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.43 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.41 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 54.55 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.21 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 75.43 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.21 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 72.35 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 73.42 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.24 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.23 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 74.42 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 70.14 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 61.42 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.1 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.54 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 75.21 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.13 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 74.22 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.43 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.11 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 72.42 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.3 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.2 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 74.22 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.444 ' O ' HG21 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.34 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.3 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.14 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.31 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 71.15 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 62.03 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 74.53 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.41 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.3 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB3' HD13 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.04 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.33 110.414 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 . . . . . 0 CA--C 1.556 1.207 0 CA-C-O 119.032 -0.509 . . . . 75.54 110.225 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.45 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.32 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.493 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.44 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.02 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 75.11 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.34 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.33 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.31 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 64.05 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.54 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.14 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.52 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.53 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 64.24 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.4 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.41 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.23 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.33 109.743 167.611 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 11' ' ' THR . 9.7 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.589 -0.893 . . . . 72.55 108.589 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 72.12 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.23 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.21 112.218 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.23 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.21 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.11 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.3 111.763 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 61.44 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.459 ' HE1' HG23 ' A' ' 62' ' ' THR . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 73.11 112.177 177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 64.33 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 74.01 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 73.22 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.34 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.15 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 74.44 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.05 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.04 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.34 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 75.45 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 73.12 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.21 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 74.32 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.02 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 72.33 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 74.33 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 72.33 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 60.15 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.33 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.45 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.15 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.34 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 71.01 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.11 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.4 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 42' ' ' PHE . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.13 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.53 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 71.01 111.541 179.805 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 120.873 0.368 . . . . 75.32 111.504 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 75.22 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 73.45 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.53 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 71.54 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.476 ' HE3' HG21 ' A' ' 66' ' ' VAL . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 73.32 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.24 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 71.12 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 74.23 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 20' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 75.34 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.35 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.53 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 64.22 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 58' ' ' MET . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 74.15 112.115 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.42 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 73.32 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.42 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.42 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 73.23 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.33 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.3 110.187 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.23 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.23 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.32 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 74.34 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.515 ' HG2' HG21 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 75.1 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 71.55 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 74.12 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.02 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.32 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 73.0 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 74.53 110.243 176.624 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 119.029 -0.51 . . . . 72.2 110.926 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 72.33 112.568 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 75.31 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.32 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.23 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.545 ' HE3' HG23 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 74.04 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.31 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.24 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 75.5 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.41 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 65.41 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.23 110.665 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 74.43 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.2 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 75.13 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 52.33 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 71.41 109.36 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 73.4 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 75.01 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.1 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.54 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 73.45 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.459 ' N ' HD13 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 75.12 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.23 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 72.54 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.508 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 75.21 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 73.12 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 75.22 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.32 111.641 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.488 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 70.52 111.365 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.11 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 71.4 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.488 HE21 ' HA2' ' A' ' 121' ' ' GLY . 27.8 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 73.42 111.844 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 74.32 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 74.4 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.42 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.33 112.354 -174.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 . . . . . 0 CA--C 1.562 1.406 0 CA-C-O 118.777 -0.63 . . . . 64.24 110.779 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.42 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.421 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 74.44 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.573 ' HB3' HG23 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 72.44 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.33 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.465 ' HG3' HG13 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 73.13 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 72.4 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.32 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.42 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.11 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.545 HG23 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 74.4 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.22 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.51 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 75.34 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 HD13 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.53 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.14 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.1 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.23 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 75.14 112.807 178.764 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 108.62 -0.881 . . . . 70.25 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.01 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.01 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.54 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 73.34 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.52 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.32 110.613 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 56' ' ' LEU . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 72.32 111.062 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 71.13 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 75.43 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.53 109.969 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.43 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 61.12 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 74.41 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.54 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 73.33 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.51 111.675 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.454 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.4 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 73.41 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.13 111.199 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.03 110.117 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.21 107.44 174.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 73.43 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.13 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 72.53 109.453 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 75.32 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 70.23 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 73.43 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 71.32 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 65.14 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 73.41 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.31 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.51 111.477 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 73.33 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.43 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.469 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.52 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 72.51 113.106 -170.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.17 0.509 . . . . 74.42 110.83 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 72.2 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.44 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 17' ' ' ALA . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.22 109.365 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 72.33 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.42 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.43 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.1 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 74.41 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.31 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.04 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 73.4 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.31 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.33 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.03 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.52 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.44 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.33 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.11 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 72.54 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.43 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.34 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.53 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 75.53 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.54 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.22 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.45 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.14 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.23 111.85 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 71.12 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.14 111.94 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.11 109.873 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.13 111.332 179.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 73.45 109.444 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 72.5 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 73.13 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 75.14 107.934 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 74.43 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 75.34 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 64.53 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 73.14 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 73.44 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 74.12 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 72.33 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 72.22 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.31 111.172 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 74.32 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 60.12 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.54 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.1 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 73.2 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 75.34 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 71.13 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 74.03 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.33 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 75.31 113.016 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 75.05 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.41 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.12 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.45 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 72.43 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.32 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.01 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.1 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 72.43 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.24 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 73.33 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 27.6 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.45 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 72.52 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 71.13 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 75.14 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 74.04 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 . . . . . 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 70.01 110.906 -179.093 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 112.212 0.449 . . . . 75.24 112.212 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.35 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.11 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 73.34 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.544 HD11 ' HA ' ' A' ' 135' ' ' PRO . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.43 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.35 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 74.31 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.14 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.501 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.3 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 54.33 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 71.11 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 75.15 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.11 109.175 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.32 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 73.51 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 71.41 109.744 170.85 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.652 0.739 . . . . 65.03 111.613 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 74.03 114.303 -163.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.53 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 54.13 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.34 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 75.51 110.896 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 74.41 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.44 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 72.41 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 72.43 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 70.43 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 64.02 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.2 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.11 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.23 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 75.3 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.42 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.33 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 71.04 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.41 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.42 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.536 ' NH2' HD11 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.24 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.471 HG13 HG12 ' A' ' 33' ' ' VAL . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 74.24 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 75.51 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.43 109.462 171.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 74.12 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.12 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.41 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.21 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 73.55 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 72.3 111.423 -177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 74.52 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 73.24 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.14 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 32' ' ' ILE . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.21 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.53 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.32 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.43 111.142 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 75.14 110.352 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 74.14 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.1 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.42 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 71.41 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.438 ' HE2' HG21 ' A' ' 66' ' ' VAL . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 70.32 110.425 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 52.13 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.13 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.33 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 73.15 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.41 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.42 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.51 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.492 HG11 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 75.23 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 74.44 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 71.22 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 75.42 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 65.34 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.35 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.54 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.33 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.52 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 71.01 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.43 109.602 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 74.22 111.876 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 74.42 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 54.53 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.11 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 71.03 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.15 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.41 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 74.23 109.647 -177.563 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 119.476 -0.297 . . . . 75.01 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 75.12 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.54 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 74.11 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.13 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 62.3 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.55 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.4 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 74.55 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.05 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.45 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 70.31 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 72.4 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 71.35 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 71.52 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.24 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.15 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 75.43 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.24 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.13 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.32 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.33 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD22 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 72.31 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.42 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.33 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 74.34 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.31 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 74.04 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 64.13 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 74.11 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 74.42 111.639 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.11 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.53 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 73.54 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.03 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.02 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.1 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 74.13 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 74.13 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 73.22 110.817 -176.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.55 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.23 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 74.34 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.33 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.41 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.54 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 74.11 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.13 109.242 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.34 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.31 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.14 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.4 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 73.23 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.3 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.03 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 74.42 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.11 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 71.34 109.444 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.44 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.44 112.773 -178.47 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 11' ' ' THR . 1.6 m . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 109.451 -0.574 . . . . 72.22 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.12 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.41 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 75.22 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.52 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.34 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.21 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB1' HD22 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.14 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 74.52 111.27 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 72.51 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.21 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.55 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 65.43 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.53 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.24 108.589 169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.43 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.21 110.458 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 74.1 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 73.31 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.03 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.11 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.41 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.4 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.41 111.517 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.51 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 63.54 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 75.44 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 73.12 109.427 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.53 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 75.33 109.93 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.04 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 74.4 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.52 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.34 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 73.23 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.32 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 75.52 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.3 111.154 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.575 0.702 . . . . 75.32 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 73.4 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 72.34 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.22 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.498 HD22 ' HB1' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.23 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.22 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 63.32 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 75.14 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.21 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 74.03 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.21 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.14 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 75.13 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.54 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.44 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 74.5 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.1 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 75.21 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.43 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.23 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 73.23 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 72.54 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.42 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 74.15 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 70.22 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.13 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 71.53 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 73.24 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.21 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.54 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 75.53 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.3 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.41 110.766 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 72.43 110.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 74.11 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 75.13 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 75.33 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 75.42 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 74.24 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.24 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.01 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.34 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.45 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.43 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.31 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.12 111.148 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.32 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.43 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.12 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.44 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 74.32 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 75.43 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 75.31 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.22 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.34 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.56 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 73.1 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 64.43 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 72.51 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 71.42 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.42 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.517 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.44 111.486 -175.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 74.54 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . 0.464 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.22 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 73.15 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.41 112.924 174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.464 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.4 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 72.22 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.495 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 29.7 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 73.02 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 72.14 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.02 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.11 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 63.14 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 74.41 109.749 172.033 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.984 -0.532 . . . . 65.32 112.149 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.429 ' HA ' HD11 ' A' ' 138' ' ' LEU . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.15 114.439 176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 74.14 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 73.32 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HB3' HG22 ' A' ' 123' ' ' VAL . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.22 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.43 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 74.31 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 75.41 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 75.53 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.05 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 73.32 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.02 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 73.45 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 74.13 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 74.32 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.23 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.41 108.56 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 72.52 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 75.3 111.506 -179.405 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 112.016 0.376 . . . . 72.11 112.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.95 -6.47 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.693 0.797 . . . . 72.43 111.306 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 150.13 29.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 124.616 1.167 . . . . 73.5 111.876 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.53 67.09 1.62 Allowed 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.756 2.97 . . . . 75.44 113.942 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.05 49.69 54.49 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 115.058 0.783 . . . . 44.52 115.058 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.82 89.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-O 121.42 0.629 . . . . 74.44 111.119 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.53 85.31 2.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.26 1.024 . . . . 65.23 109.744 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -162.77 147.22 11.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.77 1.228 . . . . 70.45 107.732 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' HB3' HE22 ' A' ' 151' ' ' GLN . 24.4 tp -68.94 118.14 11.49 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.496 -0.927 . . . . 72.43 108.496 172.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -77.18 174.56 10.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.748 1.219 . . . . 75.42 112.663 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.02 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.53 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.43 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' HB2' ' HH ' ' A' ' 24' ' ' TYR . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 65.22 111.216 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 74.23 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.22 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 75.11 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 72.03 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 70.23 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.524 ' HE3' ' HA ' ' A' ' 62' ' ' THR . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 75.42 110.138 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 63.14 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.45 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 75.24 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.523 ' HH ' ' HB2' ' A' ' 14' ' ' SER . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 74.22 108.264 169.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 72.1 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.44 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 74.33 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.33 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 71.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.42 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 74.25 110.603 -176.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 74.2 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 73.32 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 71.01 111.389 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.04 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.04 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.41 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 72.24 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 75.3 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 61.55 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.44 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.24 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 75.33 110.312 -174.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.52 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 62.23 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.43 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.03 112.86 -174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -67.04 -38.45 85.87 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.53 110.437 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -100.11 170.13 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.727 0.811 . . . . 75.31 110.139 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.34 31.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.363 0.665 . . . . 73.14 110.425 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.79 86.26 5.38 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.316 1.055 . . . . 74.32 109.738 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.99 77.21 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.58 -1.191 . . . . 73.13 112.586 -170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.41 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 64.13 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.42 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 72.44 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.44 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 74.4 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.23 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.03 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 74.15 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.524 ' HA ' ' HE3' ' A' ' 20' ' ' MET . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 73.04 110.335 170.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 74.11 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.5 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.42 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.548 HG12 ' HB3' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 73.31 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.13 112.106 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.51 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.23 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.44 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.11 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 64.1 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 72.14 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.32 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 72.43 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 72.24 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 75.14 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.43 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.534 ' HG2' HG21 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 74.23 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.41 111.6 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.43 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 73.5 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 74.35 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -82.21 126.74 32.43 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 72.43 110.669 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.642 HD21 ' HD3' ' A' ' 91' ' ' PRO . 27.5 t-20 -80.91 84.19 6.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.657 -0.868 . . . . 74.22 108.657 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -133.9 124.97 27.34 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.854 -0.795 . . . . 74.04 108.854 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.27 -55.07 4.94 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.087 -0.506 . . . . 74.35 112.053 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -172.92 3.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.78 1.232 . . . . 71.3 108.593 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.453 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 96.9 mtt180 -62.03 156.53 57.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 124.045 0.938 . . . . 72.24 112.099 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.642 ' HD3' HD21 ' A' ' 86' ' ' ASN . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 65.53 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 73.23 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.541 HG23 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.21 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HE3' HG22 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.12 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.14 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 75.31 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.11 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.11 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.05 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.44 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 74.32 110.818 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.42 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.51 111.128 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.2 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.54 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.24 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 73.24 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 72.15 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 73.24 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 61.3 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.21 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.35 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.32 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 74.33 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.44 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' O ' HG21 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.44 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.05 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.24 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.44 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.13 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 64.32 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.34 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.21 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 74.3 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 63.01 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -143.79 9.53 1.54 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 71.34 108.891 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.9 p-10 -108.34 75.79 1.0 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.563 1.145 . . . . 70.02 109.29 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.99 1.9 2.5 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.985 1.314 . . . . 75.35 113.685 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.24 51.66 1.32 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 117.792 0.269 . . . . 52.34 112.915 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.487 ' HD2' HD22 ' A' ' 138' ' ' LEU . 58.0 ttm-85 -89.82 140.7 29.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.597 0.759 . . . . 75.53 109.955 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 -73.14 142.3 82.18 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 122.934 0.493 . . . . 64.03 110.527 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 71.35 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 74.02 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 135' ' ' PRO . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 72.12 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.1 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 75.54 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.42 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 73.05 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.42 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.33 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.478 HG22 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 74.24 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.23 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 73.33 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.453 HG21 HD22 ' A' ' 9' ' ' LEU . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.54 109.522 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 70.21 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.581 HE22 ' HB3' ' A' ' 9' ' ' LEU . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.11 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 74.03 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.49 178.46 1.6 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 75.41 111.163 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.37 -62.99 1.31 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.743 1.217 . . . . 73.41 109.773 -168.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -83.32 132.15 35.03 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.068 -0.969 . . . . 63.32 108.691 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -170.21 177.84 4.05 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.153 0.981 . . . . 71.53 109.049 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -69.69 139.8 53.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.226 0.536 . . . . 74.01 110.701 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -144.27 162.51 36.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.569 1.148 . . . . 73.14 109.453 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.92 112.9 6.66 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.782 -0.821 . . . . 64.0 108.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.119 1.368 . . . . 75.34 109.717 -175.621 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 111.78 0.289 . . . . 71.24 111.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -102.49 12.47 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 122.985 0.514 . . . . 73.01 111.2 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.99 148.31 98.4 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.18 0.592 . . . . 74.14 110.645 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -51.27 157.04 4.84 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.2 2.6 . . . . 74.04 113.804 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.73 80.35 0.12 Allowed Glycine 0 C--N 1.348 1.22 0 O-C-N 123.7 0.625 . . . . 73.31 112.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.28 142.62 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.472 1.109 . . . . 74.01 109.264 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 132.57 41.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 122.756 0.423 . . . . 72.31 110.893 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 4.0 tppp? -74.31 -14.8 60.94 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.302 0.641 . . . . 74.11 110.12 171.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 tp -54.82 124.39 16.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.391 1.076 . . . . 72.53 110.939 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m -135.12 -174.55 3.64 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.53 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 75.11 111.408 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 72.44 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 75.04 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 73.34 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.53 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.12 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.42 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 74.24 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 65.31 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 60.05 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 73.45 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' HE2' HD22 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.43 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 74.32 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 74.04 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.1 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.45 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.14 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.41 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG22 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 74.12 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.568 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.22 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.41 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.56 HD22 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 74.31 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.43 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 73.43 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 74.43 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.3 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 74.21 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 74.32 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 71.42 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 71.14 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 72.53 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 74.55 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -76.01 -25.58 55.85 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 73.32 111.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 80.4 mm-40 -74.85 161.57 29.44 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.84 0.456 . . . . 75.41 111.549 -175.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.23 63.7 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.309 -0.86 . . . . 72.34 111.405 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -111.09 170.77 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.105 0.962 . . . . 75.14 109.374 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -125.18 23.95 7.55 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 75.31 111.617 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 73.13 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 65.23 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.33 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.54 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 63.33 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 75.45 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.02 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.03 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.33 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.4 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 75.22 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.44 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.43 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.13 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.3 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.12 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 73.11 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 64.45 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 75.22 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 70.54 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.42 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.54 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 73.44 106.251 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 74.2 111.874 -166.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 74.43 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 75.51 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.45 110.669 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 71.34 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.3 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.21 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.31 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.42 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 27.1 mm-40 -70.22 113.19 7.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.34 110.529 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -99.39 91.1 4.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.276 1.03 . . . . 73.41 108.881 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 85' ' ' GLU . 49.6 mtmt -127.1 -72.68 0.63 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.793 0.837 . . . . 72.12 109.972 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.29 -38.46 4.53 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 110.907 -0.877 . . . . 73.45 110.907 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -109.95 159.06 17.59 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.388 1.075 . . . . 72.14 109.95 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 -74.87 145.66 81.68 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 72.14 108.029 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HB2' HG21 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.43 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.21 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.54 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 73.52 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 73.42 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.12 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 71.22 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 113' ' ' VAL . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.24 110.868 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.33 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.23 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 73.33 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.42 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 75.01 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.01 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.13 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.31 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.24 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 71.1 109.1 176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 73.24 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.51 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.51 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 HD22 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 73.31 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.412 ' N ' HD13 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.35 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.22 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.15 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 74.13 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.52 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.53 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.458 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 71.54 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.14 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.586 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.04 112.226 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.02 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.24 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.586 HE21 ' HA2' ' A' ' 121' ' ' GLY . 28.2 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.43 110.869 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.24 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.44 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.1 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.31 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -149.19 29.42 0.8 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 72.52 109.536 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.71 -89.23 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.978 0.511 . . . . 75.1 111.339 -172.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -118.58 0.99 11.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.089 0.556 . . . . 71.14 110.643 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.71 116.45 0.74 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.301 -0.72 . . . . 71.51 111.301 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.476 ' HD3' ' H ' ' A' ' 134' ' ' ASP . 14.7 tpp180 -161.02 137.69 8.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.989 0.516 . . . . 73.42 110.213 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' H ' ' HD3' ' A' ' 133' ' ' ARG . 3.1 m-20 -56.98 134.88 80.09 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.843 1.257 . . . . 70.23 110.788 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.43 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.01 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 73.2 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.529 ' HB3' HG21 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 74.12 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.04 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 74.25 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.441 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 74.43 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.33 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 71.22 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 74.34 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 75.24 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 74.4 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.13 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.32 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.23 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 71.52 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HA ' HG22 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 65.25 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.31 156.23 22.83 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 74.31 111.031 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.425 ' HG3' ' CD2' ' A' ' 155' ' ' HIS . 7.0 pt-20 -60.33 -29.09 68.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.154 0.981 . . . . 72.23 113.36 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' CD2' ' HG3' ' A' ' 154' ' ' GLU . 90.2 m-70 -83.59 79.07 9.56 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.733 0.778 . . . . 75.32 111.712 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -135.68 140.29 44.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.627 1.171 . . . . 71.45 108.319 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -128.16 147.14 50.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.741 0.816 . . . . 75.33 109.195 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -73.68 108.7 6.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.781 0.433 . . . . 74.22 109.868 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.56 140.95 53.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.869 0.868 . . . . 71.31 111.285 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.546 1.138 . . . . 73.23 108.038 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.639 ' HG3' HG11 ' A' ' 53' ' ' VAL . 24.6 ttt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.689 0.281 . . . . 74.11 110.517 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.33 92.26 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.359 -0.978 . . . . 74.22 108.359 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 5' ' ' GLY . 6.1 mt-10 -73.63 156.3 88.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.078 0.551 . . . . 73.21 111.198 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.09 -13.42 23.62 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.672 2.248 . . . . 73.33 111.57 161.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 3' ' ' GLU . . . 94.31 56.11 1.4 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.762 -0.653 . . . . 72.53 112.235 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.86 -48.84 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.032 0.533 . . . . 73.42 110.142 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.25 33.41 2.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.252 1.421 . . . . 61.24 112.476 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.57 88.59 1.26 Allowed 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.945 0.878 . . . . 75.21 110.475 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 149' ' ' ILE . 57.0 tp -149.58 123.1 9.11 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.841 -1.911 . . . . 74.54 105.841 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p -65.99 145.47 55.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.219 0.608 . . . . 75.33 111.374 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.01 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.21 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 74.23 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 73.23 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 72.44 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 70.43 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 73.12 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.02 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.44 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.469 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 74.24 111.597 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 75.41 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 75.15 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 75.51 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 74.53 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 74.15 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 71.21 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 74.54 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.14 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.42 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 73.04 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 70.23 111.151 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.33 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 74.21 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.3 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 73.44 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 62.34 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.51 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.5 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.21 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.417 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 73.21 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 75.44 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.23 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 70.14 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.21 110.966 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 75.22 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.435 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 72.44 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -66.17 -30.09 70.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 75.31 110.078 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.26 161.02 16.62 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.606 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -22.97 49.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.176 -0.676 . . . . 73.32 109.176 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.88 98.59 3.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.782 1.233 . . . . 65.12 109.249 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 46' ' ' ILE . 1.2 mptm? -86.9 54.94 3.35 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 74.13 109.873 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG11 ' HG3' ' A' ' 1' ' ' MET . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 72.34 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.04 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.31 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.4 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.43 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.44 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.24 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.14 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.402 HG23 ' HE3' ' A' ' 20' ' ' MET . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.13 110.244 175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.31 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 74.32 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.469 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.22 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 73.24 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.12 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.33 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.42 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 74.0 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.5 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 74.22 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 70.22 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.01 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.14 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.508 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 64.15 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.31 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.2 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 73.42 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 70.34 111.5 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 73.32 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.04 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 73.54 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -76.3 142.1 41.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.11 110.18 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -77.18 79.01 3.71 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.097 -0.705 . . . . 70.12 109.097 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.97 157.07 41.59 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.091 0.956 . . . . 74.24 110.126 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.56 -82.95 0.47 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.159 -0.777 . . . . 72.35 111.159 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -132.15 -49.86 0.94 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.315 1.046 . . . . 75.21 109.38 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.531 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 -157.31 146.02 14.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.713 0.805 . . . . 75.4 109.8 -170.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 71.25 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.52 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.01 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 72.03 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.23 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 34.24 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 70.01 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 74.22 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.3 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 73.45 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.55 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB1' HD22 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.13 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 74.42 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.34 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.531 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.11 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.472 HD13 HG23 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 72.41 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.12 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.31 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.2 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 73.12 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.534 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 75.43 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 74.13 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.24 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.534 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.13 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 74.44 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.13 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 71.41 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.447 ' O ' HG21 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.35 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.33 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.421 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.24 112.415 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HE2' ' HB2' ' A' ' 130' ' ' ASP . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.42 112.221 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.04 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.421 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.3 111.53 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 74.1 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.31 112.797 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 74.2 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 73.41 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -112.34 -53.74 2.68 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.3 108.751 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' HB2' ' HE2' ' A' ' 122' ' ' TYR . 5.7 m-20 -88.87 76.26 7.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.108 -1.071 . . . . 73.44 108.108 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.8 p90 22.53 72.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 127.044 2.138 . . . . 74.24 114.164 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -100.12 -114.04 3.6 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.292 -0.867 . . . . 74.14 111.37 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -167.19 -169.92 1.38 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.43 1.092 . . . . 73.31 109.672 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.71 144.04 36.56 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 124.003 0.921 . . . . 72.43 112.404 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.04 113.828 -175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.12 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 75.3 110.454 175.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.24 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 71.12 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.34 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.58 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 72.45 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 73.13 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.31 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 72.23 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.41 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 75.13 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 73.02 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.472 HG23 HD13 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.11 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.57 HG21 HD22 ' A' ' 9' ' ' LEU . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.03 109.778 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.31 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 75.24 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.404 ' NE ' ' HB2' ' A' ' 3' ' ' GLU . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 73.24 109.935 174.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt -60.64 159.16 11.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 74.35 112.204 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.93 157.08 29.05 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.74 0.781 . . . . 64.22 111.44 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -116.82 95.6 5.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.842 -1.072 . . . . 73.41 108.125 -168.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -85.28 95.26 9.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.687 -0.688 . . . . 75.12 109.4 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -124.99 129.13 49.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.043 0.937 . . . . 73.21 109.998 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -80.61 70.64 7.38 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.026 -0.731 . . . . 74.44 109.026 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -164.81 173.04 12.19 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.842 1.657 . . . . 75.15 109.01 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 176.329 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 119.896 -0.097 . . . . 72.53 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.91 -7.98 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.153 0.581 . . . . 71.34 111.738 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -64.19 149.92 93.35 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.655 1.182 . . . . 73.0 110.759 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.59 21.12 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.949 2.432 . . . . 75.35 112.896 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.84 -68.77 0.29 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.623 -0.991 . . . . 73.22 110.623 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t 71.43 -59.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.14 1.776 . . . . 75.35 112.671 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.92 121.22 10.01 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.203 1.001 . . . . 72.12 113.233 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.1 134.67 33.22 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.819 0.848 . . . . 73.55 109.39 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -82.5 122.47 28.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.914 0.486 . . . . 75.32 109.944 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m -110.3 151.31 27.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.772 0.829 . . . . 74.03 109.122 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 74.01 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.33 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HB3' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.04 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.21 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 74.23 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 74.23 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.01 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.54 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 75.22 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 73.44 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 73.01 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 74.32 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 63.43 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.543 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.55 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.53 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.44 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.32 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 64.11 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.11 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.42 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.685 ' HD2' HG22 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 75.21 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.437 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 73.34 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.43 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.5 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB2' HH11 ' A' ' 133' ' ' ARG . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.51 108.102 -173.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.543 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 75.32 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.3 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG12 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.32 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 75.11 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 74.12 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.426 ' H ' HG12 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 75.14 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 74.12 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.22 111.334 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.24 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.13 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.45 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 64.53 111.354 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.12 -35.38 75.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 74.43 111.784 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' A' ' 46' ' ' ILE . 1.8 mp0 -77.15 151.53 35.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.362 0.665 . . . . 72.54 111.155 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.33 -65.14 0.72 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.338 -0.846 . . . . 74.34 108.734 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.01 119.29 19.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.386 -0.968 . . . . 74.43 108.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -74.08 85.61 1.83 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.22 111.96 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 72.32 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.486 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.2 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 75.45 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.52 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.53 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 72.32 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 63.14 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.11 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 75.22 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.405 HG21 ' HE3' ' A' ' 20' ' ' MET . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.01 110.478 176.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 75.44 112.657 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.14 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.51 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 75.23 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 74.11 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.04 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.12 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 74.24 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 73.33 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.44 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 71.34 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 74.41 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 74.12 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.499 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.4 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 54.22 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 73.43 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.499 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.24 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 72.22 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.537 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.12 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 73.35 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.24 111.182 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.537 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.51 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 -72.28 -30.83 65.21 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.42 109.532 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 57.15 66.59 1.13 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.656 1.582 . . . . 74.41 111.154 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -91.44 3.58 54.6 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.694 -1.139 . . . . 72.34 110.365 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.93 -101.76 0.65 Allowed Glycine 0 C--N 1.359 1.836 0 N-CA-C 111.111 -0.796 . . . . 74.12 111.111 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -143.96 -61.69 0.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.032 0.933 . . . . 72.43 109.404 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -121.0 133.31 24.12 Favored Pre-proline 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 74.13 106.061 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.22 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 75.22 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.12 108.124 172.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.32 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.53 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.24 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.45 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.3 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.51 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.14 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.41 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.23 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.52 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.33 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.35 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 63.41 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.51 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 75.31 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 75.51 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.44 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.24 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.568 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.11 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.04 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 70.05 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.685 HG22 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.14 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 74.15 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.43 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 74.55 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.477 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.53 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 74.53 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.12 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.12 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.6 HG21 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.45 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.34 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 55.43 113.539 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.34 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.23 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -126.99 3.33 6.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.33 111.907 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -168.25 92.3 0.33 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.08 0.552 . . . . 63.1 110.874 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.6 p90 44.73 22.75 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.742 1.617 . . . . 75.42 115.017 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.5 -118.34 0.05 OUTLIER Glycine 0 C--N 1.347 1.182 0 O-C-N 123.463 0.477 . . . . 64.34 112.734 -173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.453 HH11 ' HB2' ' A' ' 35' ' ' GLU . 26.1 ptt180 -171.04 -177.92 2.33 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.373 0.587 . . . . 74.4 110.819 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 143.2 98.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 123.912 0.757 . . . . 70.44 110.979 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.1 116.253 170.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.41 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.32 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.6 ' HB3' HG21 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 65.43 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 73.21 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 75.14 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.4 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 64.2 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 71.04 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.52 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.15 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.12 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 73.23 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.54 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.42 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 74.5 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.461 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt -71.07 171.61 10.6 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.34 110.624 166.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.4 126.21 27.54 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.786 . . . . 72.25 111.304 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 m170 71.7 8.04 6.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.677 1.591 . . . . 75.44 112.378 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -85.26 64.92 8.94 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.619 1.199 . . . . 75.1 108.566 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -98.8 64.53 1.47 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.358 -1.292 . . . . 74.31 107.746 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -76.91 137.25 38.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.567 -1.197 . . . . 74.12 110.213 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -166.55 163.81 17.02 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.359 0.664 . . . . 74.01 109.818 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 107.897 -1.149 . . . . 74.04 107.897 170.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.651 -0.5 . . . . 73.32 109.651 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.32 90.02 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.059 -1.83 . . . . 74.41 106.059 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 67.41 162.03 0.14 Allowed Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 125.419 1.487 . . . . 75.32 111.561 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -56.66 167.84 2.65 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.32 2.013 . . . . 72.41 112.674 164.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.95 71.31 1.95 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.32 -0.4 . . . . 73.11 112.839 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.41 68.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.044 0.937 . . . . 74.23 110.444 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.22 144.52 44.68 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.561 -0.745 . . . . 73.4 110.86 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -85.54 8.06 20.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.045 0.938 . . . . 75.14 110.841 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.0 tp -59.28 113.92 2.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.355 1.062 . . . . 71.2 110.996 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m -121.97 162.9 20.26 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 65.23 107.618 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.32 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.21 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 74.11 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.02 111.785 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 65.51 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.3 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' HB3' HD23 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 75.41 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.11 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 61.43 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.1 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.13 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.35 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HH ' ' HB3' ' A' ' 14' ' ' SER . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.11 109.242 170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 75.41 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.55 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.41 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.14 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.43 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 73.31 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 73.4 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.645 HG23 HE21 ' A' ' 49' ' ' GLN . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.11 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 HG13 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 75.43 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.448 HD21 ' HD2' ' A' ' 131' ' ' PHE . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 70.01 112.159 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 74.2 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.14 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 74.5 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.23 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.32 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.44 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.13 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 74.11 111.478 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.52 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.4 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.512 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 71.52 111.195 173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 73.0 110.306 174.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.04 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -70.58 -36.63 73.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.44 110.645 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.645 HE21 HG23 ' A' ' 32' ' ' ILE . 10.6 mm-40 -81.82 177.87 8.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.485 0.714 . . . . 64.1 110.963 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.26 -54.84 14.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.555 0.742 . . . . 63.22 111.426 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -92.32 161.2 14.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.484 -0.78 . . . . 64.22 110.933 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' HB3' HD11 ' A' ' 153' ' ' LEU . 29.2 mmtp -105.9 32.76 4.15 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.102 0.961 . . . . 64.43 110.962 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.54 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 74.14 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 74.43 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.43 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 65.13 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 75.52 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.31 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.22 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 73.21 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.41 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.42 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 75.02 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 75.44 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 73.12 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.22 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.51 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 72.04 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 75.15 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.34 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 74.35 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 60.15 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.23 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.35 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.579 HG21 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.22 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 74.04 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.34 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG3' HG21 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.12 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 75.0 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 74.02 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 73.13 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.52 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.31 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -95.97 42.68 1.09 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.44 109.791 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -71.11 90.27 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.576 0.75 . . . . 75.32 110.009 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -87.38 76.76 9.03 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.61 -0.723 . . . . 74.23 109.496 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.18 -52.32 0.26 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.882 -0.887 . . . . 44.34 110.882 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.77 -176.81 3.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.827 0.851 . . . . 73.33 110.414 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -73.94 133.15 79.19 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.401 0.68 . . . . 75.22 109.863 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.531 ' HB2' HG23 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.52 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 72.03 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 73.54 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 74.02 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 74.33 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.44 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 75.32 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.51 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.14 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.24 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 72.22 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' HB2' HG23 ' A' ' 109' ' ' VAL . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 73.2 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 72.2 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.22 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 75.53 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.3 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.401 HG23 HD21 ' A' ' 112' ' ' LEU . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.14 109.23 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 102' ' ' ALA . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.35 110.879 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.55 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.04 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.57 ' HA ' HG21 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.13 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.459 ' N ' HD11 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 73.12 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 75.23 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.42 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.34 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 73.15 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.44 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.505 ' O ' HG22 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 74.21 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 71.23 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.434 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.23 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.518 HG13 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.43 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.434 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 73.41 111.6 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.22 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.31 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 75.22 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -143.99 15.6 1.73 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.12 108.099 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.44 -76.11 0.07 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.102 0.961 . . . . 72.2 109.111 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.448 ' HD2' HD21 ' A' ' 34' ' ' ASN . 75.8 m-85 -153.42 17.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.464 1.506 . . . . 71.42 108.794 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.86 50.37 4.67 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 116.035 -0.529 . . . . 74.03 113.051 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -79.42 -176.13 5.09 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.284 0.633 . . . . 71.51 109.912 172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 -90.77 143.7 29.25 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 74.52 109.053 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.45 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.24 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.459 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 72.41 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.22 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.21 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.518 ' HG3' HG13 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.41 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.13 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 74.51 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 73.33 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.3 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.11 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 75.42 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 73.44 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 71.41 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.43 108.821 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.35 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -66.72 143.35 57.0 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 72.34 110.346 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.46 167.38 20.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.506 0.669 . . . . 74.53 111.563 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -159.56 -28.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.542 -1.208 . . . . 74.35 110.117 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -142.87 106.73 4.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 74.44 110.806 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -157.58 103.05 1.91 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.716 1.206 . . . . 65.41 108.908 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -83.1 -27.66 30.04 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.248 0.619 . . . . 73.43 110.794 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -167.11 -164.33 0.61 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.723 0.809 . . . . 74.43 110.444 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 117.829 -1.081 . . . . 73.2 109.626 177.325 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.055 -0.721 . . . . 73.14 109.055 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 m -154.93 69.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.45 1.5 . . . . 74.14 107.936 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -87.13 158.36 52.75 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 114.902 -1.045 . . . . 73.11 109.874 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.56 163.18 1.92 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.908 2.405 . . . . 74.44 113.817 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.91 69.3 1.26 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 112.086 -0.406 . . . . 74.1 112.086 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.87 74.3 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.783 1.278 . . . . 74.43 110.251 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB2' ' NH2' ' A' ' 152' ' ' ARG . . . -149.76 76.57 1.3 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.453 -1.249 . . . . 73.34 110.034 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -133.73 -179.99 5.88 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.928 -1.033 . . . . 73.25 109.197 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 70' ' ' LEU . 43.4 tp -139.32 140.32 37.52 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.566 -1.272 . . . . 74.25 107.566 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -58.28 138.92 56.01 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.837 0.855 . . . . 75.42 111.07 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 75.0 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 74.13 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.14 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.34 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 65.33 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.12 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 71.15 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.52 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.34 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 65' ' ' LYS . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.43 110.767 -177.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 72.22 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.416 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.24 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.12 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.12 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.53 109.815 174.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 75.52 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 75.45 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 75.32 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 112' ' ' LEU . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.22 112.911 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.52 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 74.2 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.401 HG13 HG11 ' A' ' 33' ' ' VAL . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 73.21 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.401 HG11 HG13 ' A' ' 32' ' ' ILE . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.34 108.882 174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.644 HD21 ' HD3' ' A' ' 133' ' ' ARG . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 74.52 113.187 -173.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.44 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 63.14 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.53 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 74.5 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 73.54 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 70.55 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.14 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.3 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 74.52 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.4 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 72.41 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 73.22 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.24 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.91 -38.76 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 64.41 109.947 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -72.01 144.01 48.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.343 -0.614 . . . . 75.13 109.343 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.01 78.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.695 0.798 . . . . 53.25 110.853 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -81.44 131.11 35.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.323 0.649 . . . . 74.53 110.443 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm -94.08 66.87 3.59 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.197 0.999 . . . . 72.32 110.282 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 74.13 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 75.33 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 74.13 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 74.31 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 75.41 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 63.45 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.35 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 75.32 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.25 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.15 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.44 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.14 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 64.11 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 72.14 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.21 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.23 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 9' ' ' LEU . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.23 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 63.23 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 73.33 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 75.31 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.05 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.13 108.387 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 72.22 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.22 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.42 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.11 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.21 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.454 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 74.22 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 74.4 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 73.35 111.786 175.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 75.51 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.76 105.02 11.68 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 65.05 110.649 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.401 HD21 ' HD3' ' A' ' 91' ' ' PRO . 26.0 t-20 -74.55 92.36 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.798 0.839 . . . . 74.55 109.014 174.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -120.5 26.62 9.05 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 73.35 111.438 -173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.43 -44.81 0.62 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 111.492 -0.643 . . . . 65.0 111.492 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 8.5 mmpt? -122.16 172.18 8.45 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.968 0.907 . . . . 73.15 110.55 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -57.94 134.57 83.63 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 124.66 1.225 . . . . 75.3 110.881 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.401 ' HD3' HD21 ' A' ' 86' ' ' ASN . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.33 110.558 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.14 109.209 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 75.01 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 74.12 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.31 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 53.44 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 75.22 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.22 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 73.33 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 63.43 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 61.24 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 74.2 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.51 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 62.44 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 72.02 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.412 ' O ' HG21 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 75.21 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.3 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.43 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG21 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 74.35 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 74.13 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.05 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.475 HG21 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.11 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.34 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 74.33 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.41 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 74.31 109.654 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 72.21 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.2 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.14 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.15 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.415 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.406 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 72.3 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.21 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.24 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 74.51 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -126.33 -73.59 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.23 106.785 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.435 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 12.4 m-20 24.05 -88.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 126.013 2.07 . . . . 73.32 113.183 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -143.63 11.88 1.68 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 125.403 1.481 . . . . 75.35 109.359 171.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.32 104.06 1.66 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 111.857 -0.497 . . . . 74.23 111.857 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.644 ' HD3' HD21 ' A' ' 34' ' ' ASN . 28.1 ptt180 -152.99 -175.17 5.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.729 0.812 . . . . 74.33 110.592 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.94 143.58 70.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.095 0.558 . . . . 74.23 111.097 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 70.43 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 72.0 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.22 111.508 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 75.23 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 73.4 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.415 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.35 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.14 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.51 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 70.42 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.33 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 63.05 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.35 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.549 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 73.01 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.32 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 72.14 109.421 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.34 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.23 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.424 ' NH2' ' HB2' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.24 109.17 173.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.445 HD13 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -62.59 146.2 52.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.31 112.651 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -45.76 68.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.476 1.511 . . . . 73.25 111.887 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.417 ' HE2' HD12 ' A' ' 153' ' ' LEU . 15.8 p80 -74.46 93.48 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 122.248 1.023 . . . . 74.13 109.539 176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -79.96 163.99 23.84 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.717 -1.128 . . . . 74.21 111.179 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.8 m170 59.07 45.69 14.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.875 0.87 . . . . 65.22 108.817 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -63.7 118.8 8.79 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 115.208 -0.905 . . . . 72.13 112.122 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -101.51 10.04 40.74 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.649 1.179 . . . . 75.01 109.802 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.204 -1.776 . . . . 75.21 106.204 163.459 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.245 0.091 . . . . 64.3 111.245 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.92 60.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.292 -1.003 . . . . 75.22 108.292 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.36 165.09 13.33 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 114.831 -1.077 . . . . 62.53 109.096 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.86 2.18 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 121.777 1.651 . . . . 70.45 111.664 170.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.5 61.79 4.57 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.613 -0.267 . . . . 73.14 112.561 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' HB ' ' HE3' ' A' ' 8' ' ' LYS . 28.8 m -125.15 141.98 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.884 0.874 . . . . 75.14 109.575 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' HD3' ' A' ' 152' ' ' ARG . . . -159.8 109.96 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.145 0.578 . . . . 74.01 109.836 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' HE3' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -164.42 178.8 7.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.308 1.043 . . . . 74.41 109.291 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.503 ' HB2' HG23 ' A' ' 149' ' ' ILE . 37.0 tp -111.69 150.87 29.57 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.012 -0.736 . . . . 75.51 109.012 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p -60.81 132.23 53.22 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.39 0.676 . . . . 74.33 110.227 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.537 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.42 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 74.33 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 71.35 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.02 112.219 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.31 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.52 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 64.31 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.441 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 72.21 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 72.43 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.439 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 73.5 110.635 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 73.31 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 74.24 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 73.31 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 75.33 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.22 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 74.1 109.663 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 72.43 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.51 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.35 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 74.53 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.694 ' HD2' ' HB3' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.4 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.11 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.45 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.03 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.441 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.33 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.44 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 74.45 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.44 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.11 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.416 ' H ' HG21 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 74.52 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 75.23 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 75.14 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 74.25 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 73.23 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 62.02 111.134 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.1 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 75.34 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.85 -32.87 52.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.31 109.954 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 11.3 mm100 -80.41 153.49 28.25 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.548 -0.751 . . . . 74.15 109.824 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.56 66.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.412 -0.813 . . . . 61.24 109.472 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.31 115.72 20.01 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.339 1.056 . . . . 74.02 109.007 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp -97.26 43.5 1.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.52 110.283 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 65.13 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 73.41 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.24 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.35 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 148' ' ' ILE . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.11 109.864 -178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.31 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.44 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.02 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.44 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 64.14 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.501 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.34 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.34 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.33 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 63.24 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 72.1 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 74.32 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.14 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.24 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.491 HD11 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.42 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.33 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.41 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.522 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.52 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.491 ' HD3' HD11 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 75.2 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 74.25 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 60.22 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 72.51 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.418 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 74.42 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.54 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 75.43 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.21 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -75.08 101.72 4.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 75.24 110.538 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.83 143.37 45.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.906 0.882 . . . . 55.11 109.712 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -108.54 -36.29 6.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.064 0.945 . . . . 73.41 110.04 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.08 -44.96 0.02 OUTLIER Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.382 -0.826 . . . . 62.02 111.171 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.26 140.77 48.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.711 -0.478 . . . . 71.02 109.711 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.48 135.15 88.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.376 1.071 . . . . 70.43 111.624 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' HG21 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 64.11 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.02 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 71.01 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG21 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.03 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.05 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 72.45 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 72.01 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.34 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.42 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.2 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.443 ' HB2' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 74.21 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 72.34 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.34 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.32 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.43 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.52 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 74.05 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.34 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 75.4 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 74.31 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 75.33 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.24 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 74.13 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.21 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 74.2 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.11 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.486 ' O ' HG22 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.22 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.43 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.3 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.534 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.41 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.509 HG23 ' HB3' ' A' ' 138' ' ' LEU . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 72.41 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.23 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.54 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.34 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.534 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.55 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 71.54 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.14 -56.73 1.17 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.02 109.197 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.694 ' HB3' ' HD2' ' A' ' 31' ' ' ARG . 45.4 m-20 -84.77 54.82 3.19 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.843 0.857 . . . . 71.22 110.694 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 p90 38.92 60.97 1.32 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 125.501 1.52 . . . . 74.35 112.675 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.78 -158.92 25.71 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.773 -1.103 . . . . 64.12 112.18 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.404 ' H ' ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -97.33 -178.23 4.09 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.906 -0.776 . . . . 75.5 108.906 175.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.654 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 -56.75 140.98 74.86 Favored Pre-proline 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 75.42 109.967 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.467 ' HA ' HD11 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.44 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.31 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.654 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.2 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 74.43 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.23 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 74.34 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.52 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.34 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.11 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.24 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 73.23 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 73.23 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 57' ' ' VAL . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 75.15 108.3 177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 9' ' ' LEU . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 73.2 109.487 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.51 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.457 ' NE2' HG22 ' A' ' 149' ' ' ILE . 25.1 mm-40 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.15 108.638 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.595 ' HD3' ' HB2' ' A' ' 7' ' ' ALA . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 74.21 109.45 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.87 179.15 4.43 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 74.34 111.108 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -71.4 -178.39 2.1 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 115.245 -0.889 . . . . 75.32 111.483 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.11 115.56 4.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.935 -0.765 . . . . 71.42 108.935 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -60.75 -33.12 72.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.943 0.897 . . . . 74.32 110.272 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.27 134.1 46.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.628 1.171 . . . . 71.32 108.308 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.44 81.99 4.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.707 0.765 . . . . 71.31 110.314 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -159.59 102.46 1.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.82 1.248 . . . . 72.24 109.039 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 CA--C 1.562 1.423 0 C-N-CA 124.875 1.27 . . . . 72.33 110.75 179.647 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.079 0.466 . . . . 71.5 110.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.8 t -125.36 126.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.752 -1.203 . . . . 70.31 107.752 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.08 160.65 48.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.71 0.804 . . . . 74.3 109.856 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.541 ' HG2' HG11 ' A' ' 6' ' ' VAL . 94.6 Cg_endo -84.53 -165.76 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.425 2.084 . . . . 72.15 111.659 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.57 55.38 5.02 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 121.942 -0.17 . . . . 72.3 112.83 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.541 HG11 ' HG2' ' A' ' 4' ' ' PRO . 12.8 m -70.75 128.7 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.669 0.788 . . . . 63.12 111.02 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.03 -175.44 5.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.839 0.855 . . . . 74.31 110.269 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.82 90.49 0.06 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.701 1.2 . . . . 74.13 111.759 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp 57.92 74.19 0.44 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.595 1.158 . . . . 73.04 110.299 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.57 HG23 ' H ' ' A' ' 11' ' ' THR . 1.9 m -98.67 -174.77 2.88 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.1 108.436 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.57 ' H ' HG23 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 74.13 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 74.12 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 72.11 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.42 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.22 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.411 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.01 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.44 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.32 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.22 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 64.53 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.02 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.438 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 74.0 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 71.4 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.529 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.42 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.44 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 74.32 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 74.42 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.42 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 60.41 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.42 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.442 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 65.22 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.22 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.32 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.22 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.44 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 73.15 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.2 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 75.14 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 75.33 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.1 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.14 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.04 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.476 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 74.14 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 74.42 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 64.53 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.553 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.21 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 74.12 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.12 -37.39 82.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 73.23 110.488 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -98.6 165.7 11.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.656 -1.156 . . . . 74.31 110.16 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.36 -61.07 2.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.663 0.785 . . . . 70.31 111.182 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.16 132.95 36.0 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.039 0.447 . . . . 71.41 110.207 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.553 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm -97.69 70.08 2.18 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.927 0.891 . . . . 70.2 112.435 -164.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.456 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 71.14 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.41 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 73.05 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.458 HD21 ' HB1' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.31 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.42 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 74.12 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.521 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.4 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.41 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.52 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 63.42 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.22 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 74.41 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 75.54 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.52 111.376 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.15 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 72.34 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.21 110.397 178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.35 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.13 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.31 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.23 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.12 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.14 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.42 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.31 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 74.21 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 73.12 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 73.12 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 72.34 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.52 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.41 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.86 61.97 7.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.22 110.6 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -98.86 121.67 41.11 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.113 -0.699 . . . . 73.44 109.113 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 114.23 27.57 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.058 0.943 . . . . 73.13 109.683 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.94 13.57 60.54 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.374 0.421 . . . . 74.44 113.468 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 89' ' ' LYS . 1.3 tpmt? -160.0 157.0 27.97 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 72.03 108.727 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -59.8 131.23 88.85 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.227 0.611 . . . . 74.43 110.743 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.35 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 54.41 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 74.55 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 71.21 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 61.21 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.11 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.14 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.44 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.31 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.41 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 63.52 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 70.14 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.32 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 74.24 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.32 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 74.25 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 75.11 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.23 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.53 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.42 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.32 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.13 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.34 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.32 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.11 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.32 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 73.43 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 73.22 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.446 ' O ' HG22 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 72.01 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.52 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.13 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.14 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 72.4 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.31 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.12 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.01 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.11 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.435 ' HB2' HD13 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 74.42 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.76 -29.5 6.75 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.3 110.744 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -125.47 61.6 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.647 0.379 . . . . 72.22 111.738 -167.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.4 p90 44.76 26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.117 1.767 . . . . 75.14 114.85 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.27 -90.77 0.03 OUTLIER Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.513 -0.635 . . . . 55.4 111.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -173.28 -176.27 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.607 0.763 . . . . 74.24 109.691 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.46 140.82 97.81 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.397 0.679 . . . . 75.42 110.836 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.52 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.05 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.24 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.31 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HB3' HG23 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 75.55 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.21 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 71.2 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.521 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.43 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.01 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.3 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.03 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 72.02 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.41 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 73.13 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.13 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 74.34 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.13 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.456 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 74.14 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.59 171.9 5.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 63.3 110.81 167.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -59.82 -29.46 68.26 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.404 -1.271 . . . . 70.13 109.671 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -59.61 99.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.387 -1.279 . . . . 71.44 108.935 162.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.46 89.09 2.13 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.375 0.67 . . . . 75.22 110.614 -173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -94.64 90.02 5.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.746 0.819 . . . . 72.35 109.671 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -116.34 39.42 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.839 0.828 . . . . 73.34 109.096 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -166.57 -41.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.132 -0.94 . . . . 71.41 109.406 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 106.715 -1.587 . . . . 71.12 106.715 -173.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.265 0.098 . . . . 73.21 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.9 m -112.49 108.34 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.927 0.87 . . . . 72.31 108.998 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -77.98 155.62 80.07 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.204 1.002 . . . . 72.35 109.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.86 147.68 24.71 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.846 2.364 . . . . 75.21 111.976 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.84 92.03 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 O-C-N 124.177 0.923 . . . . 72.11 112.549 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.14 158.07 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.154 0.982 . . . . 74.31 110.682 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.86 -173.87 4.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.022 0.439 . . . . 71.41 111.086 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 152' ' ' ARG . 13.6 ptpt -71.46 169.35 15.58 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.243 -0.889 . . . . 74.53 109.973 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.89 129.14 39.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.945 -0.761 . . . . 74.51 108.945 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -58.76 130.79 48.61 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.811 0.844 . . . . 63.22 109.965 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.13 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.11 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 62.23 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 74.34 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 74.43 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 63.25 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' HD22 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.45 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' HG3' ' A' ' 35' ' ' GLU . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 73.21 111.431 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.32 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.425 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.53 110.558 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 72.03 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 75.43 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.15 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.54 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 72.43 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.43 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 74.42 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 74.23 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.32 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.35 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.45 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 73.43 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 73.53 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 75.34 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG3' ' HB ' ' A' ' 18' ' ' THR . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.44 109.338 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.43 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.34 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.41 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.12 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.3 111.004 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.43 ' H ' HG12 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 74.44 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.42 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 74.03 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.51 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.23 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.422 HD11 HD21 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.4 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 75.14 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.51 -19.04 60.51 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.45 111.474 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 66.7 mm-40 -87.24 159.06 18.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.348 0.659 . . . . 71.53 110.16 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.96 96.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.015 0.926 . . . . 74.11 110.571 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.92 173.68 8.36 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.0 -1.0 . . . . 74.12 109.905 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp -134.73 50.8 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.306 0.642 . . . . 75.54 111.104 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.24 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 70.44 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 73.22 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 HD22 ' HB1' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.32 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG23 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.24 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 72.01 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.32 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 72.15 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.444 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 72.02 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.24 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 74.32 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 74.42 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 72.42 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HB2' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 75.03 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.01 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.3 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 64.52 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 72.13 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.41 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.44 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.438 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.34 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.573 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 70.03 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 74.41 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.52 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.573 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.44 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.33 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HZ3' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.11 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.23 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.42 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 72.01 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.6 9.55 41.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 61.0 111.511 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -65.36 96.45 0.24 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.429 0.691 . . . . 74.24 110.046 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HZ1' ' HB3' ' A' ' 87' ' ' LYS . 9.3 mtpm? -101.82 -15.79 16.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.795 0.838 . . . . 75.33 111.478 -177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.45 -42.99 54.91 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.619 0.574 . . . . 74.23 112.467 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -79.94 0.56 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.36 -0.978 . . . . 74.15 108.36 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 178.17 142.15 0.27 Allowed Pre-proline 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 73.35 106.919 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' HB2' HG21 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.24 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.493 HG11 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.14 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.23 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.552 HG21 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.31 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 74.03 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 70.41 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 71.55 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 75.12 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.42 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.41 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.43 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 65.41 111.293 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.43 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 74.02 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 74.52 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 74.42 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.414 HD11 HG23 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 74.51 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 73.31 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 74.2 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.44 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.12 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.24 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.453 ' HA ' HD23 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 70.22 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.3 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.33 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 74.24 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.492 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 73.44 111.39 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.12 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.465 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 75.24 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 63.43 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.24 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 138' ' ' LEU . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.32 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 72.2 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.11 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 75.42 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.33 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 133' ' ' ARG . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 73.22 111.888 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -141.57 26.17 1.96 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.21 108.849 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -132.11 22.82 4.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.638 -1.165 . . . . 73.41 110.788 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.0 p90 47.7 32.66 2.67 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.226 1.01 . . . . 73.21 111.797 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.77 -106.0 3.08 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.571 -0.741 . . . . 73.14 113.422 -169.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -149.86 171.13 17.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.745 0.418 . . . . 73.1 111.664 -164.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.96 145.27 89.41 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.581 -1.191 . . . . 74.2 112.032 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 75.4 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.11 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.02 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.555 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.44 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.41 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.4 ' HG3' HG13 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.3 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.33 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.444 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 72.42 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.22 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.42 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.44 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 74.11 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.441 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 71.2 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.471 HG12 HG23 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 71.33 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.23 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.35 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.51 109.047 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.482 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.42 107.504 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 46' ' ' ILE . 61.5 mt -54.35 119.75 5.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 176.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -44.97 -36.8 3.58 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.979 1.425 . . . . 72.53 112.819 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.33 139.41 6.9 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.273 -0.876 . . . . 74.15 109.737 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -102.11 174.12 6.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.057 0.943 . . . . 75.51 109.023 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.97 160.1 24.3 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.916 0.886 . . . . 73.23 109.021 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 63.19 92.57 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.599 1.16 . . . . 75.33 111.597 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.23 160.0 18.02 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.428 0.691 . . . . 72.23 109.456 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 118.966 -0.54 . . . . 72.24 109.91 179.737 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.735 -0.468 . . . . 74.5 109.735 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.31 152.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.34 0.656 . . . . 74.24 110.671 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -69.83 157.75 88.89 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.801 0.84 . . . . 75.02 110.761 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.74 26.32 0.32 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.072 2.515 . . . . 72.44 115.116 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.41 54.1 5.72 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.383 -0.287 . . . . 62.33 112.383 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.92 14.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.541 0.736 . . . . 72.33 111.624 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 102.62 11.3 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.884 0.874 . . . . 72.02 111.506 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -162.06 132.02 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.125 0.97 . . . . 75.32 108.494 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.562 HD21 ' H ' ' A' ' 10' ' ' THR . 2.1 tm? -94.39 154.32 17.53 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.278 -0.638 . . . . 75.52 109.278 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.562 ' H ' HD21 ' A' ' 9' ' ' LEU . 76.1 p -72.22 165.64 24.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.067 1.347 . . . . 74.44 113.066 -173.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 72.43 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.54 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 74.32 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.552 ' HB3' ' HH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.41 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.11 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.24 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 73.21 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 63.25 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.35 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 73.45 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.42 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 74.01 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.53 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.552 ' HH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.44 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 71.21 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.21 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 73.23 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 73.12 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 60.14 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 71.23 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.03 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.411 HG13 HG11 ' A' ' 33' ' ' VAL . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 70.13 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG11 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.43 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 70.34 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.44 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 72.14 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.1 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.34 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.15 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 75.33 111.891 -171.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.458 ' H ' HG12 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 74.0 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.41 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.23 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.1 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 65.21 110.934 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG12 ' HB1' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.32 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 73.03 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -81.31 -27.86 34.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.42 111.004 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 85.4 mm-40 -84.42 154.34 22.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.06 0.544 . . . . 75.32 111.051 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.75 65.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.345 -0.843 . . . . 65.43 109.888 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.26 112.52 14.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.541 -0.911 . . . . 73.14 108.541 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm -92.48 40.31 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.05 111.485 -167.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.597 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.11 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 75.12 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.35 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.44 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 65.24 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.479 ' HE2' HG11 ' A' ' 66' ' ' VAL . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.22 108.884 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.24 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.42 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.43 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 72.51 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.32 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.411 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 75.34 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.54 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 74.31 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.31 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.22 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 73.12 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 74.23 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 73.43 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.44 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.52 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.2 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 74.55 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.42 111.06 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.33 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.44 111.121 176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.31 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 74.11 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.456 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.42 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.32 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.15 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 75.44 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.98 35.89 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.44 111.014 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -62.17 -50.46 71.73 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.97 0.908 . . . . 73.24 112.014 -175.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' A' ' 87' ' ' LYS . 8.4 mtpm? 49.42 27.49 2.01 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.227 1.411 . . . . 64.34 113.179 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.33 55.08 0.15 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.258 -0.737 . . . . 73.33 111.258 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -166.7 159.19 13.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.177 0.991 . . . . 74.32 108.539 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -75.84 114.81 40.45 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.2 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 73.23 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.11 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 62.34 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 74.33 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.33 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 72.42 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.34 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.12 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 74.41 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.33 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.42 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 71.4 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 75.31 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.1 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 51.14 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 74.02 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 74.43 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 75.44 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.44 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.45 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.512 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 73.5 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.3 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.512 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.1 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 63.4 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 73.32 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.23 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.516 ' O ' HG21 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.23 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.52 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.12 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 75.04 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.11 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.442 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 74.15 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 72.01 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.54 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.24 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.526 ' HB3' HD13 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.21 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -112.84 -58.45 2.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.4 109.923 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.72 80.44 8.97 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.176 -0.466 . . . . 75.15 110.433 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.6 p90 40.48 38.86 0.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.591 1.556 . . . . 72.31 114.247 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.56 -113.5 0.25 Allowed Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.46 -0.791 . . . . 64.11 112.749 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -169.7 -174.68 1.92 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 73.33 109.477 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -54.7 141.27 56.8 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 73.25 111.692 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.15 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.01 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 74.24 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.587 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 73.2 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 74.4 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 75.43 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.41 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 61.42 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.33 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 73.12 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 64.11 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.5 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.54 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 73.4 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.34 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 73.43 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.597 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 74.1 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.488 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt -70.29 169.32 14.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 74.53 110.543 167.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.21 147.11 53.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.47 -0.786 . . . . 73.23 110.435 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.49 142.0 36.0 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.121 0.968 . . . . 64.34 109.519 -170.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -77.21 168.84 19.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.851 0.861 . . . . 75.33 111.481 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -67.69 94.05 0.41 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.507 -0.769 . . . . 62.15 109.848 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -84.8 53.5 2.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.216 1.407 . . . . 72.21 111.846 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -173.59 126.8 0.4 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 74.13 110.276 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.019 0.928 . . . . 61.14 109.972 171.242 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 110.197 -0.297 . . . . 74.21 110.197 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.75 -24.71 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 123.518 0.727 . . . . 73.21 111.522 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.7 pm0 -62.72 162.39 21.49 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.969 0.908 . . . . 75.31 110.774 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 56.5 Cg_endo -65.5 179.91 1.46 Allowed 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.362 2.042 . . . . 71.31 112.733 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.93 76.05 0.88 Allowed Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.83 -0.623 . . . . 75.23 112.564 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.57 165.75 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.868 0.867 . . . . 75.34 110.143 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.77 115.63 11.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.081 0.552 . . . . 74.1 110.624 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.15 -41.96 76.6 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -71.61 85.26 0.88 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.251 -1.018 . . . . 74.34 108.251 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -89.44 156.25 18.79 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.532 -1.213 . . . . 61.45 108.231 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.588 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 72.01 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.41 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.32 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 62.23 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 73.12 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 74.31 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 71.31 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.12 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 74.24 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.429 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 71.44 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.44 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 74.14 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 74.33 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 74.21 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG13 HG22 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.31 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 73.13 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 74.03 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.2 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 54.25 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.449 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.42 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.515 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 74.21 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 75.21 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.42 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.12 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.23 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.639 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.12 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.4 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 65.24 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.11 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.33 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 75.32 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 74.43 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.53 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.31 111.467 -175.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 62.22 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.54 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 72.14 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -67.71 -37.03 81.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 75.02 110.537 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HG3' ' H ' ' A' ' 51' ' ' ASP . 58.4 tp60 -80.98 144.01 32.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.619 -0.719 . . . . 73.32 109.599 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.67 91.99 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.588 0.755 . . . . 65.23 110.208 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.48 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 9.9 m-20 -79.71 112.7 17.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.994 -1.003 . . . . 65.33 109.389 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.552 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm -86.5 70.19 10.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.22 109.766 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 74.01 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.22 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.13 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 72.52 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 70.14 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.492 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.42 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 74.25 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.42 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 75.22 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.2 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.45 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.13 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.33 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.13 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.13 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.05 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.21 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 73.23 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 64.24 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 75.0 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 72.42 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 70.33 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.43 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.44 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 75.33 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.32 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 73.05 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.52 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 74.21 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 72.55 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.21 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -95.82 44.3 1.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.23 108.957 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -69.58 117.45 11.21 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.002 -0.999 . . . . 75.14 111.617 -168.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.565 ' HB2' ' HZ1' ' A' ' 87' ' ' LYS . 9.4 mtmp? -107.7 -17.05 14.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.31 1.044 . . . . 74.35 109.558 172.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.69 59.2 4.98 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.365 -0.834 . . . . 65.34 112.251 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 67.77 -79.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.576 1.55 . . . . 75.11 112.462 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -118.59 140.49 28.42 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.813 0.845 . . . . 74.5 111.084 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 73.43 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.43 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.23 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.53 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.14 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 70.32 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.31 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.22 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.532 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 73.24 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.03 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HB3' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.14 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 70.52 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 73.41 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.24 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.04 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.53 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.42 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 73.23 111.384 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.1 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.31 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 73.54 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 75.02 109.156 172.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 55.42 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 74.04 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 75.24 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.53 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 74.23 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.444 ' O ' HG22 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 74.04 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.34 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.417 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.43 110.999 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.34 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 73.23 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.421 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 26.9 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.4 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.3 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 72.03 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.42 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.11 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -108.25 -59.5 1.85 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 72.13 108.44 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.61 88.76 3.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.664 -0.698 . . . . 75.12 110.629 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.7 p90 42.13 33.27 0.37 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.056 1.742 . . . . 73.21 115.066 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.94 -105.18 0.07 OUTLIER Glycine 0 C--N 1.35 1.344 0 O-C-N 123.377 0.423 . . . . 61.34 112.05 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.75 1.46 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.771 0.828 . . . . 73.33 110.703 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.93 143.05 78.34 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.869 1.267 . . . . 72.2 111.322 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.32 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 75.21 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.43 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 74.43 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.24 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 73.34 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.03 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.1 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.42 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.55 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.45 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 74.44 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.13 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.492 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 73.01 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.13 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.34 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.34 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 172.65 3.85 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.224 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.56 173.71 1.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.514 0.673 . . . . 75.43 111.011 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -81.54 78.0 8.34 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.45 -0.796 . . . . 74.03 109.185 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -96.09 27.77 3.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.804 1.241 . . . . 72.2 110.023 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -54.27 -33.63 59.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.811 1.244 . . . . 72.12 112.956 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -73.11 88.17 1.43 Allowed 'General case' 0 C--N 1.361 1.068 0 CA-C-O 121.852 0.834 . . . . 75.35 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -132.53 -16.31 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.369 -1.287 . . . . 74.41 109.555 168.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.132 0.973 . . . . 72.23 108.675 176.612 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.437 -0.579 . . . . 54.45 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.15 -46.74 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.438 -0.949 . . . . 72.12 108.438 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.32 145.26 82.58 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 114.671 -1.15 . . . . 73.1 111.149 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 -174.25 2.2 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 123.044 2.496 . . . . 75.11 112.541 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.28 78.32 1.13 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.365 -0.38 . . . . 64.34 112.722 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.3 11.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.923 0.889 . . . . 73.24 110.43 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.17 32.91 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.045 0.938 . . . . 64.24 112.555 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 65.51 82.51 0.18 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.143 1.377 . . . . 53.22 110.918 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 tp 63.16 107.2 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.495 1.518 . . . . 73.35 111.187 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.553 HG21 ' H ' ' A' ' 11' ' ' THR . 1.4 m -141.69 -164.47 1.79 Allowed 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.43 107.155 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.553 ' H ' HG21 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 73.04 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.32 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 61.21 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.01 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 75.51 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.44 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 74.11 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.11 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 65' ' ' LYS . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.33 111.822 -177.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.33 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.418 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.24 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 70.45 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 31' ' ' ARG . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.55 109.107 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.35 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.593 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 74.52 110.659 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.45 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.31 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 73.31 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 73.52 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.477 ' NH2' ' HA ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.1 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.541 HG23 HE21 ' A' ' 49' ' ' GLN . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.52 110.525 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.24 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.423 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.53 112.928 -171.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 70.4 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.31 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.42 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.32 108.82 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 73.13 110.283 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 71.32 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.23 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.13 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.35 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 73.22 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.45 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.44 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -102.27 -37.26 8.17 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.12 110.624 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.541 HE21 HG23 ' A' ' 32' ' ' ILE . 24.2 tt0 -141.28 -172.28 3.47 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.8 -1.185 . . . . 73.42 107.8 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.593 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 83.02 -7.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.53 1.132 . . . . 73.43 113.121 168.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 63.43 35.4 12.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.839 0.855 . . . . 74.25 110.77 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.36 14.11 9.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.358 1.463 . . . . 61.12 112.725 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.44 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.21 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.455 ' HB3' HG21 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.43 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.34 109.14 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 HG23 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.32 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 75.31 109.939 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 74.05 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 74.33 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 75.32 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.44 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.53 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.31 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 20' ' ' MET . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.4 112.465 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.55 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 72.14 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.12 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.31 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.02 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.14 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.4 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.12 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.31 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.3 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.01 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.43 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.21 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.52 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.31 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.21 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.53 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.26 12.63 26.11 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.21 111.046 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.667 HD22 ' HB2' ' A' ' 89' ' ' LYS . 54.5 t30 -67.59 99.23 0.75 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.524 0.73 . . . . 60.22 109.887 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.456 ' HB3' ' HZ2' ' A' ' 87' ' ' LYS . 7.1 mtpm? -88.7 -36.26 16.29 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.754 0.822 . . . . 64.14 110.787 -177.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.75 -50.26 54.73 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 124.124 0.89 . . . . 63.21 112.511 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.667 ' HB2' HD22 ' A' ' 86' ' ' ASN . 30.0 mmmt -108.4 -176.62 3.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.925 -0.769 . . . . 72.43 108.925 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -68.12 132.85 91.76 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.24 109.118 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.21 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 74.12 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.41 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.495 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.03 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 70.53 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.35 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 74.41 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 74.31 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 64.42 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.23 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 75.51 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.23 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.11 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 75.23 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.14 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.44 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.507 HD11 HG23 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 74.44 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.44 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.22 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 75.15 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.44 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.23 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.14 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.12 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.12 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.22 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 75.33 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.54 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.35 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.22 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.43 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.21 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 72.32 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 74.22 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.43 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.31 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.435 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.51 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 73.44 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -147.03 0.87 0.74 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 71.53 110.849 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.477 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 6.0 m-20 -69.4 -81.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.452 0.701 . . . . 73.55 110.988 -174.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.9 12.78 1.28 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.815 1.246 . . . . 64.05 109.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.29 104.01 2.24 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.532 0.52 . . . . 64.34 112.205 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -162.17 -179.54 7.14 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.283 1.033 . . . . 74.21 109.758 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -94.29 146.82 32.25 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 70.4 110.112 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 71.11 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.42 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 71.54 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 74.23 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 73.13 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 73.15 110.535 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 74.11 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 74.24 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.22 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 74.3 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 63.24 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 74.14 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 74.41 109.58 171.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.507 HG23 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.11 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.43 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.45 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.45 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt -73.5 179.65 3.95 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.542 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 52.53 13.34 0.3 Allowed 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 126.723 2.009 . . . . 73.21 113.915 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.81 46.13 1.36 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.141 1.377 . . . . 73.54 108.136 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -63.37 123.67 19.32 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.427 -0.806 . . . . 74.14 111.177 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 59.85 32.93 21.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.037 1.335 . . . . 72.51 112.315 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -65.21 103.0 0.71 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.641 0.734 . . . . 74.31 110.781 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -115.19 48.1 1.21 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.784 0.802 . . . . 72.41 110.14 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 115.317 -0.856 . . . . 70.51 110.437 178.045 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.697 -0.483 . . . . 74.35 109.697 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.97 145.15 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.621 -0.881 . . . . 75.25 108.621 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.67 152.49 44.76 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.734 0.814 . . . . 75.12 109.366 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.49 -155.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.101 2.534 . . . . 74.44 113.002 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.81 65.59 2.52 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.775 -0.53 . . . . 73.12 111.775 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -80.64 -8.13 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.798 1.239 . . . . 74.13 110.728 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HA ' ' HE1' ' A' ' 75' ' ' PHE . . . -69.38 83.93 0.39 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.575 0.75 . . . . 73.25 109.517 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -92.67 43.17 1.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.073 0.94 . . . . 72.44 109.792 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.43 86.13 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.131 -1.063 . . . . 64.23 108.131 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' HB ' ' CE2' ' A' ' 12' ' ' TYR . 11.4 m -89.51 157.48 18.07 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.253 -0.885 . . . . 72.24 109.546 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.562 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 71.02 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 75.5 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.437 ' HB2' HG11 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 64.13 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 74.23 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.562 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.32 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 75.12 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.34 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.46 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 73.34 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.34 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.538 ' HE3' HG23 ' A' ' 62' ' ' THR . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.15 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.42 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.717 HG21 HH12 ' A' ' 133' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 74.11 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.54 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.01 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.15 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 55.35 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.11 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 112' ' ' LEU . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.31 110.724 -177.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.31 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 73.14 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.33 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 72.02 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.12 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 73.34 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.21 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.41 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.41 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.41 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.519 ' H ' HG21 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.45 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.544 ' H ' HG12 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 73.42 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 74.5 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 74.2 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.24 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.41 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.42 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 74.34 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -77.75 -36.54 50.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.14 110.39 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -68.95 155.59 40.03 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.705 -1.134 . . . . 75.05 110.434 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.36 -58.81 6.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.171 0.988 . . . . 62.42 110.757 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.38 173.38 12.66 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.57 0.748 . . . . 60.34 110.533 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm -128.0 19.04 6.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.38 1.072 . . . . 74.42 112.349 -170.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 73.21 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.44 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.14 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 74.43 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG21 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 74.44 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.429 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.23 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 74.54 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.476 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 74.55 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 75.44 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.538 HG23 ' HE3' ' A' ' 20' ' ' MET . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 73.4 111.292 177.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.31 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.476 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 64.51 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 73.42 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.437 HG11 ' HB2' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 73.25 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.14 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 71.52 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.35 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 75.03 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.15 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.24 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.54 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.41 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.61 ' HE1' ' HA ' ' A' ' 7' ' ' ALA . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.587 HG21 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.13 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.44 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.33 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.587 ' HG2' HG21 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.55 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 75.41 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 74.15 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 71.05 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 73.43 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -87.23 90.45 8.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 72.55 109.949 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -85.37 100.08 11.6 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.745 0.784 . . . . 74.34 111.547 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -123.17 -38.08 2.63 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.806 -0.634 . . . . 72.54 110.228 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.25 -76.78 0.5 Allowed Glycine 0 C--N 1.351 1.401 0 O-C-N 123.855 0.722 . . . . 74.4 111.999 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -114.64 -82.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -143.59 168.02 13.99 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.554 1.141 . . . . 75.51 109.215 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.5 ' HG2' HG21 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.4 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.11 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.32 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.509 HG22 ' HB3' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 64.13 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 75.41 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.04 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 71.21 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 74.21 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.34 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 54.43 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 73.04 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.42 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 73.11 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.45 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB3' HG22 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.1 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.52 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.34 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 72.33 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.55 110.722 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 75.14 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.15 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.441 HD23 ' HB1' ' A' ' 102' ' ' ALA . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.14 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.12 109.259 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.53 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 74.2 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.14 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.53 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.491 ' O ' HG22 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.15 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.12 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.44 113.383 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.02 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.3 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.455 HE21 ' HA2' ' A' ' 121' ' ' GLY . 29.2 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.23 110.903 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.41 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.52 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 53.31 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.24 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -152.95 21.28 0.58 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.43 108.505 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -149.67 97.53 2.63 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.773 0.797 . . . . 75.32 109.963 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 68.53 15.64 9.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.805 1.242 . . . . 73.04 113.794 166.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.05 40.68 29.25 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.46 -0.656 . . . . 74.01 111.46 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.717 HH12 HG21 ' A' ' 23' ' ' ILE . 39.6 ttt180 -67.36 133.43 49.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.315 1.046 . . . . 75.35 110.233 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.72 141.16 87.15 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.4 109.715 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HA ' HD13 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.44 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 75.0 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 64.11 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.542 HD21 ' HD3' ' A' ' 133' ' ' ARG . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.34 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.33 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.4 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 72.32 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.31 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.42 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 74.43 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.23 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.429 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.42 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.477 HG12 HG21 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.44 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.427 HG12 ' HE1' ' A' ' 58' ' ' MET . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.41 108.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.41 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.32 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.43 108.499 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.28 159.64 5.88 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 75.44 111.604 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.64 172.46 11.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.736 0.815 . . . . 75.32 111.742 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.0 m170 65.98 23.48 11.19 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.954 1.302 . . . . 74.41 111.32 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.76 149.24 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.494 1.118 . . . . 72.33 108.996 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.2 t60 65.65 16.22 10.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.709 1.204 . . . . 75.1 110.638 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -74.94 132.55 41.51 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.829 -0.804 . . . . 71.31 108.829 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -148.53 148.32 30.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.895 0.478 . . . . 73.53 110.159 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 123.96 0.904 . . . . 74.2 108.609 173.597 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.617 -0.512 . . . . 73.41 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.55 95.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.062 -0.718 . . . . 71.41 109.062 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -137.56 149.21 64.37 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.804 1.241 . . . . 74.11 109.182 -173.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.32 -174.66 1.06 Allowed 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.272 1.981 . . . . 74.54 111.955 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.87 52.68 4.25 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.726 -0.215 . . . . 63.54 112.733 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.04 132.02 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.896 1.278 . . . . 74.42 109.351 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.36 94.15 0.52 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.164 0.586 . . . . 73.54 110.069 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -129.8 138.72 51.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.212 0.605 . . . . 72.11 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.69 96.61 6.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.049 1.34 . . . . 74.32 107.465 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m -105.2 164.11 12.08 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 71.11 109.47 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 74.22 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.11 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.33 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.33 111.629 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.02 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.1 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 55.51 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.22 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.14 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 71.4 109.699 174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.04 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.52 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.31 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.44 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 64.35 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 63.31 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.22 113.647 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.12 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.33 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.22 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.509 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.35 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 74.11 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 73.5 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.31 111.154 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 75.14 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.34 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 75.32 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.43 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.04 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.51 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.472 ' H ' HG12 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.02 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.44 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 74.51 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.41 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.11 109.91 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 74.25 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 HD21 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 75.23 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -82.93 -7.0 59.71 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 75.03 110.351 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 27.3 mm-40 -101.36 166.66 10.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.923 0.889 . . . . 74.14 111.105 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.09 -70.54 0.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.496 1.118 . . . . 71.11 111.647 -175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 27' ' ' SER . 7.0 m-20 -86.52 147.87 25.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.71 -0.478 . . . . 74.04 109.71 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.524 ' HD2' HD21 ' A' ' 47' ' ' LEU . 45.1 mmtm -95.86 64.78 2.48 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.43 111.198 -173.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 75.22 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.43 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HB3' HG22 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 75.23 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.2 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.54 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.482 ' HE1' HG12 ' A' ' 149' ' ' ILE . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.34 110.169 175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.33 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.5 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 73.42 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.22 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.45 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.504 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 73.3 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 73.3 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.32 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.42 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.52 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 75.34 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 74.41 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 72.44 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 75.01 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.51 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.43 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 70.11 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 65.22 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 73.42 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' HG21 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 75.33 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 73.55 111.354 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.04 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.23 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.42 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.423 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.21 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.19 101.86 11.5 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 75.34 109.677 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -66.16 86.95 0.1 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.551 0.74 . . . . 71.15 109.13 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -99.52 81.81 2.56 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.935 0.894 . . . . 75.34 108.899 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 13.43 50.97 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.538 -0.755 . . . . 60.14 114.067 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -160.03 143.01 13.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.533 0.733 . . . . 73.3 109.238 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -41.78 133.55 2.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.977 1.711 . . . . 73.21 114.196 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 75.51 110.052 177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 74.35 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.05 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.51 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 72.22 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.13 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 65.22 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 74.23 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.14 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.21 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.4 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.517 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.45 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.32 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 64.52 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 74.04 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.42 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 73.45 108.353 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 75.15 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.03 110.741 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 55.44 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 64.44 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 75.2 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.35 109.784 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.32 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 75.34 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.44 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.449 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.11 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.34 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.487 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 73.12 111.088 174.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 74.32 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.45 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.487 HE21 ' HA2' ' A' ' 121' ' ' GLY . 24.4 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.42 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.43 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 70.42 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.43 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.02 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -124.13 -60.5 1.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.43 109.252 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.08 82.21 5.07 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.105 -0.952 . . . . 75.12 110.89 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 35.16 45.69 0.2 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.87 1.668 . . . . 74.13 112.901 171.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.58 -106.57 0.7 Allowed Glycine 0 C--N 1.348 1.224 0 CA-C-N 114.651 -1.159 . . . . 65.34 111.852 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.2 -177.77 2.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.397 1.079 . . . . 75.04 108.717 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.523 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 -53.54 138.3 50.83 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.976 0.91 . . . . 70.15 111.331 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.457 ' HA ' HD13 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 75.41 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.35 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.523 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.15 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.552 ' HB3' HG21 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 73.14 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 62.2 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.447 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.23 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 73.43 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.41 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.2 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.22 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.4 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 74.51 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.23 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.482 HG12 ' HE1' ' A' ' 58' ' ' MET . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 73.13 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 71.21 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 73.14 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.2 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt -61.78 155.66 22.41 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 73.25 111.82 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.33 -44.61 65.24 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.337 1.055 . . . . 74.54 112.03 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.434 ' HE2' ' NH2' ' A' ' 43' ' ' ARG . 10.4 p80 -128.79 137.44 51.53 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.302 -0.863 . . . . 75.43 108.878 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -146.79 133.47 19.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.231 0.613 . . . . 74.44 110.051 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -127.07 77.32 1.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.875 -1.158 . . . . 74.21 107.875 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -153.02 112.26 3.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.454 -1.314 . . . . 74.33 107.454 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -88.05 143.41 27.1 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.519 0.728 . . . . 74.22 110.671 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 t60 . . . . . 0 C--O 1.256 1.447 0 N-CA-C 107.404 -1.332 . . . . 74.4 107.404 172.446 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.874 -0.417 . . . . 55.12 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.6 t 58.15 86.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 124.501 1.125 . . . . 75.51 109.207 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 6' ' ' VAL . 2.8 mp0 76.52 149.06 0.12 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 125.741 1.616 . . . . 74.21 110.736 -171.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.65 42.98 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.72 2.947 . . . . 62.22 113.546 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 34.0 88.6 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 122.787 0.232 . . . . 72.23 113.057 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' HA ' ' HG3' ' A' ' 152' ' ' ARG . 28.5 m -87.16 153.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 122.867 0.467 . . . . 63.44 110.712 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.53 113.85 19.85 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.508 -0.769 . . . . 74.54 109.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -96.18 82.33 3.45 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.246 0.618 . . . . 74.42 109.599 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.523 HD21 HG22 ' A' ' 149' ' ' ILE . 38.6 tp -141.65 153.61 44.83 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.13 0.972 . . . . 75.22 109.418 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p -90.98 162.88 14.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.226 1.01 . . . . 73.2 111.416 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 73.45 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.33 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.15 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.11 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 74.2 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 74.44 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.34 110.022 172.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 75.4 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.409 ' HE1' ' HB2' ' A' ' 20' ' ' MET . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 70.43 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.4 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.23 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.43 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HB3' HG23 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 71.03 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 72.32 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.459 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 71.31 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 74.4 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.12 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.497 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.31 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD13 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.14 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 74.13 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.3 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 72.34 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 71.03 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.49 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.53 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.433 HG21 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.12 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.1 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.433 ' H ' HG21 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 70.32 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 74.3 111.338 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 75.11 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.457 ' HG3' HD23 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.53 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.32 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 64.12 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.528 HG12 HD13 ' A' ' 32' ' ' ILE . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.02 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 75.21 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -61.75 -26.85 68.32 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.14 110.988 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -113.55 161.77 16.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.298 1.039 . . . . 74.32 109.771 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.03 75.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.517 0.727 . . . . 74.43 111.926 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.81 119.02 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.971 0.909 . . . . 72.35 109.512 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.81 30.81 5.98 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.582 0.753 . . . . 74.5 110.407 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 72.54 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 72.22 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.42 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 75.5 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.448 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 74.11 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.597 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.41 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 75.42 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.33 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 74.32 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.33 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 74.32 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.44 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.02 110.15 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.51 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.03 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 73.31 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 74.42 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 75.23 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 74.32 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 74.14 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.51 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 74.01 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 74.52 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.04 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.22 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.34 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 74.51 110.945 -173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 74.53 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.03 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 72.1 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.21 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 -73.21 -19.65 61.04 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 74.13 111.887 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.428 HD22 ' HB2' ' A' ' 89' ' ' LYS . 57.9 t30 -51.33 126.68 17.62 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.534 1.134 . . . . 73.43 112.043 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -99.21 -71.36 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.832 0.853 . . . . 73.3 111.599 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.56 -42.83 93.32 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.771 0.669 . . . . 52.34 114.081 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.428 ' HB2' HD22 ' A' ' 86' ' ' ASN . 3.5 mppt? -94.8 171.79 8.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.105 0.562 . . . . 72.42 109.996 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.73 131.09 89.73 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.347 -0.842 . . . . 74.35 110.15 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HB2' HG21 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.04 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 73.2 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.44 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 74.31 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 65.02 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.32 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.33 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 72.35 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.15 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 73.01 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.11 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.41 111.306 177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.42 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.14 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 63.22 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 62.23 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 75.12 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 73.4 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.44 110.744 -172.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.14 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.34 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 75.23 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 74.44 109.045 172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 73.42 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.41 113.135 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 74.0 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.55 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.417 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.33 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.31 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.32 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.02 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 138' ' ' LEU . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 73.44 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.466 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 73.13 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.21 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 71.5 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.13 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.505 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.23 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.84 -60.19 1.73 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 73.14 109.84 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.42 63.45 2.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.604 -0.726 . . . . 64.35 111.226 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 p90 36.34 51.04 0.8 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.731 1.612 . . . . 74.32 113.116 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.26 -65.83 1.41 Allowed Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.376 -0.829 . . . . 34.1 111.577 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -178.23 158.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.926 1.29 . . . . 71.33 108.657 -172.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.06 140.75 77.47 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.23 110.897 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD13 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 71.5 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 75.31 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.22 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 135' ' ' PRO . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.35 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 72.42 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.23 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.597 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.04 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.42 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 31.22 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.02 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 74.43 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 73.44 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.448 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 75.32 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.405 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 55.41 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.523 HG22 HD21 ' A' ' 9' ' ' LEU . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.44 108.984 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 74.35 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.441 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.42 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.473 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.41 109.999 -176.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.5 HD21 HD13 ' A' ' 46' ' ' ILE . 55.5 mt -71.64 104.73 3.43 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 65.45 110.831 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 55.38 -159.68 0.19 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.79 1.306 . . . . 75.0 113.388 161.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -110.12 97.78 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.074 0.949 . . . . 74.5 109.668 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -86.38 72.07 10.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.138 -0.69 . . . . 70.01 109.138 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -71.37 -15.53 62.38 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.389 1.076 . . . . 74.01 112.672 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.39 -23.58 64.44 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.323 0.249 . . . . 63.41 110.664 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -123.9 157.31 34.54 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.353 1.061 . . . . 62.4 109.181 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.6 p80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 109.311 -0.626 . . . . 74.15 109.311 175.239 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.249 -0.649 . . . . 75.22 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 m -131.74 -175.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.461 1.104 . . . . 75.23 109.134 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.11 152.45 29.63 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.048 0.539 . . . . 73.4 112.089 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.32 173.24 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.488 2.792 . . . . 63.1 114.407 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 68.93 1.51 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 116.246 -0.434 . . . . 32.43 112.331 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.24 9.22 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.264 1.026 . . . . 74.11 110.292 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.65 -171.69 1.96 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 70.21 110.588 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? 61.38 83.67 0.14 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.947 0.899 . . . . 74.4 109.594 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 tp -72.51 146.14 47.02 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.316 -0.624 . . . . 73.43 109.316 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p -52.07 102.7 0.05 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.274 1.43 . . . . 72.34 112.114 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.43 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.13 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.12 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.566 ' HB3' HG12 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.4 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 74.22 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.34 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.34 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 62.01 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.54 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.13 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.53 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.12 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.462 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.41 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.32 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.41 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.561 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 62.01 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 70.24 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 52.41 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 63.35 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.561 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.32 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.22 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.11 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.545 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.2 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.11 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 72.03 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.1 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.22 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.1 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG11 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 73.04 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 74.3 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.43 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.461 ' H ' HG11 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.51 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.51 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.34 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.24 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 71.13 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 73.42 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.52 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -66.77 -37.75 85.22 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 61.54 110.405 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -92.74 147.48 22.83 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.053 -0.976 . . . . 74.21 111.278 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.0 83.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.108 0.963 . . . . 73.52 112.36 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.27 -21.24 64.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.782 1.03 . . . . 74.33 113.782 -170.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 60.52 42.66 13.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.529 1.132 . . . . 71.03 112.206 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 73.54 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 70.23 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HB3' HG21 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 75.42 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 73.21 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.43 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 62.31 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 73.2 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.12 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 74.22 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.41 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.51 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 74.5 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.24 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.31 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.31 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.43 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.22 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.21 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.414 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.13 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 64.31 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.42 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 70.21 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 75.4 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.589 HG21 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 74.34 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.33 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 71.4 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HG2' HG21 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.23 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 74.52 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 73.24 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.42 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.12 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.24 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.16 26.0 0.92 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 63.44 112.721 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -74.29 94.9 2.57 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.307 -0.627 . . . . 75.25 109.307 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -95.58 83.82 3.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.624 0.769 . . . . 74.41 110.752 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.55 -49.39 0.61 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.829 -0.508 . . . . 70.43 111.829 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -94.46 -178.83 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.745 -0.835 . . . . 74.23 108.745 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -77.1 125.67 86.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.45 109.698 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.525 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 62.42 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 65.31 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.51 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.43 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.41 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 54.55 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.21 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 75.43 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.21 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 72.35 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 73.42 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.24 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.23 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 74.42 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 70.14 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 61.42 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.1 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.54 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 75.21 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.13 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 74.22 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.43 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.11 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 72.42 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.481 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.3 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.2 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 74.22 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.444 ' O ' HG21 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.34 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.3 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.14 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.31 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 71.15 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 62.03 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 74.53 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.41 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.3 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB3' HD13 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.04 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -102.2 -47.79 4.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.33 110.414 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -118.72 95.4 4.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.588 0.355 . . . . 75.44 110.478 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.5 p90 41.09 31.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.19 1.796 . . . . 70.33 114.431 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.54 -95.57 0.05 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.343 -0.703 . . . . 73.14 111.343 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -178.14 -174.5 0.42 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 75.2 110.076 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 -59.6 140.47 89.04 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 123.52 0.728 . . . . 75.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.443 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.45 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.32 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.493 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.44 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.591 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.02 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 75.11 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.34 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.33 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.31 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 64.05 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.54 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.453 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.14 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.52 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.53 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 64.24 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.4 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.41 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.23 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.19 168.44 19.97 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.33 109.743 167.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.18 176.5 0.75 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.768 0.827 . . . . 72.4 111.925 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 87.09 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 122.014 0.911 . . . . 73.12 112.141 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -111.26 -28.58 8.19 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.388 -0.824 . . . . 72.34 110.012 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -84.56 90.76 7.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.465 -0.939 . . . . 70.51 108.465 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -109.94 167.47 10.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.421 0.689 . . . . 72.45 111.167 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -153.11 132.93 13.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.009 0.924 . . . . 73.35 109.877 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.695 0.798 . . . . 75.13 110.029 172.82 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.444 -0.576 . . . . 75.33 109.444 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.49 76.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.852 -1.536 . . . . 72.33 106.852 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 68.51 139.3 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.482 1.513 . . . . 63.23 112.497 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' HG2' HG22 ' A' ' 6' ' ' VAL . 72.7 Cg_endo -79.62 -168.17 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.397 2.065 . . . . 74.14 111.133 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.12 61.46 4.65 Favored Glycine 0 N--CA 1.469 0.836 0 C-N-CA 121.377 -0.439 . . . . 75.13 112.669 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.509 HG22 ' HG2' ' A' ' 4' ' ' PRO . 15.1 m -133.87 72.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-O 122.55 1.167 . . . . 74.53 109.857 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 73' ' ' HIS . . . -112.54 -5.67 14.01 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.136 -0.938 . . . . 73.43 111.209 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -70.47 -66.43 0.6 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.88 0.872 . . . . 71.42 108.974 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -155.66 114.04 3.44 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.464 -0.939 . . . . 74.04 108.464 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.404 HG21 ' H ' ' A' ' 11' ' ' THR . 9.7 m -140.2 173.0 11.95 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.189 0.996 . . . . 72.55 108.589 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.404 ' H ' HG21 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 72.12 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.23 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.21 112.218 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.23 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.21 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.11 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.3 111.763 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 61.44 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.459 ' HE1' HG23 ' A' ' 62' ' ' THR . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 73.11 112.177 177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 64.33 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.441 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 74.01 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 73.22 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.34 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.15 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 74.44 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.05 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.428 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.04 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.34 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 75.45 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 73.12 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.21 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 74.32 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.02 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 72.33 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 74.33 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 72.33 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 60.15 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.33 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.45 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.15 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.34 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 71.01 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.11 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.4 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 42' ' ' PHE . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.13 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.53 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.27 -35.14 80.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 71.01 111.541 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.59 HE21 ' HB2' ' A' ' 51' ' ' ASP . 19.2 pt20 -86.64 143.56 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.835 -0.431 . . . . 64.42 109.835 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.91 66.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.878 0.871 . . . . 64.11 111.724 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.59 ' HB2' HE21 ' A' ' 49' ' ' GLN . 5.4 m-20 -68.04 -36.21 79.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.717 1.207 . . . . 73.43 111.693 -173.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm 61.02 33.4 19.69 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.15 0.98 . . . . 75.32 111.504 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 75.22 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 73.45 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.53 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.45 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 71.54 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.476 ' HE3' HG21 ' A' ' 66' ' ' VAL . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 73.32 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.24 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 71.12 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 74.23 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' HE1' ' A' ' 20' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 75.34 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.35 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.53 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 64.22 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 HG21 ' HE3' ' A' ' 58' ' ' MET . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 74.15 112.115 -172.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.42 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 73.32 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.42 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.42 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 73.23 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.33 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.529 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.3 110.187 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.23 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 74.25 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.515 HG21 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.23 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.32 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 74.34 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.515 ' HG2' HG21 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 75.1 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 71.55 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 74.12 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.02 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.32 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 73.0 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -78.35 167.62 21.07 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 74.53 110.243 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 91' ' ' PRO . 7.0 p30 -148.23 135.92 20.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.749 -0.659 . . . . 75.53 110.023 -178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -132.11 72.98 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.082 -1.081 . . . . 74.31 108.082 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.19 3.48 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.883 -0.487 . . . . 65.52 111.883 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -81.45 139.43 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.714 0.806 . . . . 72.51 109.918 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -66.04 140.02 96.86 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.546 1.138 . . . . 72.2 110.926 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 86' ' ' ASN . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 72.33 112.568 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 75.31 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.32 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.23 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' HE3' HG23 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 74.04 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.31 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.24 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 75.5 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.41 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 65.41 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.23 110.665 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 74.43 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.2 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 75.13 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 52.33 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 71.41 109.36 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.428 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 73.4 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 75.01 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.1 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.54 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 73.45 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.459 ' N ' HD13 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 75.12 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.23 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 72.54 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.508 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 75.21 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 73.12 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 75.22 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.32 111.641 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.488 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 70.52 111.365 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.11 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.573 HG23 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 71.4 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.488 HE21 ' HA2' ' A' ' 121' ' ' GLY . 27.8 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 73.42 111.844 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 74.32 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 74.4 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.42 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -113.43 -17.64 12.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.33 112.354 -174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -149.41 82.05 1.41 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 75.21 109.861 -173.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.0 p90 40.85 28.07 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 126.629 1.972 . . . . 64.51 114.474 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.77 -76.82 0.22 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.738 0.649 . . . . 74.34 113.309 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 174.58 156.75 0.15 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.665 0.786 . . . . 73.21 110.155 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 -60.47 136.47 92.09 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 123.544 0.738 . . . . 64.24 110.779 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.42 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.421 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 74.44 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.573 ' HB3' HG23 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 72.44 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.33 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.465 ' HG3' HG13 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 73.13 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 72.4 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.32 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.42 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.11 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.545 HG23 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 74.4 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.22 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.51 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 75.34 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 HD13 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.53 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.14 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.1 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.23 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.72 179.22 1.82 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 75.14 112.807 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.74 169.55 12.7 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.817 1.647 . . . . 73.03 110.891 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -145.04 -44.65 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.057 0.943 . . . . 74.2 110.734 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -149.46 105.23 3.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.977 0.911 . . . . 73.51 108.891 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -58.05 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.409 1.484 . . . . 72.23 112.086 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.8 t60 53.95 34.36 19.4 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.433 1.093 . . . . 73.3 110.538 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -144.5 175.21 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.233 -0.894 . . . . 74.13 110.164 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.79 1.236 . . . . 71.24 107.857 173.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.442 -0.577 . . . . 73.54 109.442 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.17 160.39 4.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.47 0.652 . . . . 70.21 110.322 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.17 159.54 62.08 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 115.116 -0.947 . . . . 72.02 109.112 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.76 34.67 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.235 2.623 . . . . 63.42 115.574 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.98 -66.93 1.55 Allowed Glycine 0 C--N 1.344 0.977 0 O-C-N 121.967 -0.458 . . . . 72.2 112.136 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t 68.91 -61.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 125.209 1.403 . . . . 74.34 111.612 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.43 104.81 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.713 0.805 . . . . 62.3 108.862 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -89.14 -50.64 6.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 75.22 108.332 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -160.15 120.74 2.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.904 -1.147 . . . . 74.44 107.904 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m -138.29 158.33 44.5 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.145 0.978 . . . . 70.25 108.62 -173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.01 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.01 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' HG12 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.54 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 73.34 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.52 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.32 110.613 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB3' HD23 ' A' ' 56' ' ' LEU . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 72.32 111.062 177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 71.13 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 75.43 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.53 109.969 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.43 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 61.12 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 74.41 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.54 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 73.33 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.41 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.51 111.675 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.4 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 73.41 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.13 111.199 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.03 110.117 179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.21 107.44 174.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 73.43 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.13 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 72.53 109.453 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 75.32 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 70.23 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 73.43 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 71.32 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 65.14 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 73.41 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.447 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.31 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.51 111.477 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 73.33 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.43 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.52 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.51 -35.93 82.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 72.51 113.106 -170.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.43 -179.26 3.81 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.999 0.92 . . . . 73.44 108.907 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.33 90.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 75.43 112.235 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' OD1' ' HB3' ' A' ' 27' ' ' SER . 10.6 m-20 -67.54 122.79 18.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.514 1.126 . . . . 71.41 110.908 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm -106.83 31.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.602 1.161 . . . . 74.42 110.83 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 72.2 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.44 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 ' HB3' ' A' ' 17' ' ' ALA . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.22 109.365 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 72.33 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.42 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.43 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.1 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 74.41 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.31 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.04 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 73.4 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.31 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.33 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.03 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.52 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.44 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.33 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.11 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 72.54 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.43 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.34 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.53 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 75.53 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.54 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.22 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.45 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.14 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.23 111.85 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 71.12 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.422 ' HA ' ' HB2' ' A' ' 86' ' ' ASN . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.14 111.94 174.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.11 109.873 170.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -99.16 12.15 36.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.13 111.332 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.514 HD22 ' HB2' ' A' ' 89' ' ' LYS . 55.5 t30 -74.56 101.2 4.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.418 0.687 . . . . 71.32 110.498 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -91.18 -44.86 8.98 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.947 -1.024 . . . . 74.42 110.637 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.22 -32.4 82.45 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.692 0.62 . . . . 70.42 113.314 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.514 ' HB2' HD22 ' A' ' 86' ' ' ASN . 13.6 mmmm -125.52 -178.31 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.404 1.082 . . . . 75.44 109.039 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -72.6 135.12 81.42 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 73.45 109.444 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 72.5 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 73.13 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 75.14 107.934 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 74.43 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 75.34 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 64.53 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 73.14 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 73.44 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 74.12 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 72.33 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 72.22 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.31 111.172 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 74.32 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 60.12 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.54 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.1 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 73.2 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 75.34 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 71.13 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 74.03 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.33 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 75.31 113.016 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 75.05 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.41 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.12 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.45 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 72.43 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.32 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.01 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.1 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 72.43 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.24 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 73.33 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.52 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 27.6 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.45 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 72.52 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 71.13 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 75.14 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 74.04 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -148.49 -26.03 0.32 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 70.01 110.906 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -54.5 -60.34 3.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.212 1.005 . . . . 65.42 112.061 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -155.41 -51.16 0.09 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.507 1.523 . . . . 73.41 107.471 -168.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.36 25.15 0.02 OUTLIER Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.728 -0.669 . . . . 71.32 113.894 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -82.59 104.65 13.01 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.098 0.949 . . . . 73.42 109.818 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.56 143.07 39.25 Favored Pre-proline 0 CA--C 1.564 1.499 0 C-N-CA 124.977 1.311 . . . . 75.24 112.212 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.35 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.11 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 73.34 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.544 HD11 ' HA ' ' A' ' 135' ' ' PRO . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.43 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.35 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.431 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 74.31 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.14 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.501 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.3 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 54.33 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 71.11 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 75.15 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.11 109.175 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.32 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 73.51 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.78 164.61 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 71.41 109.744 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.98 -24.93 60.18 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.435 1.094 . . . . 70.03 113.47 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -105.07 106.48 16.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.328 0.651 . . . . 64.35 109.653 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -161.84 -42.59 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.454 0.702 . . . . 73.3 110.518 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -138.3 106.16 5.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.625 -0.879 . . . . 63.52 108.625 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -103.59 -161.9 0.87 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.59 0.756 . . . . 74.21 111.015 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.21 154.68 26.75 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.459 1.104 . . . . 73.23 111.064 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.596 -0.716 . . . . 74.53 109.24 -179.726 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.512 -0.921 . . . . 73.21 108.512 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m 50.09 18.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 126.409 1.883 . . . . 74.41 113.272 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 63.9 146.55 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 125.625 1.57 . . . . 73.22 112.385 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.68 22.9 0.75 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.371 2.714 . . . . 72.11 113.478 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.17 52.21 8.0 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.048 0.217 . . . . 71.33 112.862 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.85 -7.4 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.276 0.63 . . . . 75.13 112.382 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.58 100.69 0.7 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.102 0.561 . . . . 50.15 111.22 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -141.11 133.92 28.91 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.482 -1.303 . . . . 75.45 107.482 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.4 tp -79.35 135.19 36.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.127 0.571 . . . . 75.23 110.358 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -80.95 168.72 18.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.026 0.93 . . . . 65.03 111.613 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 74.03 114.303 -163.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.53 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 54.13 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.34 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 75.51 110.896 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 74.41 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.44 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 72.41 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 72.43 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 70.43 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 64.02 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.2 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HD11 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.11 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.23 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 75.3 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.42 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.33 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 71.04 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.41 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.606 ' HB2' HD22 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.42 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.536 ' NH2' HD11 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.24 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.592 HG22 ' HG3' ' A' ' 49' ' ' GLN . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 74.24 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 75.51 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.43 109.462 171.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 74.12 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.12 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.41 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.21 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 73.55 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 72.3 111.423 -177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 74.52 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 73.24 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.14 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.21 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.53 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.32 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp -65.77 -36.2 82.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.43 111.142 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.592 ' HG3' HG22 ' A' ' 32' ' ' ILE . 42.9 mm-40 -77.82 159.17 29.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.979 -0.749 . . . . 72.52 108.979 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.551 0.532 . . . . 73.22 109.89 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.51 146.14 45.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.918 0.887 . . . . 73.43 110.544 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -116.01 42.35 2.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.009 0.924 . . . . 75.14 110.352 178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 74.14 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.1 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.42 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 71.41 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.438 ' HE2' HG21 ' A' ' 66' ' ' VAL . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 70.32 110.425 -175.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 52.13 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.13 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.33 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 73.15 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.41 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.42 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.51 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.492 HG11 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 75.23 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 74.44 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 71.22 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 75.42 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 65.34 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.35 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.54 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.33 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.52 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 71.01 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.43 109.602 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 74.22 111.876 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 74.42 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 54.53 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.11 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 71.03 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.15 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.41 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -126.74 151.86 47.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 74.23 109.647 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -163.85 152.02 13.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.033 -0.729 . . . . 61.53 109.033 170.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -95.95 -22.37 17.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.337 0.655 . . . . 75.32 111.824 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.04 -53.1 0.05 OUTLIER Glycine 0 C--N 1.347 1.149 0 N-CA-C 112.44 -0.264 . . . . 70.3 112.44 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.44 -171.37 2.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.42 0.688 . . . . 75.41 109.792 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -95.46 140.35 22.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.469 -0.787 . . . . 75.01 110.345 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 75.12 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.54 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 74.11 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.13 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 62.3 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.55 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.4 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 74.55 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.05 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.45 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 70.31 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' CB ' HD22 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 72.4 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 71.35 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 71.52 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.24 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.15 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 75.43 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.24 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.13 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.32 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.33 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD22 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 72.31 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.42 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.33 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 74.34 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.31 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 74.04 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 64.13 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 74.11 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 74.42 111.639 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.11 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.508 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.53 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 73.54 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.03 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.02 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.1 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.508 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 74.13 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 74.13 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -106.54 -57.5 2.05 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 73.22 110.817 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.416 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 13.2 p30 -94.31 58.78 2.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.292 0.567 . . . . 65.03 110.666 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.6 p90 41.84 61.61 1.85 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.656 1.582 . . . . 73.43 112.783 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.59 -147.43 20.05 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 114.879 -1.055 . . . . 64.35 111.149 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.9 -175.58 2.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.611 0.765 . . . . 70.15 110.012 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.04 143.17 98.84 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.55 110.198 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.23 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 74.34 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.33 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.41 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.54 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 74.11 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.13 109.242 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.34 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.31 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.14 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.4 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 73.23 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.3 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.03 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 74.42 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.11 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 71.34 109.444 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.44 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt -70.38 177.75 3.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.44 112.773 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.0 -35.61 71.48 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.242 -1.344 . . . . 63.43 111.74 -172.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -83.6 81.65 8.65 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.311 -0.996 . . . . 75.25 108.311 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -60.11 122.71 15.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 74.44 110.115 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -74.15 114.93 13.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.868 -0.605 . . . . 73.24 111.053 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -88.74 10.69 19.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.969 -1.014 . . . . 72.25 110.408 170.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -146.08 142.3 28.42 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.448 1.099 . . . . 74.31 108.839 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.373 0.669 . . . . 71.11 109.434 178.672 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.485 -0.561 . . . . 75.42 109.485 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -159.2 47.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 123.131 1.443 . . . . 75.05 108.599 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.12 156.75 83.83 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.184 -1.371 . . . . 74.02 110.316 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.49 -158.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.579 2.186 . . . . 74.12 112.225 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.08 4.17 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 113.629 0.212 . . . . 50.34 113.629 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.08 -4.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.327 1.051 . . . . 73.54 112.03 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.14 122.53 25.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.19 0.996 . . . . 72.1 109.104 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -154.11 124.69 7.08 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.521 0.728 . . . . 71.04 109.806 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -81.22 95.67 7.0 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.979 -1.119 . . . . 73.42 107.979 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.483 HG23 ' H ' ' A' ' 11' ' ' THR . 1.6 m -110.67 175.34 5.46 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.422 0.689 . . . . 72.22 109.451 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.483 ' H ' HG23 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.12 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.41 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 75.22 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.52 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.34 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.21 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB1' HD22 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.14 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 74.52 111.27 175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 72.51 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.21 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.55 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 65.43 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.53 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.24 108.589 169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.43 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.582 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.21 110.458 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 74.1 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 73.31 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.03 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.11 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.41 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.4 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.656 HD21 ' HB2' ' A' ' 133' ' ' ARG . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.41 111.517 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.51 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 63.54 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 75.44 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 73.12 109.427 173.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.53 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 75.33 109.93 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.04 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 74.4 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.52 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.34 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 73.23 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.32 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 75.52 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.492 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp -69.68 -37.84 76.82 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.3 111.154 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -160.93 -110.27 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 58.65 -5.76 0.05 Allowed 'General case' 0 C--N 1.37 1.48 0 N-CA-C 115.645 1.72 . . . . 63.01 115.645 173.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 53.41 27.75 6.73 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.778 0.831 . . . . 74.45 111.137 -163.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp 62.58 31.21 16.99 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.895 1.278 . . . . 75.32 111.727 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 73.4 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 72.34 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.22 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.498 HD22 ' HB1' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.23 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.22 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 63.32 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 75.14 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.21 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 74.03 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.21 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.436 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.14 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 75.13 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.54 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.44 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 74.5 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.1 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 75.21 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.43 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.23 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 73.23 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 72.54 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.42 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 74.15 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 70.22 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.13 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 71.53 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 73.24 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.21 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.54 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 75.53 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.3 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.48 17.61 7.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.41 110.766 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.478 HD22 ' HB2' ' A' ' 89' ' ' LYS . 58.7 t30 -74.16 95.54 2.6 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.468 1.107 . . . . 73.02 109.478 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.62 ' HZ3' ' HB2' ' A' ' 87' ' ' LYS . 8.9 mtmp? -95.49 -38.16 10.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.716 0.806 . . . . 71.23 109.837 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.4 91.98 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 115.452 -0.794 . . . . 72.2 112.615 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.478 ' HB2' HD22 ' A' ' 86' ' ' ASN . 31.9 mmmt -123.54 -179.49 4.36 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.727 1.211 . . . . 72.13 108.436 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.55 131.93 42.3 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 72.43 110.084 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 74.11 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 75.13 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 75.33 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 75.42 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 74.24 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.24 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.01 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.34 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.45 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.43 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.31 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.12 111.148 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.32 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.43 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.12 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.44 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 74.32 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 75.43 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 75.31 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.22 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.34 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.56 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 73.1 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 64.43 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 72.51 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.56 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 71.42 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.42 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.517 ' HB2' ' HZ1' ' A' ' 117' ' ' LYS . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.44 111.486 -175.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 74.54 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . 0.464 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.22 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 73.15 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.41 112.924 174.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.464 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.4 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 72.22 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.495 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 29.7 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 73.02 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 72.14 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.02 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.11 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 63.14 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.59 -66.68 0.53 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 74.41 109.749 172.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.18 109.89 7.06 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 122.607 0.363 . . . . 52.4 111.352 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 58.19 24.62 11.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.971 1.308 . . . . 72.34 111.816 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.47 41.65 97.22 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 114.86 -1.064 . . . . 70.41 114.516 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.656 ' HB2' HD21 ' A' ' 34' ' ' ASN . 15.5 ttm180 -74.81 116.49 15.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.618 -0.882 . . . . 72.44 108.618 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.94 147.2 55.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 123.872 0.869 . . . . 65.32 112.149 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.429 ' HA ' HD11 ' A' ' 138' ' ' LEU . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.15 114.439 176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 74.14 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 73.32 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.528 HD21 ' HD2' ' A' ' 133' ' ' ARG . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.22 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.43 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 74.31 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 75.41 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 75.53 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.05 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 73.32 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.02 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 73.45 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 74.13 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 74.32 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.23 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.41 108.56 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 72.52 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.38 152.51 21.14 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 75.3 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.69 107.4 1.17 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.694 -1.139 . . . . 73.33 111.709 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -12.02 34.18 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.346 1.058 . . . . 73.11 111.594 168.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -123.59 114.15 19.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.966 0.906 . . . . 75.45 108.661 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -63.44 131.86 49.56 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.403 -0.591 . . . . 70.52 109.403 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 122.052 -0.405 . . . . 71.32 110.607 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -103.66 74.58 1.25 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.144 -0.687 . . . . 74.14 109.144 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.925 -1.139 . . . . 71.31 107.925 173.774 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.663 0.616 . . . . 75.42 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.02 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.53 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.43 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 41.32 111.216 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 64.41 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.22 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 51.52 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 64.34 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 63.31 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 64.44 110.138 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 40.44 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.45 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 74.55 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 72.53 108.264 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 44.33 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.44 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 63.35 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.33 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 61.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.42 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 71.14 110.603 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 61.01 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 72.03 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 61.24 111.389 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.04 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.04 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.41 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 64.53 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 74.01 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 53.04 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.44 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.24 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 72.14 110.312 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.52 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 35.42 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.43 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.03 112.86 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.53 110.437 -178.381 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.586 0.587 . . . . 71.31 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.41 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 51.22 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.42 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 54.24 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.44 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 73.42 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.23 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.03 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 65.34 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 51.31 110.335 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 64.42 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.42 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' HB1' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 62.22 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' HG21 ' A' ' 80' ' ' ILE . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.13 112.106 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.51 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.23 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.44 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.11 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 61.43 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 64.41 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.32 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 70.53 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 71.3 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 31.52 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.03 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 72.51 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.404 HG21 ' HD1' ' A' ' 67' ' ' TYR . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.41 111.6 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.43 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 62.41 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 60.41 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 70.25 110.669 -178.631 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.099 0.407 . . . . 54.0 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HB2' HG22 ' A' ' 94' ' ' VAL . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 62.14 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 65.41 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 72.04 107.615 171.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.21 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' HG21 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.12 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.14 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 64.41 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.11 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.11 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.05 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.44 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 52.24 110.818 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.42 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 91' ' ' PRO . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.41 111.128 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.2 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.54 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.24 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 70.21 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 71.31 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 72.35 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 42.32 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.21 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.35 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.32 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 64.53 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.44 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.44 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.05 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.24 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.44 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.13 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 63.34 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.34 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.21 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 62.14 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 64.24 108.891 175.191 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 119.133 -0.461 . . . . 53.13 110.527 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 63.43 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 72.43 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 60.2 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.1 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 64.12 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.42 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 70.2 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.42 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.33 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.492 HG21 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 72.1 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.23 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 61.31 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.54 109.522 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 62.24 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.11 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 71.32 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 74.12 111.163 173.148 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.53 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 74.31 111.408 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 64.12 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 64.0 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 71.33 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.53 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.12 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.42 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 52.5 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 55.53 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 51.31 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 70.11 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.568 ' HE2' HD21 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.43 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 64.25 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 62.14 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.1 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.45 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.14 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.41 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 53.15 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 60.4 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.22 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.24 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 70.33 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.43 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 64.41 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 70.14 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.3 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 73.13 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 65.22 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 51.44 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 63.42 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 63.41 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 65.12 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 62.32 111.781 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 71.12 111.617 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 63.14 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 64.45 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.33 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.54 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 61.13 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 74.43 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.02 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.03 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.33 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.4 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 74.43 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.44 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.23 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.13 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.3 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.12 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 72.32 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 52.3 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 65.33 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 64.02 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.42 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.54 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 51.32 106.251 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 79' ' ' GLU . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 72.35 111.874 -166.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 52.34 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 71.41 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 76' ' ' THR . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.45 110.669 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 70.21 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.3 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.21 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.15 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.42 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.34 110.529 -178.192 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 71.52 108.029 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.43 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.21 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.54 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 44.44 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 71.11 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.12 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 62.34 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.24 110.868 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.33 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.23 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 31.34 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 53.52 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.01 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.13 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.31 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.24 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.417 ' CG2' HD23 ' A' ' 112' ' ' LEU . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 54.1 109.1 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 64.45 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.51 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.33 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 72.24 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.424 ' N ' HD12 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.35 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.22 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.15 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 44.52 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.52 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.53 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 55.24 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.14 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.04 112.226 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.02 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.24 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.43 110.869 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.24 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.44 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.1 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.31 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 63.44 109.536 -172.449 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.006 -0.521 . . . . 70.23 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.43 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.01 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 71.25 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.546 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 73.24 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.04 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 73.24 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.442 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 54.12 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 71.42 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.33 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 70.3 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 61.15 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 74.22 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 73.42 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.13 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.32 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.23 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 64.52 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 63.02 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 65.2 111.031 179.453 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.374 0.138 . . . . 75.2 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.01 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.21 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 55.44 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 61.21 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 55.03 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 62.55 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 52.24 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.02 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.44 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 54.53 111.597 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 63.31 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 61.44 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 61.11 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 71.24 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 64.4 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 61.33 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 32.1 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.14 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.42 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 61.12 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 64.33 111.151 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.33 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 64.24 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.3 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.411 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 43.44 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 53.54 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.51 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.24 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.21 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.46 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 63.23 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 63.31 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.23 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 64.42 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.21 110.966 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 72.32 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.443 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 63.35 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 71.41 110.078 176.405 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 46' ' ' ILE . 1.2 mptm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 71.32 109.873 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 152' ' ' ARG . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 64.41 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.04 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.31 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.4 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.43 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.44 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.24 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.14 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.13 110.244 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.31 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 72.14 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.22 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 64.25 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.12 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.33 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.42 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 72.45 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.13 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 72.32 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 64.44 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.01 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.14 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 55.42 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.31 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.2 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 71.25 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 63.14 111.5 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 54.53 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.04 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 71.13 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.11 110.18 176.482 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.537 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 109.8 -0.444 . . . . 62.11 109.8 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 54.43 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.52 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.01 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 62.15 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.23 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 24.21 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 63.34 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 73.03 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.22 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 53.45 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.55 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.11 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 65.21 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.34 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.11 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 55.24 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.12 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.15 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.2 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 71.41 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 72.43 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 71.11 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.24 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.13 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 72.31 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.13 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 70.43 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.35 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.13 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.24 112.415 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.42 112.221 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.04 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.3 111.53 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 72.11 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.31 112.797 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 63.21 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 62.51 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.3 108.751 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 137' ' ' TYR . 4.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 112.404 0.52 . . . . 72.43 112.404 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.04 113.828 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.12 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.405 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 73.12 110.454 175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.24 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 65.22 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.34 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 62.21 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 72.4 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.31 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 71.4 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.41 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 64.14 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 71.3 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.03 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.03 109.778 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.31 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 64.51 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 53' ' ' VAL . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 64.51 109.935 174.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 63.54 112.204 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.122 -0.695 . . . . 74.03 109.122 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 62.11 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.33 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.04 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.21 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 71.52 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 72.03 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.01 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.54 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 72.5 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 63.45 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 64.52 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 65.12 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 52.14 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.55 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.53 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.44 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.32 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 52.2 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.11 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.42 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.725 ' HD2' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 74.41 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.447 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 71.34 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.43 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.11 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.51 108.102 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 72.43 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.3 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.24 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 74.51 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 62.24 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.469 ' H ' HG13 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 73.13 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 62.21 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.22 111.334 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.24 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.13 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.14 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 51.34 111.354 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 73.4 111.784 171.561 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.22 111.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 64.24 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.2 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 64.4 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.23 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.33 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 61.04 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 61.33 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.11 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 72.52 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.01 110.478 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 65.21 112.657 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.14 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 73.14 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 70.05 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.04 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.12 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 53.05 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 70.55 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.44 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 64.22 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 72.34 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 65.0 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 78' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.12 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 53.11 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 53.21 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.24 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 62.23 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.12 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 61.32 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' PHE . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.24 111.182 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.51 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.42 109.532 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 . . . . . 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 73.51 106.061 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.22 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 72.41 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.12 108.124 172.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.32 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.53 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.24 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.45 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.14 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.51 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.14 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.41 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.23 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.52 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.33 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.35 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 34.0 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.51 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 72.14 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 71.24 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.44 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.24 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.11 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.04 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 55.55 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.14 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 64.1 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.43 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 70.12 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.53 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 71.25 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.12 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.12 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.45 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.01 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 32.54 113.539 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.34 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.23 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.33 111.907 -176.621 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 118.984 -0.532 . . . . 53.35 110.979 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.1 116.253 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.41 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.32 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 51.3 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 70.43 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 74.44 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.4 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 61.11 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 64.21 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.52 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.02 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.12 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 64.42 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.54 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.42 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 61.05 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.34 110.624 166.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 62.11 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.02 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.21 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.593 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 43.03 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.02 111.785 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 63.24 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.3 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 60.04 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 63.44 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.11 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 51.54 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.1 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.13 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.35 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.11 109.242 170.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 54.35 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.55 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.41 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.14 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.43 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 63.01 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 70.11 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 33' ' ' VAL . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.11 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 74.12 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 63.1 112.159 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 71.05 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.14 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 72.42 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.32 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.44 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.13 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 72.31 111.478 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.52 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.4 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 62.12 111.195 173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 71.35 110.306 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.04 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.44 110.645 175.672 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' HD12 ' A' ' 153' ' ' LEU . 29.2 mmtp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.173 0.511 . . . . 63.23 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.54 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 72.3 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 71.43 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.43 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 64.12 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 74.32 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.31 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.22 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 72.52 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.41 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.42 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 71.53 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 73.05 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG13 ' HB1' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 64.4 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.22 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.51 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 51.41 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 63.43 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.34 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 72.21 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 52.4 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.23 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.35 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.22 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 72.02 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.34 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.12 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 74.44 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 51.11 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 55.03 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.52 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.31 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.44 109.791 -176.099 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 119.04 -0.505 . . . . 75.13 109.863 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.13 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 41.51 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 72.4 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 63.34 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 73.34 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.44 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 65.45 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.51 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.14 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.23 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 61.14 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 53.5 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 63.54 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.22 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 55.14 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.3 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.14 109.23 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.32 110.879 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.52 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.04 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HA ' HG22 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.13 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.466 ' N ' HD12 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 71.54 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 64.15 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.42 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.34 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 62.52 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.44 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 62.02 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 63.24 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.23 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.31 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 72.01 111.6 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.22 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.31 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 62.24 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.12 108.099 175.536 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 70.24 109.053 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.45 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.24 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 64.31 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.22 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.21 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HG3' HG11 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.41 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.13 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 42.33 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 71.41 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.3 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.11 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 74.45 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 64.43 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 64.23 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.43 108.821 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.12 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 64.41 110.346 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.351 0.119 . . . . 73.12 111.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 72.45 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 71.12 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.14 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.34 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 62.35 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.12 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 63.31 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.52 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.34 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.43 110.767 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 51.43 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.13 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.12 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.12 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' TYR . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.53 109.815 174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 72.32 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 53.11 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 71.13 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.22 112.911 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HB3' HD21 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.52 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 73.32 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 72.21 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.34 108.882 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 63.35 113.187 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.44 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 55.34 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.53 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 72.42 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 72.21 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 65.32 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.14 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.3 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 72.21 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.4 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 52.21 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 72.21 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.596 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.24 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 54.22 109.947 174.372 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm . . . . . 0 C--O 1.243 0.758 0 CA-C-O 122.154 0.978 . . . . 64.2 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 54.23 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 60.45 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 73.44 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 73.11 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 70.55 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 60.25 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.35 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 73.41 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.24 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.15 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.44 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.14 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 61.33 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 64.35 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.21 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.23 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.12 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 62.13 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 64.14 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 71.31 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.05 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.408 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.13 108.387 174.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 55.21 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.22 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.12 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.11 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.21 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 63.1 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 71.43 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 72.12 111.786 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 70.01 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 62.45 110.649 -173.396 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 119.366 -0.35 . . . . 74.22 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.33 110.558 171.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.14 109.209 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 62.33 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 63.4 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.31 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 52.22 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 71.25 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.22 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 72.24 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 54.2 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 44.3 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 73.34 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.51 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 51.31 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 53.43 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 74.1 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.3 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.43 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 73.54 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 71.15 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.05 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.11 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.34 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 72.23 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.41 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 123' ' ' VAL . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 71.04 109.654 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 63.23 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.2 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.14 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.15 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.475 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 63.04 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.21 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.24 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 73.03 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.23 106.785 170.715 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 119.465 -0.302 . . . . 74.23 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 61.22 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 51.51 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.22 111.508 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 72.2 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 64.15 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.35 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.14 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.51 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 55.05 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.33 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 54.05 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.35 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.571 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 70.31 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.32 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 71.41 109.421 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.34 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.23 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.15 109.17 173.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.31 112.651 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 110.227 -0.286 . . . . 74.33 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.41 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 63.31 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 61.23 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.407 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.02 112.219 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.31 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.52 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 63.42 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 52.13 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 71.42 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 63.45 110.635 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 70.21 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 72.33 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 71.01 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 62.43 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.21 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 72.12 109.663 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 71.3 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.51 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.35 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 70.11 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.511 ' HD3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.4 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.11 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.45 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.03 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.33 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.44 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 64.42 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.44 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.11 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG22 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 73.41 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 72.42 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 74.42 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 62.23 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 64.32 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 55.12 111.134 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.1 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 63.23 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.31 109.954 175.615 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.52 110.283 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 43.0 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 53.55 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.24 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.35 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.11 109.864 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.31 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.44 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.02 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.44 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 51.21 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.34 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.34 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.32 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 53.13 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 71.42 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 73.44 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.14 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.24 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.42 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.33 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.41 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.52 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 71.51 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 71.34 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 55.25 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 52.04 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 54.44 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.54 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 74.31 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.21 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 74.21 110.538 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 119.337 -0.363 . . . . 64.14 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' HG22 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 61.45 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.02 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 54.43 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.03 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.05 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 61.13 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 71.5 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.34 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.42 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.2 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 55.24 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 53.41 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.34 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.32 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.43 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.52 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 71.2 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.34 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 72.0 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 72.34 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 54.23 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.24 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 72.4 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.511 HG23 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.21 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 63.14 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.11 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.22 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.43 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.3 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.41 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 53.21 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.23 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.54 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.34 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.55 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 55.14 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.02 109.197 179.576 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.678 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 72.35 109.967 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.498 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.44 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.21 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.2 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB3' HG22 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 73.24 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.23 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 54.43 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.432 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.52 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.34 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.11 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.24 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.33 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 72.31 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 71.31 109.487 -178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.51 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.15 108.638 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 73.5 109.45 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 54.42 111.108 172.469 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 11' ' ' THR . 1.9 m . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.1 108.436 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 70.23 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 65.03 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 65.33 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.33 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.22 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.01 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.44 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.32 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.22 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 54.12 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.02 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 65.32 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 60.21 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.42 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.44 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 64.43 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.42 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 52.2 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.42 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 63.23 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.22 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.441 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.32 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.22 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.43 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 64.13 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.2 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 70.12 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 73.42 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.1 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.463 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.14 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.04 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 71.02 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 54.41 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 54.12 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.573 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.21 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 70.23 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 70.25 110.488 174.537 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.252 0.549 . . . . 62.31 112.435 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 61.54 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.41 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 72.43 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.31 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.4 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 62.12 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.4 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.41 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.14 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 53.34 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.22 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 64.05 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 63.34 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HA ' HD12 ' A' ' 70' ' ' LEU . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.52 111.376 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.15 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 70.15 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 67' ' ' TYR . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.21 110.397 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.35 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.13 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.31 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.23 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.12 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.14 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.42 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.31 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 61.34 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 71.24 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 72.42 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 71.21 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.52 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.41 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.22 110.6 -177.028 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.216 -0.421 . . . . 74.43 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.35 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 52.5 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 64.32 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 61.0 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 51.1 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.11 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.14 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.44 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.31 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.41 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 62.03 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 52.2 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.32 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 55.12 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.13 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 60.22 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 64.43 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.23 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.14 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.42 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.32 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.13 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.34 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.32 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.11 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.32 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 54.23 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 44.24 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 65.11 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.23 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.13 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.14 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 43.14 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.24 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.12 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.01 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.11 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' HD11 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 53.13 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.3 110.744 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 118.738 -0.648 . . . . 75.42 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.05 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.24 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.31 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 64.24 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.21 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 64.03 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.43 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.01 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.3 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.03 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 70.2 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.2 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 65.2 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.13 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 73.01 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.13 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 52.2 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 153' ' ' LEU . 14.1 mt . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 60.43 110.81 167.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 109.965 -0.383 . . . . 63.22 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.13 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.11 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 55.01 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 70.33 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 71.11 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 61.1 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.45 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 63.54 111.431 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.32 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.53 110.558 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 64.12 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 72.34 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.15 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.54 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 71.53 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.43 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 42.33 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 71.23 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.32 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.35 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.45 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 62.53 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 65.53 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 74.13 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.44 109.338 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.43 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.34 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.21 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.12 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 38' ' ' VAL . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.3 111.004 -176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.475 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 51.35 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.4 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 72.54 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.51 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.23 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.459 HD12 HD23 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.4 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 60.41 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.45 111.474 176.767 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.925 0.393 . . . . 75.54 111.104 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.24 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 23.02 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 70.45 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.32 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.24 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 61.12 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.32 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 71.51 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 55.32 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.24 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 73.54 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 71.34 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 54.33 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 72.2 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.01 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.3 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 44.21 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 55.15 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.41 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.44 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.34 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.579 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 63.41 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 63.2 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.52 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.44 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.33 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.11 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.23 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.42 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.433 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 70.55 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 60.23 111.511 -177.467 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 64.33 106.919 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.24 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.14 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.23 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.31 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 73.55 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 65.35 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 70.12 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.42 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.41 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.4 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 64.22 111.293 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.43 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 73.03 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 71.42 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 53.32 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 64.33 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 43.42 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 62.34 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.44 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.12 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.24 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 64.15 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.3 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.33 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 64.43 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 72.14 111.39 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.12 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 123' ' ' VAL . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 72.35 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 42.41 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.24 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 119' ' ' TYR . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.02 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 71.51 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.11 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 74.34 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.33 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 60.53 111.888 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.21 108.849 176.12 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 15.0 t70 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 112.032 0.382 . . . . 74.2 112.032 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 72.2 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.11 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.02 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.44 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.41 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.434 ' HG3' HG11 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.3 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.33 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 54.44 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.21 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.42 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.44 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 63.4 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 65.43 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.472 HG12 HG22 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 63.43 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.23 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.521 ' HB3' HG13 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.35 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.11 109.047 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.42 107.504 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 46' ' ' ILE . 61.5 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.547 0.827 0 N-CA-C 113.066 0.765 . . . . 74.44 113.066 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 63.21 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 52.23 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.41 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.11 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.24 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 64.04 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 52.04 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.35 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 64.23 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.42 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 71.25 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.53 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.44 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 64.52 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.21 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 65.21 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 70.51 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 64.52 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.03 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 63.32 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.1 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 52.13 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.44 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 70.11 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.1 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.34 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.15 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 38' ' ' VAL . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 72.23 111.891 -171.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.494 ' H ' HG13 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 60.35 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.41 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.23 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.1 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 64.0 110.934 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.32 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 64.43 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.42 111.004 178.776 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.05 111.485 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.601 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.11 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 60.55 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.35 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.44 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 55.22 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.22 108.884 172.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.24 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.42 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.43 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 55.53 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.32 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 64.45 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.54 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 72.41 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.31 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.22 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 61.44 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 65.12 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 71.4 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.44 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.52 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.2 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 70.45 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 78' ' ' GLU . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.42 111.06 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.33 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 76' ' ' THR . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.44 111.121 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.31 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 71.43 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.42 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.32 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.15 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 73.4 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.44 111.014 -179.539 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.2 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 53.41 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.11 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 51.2 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 73.01 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.33 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 63.42 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.34 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.12 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 55.02 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.33 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.42 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 62.31 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 54.4 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.1 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 32.5 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 63.12 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 73.14 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 72.33 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.44 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.45 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 53.42 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 64.04 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.3 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.1 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 54.41 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 63.13 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.23 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.23 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.52 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.12 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 62.33 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.11 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.438 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 73.53 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 52.14 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.54 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.24 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.21 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.4 109.923 177.718 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 119.414 -0.327 . . . . 73.25 111.692 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.15 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.01 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 72.4 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 70.12 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 73.2 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.438 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 65.13 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.41 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 54.54 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.11 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 65.12 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 62.43 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.14 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.54 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 63.05 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.34 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 71.04 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 72.35 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt . . . . . 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 70.45 110.543 167.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.242 0.681 0 N-CA-C 108.231 -1.025 . . . . 31.13 108.231 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.616 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 55.12 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.41 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.32 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 52.12 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 71.25 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 72.35 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 54.24 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.12 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 54.22 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 62' ' ' THR . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 63.11 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.44 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 64.24 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 64.14 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.645 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 71.23 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.31 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 63.34 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 64.52 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.2 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 41.01 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.42 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.603 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 61.3 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.573 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 61.42 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.42 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.12 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.23 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.12 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.4 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 60.11 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.11 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.33 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 61.14 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 70.14 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.53 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.15 111.467 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 24.5 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.54 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 52.31 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 72.31 110.537 175.384 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.22 109.766 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 33.04 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.22 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.13 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 71.11 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 63.32 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.517 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.42 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 63.41 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.42 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 72.12 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.2 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.13 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.11 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.33 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.13 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.13 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.05 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.21 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 44.04 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 55.33 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 72.02 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 54.42 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.32 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.43 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.44 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 71.4 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.32 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 71.21 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.52 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 72.03 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 64.55 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.21 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.23 108.957 177.874 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.758 -0.163 . . . . 74.5 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 62.24 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.43 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.23 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.03 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.14 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 53.45 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.31 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.22 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 64.2 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.03 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.14 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 64.24 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 72.52 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.24 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.04 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.53 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.1 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 113' ' ' VAL . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 64.14 111.384 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.1 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.31 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 70.31 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 74.31 109.156 172.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 54.32 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 62.21 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 73.5 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.53 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 73.32 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 53.13 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.3 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.43 110.999 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.34 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 70.11 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.4 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.4 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.3 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 40.24 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.42 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.11 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 64.43 108.44 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 CA--C 1.553 1.082 0 CA-C-O 118.771 -0.633 . . . . 65.23 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.32 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 73.23 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.41 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 70.04 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.24 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 62.42 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.03 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.1 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.42 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.55 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.45 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 64.32 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.01 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.517 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 53.0 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.13 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.34 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.34 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 65.3 110.224 174.439 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 11' ' ' THR . 1.4 m . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.43 107.155 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.556 ' H ' HG22 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 71.55 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.32 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 53.23 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.01 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 64.15 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.03 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 55.44 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.11 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.2 111.822 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.33 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.24 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 64.03 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.44 ' HD1' HE22 ' A' ' 151' ' ' GLN . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.55 109.107 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.35 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 65.04 110.659 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.45 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.31 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 45.45 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 64.41 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.1 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.52 110.525 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.24 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.53 112.928 -171.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 60.23 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.31 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.42 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 40' ' ' THR . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.32 108.82 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 33.32 110.283 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 63.1 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.23 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.13 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.35 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 61.14 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.15 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.44 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.12 110.624 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 112.725 0.639 . . . . 61.12 112.725 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.44 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.21 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.43 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' HG ' ' HE3' ' A' ' 58' ' ' MET . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.34 109.14 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.32 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.492 ' HE3' ' HG ' ' A' ' 56' ' ' LEU . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 73.23 109.939 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 73.15 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 64.52 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 73.33 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.44 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.53 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.31 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.4 112.465 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.14 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 63.34 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.12 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.22 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.02 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.14 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.4 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.12 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.31 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.3 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.01 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.43 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.21 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.4 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.14 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.21 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.25 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.21 111.046 -179.338 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.24 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.21 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 60.04 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.41 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.03 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 65.15 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.35 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 70.35 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 71.52 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 45.22 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.23 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 42.43 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.23 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.11 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 70.13 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.14 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.44 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 71.41 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.44 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.22 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 72.54 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.44 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.23 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.14 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.04 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.12 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.22 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 74.33 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.54 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.35 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.1 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.43 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.21 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 65.15 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 71.15 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.43 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.31 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.51 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 72.12 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 70.32 110.849 177.604 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 64.23 110.112 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 52.45 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.42 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 64.31 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HB3' HG22 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 41.33 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 61.24 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.437 ' HG3' HG11 ' A' ' 123' ' ' VAL . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 62.01 110.535 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 62.33 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 73.53 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.22 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 73.34 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 62.34 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 73.45 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 72.22 109.58 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.11 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.43 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.45 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.44 HE22 ' HD1' ' A' ' 24' ' ' TYR . 20.7 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.45 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.542 173.243 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 12' ' ' TYR . 11.4 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 109.546 -0.538 . . . . 61.42 109.546 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.598 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 70.43 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 73.23 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 31.54 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 73.34 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.32 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 64.43 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.34 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 70.11 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.34 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.15 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.42 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HB ' ' HG3' ' A' ' 31' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 71.22 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.54 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.01 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.15 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 53.25 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.11 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.31 110.724 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.31 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 64.24 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.33 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 54.21 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.12 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 65.24 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.21 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.41 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.41 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.41 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.45 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.582 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 55.11 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 73.13 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 65.21 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.24 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.41 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.42 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 72.32 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.14 110.39 -178.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.349 0.5 . . . . 74.42 112.349 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 72.34 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.44 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.14 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 54.34 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 72.14 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.23 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 64.52 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.481 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 72.23 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 74.13 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 65.03 111.292 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.31 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 53.11 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 71.42 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 62.1 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.14 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 62.04 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.35 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 74.21 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.15 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.22 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.54 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.41 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.13 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.44 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.33 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.55 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 45.43 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 65.43 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 54.11 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 72.11 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 65.31 109.949 177.14 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.215 -0.661 . . . . 75.51 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.4 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.11 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.32 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 62.5 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 73.25 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.04 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 63.13 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 72.53 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.34 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 51.53 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 71.41 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.42 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 71.33 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.45 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.1 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.52 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.34 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 71.02 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.55 110.722 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 73.24 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.15 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.14 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 109' ' ' VAL . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.12 109.259 175.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.53 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 63.14 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.14 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.12 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.15 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.12 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.44 113.383 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.02 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.3 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.23 110.903 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.41 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.52 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 52.03 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.24 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 122' ' ' TYR . 52.1 m-70 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.43 108.505 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.4 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.44 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 71.34 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 51.41 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' HB3' HG22 ' A' ' 123' ' ' VAL . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.34 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.33 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.4 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 65.02 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.31 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.42 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 72.23 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.23 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.42 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.34 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.24 108.562 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.41 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.32 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 152' ' ' ARG . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.43 108.499 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 51.21 111.604 -179.438 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 64.15 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 64.22 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.11 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.33 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.33 111.629 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.02 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.1 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 43.4 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.22 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.14 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 43.51 109.699 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.04 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.52 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.31 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.44 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 54.13 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 61.03 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.22 113.647 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.12 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.33 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.22 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.35 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 62.34 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 61.31 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.31 111.154 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 74.42 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.34 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 61.44 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.43 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.04 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.51 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.521 ' H ' HG13 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.02 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.44 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 73.51 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.41 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.11 109.91 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 65.32 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 72.1 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 65.2 110.351 174.45 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HD2' HD23 ' A' ' 47' ' ' LEU . 45.1 mmtm . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.43 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 61.51 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.43 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 74.04 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.2 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.54 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.34 110.169 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.33 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.512 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.02 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 70.43 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.22 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.12 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 63.24 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.496 HG13 ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 61.44 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.32 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.42 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.51 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 73.33 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 72.23 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 44.12 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 74.32 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.51 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.33 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 54.13 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 52.21 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 63.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 73.41 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.414 HG22 ' HE1' ' A' ' 84' ' ' PHE . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 72.21 111.354 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.04 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.23 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.42 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.21 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 73.55 109.677 178.714 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 21.3 mmm180 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 114.196 1.184 . . . . 73.21 114.196 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 73.25 110.052 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 70.44 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.43 ' HD1' HD12 ' A' ' 149' ' ' ILE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.05 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.34 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 71.24 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.13 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 64.12 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 64.44 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.14 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.21 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.4 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.43 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.32 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 63.33 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 51.12 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.42 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 148' ' ' ILE . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 71.2 108.353 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 60.42 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.03 110.741 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 44.34 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 53.31 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 72.35 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' VAL . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.35 109.784 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.21 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 73.1 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.44 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.11 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.34 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 53.24 111.088 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 73.31 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.45 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.45 ' HB3' HE22 ' A' ' 140' ' ' GLN . 4.8 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.42 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.43 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 62.41 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.43 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.02 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.43 109.252 177.216 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 119.135 -0.46 . . . . 70.15 111.331 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 74.34 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.35 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.15 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 50.1 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 61.23 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.23 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 72.44 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.41 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.2 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.22 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 72.31 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.4 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 65.44 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.23 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' HD1' ' A' ' 93' ' ' PHE . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 63.43 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 52.44 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 60.12 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.2 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 64.23 111.82 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.622 0.248 . . . . 64.35 111.416 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 65.31 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.33 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.15 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.11 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 64.33 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 65.54 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 66' ' ' VAL . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.34 110.022 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 63.22 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 65.33 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.4 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.23 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.43 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 65.42 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 64.41 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 61.41 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 64.25 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.12 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.509 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.31 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.541 HD12 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.14 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 52.44 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.3 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 64.21 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 42.23 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.53 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.12 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.1 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 65.15 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.419 ' H ' HG13 ' A' ' 38' ' ' VAL . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 64.14 111.338 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 65.13 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG3' HD22 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.0 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.32 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 61.43 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.567 HD12 HD21 ' A' ' 153' ' ' LEU . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.02 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 73.23 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.14 110.988 176.598 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.362 0.601 . . . . 74.5 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 70.34 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 70.44 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.42 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 71.53 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 63.31 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.41 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 65.1 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.24 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 63.1 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.33 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 63.12 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.44 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 17' ' ' ALA . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.02 110.15 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.51 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.03 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 54.24 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 73.35 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 71.2 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 73.13 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 70.42 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.45 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 62.31 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 71.5 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.04 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.22 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.34 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 80' ' ' ILE . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 72.32 110.945 -173.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 73.04 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.03 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 65.11 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.21 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 33.24 111.887 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 119.305 -0.378 . . . . 74.35 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.04 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 61.35 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.44 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 54.12 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 61.5 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.32 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.33 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 62.22 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.15 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 62.03 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.11 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.41 111.306 177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.42 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.14 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 30.33 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 51.03 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 74.23 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 71.21 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 113' ' ' VAL . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.44 110.744 -172.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.14 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.02 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 71.2 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 109' ' ' VAL . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 52.21 109.045 172.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 71.11 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.41 113.135 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 62.45 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.14 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.33 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.31 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.32 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.02 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 51.15 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 71.54 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.21 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 50.41 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.13 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.23 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 . . . . . 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 64.43 109.84 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.23 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 55.14 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 74.33 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.22 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 128' ' ' ASP . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.35 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 70.05 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.23 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.04 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.42 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 30.33 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.02 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 72.13 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 71.11 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 73.55 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 50.23 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.44 108.984 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 51.33 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.45 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.42 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.41 109.999 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 46' ' ' ILE . 55.5 mt . . . . . 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 64.33 110.831 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.128 0.49 . . . . 72.34 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.13 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.12 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.4 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 65.12 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.34 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.34 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 25.41 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.54 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.13 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.53 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.12 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.41 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.32 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.41 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 53.51 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 55.43 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 51.45 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 51.41 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.567 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.32 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.22 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.11 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.2 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.11 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 70.44 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.1 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.22 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.1 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 72.51 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 64.14 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.43 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.516 ' H ' HG13 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.51 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.411 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.51 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.34 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.24 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 22.33 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 62.54 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.52 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 53.43 110.405 175.764 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 112.206 0.447 . . . . 71.03 112.206 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 54.12 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 44.12 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 71.53 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 70.12 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.43 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 42.11 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 71.32 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.12 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 71.51 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.41 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.51 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 54.55 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.24 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.587 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.31 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.31 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.43 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.22 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.21 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.413 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.13 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 61.25 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.04 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 62.43 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 72.31 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 61.11 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.33 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 65.55 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.23 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 71.33 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 71.21 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.42 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.12 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.24 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 61.2 112.721 -173.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.45 109.698 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 50.21 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 45.53 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.51 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.43 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.41 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 41.15 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.21 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 72.55 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.21 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 63.44 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 51.54 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.24 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.23 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 71.31 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 62.43 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 55.04 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.1 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.12 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 72.32 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.13 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 63.41 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.43 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.11 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 62.42 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.3 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.2 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 65.42 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.34 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.3 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.14 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.31 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 64.42 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 61.03 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 65.41 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.23 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.3 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.04 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.33 110.414 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 . . . . . 0 CA--C 1.556 1.207 0 CA-C-O 119.032 -0.509 . . . . 75.54 110.225 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.45 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.32 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.505 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.31 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.02 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 72.54 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.34 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.33 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.31 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 63.12 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.23 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.14 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.52 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.53 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 60.24 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.41 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.23 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.33 109.743 167.611 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HD1' ' A' ' 12' ' ' TYR . 9.7 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.589 -0.893 . . . . 51.24 108.589 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 50.31 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.23 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 18' ' ' THR . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.04 112.218 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.23 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.21 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.11 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 14' ' ' SER . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.3 111.763 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 54.43 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 70.01 112.177 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 45.14 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 73.55 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 63.02 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.34 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.15 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 63.1 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.05 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.04 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.34 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 74.43 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 61.04 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.21 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 71.13 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.02 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 71.35 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 70.34 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 71.3 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 54.12 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.33 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.45 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.15 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.34 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 63.12 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.11 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.4 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.13 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.53 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 64.14 111.541 179.805 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 120.873 0.368 . . . . 64.52 111.504 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 63.43 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 72.33 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.53 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.433 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 63.13 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.24 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 73.44 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 58' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 52.41 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.35 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.23 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 61.55 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 50.21 112.115 -172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.42 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 72.35 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.42 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.05 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 54.23 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.33 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.3 110.187 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.11 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 70.5 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.23 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.32 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 71.4 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 62.43 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 60.13 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 52.42 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.02 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.32 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 64.44 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 73.22 110.243 176.624 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 119.029 -0.51 . . . . 71.23 110.926 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 71.54 112.568 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 55.45 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.468 ' HD2' ' HB2' ' A' ' 83' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.32 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.23 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.573 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 1.5 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.31 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.2 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 74.21 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.41 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 61.35 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.2 110.665 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 65.51 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.2 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 62.13 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 43.33 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.429 ' CG2' HD23 ' A' ' 112' ' ' LEU . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 54.13 109.36 -175.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 53.41 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 72.55 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.1 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.54 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 64.15 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.471 ' N ' HD12 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 63.44 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.23 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 64.33 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 41.03 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 72.52 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.521 ' O ' HG23 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 72.34 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.24 111.641 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 55.41 111.365 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.11 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 65.51 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 72.02 111.844 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 72.02 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 63.35 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.22 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.33 112.354 -174.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 . . . . . 0 CA--C 1.562 1.406 0 CA-C-O 118.777 -0.63 . . . . 64.24 110.779 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.42 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 73.13 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 51.33 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.33 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.521 ' HG3' HG11 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 63.04 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.499 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 63.24 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.32 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.42 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.11 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.573 HG21 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 73.34 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.22 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.51 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 63.31 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.468 HD12 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.53 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.14 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.1 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.23 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 63.33 112.807 178.764 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 108.62 -0.881 . . . . 61.5 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.01 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.01 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.54 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 71.54 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.52 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' MET . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.32 110.613 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 62.02 111.062 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 63.54 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 72.2 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.53 109.969 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.43 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 54.2 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 71.35 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 36' ' ' SER . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 74.31 108.202 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.14 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 72.24 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.51 111.675 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.4 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 71.4 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.13 111.199 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 33' ' ' VAL . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.03 110.117 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 32' ' ' ILE . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.21 107.44 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 64.43 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.13 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.451 ' H ' ' HE2' ' A' ' 24' ' ' TYR . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 55.31 109.453 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 64.25 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 62.13 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 64.02 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 64.55 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 63.54 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 72.35 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.31 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.51 111.477 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 61.1 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.2 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.44 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 62.04 113.106 -170.986 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.17 0.509 . . . . 63.25 110.83 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 62.25 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.44 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.22 109.365 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 64.41 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.42 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.43 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.1 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 71.45 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.31 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.04 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 72.14 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.31 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.33 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.03 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.52 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.44 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.33 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.11 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 71.22 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.43 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.34 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.53 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 63.22 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.54 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.22 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.45 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.14 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.11 111.85 -176.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 70.54 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.14 111.94 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.11 109.873 170.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.13 111.332 179.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 71.43 109.444 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 63.51 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 71.14 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HD1' HD12 ' A' ' 149' ' ' ILE . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 64.51 107.934 174.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 72.52 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 63.41 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 24.34 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 55.54 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 63.3 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 41.22 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 54.22 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.31 111.172 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 73.12 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 54.51 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.54 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.1 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 62.42 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 63.41 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 64.23 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 70.14 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.33 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 73.22 113.016 -177.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 73.42 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.41 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.12 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.45 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 62.41 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.32 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.522 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.01 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.1 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 43.24 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.24 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 34.02 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.5 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.45 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 63.31 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 45.24 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 74.13 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 61.53 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 47.3 m80 . . . . . 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 63.03 110.906 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 112.212 0.449 . . . . 75.24 112.212 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD12 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.35 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.11 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 65.21 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.43 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.35 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 70.14 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.14 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 61.22 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.3 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 43.21 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 70.35 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 73.12 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.41 HD12 ' HD1' ' A' ' 93' ' ' PHE . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.11 109.175 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.32 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 72.13 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 62.34 109.744 170.85 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.652 0.739 . . . . 65.03 111.613 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 72.34 114.303 -163.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.53 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 53.01 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 74.24 110.896 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 65.02 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.35 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 64.34 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 54.32 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 64.14 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 43.4 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.2 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.548 HD12 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.11 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.23 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 72.34 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.667 HD21 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.04 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.33 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 62.53 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.41 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB2' HD21 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.42 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.24 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.513 HG13 HG12 ' A' ' 33' ' ' VAL . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 73.13 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 73.11 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.42 109.462 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 64.41 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.12 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.41 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 41' ' ' THR . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.21 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 44.02 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.437 ' H ' HG13 ' A' ' 38' ' ' VAL . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 70.3 111.423 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 73.52 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 54.53 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.14 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 32' ' ' ILE . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.14 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.53 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.32 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.43 111.142 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 26.7 mmtm . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 70.21 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 61.14 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.1 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.42 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 65.01 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 55.31 110.425 -175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 43.44 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.13 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.33 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 72.35 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.31 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.42 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.51 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 74.33 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 73.01 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 64.05 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 74.54 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 63.11 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.35 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.54 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.33 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.52 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 53.54 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.34 109.602 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' THR . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 62.34 111.876 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 73.14 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 52.14 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.11 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 54.43 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.15 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.41 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 61.12 109.647 -177.563 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 119.476 -0.297 . . . . 70.35 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 62.23 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.54 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 73.12 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.13 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 61.25 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.55 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.4 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 63.34 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.05 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.45 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 55.15 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 62.1 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 61.31 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 55.33 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.24 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.15 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 64.34 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.24 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.13 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.32 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.33 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 62.0 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.42 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.33 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 72.33 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.31 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 72.22 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 55.41 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 62.31 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 51.33 111.639 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.11 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.53 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 63.42 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.03 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.02 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.1 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 73.12 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 53.53 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 72.31 110.817 -176.937 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.55 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.23 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 71.22 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.33 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.41 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.54 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 34.11 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.13 109.242 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.34 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.31 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.14 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.4 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 71.33 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.3 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.03 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 70.22 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.11 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 65.44 109.444 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.44 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.44 112.773 -178.47 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 11' ' ' THR . 1.6 m . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 109.451 -0.574 . . . . 72.22 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.497 ' H ' HG22 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.12 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.41 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 64.01 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.52 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.34 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.11 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.14 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' CE2' ' A' ' 24' ' ' TYR . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 73.13 111.27 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 60.44 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.13 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.55 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 60.42 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.25 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 18' ' ' THR . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.24 108.589 169.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.43 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.21 110.458 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 73.01 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 64.03 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.03 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.11 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.41 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.4 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.41 111.517 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.51 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 44.5 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 62.14 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 40' ' ' THR . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 64.02 109.427 173.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.53 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 38' ' ' VAL . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 72.01 109.93 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.04 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 71.45 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.52 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.34 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 43.53 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.32 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 63.23 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.3 111.154 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.575 0.702 . . . . 73.51 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 71.41 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 33.02 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.22 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.23 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.22 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 62.23 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 61.42 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.21 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 61.24 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.21 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.14 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 74.11 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.54 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.44 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 73.22 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.1 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 73.44 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.24 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.23 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 72.52 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 60.04 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.42 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 73.1 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 64.23 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.13 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 55.42 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 70.52 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.21 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.54 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 72.52 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.3 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.41 110.766 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 64.54 110.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 72.12 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 73.11 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 73.33 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 73.05 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.24 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.01 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.13 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.45 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.43 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.31 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.12 111.148 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.32 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.43 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.12 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.44 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 71.22 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 33.45 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 45.42 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.22 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.34 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 72.34 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 62.1 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 71.43 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 70.42 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.42 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.44 111.486 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 53.3 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.489 ' O ' HG23 ' A' ' 123' ' ' VAL . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.22 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 62.23 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.41 112.924 174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.4 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 71.2 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.494 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.3 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 63.43 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 71.34 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.02 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.11 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 54.45 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 65.34 109.749 172.033 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.984 -0.532 . . . . 65.32 112.149 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.15 114.439 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 71.24 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 64.21 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 123' ' ' VAL . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.22 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.43 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 65.01 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 64.45 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 52.11 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.05 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 71.31 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.02 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 65.45 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 72.32 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 64.13 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.23 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' A' ' 56' ' ' LEU . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.31 108.56 171.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 61.33 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 64.5 111.506 -179.405 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 112.016 0.376 . . . . 62.24 112.016 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.95 -6.47 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.693 0.797 . . . . 72.43 111.306 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 150.13 29.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 124.616 1.167 . . . . 73.3 111.876 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.53 67.09 1.62 Allowed 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.756 2.97 . . . . 75.44 113.942 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.05 49.69 54.49 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 115.058 0.783 . . . . 44.52 115.058 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.82 89.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-O 121.42 0.629 . . . . 73.22 111.119 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.53 85.31 2.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.26 1.024 . . . . 65.23 109.744 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -162.77 147.22 11.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.77 1.228 . . . . 62.21 107.732 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB3' HE22 ' A' ' 151' ' ' GLN . 24.4 tp -68.94 118.14 11.49 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.496 -0.927 . . . . 63.35 108.496 172.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -77.18 174.56 10.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.748 1.219 . . . . 75.42 112.663 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.02 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.53 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.43 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 41.32 111.216 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 64.41 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.22 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 51.52 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 64.34 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 63.31 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 64.44 110.138 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 40.44 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.45 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 74.55 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 72.53 108.264 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 44.33 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.44 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 63.35 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.33 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 61.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.42 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 71.14 110.603 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 61.01 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 72.03 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 61.24 111.389 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.04 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.04 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.41 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 64.53 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 74.01 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 53.04 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.44 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.24 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 72.14 110.312 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.52 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 35.42 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.43 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.03 112.86 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -67.04 -38.45 85.87 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.53 110.437 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -100.11 170.13 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.727 0.811 . . . . 74.25 110.139 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.34 31.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.363 0.665 . . . . 41.43 110.425 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.79 86.26 5.38 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.316 1.055 . . . . 44.31 109.738 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.99 77.21 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.58 -1.191 . . . . 71.31 112.586 -170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.41 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 51.22 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.42 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 54.24 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.44 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 73.42 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.23 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.03 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 65.34 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 51.31 110.335 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 64.42 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.42 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' HB1' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 62.22 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' HG21 ' A' ' 80' ' ' ILE . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.13 112.106 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.51 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.23 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.44 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.11 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 61.43 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 64.41 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.32 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 70.53 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 71.3 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 31.52 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.03 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 72.51 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.404 HG21 ' HD1' ' A' ' 67' ' ' TYR . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.41 111.6 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.43 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 62.41 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 60.41 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -82.21 126.74 32.43 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 70.25 110.669 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -80.91 84.19 6.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.657 -0.868 . . . . 74.22 108.657 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -133.9 124.97 27.34 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.854 -0.795 . . . . 64.25 108.854 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.27 -55.07 4.94 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.087 -0.506 . . . . 74.01 112.053 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -172.92 3.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.78 1.232 . . . . 71.3 108.593 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -62.03 156.53 57.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 124.045 0.938 . . . . 54.0 112.099 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HB2' HG22 ' A' ' 94' ' ' VAL . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 62.14 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 65.41 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 72.04 107.615 171.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.21 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' HG21 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.12 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.14 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 64.41 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.11 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.11 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.05 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.44 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 52.24 110.818 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.42 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 91' ' ' PRO . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.41 111.128 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.2 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.54 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.24 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 70.21 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 71.31 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 72.35 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 42.32 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.21 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.35 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.32 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 64.53 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.44 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.44 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.05 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.24 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.44 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.13 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 63.34 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.34 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.21 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 64.22 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 62.14 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -143.79 9.53 1.54 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 64.24 108.891 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.9 p-10 -108.34 75.79 1.0 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.563 1.145 . . . . 70.02 109.29 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.99 1.9 2.5 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.985 1.314 . . . . 75.35 113.685 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.24 51.66 1.32 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 117.792 0.269 . . . . 50.31 112.915 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.532 ' HD2' HD23 ' A' ' 138' ' ' LEU . 58.0 ttm-85 -89.82 140.7 29.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.597 0.759 . . . . 75.53 109.955 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 -73.14 142.3 82.18 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 122.934 0.493 . . . . 53.13 110.527 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 63.43 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 72.43 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 60.2 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.1 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 64.12 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.42 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 70.2 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.42 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.33 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.492 HG21 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 72.1 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.23 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 61.31 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.43 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 9' ' ' LEU . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.54 109.522 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 62.24 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.627 HE22 ' HB3' ' A' ' 9' ' ' LEU . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.11 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 71.32 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.49 178.46 1.6 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 74.12 111.163 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 154' ' ' GLU . 2.7 mp0 -63.37 -62.99 1.31 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.743 1.217 . . . . 73.41 109.773 -168.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -83.32 132.15 35.03 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.068 -0.969 . . . . 63.32 108.691 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -170.21 177.84 4.05 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.153 0.981 . . . . 62.02 109.049 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -69.69 139.8 53.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.226 0.536 . . . . 64.34 110.701 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -144.27 162.51 36.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.569 1.148 . . . . 73.14 109.453 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.92 112.9 6.66 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.782 -0.821 . . . . 64.0 108.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.119 1.368 . . . . 42.24 109.717 -175.621 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 111.78 0.289 . . . . 64.15 111.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -102.49 12.47 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 122.985 0.514 . . . . 64.33 111.2 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.99 148.31 98.4 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.18 0.592 . . . . 74.14 110.645 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -51.27 157.04 4.84 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.2 2.6 . . . . 60.41 113.804 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.73 80.35 0.12 Allowed Glycine 0 C--N 1.348 1.22 0 O-C-N 123.7 0.625 . . . . 73.31 112.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.28 142.62 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.472 1.109 . . . . 74.01 109.264 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 132.57 41.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 122.756 0.423 . . . . 72.31 110.893 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 4.0 tppp? -74.31 -14.8 60.94 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.302 0.641 . . . . 74.11 110.12 171.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 tp -54.82 124.39 16.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.391 1.076 . . . . 72.53 110.939 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m -135.12 -174.55 3.64 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.31 108.115 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.53 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 74.31 111.408 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 64.12 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 64.0 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 71.33 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.53 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.12 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.42 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 52.5 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 55.53 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 51.31 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 70.11 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.568 ' HE2' HD21 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.43 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 64.25 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 62.14 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.1 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.45 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.14 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.41 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 53.15 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 60.4 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.22 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.24 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 70.33 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.43 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 64.41 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 70.14 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.3 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 73.13 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 65.22 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 51.44 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 63.42 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 63.41 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 65.12 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -76.01 -25.58 55.85 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 62.32 111.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 18.5 mm100 -74.85 161.57 29.44 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.84 0.456 . . . . 75.41 111.549 -175.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.23 63.7 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.309 -0.86 . . . . 72.34 111.405 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -111.09 170.77 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.105 0.962 . . . . 65.1 109.374 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -125.18 23.95 7.55 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 71.12 111.617 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 63.14 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 64.45 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.33 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.54 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 61.13 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 74.43 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.02 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.03 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.33 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.4 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 74.43 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.44 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.23 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.13 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.3 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.12 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 72.32 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 52.3 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 65.33 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 64.02 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.42 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.54 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 51.32 106.251 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 79' ' ' GLU . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 72.35 111.874 -166.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 52.34 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 71.41 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 76' ' ' THR . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.45 110.669 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 70.21 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.3 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.21 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.15 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.42 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 27.1 mm-40 -70.22 113.19 7.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.34 110.529 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -99.39 91.1 4.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.276 1.03 . . . . 71.33 108.881 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 85' ' ' GLU . 49.6 mtmt -127.1 -72.68 0.63 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.793 0.837 . . . . 64.12 109.972 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.29 -38.46 4.53 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 110.907 -0.877 . . . . 73.45 110.907 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -109.95 159.06 17.59 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.388 1.075 . . . . 63.21 109.95 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 -74.87 145.66 81.68 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 71.52 108.029 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.43 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.21 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.54 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 44.44 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 71.11 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.12 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 62.34 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.24 110.868 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.33 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.23 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 31.34 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 53.52 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.01 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.13 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.31 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.24 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.417 ' CG2' HD23 ' A' ' 112' ' ' LEU . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 54.1 109.1 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 64.45 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.51 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.33 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 72.24 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.424 ' N ' HD12 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.35 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.22 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.15 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 44.52 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.52 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.53 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 55.24 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.14 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.04 112.226 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.02 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.24 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.43 110.869 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.24 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.44 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.1 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.31 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -149.19 29.42 0.8 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 63.44 109.536 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.71 -89.23 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.978 0.511 . . . . 75.1 111.339 -172.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -118.58 0.99 11.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.089 0.556 . . . . 63.12 110.643 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.71 116.45 0.74 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.301 -0.72 . . . . 71.51 111.301 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.488 ' HD3' ' H ' ' A' ' 134' ' ' ASP . 14.7 tpp180 -161.02 137.69 8.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.989 0.516 . . . . 73.13 110.213 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 133' ' ' ARG . 3.1 m-20 -56.98 134.88 80.09 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.843 1.257 . . . . 70.23 110.788 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.43 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.01 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 71.25 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.546 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 73.24 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.04 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 73.24 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.442 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 54.12 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 71.42 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.33 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 70.3 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 61.15 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 74.22 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 73.42 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.13 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.32 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.23 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 64.52 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 63.02 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.31 156.23 22.83 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 65.2 111.031 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.33 -29.09 68.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.154 0.981 . . . . 72.23 113.36 -175.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -83.59 79.07 9.56 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.733 0.778 . . . . 75.32 111.712 -174.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -135.68 140.29 44.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.627 1.171 . . . . 70.22 108.319 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -128.16 147.14 50.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.741 0.816 . . . . 63.43 109.195 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -73.68 108.7 6.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.781 0.433 . . . . 74.22 109.868 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.56 140.95 53.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.869 0.868 . . . . 64.44 111.285 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.546 1.138 . . . . 61.54 108.038 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.652 ' HG3' HG11 ' A' ' 53' ' ' VAL . 24.6 ttt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.689 0.281 . . . . 63.34 110.517 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.33 92.26 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.359 -0.978 . . . . 52.14 108.359 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 5' ' ' GLY . 6.1 mt-10 -73.63 156.3 88.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.078 0.551 . . . . 73.21 111.198 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.09 -13.42 23.62 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.672 2.248 . . . . 63.23 111.57 161.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 3' ' ' GLU . . . 94.31 56.11 1.4 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.762 -0.653 . . . . 64.02 112.235 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.86 -48.84 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.032 0.533 . . . . 53.51 110.142 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.25 33.41 2.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.252 1.421 . . . . 23.24 112.476 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.57 88.59 1.26 Allowed 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.945 0.878 . . . . 75.21 110.475 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 149' ' ' ILE . 57.0 tp -149.58 123.1 9.11 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.841 -1.911 . . . . 74.54 105.841 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p -65.99 145.47 55.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.219 0.608 . . . . 75.2 111.374 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.01 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.21 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 55.44 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 61.21 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 55.03 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 62.55 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 52.24 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.02 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.44 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 54.53 111.597 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 63.31 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 61.44 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 61.11 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 71.24 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 64.4 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 61.33 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 32.1 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.14 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.42 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 61.12 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 64.33 111.151 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.33 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 64.24 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.3 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.411 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 43.44 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 53.54 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.51 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.24 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.21 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.46 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 63.23 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 63.31 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.23 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 64.42 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.21 110.966 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 72.32 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.443 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 63.35 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -66.17 -30.09 70.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 71.41 110.078 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -89.26 161.02 16.62 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.606 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -22.97 49.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.176 -0.676 . . . . 50.05 109.176 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.88 98.59 3.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.782 1.233 . . . . 65.12 109.249 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 46' ' ' ILE . 1.2 mptm? -86.9 54.94 3.35 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 71.32 109.873 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.652 HG11 ' HG3' ' A' ' 1' ' ' MET . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 64.41 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.04 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.31 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.4 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.43 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.44 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.24 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.14 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.13 110.244 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.31 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 72.14 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.22 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 64.25 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.12 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.33 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.42 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 72.45 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.13 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 72.32 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 64.44 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.01 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.14 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 55.42 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.31 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.2 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 71.25 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 63.14 111.5 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 54.53 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.04 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 71.13 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -76.3 142.1 41.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.11 110.18 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -77.18 79.01 3.71 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.097 -0.705 . . . . 53.14 109.097 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.97 157.07 41.59 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.091 0.956 . . . . 74.24 110.126 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.56 -82.95 0.47 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.159 -0.777 . . . . 60.21 111.159 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -132.15 -49.86 0.94 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.315 1.046 . . . . 74.42 109.38 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 -157.31 146.02 14.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.713 0.805 . . . . 62.11 109.8 -170.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 54.43 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.52 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.01 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 62.15 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.23 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 24.21 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 63.34 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 73.03 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.22 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 53.45 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.55 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.11 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 65.21 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.34 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.11 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 55.24 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.12 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.15 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.2 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 71.41 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 72.43 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 71.11 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.24 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.13 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 72.31 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.13 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 70.43 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.35 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.13 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.24 112.415 177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HE2' ' HB2' ' A' ' 130' ' ' ASP . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.42 112.221 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.04 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.3 111.53 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 72.11 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.31 112.797 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 63.21 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 62.51 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -112.34 -53.74 2.68 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.3 108.751 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' HB2' ' HE2' ' A' ' 122' ' ' TYR . 5.7 m-20 -88.87 76.26 7.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.108 -1.071 . . . . 73.44 108.108 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.8 p90 22.53 72.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 127.044 2.138 . . . . 74.24 114.164 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -100.12 -114.04 3.6 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.292 -0.867 . . . . 74.14 111.37 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -167.19 -169.92 1.38 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.43 1.092 . . . . 73.14 109.672 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 137' ' ' TYR . 4.8 m-20 -53.71 144.04 36.56 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 124.003 0.921 . . . . 72.43 112.404 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.04 113.828 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.12 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.405 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 73.12 110.454 175.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.24 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 65.22 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.34 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 62.21 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 72.4 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.31 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 71.4 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.41 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 64.14 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 71.3 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.03 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 9' ' ' LEU . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.03 109.778 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.31 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 64.51 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 53' ' ' VAL . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 64.51 109.935 174.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt -60.64 159.16 11.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 63.54 112.204 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.93 157.08 29.05 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.74 0.781 . . . . 64.22 111.44 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -116.82 95.6 5.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.842 -1.072 . . . . 73.41 108.125 -168.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -85.28 95.26 9.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.687 -0.688 . . . . 75.12 109.4 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -124.99 129.13 49.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.043 0.937 . . . . 61.41 109.998 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -80.61 70.64 7.38 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.026 -0.731 . . . . 74.44 109.026 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -164.81 173.04 12.19 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.842 1.657 . . . . 61.21 109.01 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.011 -0.737 . . . . 73.14 109.011 176.329 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 119.896 -0.097 . . . . 72.53 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.91 -7.98 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.153 0.581 . . . . 71.34 111.738 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -64.19 149.92 93.35 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.655 1.182 . . . . 73.0 110.759 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.59 21.12 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.949 2.432 . . . . 73.42 112.896 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.84 -68.77 0.29 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.623 -0.991 . . . . 73.22 110.623 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t 71.43 -59.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.14 1.776 . . . . 72.35 112.671 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.92 121.22 10.01 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.203 1.001 . . . . 42.34 113.233 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.1 134.67 33.22 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.819 0.848 . . . . 71.24 109.39 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -82.5 122.47 28.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.914 0.486 . . . . 52.15 109.944 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m -110.3 151.31 27.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.772 0.829 . . . . 74.03 109.122 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 62.11 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.33 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.04 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.21 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 71.52 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 72.03 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.01 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.54 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 72.5 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 63.45 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 64.52 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 65.12 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 52.14 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.55 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.53 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.44 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.32 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 52.2 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.11 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.42 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.725 ' HD2' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 74.41 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.447 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 71.34 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.43 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.11 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HB2' HH11 ' A' ' 133' ' ' ARG . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.51 108.102 -173.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 72.43 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.3 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.24 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 74.51 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 62.24 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.469 ' H ' HG13 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 73.13 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 62.21 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.22 111.334 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.24 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.13 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.14 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 51.34 111.354 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.12 -35.38 75.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 73.4 111.784 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 46' ' ' ILE . 1.8 mp0 -77.15 151.53 35.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.362 0.665 . . . . 72.54 111.155 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.33 -65.14 0.72 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.338 -0.846 . . . . 53.21 108.734 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.01 119.29 19.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.386 -0.968 . . . . 72.14 108.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -74.08 85.61 1.83 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.22 111.96 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 64.24 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.2 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 64.4 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.23 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.33 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 61.04 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 61.33 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.11 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 72.52 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.01 110.478 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 65.21 112.657 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.14 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 73.14 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 70.05 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.04 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.12 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 53.05 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 70.55 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.44 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 64.22 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.02 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 72.34 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 65.0 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 78' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.12 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 53.11 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 53.21 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.24 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 62.23 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.12 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 61.32 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' PHE . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.24 111.182 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.51 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 -72.28 -30.83 65.21 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.42 109.532 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 57.15 66.59 1.13 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.656 1.582 . . . . 74.41 111.154 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -91.44 3.58 54.6 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.694 -1.139 . . . . 72.34 110.365 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.93 -101.76 0.65 Allowed Glycine 0 C--N 1.359 1.836 0 N-CA-C 111.111 -0.796 . . . . 74.12 111.111 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -143.96 -61.69 0.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.032 0.933 . . . . 72.43 109.404 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -121.0 133.31 24.12 Favored Pre-proline 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 73.51 106.061 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.22 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 72.41 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.12 108.124 172.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.32 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.53 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.24 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.45 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.14 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.51 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.14 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.41 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.23 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.52 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.33 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.35 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 34.0 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.51 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 72.14 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 71.24 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.44 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.24 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.11 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.04 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 55.55 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.14 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 64.1 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.43 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 70.12 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.53 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 71.25 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.12 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.12 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.45 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.01 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 32.54 113.539 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.34 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.23 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -126.99 3.33 6.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.33 111.907 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -168.25 92.3 0.33 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.08 0.552 . . . . 63.1 110.874 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.6 p90 44.73 22.75 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.742 1.617 . . . . 75.42 115.017 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.5 -118.34 0.05 OUTLIER Glycine 0 C--N 1.347 1.182 0 O-C-N 123.463 0.477 . . . . 64.34 112.734 -173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 35' ' ' GLU . 26.1 ptt180 -171.04 -177.92 2.33 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.373 0.587 . . . . 72.51 110.819 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 143.2 98.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 123.912 0.757 . . . . 53.35 110.979 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.1 116.253 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.41 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.32 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 51.3 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 70.43 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 74.44 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.4 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 61.11 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 64.21 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.52 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.02 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.12 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 64.42 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.54 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.42 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 61.05 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt -71.07 171.61 10.6 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.34 110.624 166.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.4 126.21 27.54 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.786 . . . . 72.25 111.304 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 m170 71.7 8.04 6.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.677 1.591 . . . . 75.44 112.378 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -85.26 64.92 8.94 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.619 1.199 . . . . 72.45 108.566 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -98.8 64.53 1.47 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.358 -1.292 . . . . 74.31 107.746 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -76.91 137.25 38.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.567 -1.197 . . . . 74.12 110.213 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -166.55 163.81 17.02 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.359 0.664 . . . . 74.01 109.818 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 107.897 -1.149 . . . . 74.04 107.897 170.822 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.651 -0.5 . . . . 73.32 109.651 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.32 90.02 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.059 -1.83 . . . . 74.41 106.059 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 67.41 162.03 0.14 Allowed Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 125.419 1.487 . . . . 75.32 111.561 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -56.66 167.84 2.65 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.32 2.013 . . . . 72.41 112.674 164.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.95 71.31 1.95 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.32 -0.4 . . . . 73.11 112.839 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.41 68.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.044 0.937 . . . . 74.23 110.444 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.22 144.52 44.68 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.561 -0.745 . . . . 62.3 110.86 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -85.54 8.06 20.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.045 0.938 . . . . 72.13 110.841 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD21 HE22 ' A' ' 151' ' ' GLN . 56.0 tp -59.28 113.92 2.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.355 1.062 . . . . 71.2 110.996 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m -121.97 162.9 20.26 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 62.11 107.618 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.02 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.21 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.593 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 43.03 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.02 111.785 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 63.24 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.3 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 60.04 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 63.44 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.11 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 51.54 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.1 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.13 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.35 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.11 109.242 170.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 54.35 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.55 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.41 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.14 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.43 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 63.01 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 70.11 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.654 HG22 HE21 ' A' ' 49' ' ' GLN . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.11 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 74.12 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.484 HD22 ' HD2' ' A' ' 131' ' ' PHE . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 63.1 112.159 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 71.05 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.14 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 72.42 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.11 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.32 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.44 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.13 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 72.31 111.478 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.52 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.4 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 62.12 111.195 173.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 71.35 110.306 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.04 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -70.58 -36.63 73.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.44 110.645 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.654 HE21 HG22 ' A' ' 32' ' ' ILE . 10.6 mm-40 -81.82 177.87 8.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.485 0.714 . . . . 64.1 110.963 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.26 -54.84 14.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.555 0.742 . . . . 40.24 111.426 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -92.32 161.2 14.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.484 -0.78 . . . . 64.22 110.933 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' HD12 ' A' ' 153' ' ' LEU . 29.2 mmtp -105.9 32.76 4.15 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.102 0.961 . . . . 63.23 110.962 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.54 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 72.3 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 71.43 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.43 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 64.12 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 74.32 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.31 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.22 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 72.52 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.41 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.42 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 71.53 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 73.05 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG13 ' HB1' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 64.4 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.22 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.51 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 51.41 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 63.43 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.34 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 72.21 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 52.4 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.23 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.35 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.22 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 72.02 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.34 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.12 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 74.44 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 51.11 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 55.03 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.52 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.31 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -95.97 42.68 1.09 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.44 109.791 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -71.11 90.27 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.576 0.75 . . . . 71.15 110.009 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -87.38 76.76 9.03 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.61 -0.723 . . . . 74.23 109.496 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.18 -52.32 0.26 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.882 -0.887 . . . . 44.1 110.882 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.77 -176.81 3.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.827 0.851 . . . . 71.13 110.414 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -73.94 133.15 79.19 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.401 0.68 . . . . 75.13 109.863 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.13 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 41.51 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 72.4 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 63.34 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 73.34 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.44 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 65.45 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.51 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.14 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.23 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 61.14 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 53.5 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 63.54 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.22 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 55.14 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.3 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.14 109.23 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.32 110.879 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.52 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.04 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HA ' HG22 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.13 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.466 ' N ' HD12 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 71.54 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 64.15 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.42 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.34 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 62.52 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.44 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 62.02 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 63.24 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.23 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.31 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 72.01 111.6 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.22 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.31 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.23 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 62.24 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -143.99 15.6 1.73 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.12 108.099 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.44 -76.11 0.07 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.102 0.961 . . . . 72.2 109.111 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 34' ' ' ASN . 75.8 m-85 -153.42 17.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.464 1.506 . . . . 71.42 108.794 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.86 50.37 4.67 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 116.035 -0.529 . . . . 74.03 113.051 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HD3' ' HB2' ' A' ' 137' ' ' TYR . 3.0 ptp180 -79.42 -176.13 5.09 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.284 0.633 . . . . 61.43 109.912 172.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 -90.77 143.7 29.25 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 70.24 109.053 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.45 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.24 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 64.31 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.22 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.21 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HG3' HG11 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.41 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.13 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.13 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 42.33 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 71.41 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.3 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.11 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 74.45 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 64.43 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 64.23 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.456 HE22 HD21 ' A' ' 9' ' ' LEU . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.43 108.821 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.12 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -66.72 143.35 57.0 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 64.41 110.346 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.46 167.38 20.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.506 0.669 . . . . 71.32 111.563 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -159.56 -28.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.542 -1.208 . . . . 74.35 110.117 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -142.87 106.73 4.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 73.11 110.806 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -157.58 103.05 1.91 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.716 1.206 . . . . 65.41 108.908 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -83.1 -27.66 30.04 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.248 0.619 . . . . 73.43 110.794 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -167.11 -164.33 0.61 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.723 0.809 . . . . 74.04 110.444 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 117.829 -1.081 . . . . 73.2 109.626 177.325 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.055 -0.721 . . . . 71.43 109.055 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 m -154.93 69.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.45 1.5 . . . . 53.34 107.936 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -87.13 158.36 52.75 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 114.902 -1.045 . . . . 73.11 109.874 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.56 163.18 1.92 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.908 2.405 . . . . 73.4 113.817 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.91 69.3 1.26 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 112.086 -0.406 . . . . 74.1 112.086 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.87 74.3 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.783 1.278 . . . . 74.43 110.251 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB3' ' NH2' ' A' ' 152' ' ' ARG . . . -149.76 76.57 1.3 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.453 -1.249 . . . . 50.25 110.034 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -133.73 -179.99 5.88 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.928 -1.033 . . . . 73.25 109.197 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 HD21 ' A' ' 70' ' ' LEU . 43.4 tp -139.32 140.32 37.52 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.566 -1.272 . . . . 74.25 107.566 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -58.28 138.92 56.01 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.837 0.855 . . . . 73.12 111.07 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 72.45 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 71.12 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.14 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.34 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 62.35 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.12 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 63.31 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.52 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.34 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.43 110.767 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 51.43 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.13 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.12 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.12 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' TYR . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.53 109.815 174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 72.32 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 53.11 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 71.13 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.22 112.911 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HB3' HD21 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.52 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 73.32 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 72.21 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.34 108.882 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.686 HD22 ' HD3' ' A' ' 133' ' ' ARG . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 63.35 113.187 -173.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.44 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 55.34 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.53 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 72.42 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 72.21 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 65.32 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.14 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.3 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 72.21 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.4 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 52.21 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 72.21 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.596 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.24 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.91 -38.76 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 54.22 109.947 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -72.01 144.01 48.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.343 -0.614 . . . . 64.03 109.343 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.01 78.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.695 0.798 . . . . 53.22 110.853 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -81.44 131.11 35.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.323 0.649 . . . . 64.03 110.443 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm -94.08 66.87 3.59 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.197 0.999 . . . . 64.2 110.282 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 54.23 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 60.45 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 73.44 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 73.11 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 70.55 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 60.25 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.35 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 73.41 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.24 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.15 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.44 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.14 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 61.33 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 64.35 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.21 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.23 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 9' ' ' LEU . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.12 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 62.13 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 64.14 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 71.31 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.05 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.408 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.13 108.387 174.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 55.21 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.22 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.12 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.11 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.21 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 63.1 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 71.43 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 72.12 111.786 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 70.01 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.76 105.02 11.68 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 62.45 110.649 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.55 92.36 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.798 0.839 . . . . 74.33 109.014 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -120.5 26.62 9.05 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 72.43 111.438 -173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.43 -44.81 0.62 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 111.492 -0.643 . . . . 62.44 111.492 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 89' ' ' LYS . 8.5 mmpt? -122.16 172.18 8.45 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.968 0.907 . . . . 73.15 110.55 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -57.94 134.57 83.63 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 124.66 1.225 . . . . 74.22 110.881 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.33 110.558 171.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.14 109.209 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 62.33 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 63.4 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.31 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 52.22 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.24 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 71.25 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.22 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 72.24 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 54.2 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 44.3 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.21 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 73.34 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.51 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 51.31 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 53.43 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 74.1 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.3 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.43 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 73.54 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 71.15 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.05 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.11 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.34 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 72.23 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.41 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 123' ' ' VAL . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 71.04 109.654 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 63.23 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.2 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.14 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.15 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.475 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 63.04 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.21 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.24 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 73.03 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -126.33 -73.59 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.23 106.785 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 12.4 m-20 24.05 -88.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 126.013 2.07 . . . . 71.24 113.183 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -143.63 11.88 1.68 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 125.403 1.481 . . . . 75.11 109.359 171.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.32 104.06 1.66 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 111.857 -0.497 . . . . 74.23 111.857 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.686 ' HD3' HD22 ' A' ' 34' ' ' ASN . 28.1 ptt180 -152.99 -175.17 5.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.729 0.812 . . . . 74.33 110.592 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.94 143.58 70.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.095 0.558 . . . . 74.23 111.097 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 61.22 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 51.51 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.22 111.508 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 72.2 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 64.15 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.35 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.14 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.51 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 55.05 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.33 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 54.05 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.35 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.571 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 70.31 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.32 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.402 HG21 HD22 ' A' ' 9' ' ' LEU . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 71.41 109.421 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.34 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.23 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.431 ' NH2' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.15 109.17 173.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -62.59 146.2 52.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.31 112.651 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -45.76 68.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.476 1.511 . . . . 73.25 111.887 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -74.46 93.48 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 122.248 1.023 . . . . 74.13 109.539 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -79.96 163.99 23.84 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.717 -1.128 . . . . 74.21 111.179 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.8 m170 59.07 45.69 14.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.875 0.87 . . . . 63.23 108.817 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -63.7 118.8 8.79 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 115.208 -0.905 . . . . 72.13 112.122 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -101.51 10.04 40.74 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.649 1.179 . . . . 75.01 109.802 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.204 -1.776 . . . . 74.44 106.204 163.459 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.245 0.091 . . . . 64.3 111.245 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.92 60.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.292 -1.003 . . . . 75.22 108.292 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.36 165.09 13.33 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 114.831 -1.077 . . . . 62.53 109.096 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.86 2.18 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 121.777 1.651 . . . . 70.45 111.664 170.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.5 61.79 4.57 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.613 -0.267 . . . . 73.14 112.561 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HE3' ' A' ' 8' ' ' LYS . 28.8 m -125.15 141.98 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.884 0.874 . . . . 63.54 109.575 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . . . -159.8 109.96 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.145 0.578 . . . . 74.01 109.836 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -164.42 178.8 7.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.308 1.043 . . . . 74.41 109.291 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 149' ' ' ILE . 37.0 tp -111.69 150.87 29.57 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.012 -0.736 . . . . 70.11 109.012 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p -60.81 132.23 53.22 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.39 0.676 . . . . 74.33 110.227 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.41 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 63.31 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 61.23 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.407 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.02 112.219 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.31 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.52 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 63.42 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 52.13 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 71.42 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 63.45 110.635 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 70.21 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 72.33 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 71.01 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 62.43 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.21 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 72.12 109.663 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 71.3 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.51 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.35 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 70.11 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.706 ' HD2' ' HB3' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.4 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.11 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.45 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.03 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.33 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.44 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 64.42 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.44 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.11 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG22 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 73.41 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 72.42 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 74.42 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 62.23 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 64.32 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 55.12 111.134 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.1 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 63.23 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.85 -32.87 52.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.31 109.954 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 23.2 mm-40 -80.41 153.49 28.25 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.548 -0.751 . . . . 74.15 109.824 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.56 66.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.412 -0.813 . . . . 61.24 109.472 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.31 115.72 20.01 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.339 1.056 . . . . 74.02 109.007 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp -97.26 43.5 1.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.52 110.283 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 43.0 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 53.55 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.24 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.35 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.11 109.864 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.31 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.44 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.02 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.44 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 51.21 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.34 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.34 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.32 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 53.13 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 71.42 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 73.44 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.14 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.24 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.42 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.33 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.41 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.52 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 71.51 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 71.34 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 55.25 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 52.04 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 54.44 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.54 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 74.31 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.21 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -75.08 101.72 4.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 74.21 110.538 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.83 143.37 45.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.906 0.882 . . . . 55.11 109.712 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -108.54 -36.29 6.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.064 0.945 . . . . 70.41 110.04 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.08 -44.96 0.02 OUTLIER Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.382 -0.826 . . . . 62.02 111.171 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.26 140.77 48.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.711 -0.478 . . . . 63.35 109.711 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.48 135.15 88.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.376 1.071 . . . . 64.14 111.624 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' HG22 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 61.45 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.02 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 54.43 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.03 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.05 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 61.13 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 71.5 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.34 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.42 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.2 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 55.24 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 53.41 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.34 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.32 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.43 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.52 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 71.2 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.34 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 72.0 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 72.34 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 54.23 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.24 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 72.4 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.511 HG23 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.21 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 63.14 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.11 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.22 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.43 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.3 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.41 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 53.21 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.23 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.54 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.34 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.55 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 55.14 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.14 -56.73 1.17 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.02 109.197 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.706 ' HB3' ' HD2' ' A' ' 31' ' ' ARG . 45.4 m-20 -84.77 54.82 3.19 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.843 0.857 . . . . 71.22 110.694 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 p90 38.92 60.97 1.32 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 125.501 1.52 . . . . 74.35 112.675 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.78 -158.92 25.71 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.773 -1.103 . . . . 64.12 112.18 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -97.33 -178.23 4.09 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.906 -0.776 . . . . 64.13 108.906 175.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.678 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 -56.75 140.98 74.86 Favored Pre-proline 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 72.35 109.967 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.498 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.44 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.21 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.2 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB3' HG22 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 73.24 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.23 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 54.43 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.432 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.52 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.34 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.11 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.24 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.33 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 72.31 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 9' ' ' LEU . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 71.31 109.487 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.51 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.456 ' NE2' HG22 ' A' ' 149' ' ' ILE . 25.1 mm-40 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.15 108.638 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 73.5 109.45 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.87 179.15 4.43 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 54.42 111.108 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -71.4 -178.39 2.1 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 115.245 -0.889 . . . . 75.32 111.483 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.11 115.56 4.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.935 -0.765 . . . . 71.21 108.935 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -60.75 -33.12 72.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.943 0.897 . . . . 74.32 110.272 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.27 134.1 46.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.628 1.171 . . . . 71.11 108.308 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.44 81.99 4.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.707 0.765 . . . . 71.31 110.314 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -159.59 102.46 1.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.82 1.248 . . . . 72.24 109.039 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 CA--C 1.562 1.423 0 C-N-CA 124.875 1.27 . . . . 72.33 110.75 179.647 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.079 0.466 . . . . 71.5 110.101 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.8 t -125.36 126.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.752 -1.203 . . . . 70.22 107.752 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.08 160.65 48.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.71 0.804 . . . . 74.3 109.856 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HG2' HG13 ' A' ' 6' ' ' VAL . 94.6 Cg_endo -84.53 -165.76 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.425 2.084 . . . . 72.15 111.659 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.57 55.38 5.02 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 121.942 -0.17 . . . . 72.3 112.83 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG13 ' HG2' ' A' ' 4' ' ' PRO . 12.8 m -70.75 128.7 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.669 0.788 . . . . 55.22 111.02 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.03 -175.44 5.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.839 0.855 . . . . 73.32 110.269 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.82 90.49 0.06 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.701 1.2 . . . . 73.24 111.759 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp 57.92 74.19 0.44 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.595 1.158 . . . . 64.32 110.299 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 11' ' ' THR . 1.9 m -98.67 -174.77 2.88 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.1 108.436 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 70.23 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 65.03 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 65.33 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.33 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.22 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.01 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.44 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.32 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.22 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 54.12 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.02 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 65.32 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 60.21 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.42 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.44 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 73.14 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 64.43 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.42 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 52.2 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.42 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 63.23 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.22 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.441 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.32 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.22 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.43 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 64.13 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.2 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 70.12 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 73.42 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.1 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.463 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.14 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.04 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 71.02 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 54.41 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 54.12 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.573 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.21 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 70.23 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.12 -37.39 82.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 70.25 110.488 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -98.6 165.7 11.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.656 -1.156 . . . . 65.32 110.16 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.36 -61.07 2.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.663 0.785 . . . . 63.35 111.182 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.16 132.95 36.0 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.039 0.447 . . . . 61.51 110.207 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm -97.69 70.08 2.18 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.927 0.891 . . . . 62.31 112.435 -164.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 61.54 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.41 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 72.43 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.31 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.4 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 62.12 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.4 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.41 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.14 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 53.34 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.22 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 64.05 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 63.34 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HA ' HD12 ' A' ' 70' ' ' LEU . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.52 111.376 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.15 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 70.15 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 67' ' ' TYR . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.21 110.397 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.35 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.13 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.31 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.23 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.12 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.14 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.42 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.31 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 61.34 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 71.24 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 72.42 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 71.21 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.52 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.41 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.86 61.97 7.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.22 110.6 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -98.86 121.67 41.11 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.113 -0.699 . . . . 73.44 109.113 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 114.23 27.57 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.058 0.943 . . . . 71.1 109.683 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.94 13.57 60.54 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.374 0.421 . . . . 74.44 113.468 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 89' ' ' LYS . 1.3 tpmt? -160.0 157.0 27.97 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 71.22 108.727 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -59.8 131.23 88.85 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.227 0.611 . . . . 74.43 110.743 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.35 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 52.5 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 64.32 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 61.0 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 51.1 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.11 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.14 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.44 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.31 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.41 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 62.03 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 52.2 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.32 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 55.12 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.13 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 60.22 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 64.43 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.23 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.14 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.42 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.32 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.13 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.34 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.32 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.11 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.32 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 54.23 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 44.24 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 65.11 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.23 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.13 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.14 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 43.14 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.24 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.12 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.01 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.11 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' HD11 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 53.13 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.76 -29.5 6.75 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.3 110.744 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -125.47 61.6 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.647 0.379 . . . . 72.22 111.738 -167.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.4 p90 44.76 26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.117 1.767 . . . . 75.14 114.85 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.27 -90.77 0.03 OUTLIER Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.513 -0.635 . . . . 51.31 111.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -173.28 -176.27 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.607 0.763 . . . . 74.24 109.691 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.46 140.82 97.81 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.397 0.679 . . . . 75.42 110.836 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.05 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.24 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.31 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 64.24 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.21 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 64.03 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.43 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.01 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.3 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.03 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 70.2 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.2 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 65.2 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.13 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 73.01 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.13 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 52.2 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 153' ' ' LEU . 14.1 mt -67.59 171.9 5.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 60.43 110.81 167.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -59.82 -29.46 68.26 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.404 -1.271 . . . . 55.23 109.671 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -59.61 99.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.387 -1.279 . . . . 71.44 108.935 162.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.46 89.09 2.13 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.375 0.67 . . . . 63.13 110.614 -173.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -94.64 90.02 5.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.746 0.819 . . . . 63.21 109.671 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -116.34 39.42 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.839 0.828 . . . . 61.51 109.096 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -166.57 -41.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.132 -0.94 . . . . 71.41 109.406 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 106.715 -1.587 . . . . 71.12 106.715 -173.951 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.265 0.098 . . . . 73.21 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.9 m -112.49 108.34 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.927 0.87 . . . . 62.23 108.998 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -77.98 155.62 80.07 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.204 1.002 . . . . 65.53 109.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.86 147.68 24.71 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.846 2.364 . . . . 75.21 111.976 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.84 92.03 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 O-C-N 124.177 0.923 . . . . 72.11 112.549 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.14 158.07 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.154 0.982 . . . . 74.31 110.682 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.86 -173.87 4.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.022 0.439 . . . . 71.41 111.086 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 152' ' ' ARG . 13.6 ptpt -71.46 169.35 15.58 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.243 -0.889 . . . . 72.42 109.973 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.89 129.14 39.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.945 -0.761 . . . . 65.02 108.945 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -58.76 130.79 48.61 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.811 0.844 . . . . 63.22 109.965 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.13 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.11 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 55.01 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 70.33 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 71.11 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 61.1 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.45 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 63.54 111.431 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.32 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.53 110.558 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 64.12 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 72.34 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.15 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.54 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 71.53 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.43 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 42.33 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 71.23 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.32 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.35 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.45 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 62.53 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 65.53 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 74.13 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.44 109.338 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.43 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.34 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.21 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.12 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 38' ' ' VAL . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.3 111.004 -176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.475 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 51.35 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.4 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 72.54 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.51 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.23 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.459 HD12 HD23 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.4 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 60.41 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.51 -19.04 60.51 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.45 111.474 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 66.7 mm-40 -87.24 159.06 18.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.348 0.659 . . . . 63.33 110.16 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.96 96.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.015 0.926 . . . . 74.11 110.571 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.92 173.68 8.36 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.0 -1.0 . . . . 70.33 109.905 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp -134.73 50.8 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.306 0.642 . . . . 75.54 111.104 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.24 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 23.02 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 70.45 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.32 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.24 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 61.12 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.32 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 71.51 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 55.32 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.24 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 73.54 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 71.34 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 54.33 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 72.2 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.01 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.3 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 44.21 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 55.15 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.41 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.44 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.34 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.579 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 63.41 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 63.2 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.52 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.44 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.33 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.11 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.23 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.42 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.433 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 70.55 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.6 9.55 41.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 60.23 111.511 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -65.36 96.45 0.24 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.429 0.691 . . . . 63.22 110.046 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -101.82 -15.79 16.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.795 0.838 . . . . 75.33 111.478 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.45 -42.99 54.91 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.619 0.574 . . . . 74.23 112.467 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -79.94 0.56 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.36 -0.978 . . . . 61.35 108.36 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 178.17 142.15 0.27 Allowed Pre-proline 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 64.33 106.919 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.24 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.14 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.23 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.31 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 73.55 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 65.35 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 70.12 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.42 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.41 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.4 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 64.22 111.293 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.43 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 73.03 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 71.42 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 53.32 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 64.33 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 43.42 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 62.34 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.44 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.12 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.24 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 64.15 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.3 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.33 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 64.43 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 72.14 111.39 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.12 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 123' ' ' VAL . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.41 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 72.35 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 42.41 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.24 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 119' ' ' TYR . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.02 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 71.51 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.11 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 74.34 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.33 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 133' ' ' ARG . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 60.53 111.888 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -141.57 26.17 1.96 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.21 108.849 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -132.11 22.82 4.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.638 -1.165 . . . . 52.0 110.788 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.0 p90 47.7 32.66 2.67 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.226 1.01 . . . . 64.23 111.797 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.77 -106.0 3.08 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.571 -0.741 . . . . 62.4 113.422 -169.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -149.86 171.13 17.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.745 0.418 . . . . 70.3 111.664 -164.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 15.0 t70 -60.96 145.27 89.41 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.581 -1.191 . . . . 74.2 112.032 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 72.2 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.11 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.02 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.44 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.41 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.434 ' HG3' HG11 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.3 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.33 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 54.44 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.21 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.42 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.44 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 63.4 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 65.43 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.472 HG12 HG22 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 63.43 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.23 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.521 ' HB3' HG13 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.35 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.11 109.047 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.42 107.504 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 46' ' ' ILE . 61.5 mt -54.35 119.75 5.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.13 109.621 176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -44.97 -36.8 3.58 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.979 1.425 . . . . 72.53 112.819 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.33 139.41 6.9 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.273 -0.876 . . . . 74.15 109.737 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -102.11 174.12 6.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.057 0.943 . . . . 75.51 109.023 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.97 160.1 24.3 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.916 0.886 . . . . 73.23 109.021 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 63.19 92.57 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.599 1.16 . . . . 61.14 111.597 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.23 160.0 18.02 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.428 0.691 . . . . 62.05 109.456 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 118.966 -0.54 . . . . 72.24 109.91 179.737 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.735 -0.468 . . . . 61.11 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.31 152.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.34 0.656 . . . . 73.43 110.671 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -69.83 157.75 88.89 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.801 0.84 . . . . 75.02 110.761 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.74 26.32 0.32 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.072 2.515 . . . . 33.22 115.116 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.41 54.1 5.72 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.383 -0.287 . . . . 35.3 112.383 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.92 14.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.541 0.736 . . . . 72.33 111.624 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 102.62 11.3 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.884 0.874 . . . . 72.02 111.506 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -162.06 132.02 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.125 0.97 . . . . 61.53 108.494 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD22 ' H ' ' A' ' 10' ' ' THR . 2.1 tm? -94.39 154.32 17.53 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.278 -0.638 . . . . 75.52 109.278 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.573 ' H ' HD22 ' A' ' 9' ' ' LEU . 76.1 p -72.22 165.64 24.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.067 1.347 . . . . 74.44 113.066 -173.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 63.21 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 52.23 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.41 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.11 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.24 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 64.04 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 52.04 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.35 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 64.23 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.42 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 71.25 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.53 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.44 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 64.52 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.21 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 65.21 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 70.51 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 64.52 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.03 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 63.32 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.1 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 52.13 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.44 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 70.11 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.1 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.34 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.15 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 38' ' ' VAL . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 72.23 111.891 -171.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 ' H ' HG13 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 60.35 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.41 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.23 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.1 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 64.0 110.934 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.32 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 64.43 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -81.31 -27.86 34.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.42 111.004 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 85.4 mm-40 -84.42 154.34 22.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.06 0.544 . . . . 72.33 111.051 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.75 65.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.345 -0.843 . . . . 65.43 109.888 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.26 112.52 14.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.541 -0.911 . . . . 73.14 108.541 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm -92.48 40.31 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.05 111.485 -167.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.601 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.11 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 60.55 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.35 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.44 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 55.22 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.22 108.884 172.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.24 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.42 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.43 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 55.53 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.32 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 64.45 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.54 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 72.41 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.31 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.22 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 61.44 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 65.12 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 71.4 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.44 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.52 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.2 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 70.45 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 78' ' ' GLU . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.42 111.06 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.33 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 76' ' ' THR . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.44 111.121 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.31 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 71.43 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.42 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.32 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.15 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 73.4 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.98 35.89 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.44 111.014 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -62.17 -50.46 71.73 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.97 0.908 . . . . 72.32 112.014 -175.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? 49.42 27.49 2.01 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.227 1.411 . . . . 64.34 113.179 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.33 55.08 0.15 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.258 -0.737 . . . . 73.33 111.258 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -166.7 159.19 13.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.177 0.991 . . . . 64.43 108.539 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -75.84 114.81 40.45 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.2 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 53.41 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.11 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 51.2 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 73.01 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.33 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 63.42 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.34 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.12 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 55.02 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.33 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.42 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 62.31 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 54.4 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.1 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 32.5 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 63.12 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 73.14 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 72.33 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.44 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.45 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 53.42 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 64.04 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.3 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.1 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 54.41 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 63.13 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.23 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.23 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.52 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.12 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 62.33 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.11 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.438 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 73.53 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 52.14 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.54 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.24 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.21 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -112.84 -58.45 2.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.4 109.923 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.72 80.44 8.97 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.176 -0.466 . . . . 71.21 110.433 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.6 p90 40.48 38.86 0.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.591 1.556 . . . . 71.0 114.247 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.56 -113.5 0.25 Allowed Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.46 -0.791 . . . . 53.3 112.749 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -169.7 -174.68 1.92 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 63.31 109.477 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -54.7 141.27 56.8 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 73.25 111.692 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.15 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.01 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 72.4 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 70.12 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 73.2 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.438 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 65.13 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.41 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 54.54 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.11 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 65.12 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 62.43 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.14 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.54 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 63.05 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.34 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 71.04 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 72.35 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt -70.29 169.32 14.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 70.45 110.543 167.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.21 147.11 53.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.47 -0.786 . . . . 63.22 110.435 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.49 142.0 36.0 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.121 0.968 . . . . 63.14 109.519 -170.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -77.21 168.84 19.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.851 0.861 . . . . 75.33 111.481 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -67.69 94.05 0.41 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.507 -0.769 . . . . 62.15 109.848 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -84.8 53.5 2.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.216 1.407 . . . . 72.21 111.846 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -173.59 126.8 0.4 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 74.13 110.276 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.019 0.928 . . . . 51.31 109.972 171.242 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 110.197 -0.297 . . . . 73.45 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.75 -24.71 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 123.518 0.727 . . . . 72.24 111.522 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.7 pm0 -62.72 162.39 21.49 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.969 0.908 . . . . 70.31 110.774 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 56.5 Cg_endo -65.5 179.91 1.46 Allowed 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.362 2.042 . . . . 65.24 112.733 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.93 76.05 0.88 Allowed Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.83 -0.623 . . . . 60.22 112.564 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.57 165.75 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.868 0.867 . . . . 63.23 110.143 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.77 115.63 11.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.081 0.552 . . . . 72.25 110.624 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.15 -41.96 76.6 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -71.61 85.26 0.88 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.251 -1.018 . . . . 74.02 108.251 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -89.44 156.25 18.79 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.532 -1.213 . . . . 31.13 108.231 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.616 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 55.12 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.41 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.32 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 52.12 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 71.25 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 72.35 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 54.24 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.12 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 54.22 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 62' ' ' THR . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 63.11 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.44 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 64.24 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 64.14 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.645 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 71.23 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.31 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 63.34 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 64.52 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.2 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 41.01 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.42 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 61.3 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.573 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 61.42 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.42 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.12 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.23 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.12 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.4 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 60.11 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.11 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.33 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 61.14 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 70.14 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.53 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.15 111.467 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 24.5 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.54 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 52.31 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -67.71 -37.03 81.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 72.31 110.537 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 51' ' ' ASP . 58.4 tp60 -80.98 144.01 32.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.619 -0.719 . . . . 53.54 109.599 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.67 91.99 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.588 0.755 . . . . 65.23 110.208 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.519 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 9.9 m-20 -79.71 112.7 17.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.994 -1.003 . . . . 65.33 109.389 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm -86.5 70.19 10.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.22 109.766 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 33.04 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.22 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.13 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 71.11 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 63.32 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.517 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.42 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 63.41 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.42 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 72.12 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.2 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.13 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.11 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.33 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.13 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.13 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.05 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.21 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 44.04 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 55.33 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 72.02 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 54.42 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.32 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.43 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.44 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 71.4 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.32 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 71.21 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.52 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 72.03 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 64.55 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.21 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -95.82 44.3 1.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.23 108.957 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.58 117.45 11.21 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.002 -0.999 . . . . 75.14 111.617 -168.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -107.7 -17.05 14.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.31 1.044 . . . . 44.43 109.558 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.69 59.2 4.98 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.365 -0.834 . . . . 62.44 112.251 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 67.77 -79.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.576 1.55 . . . . 75.11 112.462 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -118.59 140.49 28.42 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.813 0.845 . . . . 74.5 111.084 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 62.24 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.43 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.23 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.03 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.14 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 53.45 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.31 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.22 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 64.2 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.03 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.14 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 64.24 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 72.52 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.24 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.04 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.53 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.1 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 113' ' ' VAL . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 64.14 111.384 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.1 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.31 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 70.31 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 74.31 109.156 172.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 54.32 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 62.21 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 73.5 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.53 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 73.32 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 53.13 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.3 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.43 110.999 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.34 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 70.11 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.416 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.4 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.4 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.3 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 40.24 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.42 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.11 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -108.25 -59.5 1.85 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 64.43 108.44 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.61 88.76 3.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.664 -0.698 . . . . 64.2 110.629 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.7 p90 42.13 33.27 0.37 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.056 1.742 . . . . 71.4 115.066 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.94 -105.18 0.07 OUTLIER Glycine 0 C--N 1.35 1.344 0 O-C-N 123.377 0.423 . . . . 61.34 112.05 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.75 1.46 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.771 0.828 . . . . 73.33 110.703 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.93 143.05 78.34 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.869 1.267 . . . . 65.23 111.322 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.32 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 73.23 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.41 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 70.04 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.24 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 62.42 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.03 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.1 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.42 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.55 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.45 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 64.32 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.01 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.517 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 53.0 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.13 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.34 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.34 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 172.65 3.85 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 65.3 110.224 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.56 173.71 1.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.514 0.673 . . . . 75.43 111.011 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -81.54 78.0 8.34 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.45 -0.796 . . . . 74.03 109.185 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -96.09 27.77 3.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.804 1.241 . . . . 71.14 110.023 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -54.27 -33.63 59.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.811 1.244 . . . . 70.13 112.956 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -73.11 88.17 1.43 Allowed 'General case' 0 C--N 1.361 1.068 0 CA-C-O 121.852 0.834 . . . . 75.35 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -132.53 -16.31 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.369 -1.287 . . . . 72.53 109.555 168.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.132 0.973 . . . . 71.3 108.675 176.612 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.437 -0.579 . . . . 54.45 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.15 -46.74 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.438 -0.949 . . . . 72.12 108.438 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.32 145.26 82.58 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 114.671 -1.15 . . . . 73.1 111.149 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 -174.25 2.2 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 123.044 2.496 . . . . 51.13 112.541 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.28 78.32 1.13 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.365 -0.38 . . . . 34.54 112.722 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.3 11.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.923 0.889 . . . . 73.24 110.43 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.17 32.91 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.045 0.938 . . . . 33.11 112.555 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 65.51 82.51 0.18 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.143 1.377 . . . . 53.22 110.918 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 tp 63.16 107.2 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.495 1.518 . . . . 73.35 111.187 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 11' ' ' THR . 1.4 m -141.69 -164.47 1.79 Allowed 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.43 107.155 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.556 ' H ' HG22 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 71.55 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.32 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 53.23 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.01 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 64.15 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.03 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 55.44 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.11 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.2 111.822 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.33 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.24 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 64.03 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.44 ' HD1' HE22 ' A' ' 151' ' ' GLN . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.55 109.107 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.35 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.611 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 65.04 110.659 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.45 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.31 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 45.45 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 64.41 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' NH2' ' HA ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.1 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.52 110.525 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.24 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.53 112.928 -171.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 60.23 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.31 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.42 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 40' ' ' THR . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.32 108.82 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 33.32 110.283 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 63.1 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.23 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.13 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.35 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 61.14 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.15 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.44 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -102.27 -37.26 8.17 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.12 110.624 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 50' ' ' ALA . 34.5 tt0 -141.28 -172.28 3.47 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.8 -1.185 . . . . 73.42 107.8 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 83.02 -7.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.53 1.132 . . . . 54.04 113.121 168.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 63.43 35.4 12.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.839 0.855 . . . . 73.42 110.77 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.36 14.11 9.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.358 1.463 . . . . 61.12 112.725 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.44 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.21 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.43 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' HG ' ' HE3' ' A' ' 58' ' ' MET . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.34 109.14 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.32 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.492 ' HE3' ' HG ' ' A' ' 56' ' ' LEU . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 73.23 109.939 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 73.15 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 64.52 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 73.33 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.44 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.53 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.31 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.4 112.465 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.14 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 63.34 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.12 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.22 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.02 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.14 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.4 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.12 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.31 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.3 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.01 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.43 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.21 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.4 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.14 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.21 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.25 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.26 12.63 26.11 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.21 111.046 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -67.59 99.23 0.75 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.524 0.73 . . . . 51.21 109.887 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -88.7 -36.26 16.29 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.754 0.822 . . . . 64.14 110.787 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.75 -50.26 54.73 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 124.124 0.89 . . . . 55.12 112.511 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -108.4 -176.62 3.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.925 -0.769 . . . . 72.43 108.925 174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -68.12 132.85 91.76 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.24 109.118 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.21 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 60.04 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.41 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.03 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 65.15 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.35 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 70.35 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 71.52 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 45.22 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.23 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 42.43 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.23 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.11 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 70.13 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.14 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.44 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 71.41 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.44 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.22 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 72.54 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.44 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.23 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.14 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.04 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.12 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.22 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 74.33 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.54 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.35 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.1 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.43 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.21 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 65.15 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 71.15 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.43 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.31 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.51 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 72.12 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -147.03 0.87 0.74 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 70.32 110.849 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.474 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 6.0 m-20 -69.4 -81.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.452 0.701 . . . . 73.55 110.988 -174.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.9 12.78 1.28 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.815 1.246 . . . . 55.12 109.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.29 104.01 2.24 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.532 0.52 . . . . 61.4 112.205 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -162.17 -179.54 7.14 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.283 1.033 . . . . 74.21 109.758 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -94.29 146.82 32.25 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 64.23 110.112 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 52.45 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.42 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 64.31 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HB3' HG22 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 41.33 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 61.24 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.437 ' HG3' HG11 ' A' ' 123' ' ' VAL . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 62.01 110.535 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 62.33 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 73.53 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.22 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 73.34 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 62.34 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 73.45 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 72.22 109.58 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.11 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.43 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.45 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.44 HE22 ' HD1' ' A' ' 24' ' ' TYR . 20.7 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.23 108.038 175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.45 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt -73.5 179.65 3.95 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.542 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 52.53 13.34 0.3 Allowed 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 126.723 2.009 . . . . 72.31 113.915 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.81 46.13 1.36 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.141 1.377 . . . . 71.32 108.136 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -63.37 123.67 19.32 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.427 -0.806 . . . . 73.34 111.177 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 59.85 32.93 21.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.037 1.335 . . . . 72.51 112.315 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -65.21 103.0 0.71 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.641 0.734 . . . . 64.11 110.781 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -115.19 48.1 1.21 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.784 0.802 . . . . 72.41 110.14 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 115.317 -0.856 . . . . 52.22 110.437 178.045 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.697 -0.483 . . . . 74.03 109.697 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.97 145.15 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.621 -0.881 . . . . 75.25 108.621 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.67 152.49 44.76 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.734 0.814 . . . . 71.32 109.366 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.49 -155.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.101 2.534 . . . . 74.44 113.002 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.81 65.59 2.52 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.775 -0.53 . . . . 63.44 111.775 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -80.64 -8.13 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.798 1.239 . . . . 74.13 110.728 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HA ' ' HE1' ' A' ' 75' ' ' PHE . . . -69.38 83.93 0.39 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.575 0.75 . . . . 73.25 109.517 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -92.67 43.17 1.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.073 0.94 . . . . 65.32 109.792 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.43 86.13 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.131 -1.063 . . . . 64.23 108.131 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 12' ' ' TYR . 11.4 m -89.51 157.48 18.07 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.253 -0.885 . . . . 61.42 109.546 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.598 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 70.43 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 73.23 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 31.54 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 73.34 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.32 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 64.43 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.34 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 70.11 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.34 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.15 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.42 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.736 HG22 HH12 ' A' ' 133' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 71.22 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.54 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.01 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.15 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 53.25 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.11 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.31 110.724 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.31 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 64.24 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.33 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 54.21 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.12 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 65.24 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.21 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.41 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.41 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.41 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.45 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.582 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 55.11 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 73.13 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 65.21 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.24 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.41 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.42 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 72.32 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -77.75 -36.54 50.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.14 110.39 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -68.95 155.59 40.03 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.705 -1.134 . . . . 75.05 110.434 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.36 -58.81 6.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.171 0.988 . . . . 60.25 110.757 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.38 173.38 12.66 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.57 0.748 . . . . 54.22 110.533 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm -128.0 19.04 6.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.38 1.072 . . . . 74.42 112.349 -170.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 72.34 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.44 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.14 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 54.34 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 72.14 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.23 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 64.52 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 72.23 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 74.13 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 65.03 111.292 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.31 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 53.11 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 71.42 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 62.1 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.14 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 62.04 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.35 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 74.21 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.15 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.22 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.54 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.41 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HE1' ' HA ' ' A' ' 7' ' ' ALA . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.14 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.13 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.44 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.33 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.55 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 45.43 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 65.43 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 54.11 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 72.11 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -87.23 90.45 8.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 65.31 109.949 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -85.37 100.08 11.6 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.745 0.784 . . . . 64.33 111.547 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -123.17 -38.08 2.63 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.806 -0.634 . . . . 72.54 110.228 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.25 -76.78 0.5 Allowed Glycine 0 C--N 1.351 1.401 0 O-C-N 123.855 0.722 . . . . 72.53 111.999 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -114.64 -82.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -143.59 168.02 13.99 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.554 1.141 . . . . 75.51 109.215 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.4 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.11 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.32 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 62.5 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 73.25 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.04 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 63.13 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 72.53 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.34 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 51.53 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 71.41 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.42 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 71.33 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.45 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.1 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.52 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.34 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 71.02 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.55 110.722 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 73.24 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.15 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.14 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 109' ' ' VAL . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.12 109.259 175.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.53 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 63.14 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.14 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.12 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.15 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.12 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.44 113.383 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.02 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.3 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.23 110.903 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.41 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.52 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 52.03 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.24 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 122' ' ' TYR . 52.1 m-70 -152.95 21.28 0.58 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.43 108.505 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -149.67 97.53 2.63 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.773 0.797 . . . . 75.32 109.963 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 68.53 15.64 9.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.805 1.242 . . . . 73.04 113.794 166.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.05 40.68 29.25 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.46 -0.656 . . . . 23.1 111.46 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.736 HH12 HG22 ' A' ' 23' ' ' ILE . 39.6 ttt180 -67.36 133.43 49.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.315 1.046 . . . . 75.35 110.233 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.72 141.16 87.15 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.4 109.715 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.44 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 71.34 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 51.41 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.573 HD23 ' HD3' ' A' ' 133' ' ' ARG . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.34 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.33 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.4 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 65.02 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.21 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.31 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.42 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 72.23 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.23 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.42 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.34 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.24 108.562 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.41 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.32 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 152' ' ' ARG . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.43 108.499 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.28 159.64 5.88 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 51.21 111.604 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.64 172.46 11.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.736 0.815 . . . . 75.32 111.742 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.0 m170 65.98 23.48 11.19 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.954 1.302 . . . . 74.41 111.32 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.76 149.24 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.494 1.118 . . . . 71.2 108.996 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.2 t60 65.65 16.22 10.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.709 1.204 . . . . 74.21 110.638 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -74.94 132.55 41.51 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.829 -0.804 . . . . 71.31 108.829 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -148.53 148.32 30.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.895 0.478 . . . . 73.53 110.159 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 123.96 0.904 . . . . 74.2 108.609 173.597 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.617 -0.512 . . . . 54.24 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.55 95.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.062 -0.718 . . . . 71.32 109.062 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -137.56 149.21 64.37 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.804 1.241 . . . . 74.11 109.182 -173.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.32 -174.66 1.06 Allowed 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.272 1.981 . . . . 74.54 111.955 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.87 52.68 4.25 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.726 -0.215 . . . . 63.54 112.733 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.04 132.02 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.896 1.278 . . . . 64.03 109.351 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.36 94.15 0.52 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.164 0.586 . . . . 73.54 110.069 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -129.8 138.72 51.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.212 0.605 . . . . 64.23 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.69 96.61 6.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.049 1.34 . . . . 74.32 107.465 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m -105.2 164.11 12.08 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 64.15 109.47 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 64.22 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.11 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.33 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.33 111.629 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.02 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.1 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 43.4 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.22 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.14 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 43.51 109.699 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.04 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.52 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.31 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.44 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 54.13 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 61.03 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.22 113.647 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.12 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.33 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.22 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.35 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 62.34 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 61.31 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.31 111.154 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 74.42 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.34 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 61.44 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.43 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.04 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.51 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.521 ' H ' HG13 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.02 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.44 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 73.51 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.41 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.11 109.91 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 65.32 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 72.1 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -82.93 -7.0 59.71 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 65.2 110.351 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 27.3 mm-40 -101.36 166.66 10.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.923 0.889 . . . . 70.22 111.105 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.09 -70.54 0.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.496 1.118 . . . . 71.11 111.647 -175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 27' ' ' SER . 7.0 m-20 -86.52 147.87 25.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.71 -0.478 . . . . 63.32 109.71 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HD2' HD23 ' A' ' 47' ' ' LEU . 45.1 mmtm -95.86 64.78 2.48 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.43 111.198 -173.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 61.51 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.43 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 74.04 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.2 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.54 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.34 110.169 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.33 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.512 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.02 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 70.43 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.22 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.12 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 63.24 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.496 HG13 ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 61.44 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.32 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.42 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.51 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 73.33 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 72.23 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 44.12 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 74.32 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.51 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.33 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 54.13 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 52.21 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 63.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 73.41 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.414 HG22 ' HE1' ' A' ' 84' ' ' PHE . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 72.21 111.354 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.04 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.23 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.42 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.21 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.19 101.86 11.5 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 73.55 109.677 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.16 86.95 0.1 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.551 0.74 . . . . 52.44 109.13 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -99.52 81.81 2.56 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.935 0.894 . . . . 73.32 108.899 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 13.43 50.97 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.538 -0.755 . . . . 24.32 114.067 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -160.03 143.01 13.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.533 0.733 . . . . 73.3 109.238 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 21.3 mmm180 -41.78 133.55 2.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.977 1.711 . . . . 73.21 114.196 -173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 73.25 110.052 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 70.44 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.43 ' HD1' HD12 ' A' ' 149' ' ' ILE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.05 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.34 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 71.24 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.13 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 64.12 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 64.44 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.14 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.21 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.4 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.43 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.32 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 63.33 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 51.12 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.42 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 148' ' ' ILE . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 71.2 108.353 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 60.42 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.03 110.741 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 44.34 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 53.31 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 72.35 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' VAL . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.35 109.784 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.21 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 73.1 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.44 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.11 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.34 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 53.24 111.088 174.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 73.31 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.45 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.45 ' HB3' HE22 ' A' ' 140' ' ' GLN . 4.8 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.42 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.43 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 62.41 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.43 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.02 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -124.13 -60.5 1.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.43 109.252 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.08 82.21 5.07 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.105 -0.952 . . . . 75.12 110.89 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 35.16 45.69 0.2 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.87 1.668 . . . . 74.13 112.901 171.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.58 -106.57 0.7 Allowed Glycine 0 C--N 1.348 1.224 0 CA-C-N 114.651 -1.159 . . . . 65.34 111.852 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.2 -177.77 2.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.397 1.079 . . . . 74.44 108.717 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 -53.54 138.3 50.83 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.976 0.91 . . . . 70.15 111.331 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 74.34 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.35 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.15 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 50.1 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 61.23 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.23 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 72.44 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.41 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.2 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.22 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 72.31 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.4 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 65.44 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.23 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' HD1' ' A' ' 93' ' ' PHE . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 63.43 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 52.44 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 60.12 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.2 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt -61.78 155.66 22.41 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 64.23 111.82 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.33 -44.61 65.24 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.337 1.055 . . . . 73.21 112.03 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -128.79 137.44 51.53 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.302 -0.863 . . . . 75.43 108.878 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -146.79 133.47 19.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.231 0.613 . . . . 74.44 110.051 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -127.07 77.32 1.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.875 -1.158 . . . . 74.21 107.875 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -153.02 112.26 3.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.454 -1.314 . . . . 74.33 107.454 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -88.05 143.41 27.1 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.519 0.728 . . . . 74.22 110.671 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 t60 . . . . . 0 C--O 1.256 1.447 0 N-CA-C 107.404 -1.332 . . . . 74.4 107.404 172.446 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.874 -0.417 . . . . 42.53 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.6 t 58.15 86.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 124.501 1.125 . . . . 75.51 109.207 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.8 mp0 76.52 149.06 0.12 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 125.741 1.616 . . . . 74.21 110.736 -171.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.65 42.98 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.72 2.947 . . . . 54.34 113.546 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 34.0 88.6 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 122.787 0.232 . . . . 72.23 113.057 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 3' ' ' GLU . 28.5 m -87.16 153.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 122.867 0.467 . . . . 60.12 110.712 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.53 113.85 19.85 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.508 -0.769 . . . . 74.54 109.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -96.18 82.33 3.45 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.246 0.618 . . . . 74.33 109.599 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 149' ' ' ILE . 38.6 tp -141.65 153.61 44.83 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.13 0.972 . . . . 75.22 109.418 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p -90.98 162.88 14.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.226 1.01 . . . . 64.35 111.416 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 65.31 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.33 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.15 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.11 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 64.33 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 65.54 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 66' ' ' VAL . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.34 110.022 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 63.22 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 65.33 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.4 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.23 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.43 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 65.42 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 64.41 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 61.41 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 64.25 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.12 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.509 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.31 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.541 HD12 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.14 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 52.44 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.3 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 64.21 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 42.23 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.53 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.12 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.1 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 65.15 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.419 ' H ' HG13 ' A' ' 38' ' ' VAL . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 64.14 111.338 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 65.13 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG3' HD22 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.0 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.32 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 61.43 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.567 HD12 HD21 ' A' ' 153' ' ' LEU . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.02 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 73.23 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -61.75 -26.85 68.32 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.14 110.988 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -113.55 161.77 16.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.298 1.039 . . . . 70.32 109.771 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.03 75.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.517 0.727 . . . . 73.44 111.926 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.81 119.02 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.971 0.909 . . . . 72.35 109.512 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.81 30.81 5.98 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.582 0.753 . . . . 74.5 110.407 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 70.34 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 70.44 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.42 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.14 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 71.53 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 63.31 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.41 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 65.1 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.24 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 63.1 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.33 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 63.12 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.44 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 17' ' ' ALA . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.02 110.15 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.51 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.03 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 54.24 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 73.35 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 71.2 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 73.13 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 70.42 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.45 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 62.31 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 71.5 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.04 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.22 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.34 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 80' ' ' ILE . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 72.32 110.945 -173.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 73.04 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.03 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 65.11 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.21 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 -73.21 -19.65 61.04 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 33.24 111.887 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.462 HD21 ' HB2' ' A' ' 89' ' ' LYS . 57.9 t30 -51.33 126.68 17.62 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.534 1.134 . . . . 72.12 112.043 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -99.21 -71.36 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.832 0.853 . . . . 73.3 111.599 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.56 -42.83 93.32 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.771 0.669 . . . . 52.34 114.081 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 86' ' ' ASN . 3.5 mppt? -94.8 171.79 8.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.105 0.562 . . . . 72.41 109.996 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.73 131.09 89.73 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.347 -0.842 . . . . 74.35 110.15 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.04 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 61.35 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.44 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 54.12 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 61.5 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.32 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.33 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 62.22 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.15 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 62.03 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.11 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.41 111.306 177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.42 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.14 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 30.33 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 51.03 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 74.23 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 71.21 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 113' ' ' VAL . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.44 110.744 -172.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.14 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.02 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 71.2 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 109' ' ' VAL . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 52.21 109.045 172.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 71.11 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.41 113.135 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 62.45 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.14 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.21 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.33 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.31 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.32 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.02 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 51.15 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 71.54 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.21 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 50.41 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.13 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.23 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.84 -60.19 1.73 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 64.43 109.84 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.42 63.45 2.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.604 -0.726 . . . . 64.35 111.226 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 p90 36.34 51.04 0.8 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.731 1.612 . . . . 72.41 113.116 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.26 -65.83 1.41 Allowed Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.376 -0.829 . . . . 34.1 111.577 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -178.23 158.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.926 1.29 . . . . 71.33 108.657 -172.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.06 140.75 77.47 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.23 110.897 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 55.14 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 74.33 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.22 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 128' ' ' ASP . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.35 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 70.05 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.23 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.04 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.42 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 30.33 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.02 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 72.13 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 71.11 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 73.55 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 50.23 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.551 HG21 HD22 ' A' ' 9' ' ' LEU . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.44 108.984 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 51.33 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.45 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.42 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.41 109.999 -176.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 46' ' ' ILE . 55.5 mt -71.64 104.73 3.43 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 64.33 110.831 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 55.38 -159.68 0.19 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.79 1.306 . . . . 75.0 113.388 161.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -110.12 97.78 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.074 0.949 . . . . 73.1 109.668 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -86.38 72.07 10.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.138 -0.69 . . . . 70.01 109.138 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -71.37 -15.53 62.38 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.389 1.076 . . . . 73.13 112.672 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.39 -23.58 64.44 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.323 0.249 . . . . 44.33 110.664 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -123.9 157.31 34.54 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.353 1.061 . . . . 42.32 109.181 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.6 p80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 109.311 -0.626 . . . . 73.43 109.311 175.239 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.249 -0.649 . . . . 74.42 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 m -131.74 -175.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.461 1.104 . . . . 75.23 109.134 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.11 152.45 29.63 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.048 0.539 . . . . 73.4 112.089 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.32 173.24 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.488 2.792 . . . . 63.1 114.407 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 68.93 1.51 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 116.246 -0.434 . . . . 32.43 112.331 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.24 9.22 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.264 1.026 . . . . 70.44 110.292 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.65 -171.69 1.96 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 70.21 110.588 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? 61.38 83.67 0.14 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.947 0.899 . . . . 72.41 109.594 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 tp -72.51 146.14 47.02 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.316 -0.624 . . . . 40.01 109.316 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p -52.07 102.7 0.05 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.274 1.43 . . . . 72.34 112.114 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.13 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.12 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.4 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 65.12 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.34 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.34 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 25.41 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.54 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.13 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.53 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.12 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.41 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.32 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.41 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 53.51 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 55.43 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 51.45 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 51.41 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.567 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.32 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.22 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.11 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.2 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.11 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 70.44 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.1 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.22 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.1 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 72.51 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 64.14 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.43 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.516 ' H ' HG13 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.51 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.411 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.51 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.34 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.24 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 22.33 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 62.54 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.52 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -66.77 -37.75 85.22 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 53.43 110.405 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -92.74 147.48 22.83 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.053 -0.976 . . . . 72.35 111.278 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.0 83.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.108 0.963 . . . . 73.52 112.36 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.27 -21.24 64.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.782 1.03 . . . . 51.4 113.782 -170.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 60.52 42.66 13.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.529 1.132 . . . . 71.03 112.206 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 54.12 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 44.12 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 71.53 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 70.12 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.43 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 42.11 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 71.32 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.12 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 71.51 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.41 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.51 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 54.55 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.24 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.587 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.31 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.31 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.43 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.22 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.21 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.413 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.13 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 61.25 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.04 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 62.43 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 72.31 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 61.11 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.33 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 65.55 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.23 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 71.33 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 71.21 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.42 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.12 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.24 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.16 26.0 0.92 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 61.2 112.721 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -74.29 94.9 2.57 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.307 -0.627 . . . . 75.25 109.307 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -95.58 83.82 3.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.624 0.769 . . . . 74.22 110.752 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.55 -49.39 0.61 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.829 -0.508 . . . . 70.43 111.829 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -94.46 -178.83 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.745 -0.835 . . . . 73.34 108.745 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -77.1 125.67 86.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.45 109.698 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 50.21 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 45.53 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.51 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.43 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.41 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 41.15 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.21 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 72.55 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.21 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 63.44 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 51.54 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.24 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.23 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 71.31 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 62.43 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 55.04 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.1 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.12 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 72.32 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.13 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 63.41 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.43 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.11 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 62.42 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.3 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.2 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 65.42 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.34 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.3 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.14 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.31 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 64.42 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 61.03 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 65.41 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.23 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.3 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.04 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -102.2 -47.79 4.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.33 110.414 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -118.72 95.4 4.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.588 0.355 . . . . 71.4 110.478 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.5 p90 41.09 31.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.19 1.796 . . . . 60.14 114.431 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.54 -95.57 0.05 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.343 -0.703 . . . . 72.31 111.343 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -178.14 -174.5 0.42 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 75.2 110.076 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 -59.6 140.47 89.04 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 123.52 0.728 . . . . 75.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.45 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.32 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.505 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.31 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.02 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 72.54 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.34 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.21 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.33 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.31 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 63.12 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.23 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.14 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.52 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.53 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 60.24 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.41 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.23 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.19 168.44 19.97 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.33 109.743 167.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.18 176.5 0.75 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.768 0.827 . . . . 72.4 111.925 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 87.09 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 122.014 0.911 . . . . 73.12 112.141 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -111.26 -28.58 8.19 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.388 -0.824 . . . . 72.34 110.012 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -84.56 90.76 7.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.465 -0.939 . . . . 70.51 108.465 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -109.94 167.47 10.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.421 0.689 . . . . 72.14 111.167 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -153.11 132.93 13.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.009 0.924 . . . . 73.35 109.877 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.695 0.798 . . . . 74.4 110.029 172.82 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.444 -0.576 . . . . 75.33 109.444 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.49 76.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.852 -1.536 . . . . 52.34 106.852 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 68.51 139.3 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.482 1.513 . . . . 53.35 112.497 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' A' ' 6' ' ' VAL . 72.7 Cg_endo -79.62 -168.17 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.397 2.065 . . . . 74.14 111.133 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.12 61.46 4.65 Favored Glycine 0 N--CA 1.469 0.836 0 C-N-CA 121.377 -0.439 . . . . 75.13 112.669 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' PRO . 15.1 m -133.87 72.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-O 122.55 1.167 . . . . 61.12 109.857 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' HIS . . . -112.54 -5.67 14.01 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.136 -0.938 . . . . 73.43 111.209 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -70.47 -66.43 0.6 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.88 0.872 . . . . 65.53 108.974 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -155.66 114.04 3.44 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.464 -0.939 . . . . 74.04 108.464 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 9.7 m -140.2 173.0 11.95 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.189 0.996 . . . . 51.24 108.589 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 50.31 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.23 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 18' ' ' THR . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.04 112.218 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.23 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.21 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.11 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 14' ' ' SER . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.3 111.763 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 54.43 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 70.01 112.177 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 45.14 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 73.55 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 63.02 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.34 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.15 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 63.1 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.05 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.04 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.34 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 74.43 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 61.04 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.21 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 71.13 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.02 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 71.35 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 70.34 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 71.3 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 54.12 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.33 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.45 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.15 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.34 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 63.12 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.11 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.4 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.429 ' HA ' HE21 ' A' ' 49' ' ' GLN . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.13 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.53 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.27 -35.14 80.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 64.14 111.541 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' A' ' 46' ' ' ILE . 11.7 pt20 -86.64 143.56 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.835 -0.431 . . . . 64.42 109.835 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.91 66.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.878 0.871 . . . . 64.11 111.724 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.04 -36.21 79.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.717 1.207 . . . . 73.43 111.693 -173.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 49.3 mmtm 61.02 33.4 19.69 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.15 0.98 . . . . 64.52 111.504 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 63.43 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 72.33 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.53 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 65.11 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.433 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 63.13 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.24 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 73.44 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 58' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 52.41 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.35 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.23 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 61.55 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 50.21 112.115 -172.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.42 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 72.35 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.42 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.05 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 54.23 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.33 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.564 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.3 110.187 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.11 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 70.5 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.23 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.32 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 71.4 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 62.43 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 60.13 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 52.42 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.02 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.32 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 64.44 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -78.35 167.62 21.07 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 73.22 110.243 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.23 135.92 20.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.749 -0.659 . . . . 72.03 110.023 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -132.11 72.98 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.082 -1.081 . . . . 61.24 108.082 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.19 3.48 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.883 -0.487 . . . . 65.52 111.883 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -81.45 139.43 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.714 0.806 . . . . 72.51 109.918 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -66.04 140.02 96.86 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.546 1.138 . . . . 71.23 110.926 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 71.54 112.568 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 55.45 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.468 ' HD2' ' HB2' ' A' ' 83' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.32 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.23 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.573 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 1.5 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.31 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.2 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 74.21 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.41 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 61.35 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.2 110.665 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 65.51 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.2 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 62.13 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 43.33 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.429 ' CG2' HD23 ' A' ' 112' ' ' LEU . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 54.13 109.36 -175.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 53.41 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 72.55 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.1 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.54 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 64.15 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.471 ' N ' HD12 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 63.44 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.23 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 64.33 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 41.03 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 72.52 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.521 ' O ' HG23 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 72.34 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.24 111.641 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 55.41 111.365 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.11 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 65.51 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 72.02 111.844 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 72.02 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 63.35 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.22 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -113.43 -17.64 12.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.33 112.354 -174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -149.41 82.05 1.41 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 75.21 109.861 -173.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.0 p90 40.85 28.07 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 126.629 1.972 . . . . 64.51 114.474 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.77 -76.82 0.22 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.738 0.649 . . . . 73.33 113.309 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 174.58 156.75 0.15 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.665 0.786 . . . . 55.31 110.155 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 -60.47 136.47 92.09 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 123.544 0.738 . . . . 64.24 110.779 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.42 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 73.13 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 51.33 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.33 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.521 ' HG3' HG11 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 63.04 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.499 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 63.24 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.32 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.42 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.11 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.573 HG21 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 73.34 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.22 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.51 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 63.31 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.468 HD12 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.53 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.14 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.1 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.23 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.72 179.22 1.82 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 63.33 112.807 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.74 169.55 12.7 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.817 1.647 . . . . 73.03 110.891 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -145.04 -44.65 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.057 0.943 . . . . 74.2 110.734 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -149.46 105.23 3.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.977 0.911 . . . . 73.51 108.891 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -58.05 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.409 1.484 . . . . 72.23 112.086 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.8 t60 53.95 34.36 19.4 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.433 1.093 . . . . 72.42 110.538 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -144.5 175.21 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.233 -0.894 . . . . 74.13 110.164 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.79 1.236 . . . . 64.4 107.857 173.579 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.442 -0.577 . . . . 62.31 109.442 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.17 160.39 4.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.47 0.652 . . . . 70.21 110.322 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.17 159.54 62.08 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 115.116 -0.947 . . . . 72.02 109.112 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.76 34.67 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.235 2.623 . . . . 63.42 115.574 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.98 -66.93 1.55 Allowed Glycine 0 C--N 1.344 0.977 0 O-C-N 121.967 -0.458 . . . . 53.13 112.136 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t 68.91 -61.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 125.209 1.403 . . . . 74.34 111.612 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.43 104.81 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.713 0.805 . . . . 61.51 108.862 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -89.14 -50.64 6.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 72.44 108.332 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -160.15 120.74 2.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.904 -1.147 . . . . 74.44 107.904 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m -138.29 158.33 44.5 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.145 0.978 . . . . 61.5 108.62 -173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.01 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.01 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.54 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 71.54 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.52 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' MET . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.32 110.613 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 62.02 111.062 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 63.54 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 72.2 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.53 109.969 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.43 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 54.2 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 71.35 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 36' ' ' SER . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 74.31 108.202 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.14 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 72.24 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.51 111.675 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.4 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 71.4 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.13 111.199 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 33' ' ' VAL . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.03 110.117 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 32' ' ' ILE . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.21 107.44 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 64.43 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.13 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.451 ' H ' ' HE2' ' A' ' 24' ' ' TYR . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 55.31 109.453 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 64.25 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 62.13 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 64.02 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 64.55 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 63.54 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 72.35 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.31 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.51 111.477 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 61.1 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.2 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.44 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.51 -35.93 82.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 62.04 113.106 -170.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.43 -179.26 3.81 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.999 0.92 . . . . 63.35 108.907 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.33 90.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 51.41 112.235 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 27' ' ' SER . 10.6 m-20 -67.54 122.79 18.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.514 1.126 . . . . 71.41 110.908 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm -106.83 31.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.602 1.161 . . . . 63.25 110.83 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 62.25 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.44 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.22 109.365 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 64.41 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.42 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.43 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.1 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 71.45 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.31 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.04 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 72.14 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.31 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.33 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.03 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.52 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.44 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.33 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.11 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 71.22 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.43 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.34 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.53 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 63.22 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.54 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.22 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.45 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.14 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.11 111.85 -176.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 70.54 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ASN . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.14 111.94 174.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.11 109.873 170.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -99.16 12.15 36.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.13 111.332 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' PHE . 1.5 t-20 -74.56 101.2 4.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.418 0.687 . . . . 70.53 110.498 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -91.18 -44.86 8.98 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.947 -1.024 . . . . 64.32 110.637 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.22 -32.4 82.45 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.692 0.62 . . . . 70.42 113.314 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -125.52 -178.31 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.404 1.082 . . . . 72.33 109.039 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -72.6 135.12 81.42 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 71.43 109.444 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 63.51 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 71.14 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HD1' HD12 ' A' ' 149' ' ' ILE . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 64.51 107.934 174.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 72.52 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 63.41 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 24.34 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 55.54 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 63.3 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 41.22 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 54.22 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.31 111.172 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 73.12 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 54.51 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.54 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.1 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 62.42 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 63.41 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 64.23 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 70.14 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.33 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 73.22 113.016 -177.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 73.42 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.41 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.12 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.45 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 62.41 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.32 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.522 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.01 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.1 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 43.24 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.24 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 34.02 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.5 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.45 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 63.31 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 45.24 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 74.13 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 61.53 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 47.3 m80 -148.49 -26.03 0.32 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 63.03 110.906 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -54.5 -60.34 3.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.212 1.005 . . . . 64.24 112.061 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -155.41 -51.16 0.09 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.507 1.523 . . . . 73.41 107.471 -168.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.36 25.15 0.02 OUTLIER Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.728 -0.669 . . . . 71.32 113.894 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -82.59 104.65 13.01 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.098 0.949 . . . . 73.42 109.818 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.56 143.07 39.25 Favored Pre-proline 0 CA--C 1.564 1.499 0 C-N-CA 124.977 1.311 . . . . 75.24 112.212 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD12 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.35 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.11 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 65.21 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.43 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.35 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 70.14 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.54 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.14 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 61.22 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.3 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 43.21 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 70.35 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 73.12 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.41 HD12 ' HD1' ' A' ' 93' ' ' PHE . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.11 109.175 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.32 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 72.13 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.78 164.61 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 62.34 109.744 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.98 -24.93 60.18 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.435 1.094 . . . . 70.03 113.47 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -105.07 106.48 16.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.328 0.651 . . . . 64.35 109.653 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -161.84 -42.59 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.454 0.702 . . . . 73.3 110.518 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -138.3 106.16 5.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.625 -0.879 . . . . 63.52 108.625 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -103.59 -161.9 0.87 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.59 0.756 . . . . 74.21 111.015 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.21 154.68 26.75 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.459 1.104 . . . . 70.05 111.064 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.596 -0.716 . . . . 74.53 109.24 -179.726 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.512 -0.921 . . . . 62.23 108.512 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m 50.09 18.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 126.409 1.883 . . . . 74.41 113.272 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 63.9 146.55 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 125.625 1.57 . . . . 64.34 112.385 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.68 22.9 0.75 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.371 2.714 . . . . 63.33 113.478 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.17 52.21 8.0 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.048 0.217 . . . . 71.1 112.862 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.85 -7.4 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.276 0.63 . . . . 41.43 112.382 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.58 100.69 0.7 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.102 0.561 . . . . 50.15 111.22 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -141.11 133.92 28.91 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.482 -1.303 . . . . 75.35 107.482 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.405 HD11 HD21 ' A' ' 70' ' ' LEU . 48.4 tp -79.35 135.19 36.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.127 0.571 . . . . 61.33 110.358 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -80.95 168.72 18.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.026 0.93 . . . . 65.03 111.613 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 72.34 114.303 -163.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.53 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 53.01 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.24 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 74.24 110.896 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 65.02 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.35 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 64.34 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 54.32 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 64.14 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 43.4 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.2 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.548 HD12 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.11 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.23 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 72.34 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.667 HD21 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.04 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.33 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 62.53 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.41 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB2' HD21 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.42 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.24 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 49' ' ' GLN . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 73.13 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 73.11 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.42 109.462 171.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 64.41 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.12 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.41 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 41' ' ' THR . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.21 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 44.02 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.437 ' H ' HG13 ' A' ' 38' ' ' VAL . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 70.3 111.423 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 73.52 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 54.53 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.14 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.14 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.53 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.32 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp -65.77 -36.2 82.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.43 111.142 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' HG3' HG22 ' A' ' 32' ' ' ILE . 42.9 mm-40 -77.82 159.17 29.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.979 -0.749 . . . . 72.52 108.979 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.551 0.532 . . . . 72.2 109.89 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.51 146.14 45.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.918 0.887 . . . . 63.44 110.544 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 26.7 mmtm -116.01 42.35 2.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.009 0.924 . . . . 70.21 110.352 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 61.14 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.1 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.42 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 65.01 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 55.31 110.425 -175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 43.44 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.13 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.33 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 72.35 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.31 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.42 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.51 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 74.33 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 73.01 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 64.05 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 74.54 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 63.11 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.35 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.54 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.33 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.52 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 53.54 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.34 109.602 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' THR . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 62.34 111.876 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 73.14 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 52.14 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.11 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 54.43 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.15 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.41 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -126.74 151.86 47.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 61.12 109.647 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -163.85 152.02 13.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.033 -0.729 . . . . 61.53 109.033 170.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -95.95 -22.37 17.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.337 0.655 . . . . 75.32 111.824 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.04 -53.1 0.05 OUTLIER Glycine 0 C--N 1.347 1.149 0 N-CA-C 112.44 -0.264 . . . . 70.3 112.44 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.44 -171.37 2.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.42 0.688 . . . . 71.21 109.792 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -95.46 140.35 22.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.469 -0.787 . . . . 70.35 110.345 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 62.23 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.54 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 73.12 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.13 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 61.25 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.55 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.4 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 63.34 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.05 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.45 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 55.15 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 62.1 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 61.31 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 55.33 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.24 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.15 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 64.34 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.24 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.13 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.32 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.33 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 62.0 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.42 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.33 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 72.33 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.31 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 72.22 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 55.41 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 62.31 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 51.33 111.639 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.11 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.53 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 63.42 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.03 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.02 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.1 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 73.12 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 53.53 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -106.54 -57.5 2.05 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 72.31 110.817 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 13.2 p30 -94.31 58.78 2.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.292 0.567 . . . . 63.12 110.666 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.6 p90 41.84 61.61 1.85 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.656 1.582 . . . . 73.43 112.783 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.59 -147.43 20.05 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 114.879 -1.055 . . . . 62.4 111.149 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.9 -175.58 2.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.611 0.765 . . . . 63.42 110.012 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.04 143.17 98.84 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.55 110.198 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.23 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 71.22 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.33 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.41 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.54 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 34.11 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.13 109.242 172.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.34 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.31 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.14 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.4 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 71.33 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.3 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.03 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 70.22 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.11 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 65.44 109.444 175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.44 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt -70.38 177.75 3.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.44 112.773 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.0 -35.61 71.48 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.242 -1.344 . . . . 63.43 111.74 -172.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -83.6 81.65 8.65 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.311 -0.996 . . . . 75.25 108.311 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -60.11 122.71 15.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 74.44 110.115 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -74.15 114.93 13.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.868 -0.605 . . . . 73.24 111.053 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -88.74 10.69 19.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.969 -1.014 . . . . 55.2 110.408 170.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -146.08 142.3 28.42 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.448 1.099 . . . . 74.31 108.839 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.373 0.669 . . . . 71.11 109.434 178.672 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.485 -0.561 . . . . 75.42 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -159.2 47.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 123.131 1.443 . . . . 75.05 108.599 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.12 156.75 83.83 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.184 -1.371 . . . . 74.02 110.316 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.49 -158.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.579 2.186 . . . . 74.12 112.225 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.08 4.17 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 113.629 0.212 . . . . 50.34 113.629 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.08 -4.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.327 1.051 . . . . 73.54 112.03 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.14 122.53 25.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.19 0.996 . . . . 72.1 109.104 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -154.11 124.69 7.08 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.521 0.728 . . . . 71.04 109.806 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -81.22 95.67 7.0 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.979 -1.119 . . . . 73.42 107.979 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 11' ' ' THR . 1.6 m -110.67 175.34 5.46 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.422 0.689 . . . . 72.22 109.451 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.497 ' H ' HG22 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.12 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.41 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 64.01 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.52 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.34 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.11 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.14 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' CE2' ' A' ' 24' ' ' TYR . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 73.13 111.27 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 60.44 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.13 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.55 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 60.42 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.25 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 18' ' ' THR . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.24 108.589 169.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.43 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.21 110.458 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 73.01 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 64.03 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.03 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.11 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.41 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.4 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.729 HD22 ' HB2' ' A' ' 133' ' ' ARG . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.41 111.517 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.51 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 44.5 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 62.14 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 40' ' ' THR . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 64.02 109.427 173.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.53 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 38' ' ' VAL . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 72.01 109.93 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.04 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 71.45 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.52 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.34 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 43.53 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.32 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 63.23 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp -69.68 -37.84 76.82 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.3 111.154 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -160.93 -110.27 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 58.65 -5.76 0.05 Allowed 'General case' 0 C--N 1.37 1.48 0 N-CA-C 115.645 1.72 . . . . 43.45 115.645 173.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 53.41 27.75 6.73 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.778 0.831 . . . . 74.45 111.137 -163.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp 62.58 31.21 16.99 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.895 1.278 . . . . 73.51 111.727 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 71.41 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 33.02 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.22 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.23 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.22 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 62.23 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 61.42 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.21 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 61.24 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.21 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.14 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 74.11 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.54 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.44 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 73.22 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.1 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 73.44 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.24 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.23 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 72.52 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 60.04 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.42 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 73.1 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 64.23 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.13 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 55.42 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 70.52 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.21 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.54 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 72.52 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.3 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.48 17.61 7.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.41 110.766 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 89' ' ' LYS . 58.7 t30 -74.16 95.54 2.6 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.468 1.107 . . . . 73.02 109.478 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -95.49 -38.16 10.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.716 0.806 . . . . 71.23 109.837 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.4 91.98 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 115.452 -0.794 . . . . 62.33 112.615 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' ASN . 31.9 mmmt -123.54 -179.49 4.36 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.727 1.211 . . . . 72.13 108.436 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.55 131.93 42.3 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 64.54 110.084 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 72.12 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 73.11 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 73.33 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 73.05 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.24 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.01 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.13 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.45 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.43 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.31 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.12 111.148 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.32 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.43 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.12 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.44 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 71.22 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 33.45 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 45.42 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.22 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.34 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 72.34 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 62.1 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 71.43 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 70.42 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.42 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.44 111.486 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 53.3 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.489 ' O ' HG23 ' A' ' 123' ' ' VAL . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.22 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 62.23 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.41 112.924 174.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.4 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 71.2 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.494 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 4.3 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 63.43 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 71.34 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.02 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.11 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 54.45 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.59 -66.68 0.53 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 65.34 109.749 172.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.18 109.89 7.06 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 122.607 0.363 . . . . 51.13 111.352 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 58.19 24.62 11.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.971 1.308 . . . . 72.34 111.816 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.47 41.65 97.22 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 114.86 -1.064 . . . . 70.41 114.516 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.729 ' HB2' HD22 ' A' ' 34' ' ' ASN . 15.5 ttm180 -74.81 116.49 15.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.618 -0.882 . . . . 71.11 108.618 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.94 147.2 55.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 123.872 0.869 . . . . 65.32 112.149 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.15 114.439 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 71.24 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 64.21 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD23 ' HD2' ' A' ' 133' ' ' ARG . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.22 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.43 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 65.01 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 64.45 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 52.11 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.05 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 71.31 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.02 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 65.45 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 72.32 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 64.13 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.23 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' A' ' 56' ' ' LEU . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.31 108.56 171.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 61.33 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.38 152.51 21.14 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 64.5 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.69 107.4 1.17 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.694 -1.139 . . . . 41.21 111.709 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -63.99 -12.02 34.18 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.346 1.058 . . . . 73.11 111.594 168.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -123.59 114.15 19.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.966 0.906 . . . . 75.45 108.661 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -63.44 131.86 49.56 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.403 -0.591 . . . . 70.52 109.403 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 122.052 -0.405 . . . . 71.32 110.607 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -103.66 74.58 1.25 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.144 -0.687 . . . . 74.0 109.144 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.925 -1.139 . . . . 64.44 107.925 173.774 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 112.663 0.616 . . . . 75.420000000000002 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.020000000000003 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.530000000000001 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.430000000000007 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 41.32 111.216 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 64.409999999999997 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.219999999999999 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 51.520000000000003 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 64.340000000000003 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 63.310000000000002 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 64.439999999999998 110.138 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 40.439999999999998 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.450000000000003 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 74.549999999999997 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 72.530000000000001 108.264 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 44.329999999999998 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.439999999999998 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 63.350000000000001 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.329999999999998 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 61.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.420000000000002 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 71.140000000000001 110.603 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 61.009999999999998 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 72.030000000000001 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 61.240000000000002 111.389 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.039999999999999 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.040000000000006 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.409999999999997 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 64.530000000000001 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 74.010000000000005 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 53.039999999999999 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.439999999999998 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.239999999999995 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 72.140000000000001 110.312 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.519999999999996 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 35.420000000000002 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.430000000000007 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.030000000000001 112.86 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.530000000000001 110.437 -178.381 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 112.586 0.587 . . . . 71.310000000000002 112.586 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.409999999999997 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 51.219999999999999 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.420000000000002 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 54.240000000000002 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.439999999999998 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 73.420000000000002 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.229999999999997 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.030000000000001 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 65.340000000000003 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 51.310000000000002 110.335 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 64.420000000000002 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.420000000000002 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' HB1' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 62.219999999999999 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' HG21 ' A' ' 80' ' ' ILE . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.130000000000003 112.106 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.509999999999998 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.230000000000004 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.439999999999998 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.109999999999999 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 61.43 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 64.409999999999997 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.319999999999993 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 70.530000000000001 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 71.299999999999997 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 31.52 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.030000000000001 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 72.510000000000005 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.404 HG21 ' HD1' ' A' ' 67' ' ' TYR . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.409999999999997 111.6 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.430000000000007 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 62.409999999999997 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 60.409999999999997 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 70.25 110.669 -178.631 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 112.099 0.407 . . . . 54.0 112.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.577 ' HB2' HG22 ' A' ' 94' ' ' VAL . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 62.140000000000001 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 65.409999999999997 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 72.040000000000006 107.615 171.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.209999999999994 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' HG21 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.120000000000005 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.140000000000001 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 64.409999999999997 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.109999999999999 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.109999999999999 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.049999999999997 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.439999999999998 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 52.240000000000002 110.818 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.420000000000002 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 91' ' ' PRO . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.409999999999997 111.128 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.200000000000003 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.539999999999999 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.239999999999995 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 70.209999999999994 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 71.310000000000002 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 72.349999999999994 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 42.32 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.349999999999994 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.319999999999993 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 64.530000000000001 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.439999999999998 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.439999999999998 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.049999999999997 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.240000000000002 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.439999999999998 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.129999999999995 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 63.340000000000003 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.340000000000003 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 64.219999999999999 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 62.140000000000001 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 64.239999999999995 108.891 175.191 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 . . . . . 0 CA--C 1.561 1.401 0 CA-C-O 119.133 -0.461 . . . . 53.130000000000003 110.527 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 63.43 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 72.430000000000007 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 60.200000000000003 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 64.120000000000005 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.420000000000002 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 70.200000000000003 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.420000000000002 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.329999999999998 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.492 HG21 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 72.099999999999994 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.230000000000004 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 61.310000000000002 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.430000000000007 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.540000000000006 109.522 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 62.240000000000002 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.109999999999999 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 71.319999999999993 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 74.120000000000005 111.163 173.148 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m . . . . . 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.310000000000002 108.115 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.530000000000001 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 74.310000000000002 111.408 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 64.120000000000005 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 64.0 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 71.329999999999998 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.530000000000001 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.120000000000005 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.420000000000002 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 52.5 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 55.530000000000001 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 51.310000000000002 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 70.109999999999999 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.568 ' HE2' HD21 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.430000000000007 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 64.25 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 62.140000000000001 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.099999999999994 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.450000000000003 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.140000000000001 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.409999999999997 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 53.149999999999999 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 60.399999999999999 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.219999999999999 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 70.329999999999998 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.430000000000007 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 64.409999999999997 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 70.140000000000001 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.299999999999997 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 73.129999999999995 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 65.219999999999999 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 51.439999999999998 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 63.420000000000002 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 63.409999999999997 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 65.120000000000005 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 62.32 111.781 -179.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm . . . . . 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 71.120000000000005 111.617 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 63.140000000000001 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 64.450000000000003 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.329999999999998 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.540000000000006 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 61.130000000000003 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 74.430000000000007 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.019999999999996 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.030000000000001 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.400000000000006 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 74.430000000000007 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.439999999999998 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.230000000000004 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.129999999999995 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.299999999999997 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.120000000000005 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 72.319999999999993 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 52.299999999999997 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 65.329999999999998 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 64.019999999999996 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.420000000000002 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.540000000000006 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 51.32 106.251 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 79' ' ' GLU . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 72.349999999999994 111.874 -166.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 52.340000000000003 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 71.409999999999997 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 76' ' ' THR . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.450000000000003 110.669 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 70.209999999999994 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.299999999999997 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.209999999999994 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.150000000000006 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.420000000000002 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 . . . . . 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.340000000000003 110.529 -178.192 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 71.519999999999996 108.029 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.430000000000007 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.209999999999994 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.540000000000006 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 44.439999999999998 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 71.109999999999999 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.120000000000005 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 62.340000000000003 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.239999999999995 110.868 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.329999999999998 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 31.34 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 53.520000000000003 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.010000000000005 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.129999999999995 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.310000000000002 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.417 ' CG2' HD23 ' A' ' 112' ' ' LEU . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 54.100000000000001 109.1 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.400000000000006 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 64.450000000000003 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.510000000000005 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.329999999999998 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 72.239999999999995 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.424 ' N ' HD12 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.349999999999994 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.219999999999999 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.150000000000006 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 44.520000000000003 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.519999999999996 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.530000000000001 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 55.240000000000002 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.140000000000001 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.643 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.040000000000006 112.226 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.019999999999996 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.240000000000002 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.643 HE21 ' HA2' ' A' ' 121' ' ' GLY . 28.2 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.430000000000007 110.869 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.239999999999995 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.439999999999998 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.099999999999994 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.310000000000002 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 63.439999999999998 109.536 -172.449 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.006 -0.521 . . . . 70.230000000000004 110.788 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.430000000000007 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.010000000000005 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 71.25 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.546 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 73.239999999999995 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.040000000000006 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 73.239999999999995 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.442 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 54.119999999999997 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 71.420000000000002 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.329999999999998 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 70.299999999999997 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 61.149999999999999 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 74.219999999999999 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 73.420000000000002 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.129999999999995 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.319999999999993 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.230000000000004 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 64.519999999999996 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 63.020000000000003 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 65.200000000000003 111.031 179.453 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 111.374 0.138 . . . . 75.200000000000003 111.374 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.010000000000005 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.209999999999994 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 55.439999999999998 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 61.210000000000001 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 55.030000000000001 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 62.549999999999997 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 52.240000000000002 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.019999999999996 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.439999999999998 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 54.530000000000001 111.597 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 63.310000000000002 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 61.439999999999998 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 61.109999999999999 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 71.239999999999995 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 64.400000000000006 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 61.329999999999998 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 32.100000000000001 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.140000000000001 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.420000000000002 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 61.119999999999997 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 64.329999999999998 111.151 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.329999999999998 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 64.239999999999995 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.299999999999997 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.411 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 43.439999999999998 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 53.539999999999999 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.510000000000005 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.239999999999995 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.209999999999994 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.46 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 63.229999999999997 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 63.310000000000002 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.230000000000004 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 64.420000000000002 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.209999999999994 110.966 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 72.319999999999993 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.443 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 63.350000000000001 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 71.409999999999997 110.078 176.405 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 46' ' ' ILE . 1.2 mptm? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 71.319999999999993 109.873 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HG2' ' A' ' 152' ' ' ARG . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 64.409999999999997 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.040000000000006 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.310000000000002 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.400000000000006 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.430000000000007 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.439999999999998 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.239999999999995 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.140000000000001 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.129999999999995 110.244 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.310000000000002 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 72.140000000000001 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.219999999999999 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 64.25 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.120000000000005 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.329999999999998 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.420000000000002 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 72.450000000000003 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.129999999999995 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 72.319999999999993 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 64.439999999999998 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.010000000000005 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.140000000000001 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 55.420000000000002 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.310000000000002 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.200000000000003 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 71.25 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 63.140000000000001 111.5 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 54.530000000000001 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.040000000000006 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 71.129999999999995 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.109999999999999 110.18 176.482 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.537 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 109.8 -0.444 . . . . 62.109999999999999 109.8 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 54.43 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.519999999999996 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.010000000000005 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 62.149999999999999 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.230000000000004 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 24.210000000000001 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 63.340000000000003 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 73.030000000000001 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.219999999999999 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 53.450000000000003 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.549999999999997 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.109999999999999 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 65.209999999999994 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.340000000000003 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.109999999999999 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 55.240000000000002 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.120000000000005 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.150000000000006 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.200000000000003 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 71.409999999999997 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 72.430000000000007 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 71.109999999999999 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.239999999999995 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.129999999999995 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 72.310000000000002 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.129999999999995 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 70.430000000000007 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.349999999999994 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.129999999999995 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.465 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.239999999999995 112.415 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.420000000000002 112.221 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.040000000000006 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.465 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.299999999999997 111.53 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 72.109999999999999 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.310000000000002 112.797 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 63.210000000000001 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 62.509999999999998 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.299999999999997 108.751 -179.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 137' ' ' TYR . 4.8 m-20 . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 112.404 0.52 . . . . 72.430000000000007 112.404 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.040000000000006 113.828 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.120000000000005 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.405 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 73.120000000000005 110.454 175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.239999999999995 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 65.219999999999999 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.340000000000003 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 62.210000000000001 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 72.400000000000006 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.310000000000002 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 71.400000000000006 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.409999999999997 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 64.140000000000001 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 71.299999999999997 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.030000000000001 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.030000000000001 109.778 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.310000000000002 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 64.510000000000005 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 53' ' ' VAL . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 64.510000000000005 109.935 174.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt . . . . . 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 63.539999999999999 112.204 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 109.122 -0.695 . . . . 74.030000000000001 109.122 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 62.109999999999999 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.040000000000006 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.209999999999994 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 71.519999999999996 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 72.030000000000001 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.009999999999998 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.540000000000006 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 72.5 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 63.450000000000003 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 64.519999999999996 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 65.120000000000005 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 52.140000000000001 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.549999999999997 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.530000000000001 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.439999999999998 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.319999999999993 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 52.200000000000003 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.109999999999999 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.420000000000002 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.725 ' HD2' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 74.409999999999997 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.447 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 71.340000000000003 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.430000000000007 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.109999999999999 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.510000000000005 108.102 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 72.430000000000007 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.299999999999997 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.239999999999995 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 74.510000000000005 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 62.240000000000002 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.469 ' H ' HG13 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 73.129999999999995 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 62.210000000000001 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.219999999999999 111.334 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.239999999999995 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.129999999999995 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.140000000000001 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 51.340000000000003 111.354 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 73.400000000000006 111.784 171.561 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.219999999999999 111.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 64.239999999999995 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.200000000000003 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 64.400000000000006 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.230000000000004 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.329999999999998 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 61.039999999999999 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 61.329999999999998 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.109999999999999 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.010000000000005 110.478 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 112.657 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.140000000000001 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 73.140000000000001 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 70.049999999999997 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.040000000000006 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.120000000000005 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 53.049999999999997 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 70.549999999999997 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.439999999999998 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 64.219999999999999 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.019999999999996 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 72.340000000000003 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 65.0 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 78' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.120000000000005 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 53.109999999999999 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 53.210000000000001 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.239999999999995 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 62.229999999999997 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.120000000000005 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 61.32 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' PHE . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.239999999999995 111.182 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.510000000000005 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 . . . . . 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.420000000000002 109.532 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 . . . . . 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 73.510000000000005 106.061 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.219999999999999 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 72.409999999999997 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.434 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.120000000000005 108.124 172.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.319999999999993 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.530000000000001 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.239999999999995 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.450000000000003 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.140000000000001 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.510000000000005 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.140000000000001 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.409999999999997 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.519999999999996 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.329999999999998 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.350000000000001 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 34.0 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.510000000000005 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 72.140000000000001 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 71.239999999999995 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.439999999999998 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.239999999999995 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.109999999999999 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 55.549999999999997 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.140000000000001 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 64.099999999999994 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.430000000000007 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 70.120000000000005 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.530000000000001 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 71.25 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.119999999999997 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.120000000000005 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.450000000000003 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.009999999999998 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 32.539999999999999 113.539 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.340000000000003 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.230000000000004 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.329999999999998 111.907 -176.621 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 118.984 -0.532 . . . . 53.350000000000001 110.979 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.099999999999994 116.253 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.409999999999997 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.319999999999993 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 51.299999999999997 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 70.430000000000007 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 74.439999999999998 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.400000000000006 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 61.109999999999999 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 64.209999999999994 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.519999999999996 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.019999999999996 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.120000000000005 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.450000000000003 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 64.420000000000002 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.540000000000006 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.420000000000002 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 61.049999999999997 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt . . . . . 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.340000000000003 110.624 166.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 62.109999999999999 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.019999999999996 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.209999999999994 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.593 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 43.030000000000001 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.019999999999996 111.785 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 63.240000000000002 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.299999999999997 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 60.039999999999999 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 63.439999999999998 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.109999999999999 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 51.539999999999999 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.099999999999994 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.129999999999995 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.349999999999994 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.109999999999999 109.242 170.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 54.350000000000001 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.549999999999997 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.409999999999997 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.140000000000001 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.430000000000007 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 63.009999999999998 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 70.109999999999999 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.554 HG13 HG12 ' A' ' 33' ' ' VAL . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.109999999999999 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 74.120000000000005 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 63.100000000000001 112.159 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 71.049999999999997 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.140000000000001 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 72.420000000000002 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.109999999999999 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.319999999999993 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.439999999999998 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.129999999999995 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 72.310000000000002 111.478 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.519999999999996 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.400000000000006 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 62.119999999999997 111.195 173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 71.349999999999994 110.306 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.040000000000006 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.439999999999998 110.645 175.672 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' HD12 ' A' ' 153' ' ' LEU . 29.2 mmtp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 121.173 0.511 . . . . 63.229999999999997 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.540000000000006 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 72.299999999999997 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 71.430000000000007 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.430000000000007 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 64.120000000000005 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 74.319999999999993 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.310000000000002 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.219999999999999 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 72.519999999999996 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.409999999999997 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.420000000000002 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 71.530000000000001 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 73.049999999999997 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.593 HG13 ' HB1' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 64.400000000000006 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.219999999999999 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.509999999999998 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 51.409999999999997 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 63.43 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.340000000000003 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 72.209999999999994 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 52.399999999999999 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.230000000000004 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.349999999999994 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.219999999999999 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 72.019999999999996 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.340000000000003 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.119999999999997 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 74.439999999999998 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 51.109999999999999 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 55.030000000000001 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.519999999999996 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.310000000000002 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.439999999999998 109.791 -176.099 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 119.04 -0.505 . . . . 75.129999999999995 109.863 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.129999999999995 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 41.509999999999998 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 72.400000000000006 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 63.340000000000003 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 73.340000000000003 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.439999999999998 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 65.450000000000003 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.510000000000005 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.140000000000001 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.230000000000004 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 61.140000000000001 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 53.5 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 63.539999999999999 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.219999999999999 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 55.140000000000001 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.299999999999997 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.140000000000001 109.23 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.319999999999993 110.879 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.519999999999996 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.040000000000006 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HA ' HG22 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.129999999999995 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.466 ' N ' HD12 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 71.540000000000006 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 64.150000000000006 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.420000000000002 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.340000000000003 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 62.520000000000003 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.439999999999998 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 62.020000000000003 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 63.240000000000002 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.482 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.230000000000004 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.310000000000002 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.482 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 72.010000000000005 111.6 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.219999999999999 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.310000000000002 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.230000000000004 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 62.240000000000002 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.120000000000005 108.099 175.536 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 70.239999999999995 109.053 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.450000000000003 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.239999999999995 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 64.310000000000002 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.219999999999999 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.209999999999994 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HG3' HG11 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.409999999999997 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.129999999999995 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.129999999999995 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 42.329999999999998 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 71.409999999999997 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.299999999999997 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.109999999999999 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 74.450000000000003 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 64.430000000000007 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 64.230000000000004 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.430000000000007 108.821 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.120000000000005 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 64.409999999999997 110.346 174.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.245 0.846 0 CA-C-O 120.351 0.119 . . . . 73.120000000000005 111.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 72.450000000000003 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 71.120000000000005 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.140000000000001 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.340000000000003 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 62.350000000000001 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.120000000000005 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 63.310000000000002 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.519999999999996 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.340000000000003 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.430000000000007 110.767 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 51.43 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.129999999999995 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.120000000000005 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.120000000000005 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' TYR . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.530000000000001 109.815 174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 72.319999999999993 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 53.109999999999999 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 71.129999999999995 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.219999999999999 112.911 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HB3' HD21 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.519999999999996 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 73.319999999999993 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 72.209999999999994 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.340000000000003 108.882 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 63.350000000000001 113.187 -173.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.439999999999998 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 55.340000000000003 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.530000000000001 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 72.420000000000002 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 72.209999999999994 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 65.319999999999993 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.140000000000001 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.299999999999997 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 72.209999999999994 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.400000000000006 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 52.210000000000001 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 72.209999999999994 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.596 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.239999999999995 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 54.219999999999999 109.947 174.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm . . . . . 0 C--O 1.243 0.758 0 CA-C-O 122.154 0.978 . . . . 64.200000000000003 110.282 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 54.229999999999997 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 60.450000000000003 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 73.439999999999998 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 73.109999999999999 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 70.549999999999997 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 60.25 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.349999999999994 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 73.409999999999997 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.239999999999995 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.150000000000006 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.439999999999998 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.140000000000001 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 61.329999999999998 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 64.349999999999994 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.209999999999994 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.230000000000004 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.120000000000005 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 62.130000000000003 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 64.140000000000001 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 71.310000000000002 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.049999999999997 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.408 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.129999999999995 108.387 174.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 55.210000000000001 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.219999999999999 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.120000000000005 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.109999999999999 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.209999999999994 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 63.100000000000001 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 71.430000000000007 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 72.120000000000005 111.786 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 70.010000000000005 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 62.450000000000003 110.649 -173.396 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 . . . . . 0 CA--C 1.544 0.747 0 CA-C-O 119.366 -0.35 . . . . 74.219999999999999 110.881 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.329999999999998 110.558 171.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.140000000000001 109.209 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 62.329999999999998 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 63.399999999999999 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.310000000000002 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 52.219999999999999 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 71.25 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.219999999999999 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 72.239999999999995 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 54.200000000000003 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 44.299999999999997 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 73.340000000000003 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.510000000000005 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 51.310000000000002 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 53.43 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 74.099999999999994 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.299999999999997 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.430000000000007 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 73.540000000000006 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 71.150000000000006 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.049999999999997 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.109999999999999 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.340000000000003 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 72.230000000000004 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.409999999999997 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 123' ' ' VAL . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 71.040000000000006 109.654 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 63.229999999999997 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.200000000000003 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.140000000000001 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.150000000000006 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.475 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 63.039999999999999 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.209999999999994 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.239999999999995 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 73.030000000000001 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.230000000000004 106.785 170.715 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 119.465 -0.302 . . . . 74.230000000000004 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 61.219999999999999 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 51.509999999999998 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.219999999999999 111.508 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 72.200000000000003 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 64.150000000000006 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.349999999999994 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.140000000000001 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.510000000000005 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 55.049999999999997 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.329999999999998 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 54.049999999999997 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.349999999999994 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.571 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.319999999999993 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 71.409999999999997 109.421 -176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.340000000000003 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.230000000000004 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.150000000000006 109.17 173.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt . . . . . 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.310000000000002 112.651 -176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 C--O 1.244 0.782 0 N-CA-C 110.227 -0.286 . . . . 74.329999999999998 110.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.409999999999997 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 63.310000000000002 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 61.229999999999997 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.407 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.019999999999996 112.219 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.310000000000002 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.519999999999996 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 63.420000000000002 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 52.130000000000003 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 71.420000000000002 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 63.450000000000003 110.635 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 70.209999999999994 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 72.329999999999998 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 71.010000000000005 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 62.43 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.209999999999994 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 72.120000000000005 109.663 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 71.299999999999997 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.510000000000005 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.349999999999994 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 70.109999999999999 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.511 ' HD3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.400000000000006 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.109999999999999 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.450000000000003 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.030000000000001 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.329999999999998 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.439999999999998 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 64.420000000000002 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.439999999999998 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.109999999999999 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG22 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 73.409999999999997 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 72.420000000000002 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 62.229999999999997 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 64.319999999999993 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 55.119999999999997 111.134 177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.099999999999994 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 63.229999999999997 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.310000000000002 109.954 175.615 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.519999999999996 110.283 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 43.0 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 53.549999999999997 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.239999999999995 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.349999999999994 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.109999999999999 109.864 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.310000000000002 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.439999999999998 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.019999999999996 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 51.210000000000001 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.340000000000003 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.340000000000003 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.319999999999993 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 53.130000000000003 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 71.420000000000002 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 73.439999999999998 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.140000000000001 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.239999999999995 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.420000000000002 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.409999999999997 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.519999999999996 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 71.510000000000005 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 71.340000000000003 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 55.25 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 52.039999999999999 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 54.439999999999998 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.539999999999999 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 74.310000000000002 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.209999999999994 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 74.209999999999994 110.538 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 . . . . . 0 CA--C 1.553 1.077 0 CA-C-O 119.337 -0.363 . . . . 64.140000000000001 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' HG22 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 61.450000000000003 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.019999999999996 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 54.43 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.030000000000001 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.049999999999997 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 61.130000000000003 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 71.5 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.340000000000003 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.420000000000002 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.200000000000003 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 55.240000000000002 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 53.409999999999997 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.340000000000003 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.319999999999993 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.430000000000007 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.519999999999996 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 71.200000000000003 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.340000000000003 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 72.0 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 72.340000000000003 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 54.229999999999997 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.239999999999995 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 72.400000000000006 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.511 HG23 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.209999999999994 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 63.140000000000001 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.109999999999999 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.219999999999999 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.430000000000007 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.299999999999997 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.409999999999997 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 53.210000000000001 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.230000000000004 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.540000000000006 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.340000000000003 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.549999999999997 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 55.140000000000001 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.019999999999996 109.197 179.576 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.678 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 72.349999999999994 109.967 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.498 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.439999999999998 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.209999999999994 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.200000000000003 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB3' HG22 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 73.239999999999995 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.230000000000004 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 54.43 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.432 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.519999999999996 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.340000000000003 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.109999999999999 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.239999999999995 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.329999999999998 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 72.310000000000002 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 74.319999999999993 108.3 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.456 HG22 ' NE2' ' A' ' 151' ' ' GLN . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 71.310000000000002 109.487 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.510000000000005 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.456 ' NE2' HG22 ' A' ' 149' ' ' ILE . 25.1 mm-40 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.150000000000006 108.638 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 73.5 109.45 171.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 54.420000000000002 111.108 172.469 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 11' ' ' THR . 1.9 m . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.099999999999994 108.436 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 70.230000000000004 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 65.030000000000001 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 65.329999999999998 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.329999999999998 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.219999999999999 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.010000000000005 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.439999999999998 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.319999999999993 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.219999999999999 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 54.119999999999997 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.019999999999996 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 65.319999999999993 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 60.210000000000001 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.420000000000002 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.439999999999998 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 73.140000000000001 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 64.430000000000007 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.420000000000002 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 52.200000000000003 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.420000000000002 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 63.229999999999997 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.219999999999999 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.441 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.319999999999993 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.219999999999999 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.430000000000007 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 64.129999999999995 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.200000000000003 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 70.120000000000005 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 73.420000000000002 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.099999999999994 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.463 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.140000000000001 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.040000000000006 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 71.019999999999996 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 54.409999999999997 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 54.119999999999997 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.573 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.209999999999994 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 70.230000000000004 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm . . . . . 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 70.25 110.488 174.537 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm . . . . . 0 CA--C 1.549 0.934 0 CA-C-O 121.252 0.549 . . . . 62.310000000000002 112.435 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 61.539999999999999 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.409999999999997 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 72.430000000000007 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.310000000000002 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.400000000000006 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 62.119999999999997 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.400000000000006 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.409999999999997 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.140000000000001 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 53.340000000000003 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.219999999999999 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 64.049999999999997 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 63.340000000000003 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HA ' HD12 ' A' ' 70' ' ' LEU . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.519999999999996 111.376 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.150000000000006 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 70.150000000000006 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 67' ' ' TYR . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.209999999999994 110.397 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.349999999999994 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.129999999999995 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.310000000000002 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.230000000000004 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.120000000000005 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.140000000000001 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.420000000000002 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.310000000000002 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 61.340000000000003 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 71.239999999999995 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 72.420000000000002 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 71.209999999999994 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.519999999999996 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.409999999999997 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.219999999999999 110.6 -177.028 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.216 -0.421 . . . . 74.430000000000007 110.743 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.350000000000001 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 52.5 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 64.319999999999993 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 61.0 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 51.100000000000001 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.109999999999999 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.140000000000001 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.439999999999998 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.310000000000002 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.409999999999997 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 62.030000000000001 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 52.200000000000003 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.319999999999993 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 55.119999999999997 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.129999999999995 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 60.219999999999999 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 64.430000000000007 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.230000000000004 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.140000000000001 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.420000000000002 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.319999999999993 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.129999999999995 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.340000000000003 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.319999999999993 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.109999999999999 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.319999999999993 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 54.229999999999997 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 44.240000000000002 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 65.109999999999999 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.230000000000004 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.129999999999995 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.140000000000001 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 43.140000000000001 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.240000000000002 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.120000000000005 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.010000000000005 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.109999999999999 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' HD11 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 53.130000000000003 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.299999999999997 110.744 179.94 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.55 0.97 0 CA-C-O 118.738 -0.648 . . . . 75.420000000000002 110.836 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.049999999999997 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.239999999999995 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.310000000000002 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 64.239999999999995 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.209999999999994 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 64.030000000000001 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.129999999999995 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.430000000000007 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.009999999999998 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.299999999999997 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.030000000000001 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 70.200000000000003 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.200000000000003 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.129999999999995 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 73.010000000000005 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.129999999999995 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 52.200000000000003 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 153' ' ' LEU . 14.1 mt . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 60.43 110.81 167.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 CA--C 1.552 1.05 0 N-CA-C 109.965 -0.383 . . . . 63.219999999999999 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.129999999999995 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.109999999999999 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 55.009999999999998 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 70.329999999999998 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 71.109999999999999 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 61.100000000000001 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.450000000000003 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 63.539999999999999 111.431 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.319999999999993 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.530000000000001 110.558 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 64.120000000000005 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 72.340000000000003 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.150000000000006 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.540000000000006 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 71.530000000000001 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.430000000000007 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 42.329999999999998 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 71.230000000000004 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.319999999999993 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.349999999999994 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.450000000000003 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 62.530000000000001 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 65.530000000000001 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 74.129999999999995 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.439999999999998 109.338 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.430000000000007 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.340000000000003 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.209999999999994 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.120000000000005 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 38' ' ' VAL . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.299999999999997 111.004 -176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.475 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 51.350000000000001 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.400000000000006 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 72.540000000000006 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.510000000000005 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.229999999999997 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.459 HD12 HD23 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.400000000000006 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 60.409999999999997 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp . . . . . 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.450000000000003 111.474 176.767 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 120.925 0.393 . . . . 75.540000000000006 111.104 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.239999999999995 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 23.02 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 70.450000000000003 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.319999999999993 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.239999999999995 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 61.119999999999997 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.319999999999993 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 71.510000000000005 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 55.32 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.239999999999995 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 73.540000000000006 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 54.329999999999998 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 72.200000000000003 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.010000000000005 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.299999999999997 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 44.210000000000001 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 55.149999999999999 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.409999999999997 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.409999999999997 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.439999999999998 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.340000000000003 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.579 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 63.409999999999997 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 63.200000000000003 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.519999999999996 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.439999999999998 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.329999999999998 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.109999999999999 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.229999999999997 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.420000000000002 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.433 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 70.549999999999997 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 60.229999999999997 111.511 -177.467 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 64.329999999999998 106.919 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.239999999999995 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.140000000000001 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.230000000000004 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.310000000000002 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 73.549999999999997 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 65.349999999999994 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 70.120000000000005 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.420000000000002 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.409999999999997 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.400000000000006 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 64.219999999999999 111.293 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.430000000000007 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 73.030000000000001 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 71.420000000000002 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 53.32 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 64.329999999999998 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 43.420000000000002 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 62.340000000000003 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.439999999999998 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.120000000000005 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.239999999999995 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 64.150000000000006 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.299999999999997 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.329999999999998 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 64.430000000000007 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 72.140000000000001 111.39 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.119999999999997 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 123' ' ' VAL . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.409999999999997 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 72.349999999999994 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 42.409999999999997 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.239999999999995 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 119' ' ' TYR . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.019999999999996 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 71.510000000000005 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.109999999999999 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.329999999999998 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 60.530000000000001 111.888 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.209999999999994 108.849 176.12 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 15.0 t70 . . . . . 0 CA--C 1.568 1.644 0 N-CA-C 112.032 0.382 . . . . 74.200000000000003 112.032 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 72.200000000000003 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.109999999999999 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.019999999999996 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.439999999999998 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.409999999999997 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.434 ' HG3' HG11 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.299999999999997 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.329999999999998 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 54.439999999999998 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.210000000000001 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.420000000000002 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.439999999999998 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 63.399999999999999 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 65.430000000000007 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.472 HG12 HG22 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 63.43 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.230000000000004 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.521 ' HB3' HG13 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.349999999999994 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.109999999999999 109.047 173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.420000000000002 107.504 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 46' ' ' ILE . 61.5 mt . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.129999999999995 109.621 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 CA--C 1.547 0.827 0 N-CA-C 113.066 0.765 . . . . 74.439999999999998 113.066 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 63.210000000000001 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 52.229999999999997 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.409999999999997 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.109999999999999 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.239999999999995 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 64.040000000000006 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 52.039999999999999 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.350000000000001 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 64.230000000000004 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.420000000000002 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 71.25 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.530000000000001 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.439999999999998 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 64.519999999999996 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.209999999999994 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 65.209999999999994 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 70.510000000000005 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 54.219999999999999 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 64.519999999999996 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.030000000000001 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 63.32 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.099999999999994 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 52.130000000000003 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.439999999999998 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 70.109999999999999 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.099999999999994 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.340000000000003 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 38' ' ' VAL . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 72.230000000000004 111.891 -171.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.494 ' H ' HG13 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 60.350000000000001 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.409999999999997 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.099999999999994 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 64.0 110.934 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.319999999999993 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 64.430000000000007 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.420000000000002 111.004 178.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.049999999999997 111.485 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.601 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.109999999999999 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 60.549999999999997 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.349999999999994 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.439999999999998 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 55.219999999999999 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.219999999999999 108.884 172.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.239999999999995 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.420000000000002 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.430000000000007 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 55.530000000000001 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.319999999999993 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 64.450000000000003 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.540000000000006 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 72.409999999999997 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.310000000000002 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.219999999999999 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 61.439999999999998 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 65.120000000000005 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 71.400000000000006 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.439999999999998 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.519999999999996 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.200000000000003 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 70.450000000000003 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 78' ' ' GLU . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.420000000000002 111.06 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.329999999999998 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 76' ' ' THR . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.439999999999998 111.121 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.310000000000002 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 71.430000000000007 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.420000000000002 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.319999999999993 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.150000000000006 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 73.400000000000006 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 . . . . . 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.439999999999998 111.014 -179.539 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 . . . . . 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.200000000000003 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 53.409999999999997 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.109999999999999 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 51.200000000000003 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 73.010000000000005 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.329999999999998 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 63.420000000000002 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.340000000000003 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.120000000000005 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 55.020000000000003 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.329999999999998 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.420000000000002 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 62.310000000000002 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 54.399999999999999 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.099999999999994 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 32.5 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 63.119999999999997 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 72.329999999999998 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.439999999999998 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.450000000000003 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.53 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 53.420000000000002 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 64.040000000000006 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.299999999999997 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.099999999999994 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 54.409999999999997 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 63.130000000000003 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.230000000000004 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.230000000000004 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.519999999999996 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.120000000000005 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 62.329999999999998 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.109999999999999 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.438 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 73.530000000000001 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 52.140000000000001 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.540000000000006 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.240000000000002 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.210000000000001 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.400000000000006 109.923 177.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 119.414 -0.327 . . . . 73.25 111.692 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.150000000000006 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.010000000000005 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 72.400000000000006 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 70.120000000000005 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 73.200000000000003 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.438 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 65.129999999999995 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.409999999999997 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 54.539999999999999 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.109999999999999 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 65.120000000000005 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 62.43 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.140000000000001 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.540000000000006 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 63.049999999999997 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.340000000000003 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 71.040000000000006 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 72.349999999999994 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt . . . . . 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 70.450000000000003 110.543 167.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 C--O 1.242 0.681 0 N-CA-C 108.231 -1.025 . . . . 31.129999999999999 108.231 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.616 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 55.119999999999997 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.409999999999997 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.319999999999993 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 52.119999999999997 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 71.25 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 72.349999999999994 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 54.240000000000002 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.120000000000005 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 54.219999999999999 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 62' ' ' THR . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 63.109999999999999 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.439999999999998 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 64.239999999999995 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 64.140000000000001 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.645 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 71.230000000000004 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.310000000000002 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 63.340000000000003 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 64.519999999999996 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.200000000000003 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 41.009999999999998 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.420000000000002 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.603 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 61.299999999999997 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.573 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 61.420000000000002 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.420000000000002 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.120000000000005 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.230000000000004 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.120000000000005 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.400000000000006 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 60.109999999999999 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.109999999999999 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.329999999999998 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 61.140000000000001 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 70.140000000000001 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.8 OUTLIER -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.150000000000006 111.467 -175.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 24.5 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.540000000000006 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 52.310000000000002 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 72.310000000000002 110.537 175.384 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.219999999999999 109.766 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 33.039999999999999 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.219999999999999 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.129999999999995 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 71.109999999999999 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 63.32 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.517 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.420000000000002 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 63.409999999999997 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.420000000000002 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 72.120000000000005 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.129999999999995 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.109999999999999 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.329999999999998 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.129999999999995 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.129999999999995 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.049999999999997 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.209999999999994 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 44.039999999999999 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 55.329999999999998 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 72.019999999999996 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 54.420000000000002 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.32 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.430000000000007 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.439999999999998 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 71.400000000000006 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.319999999999993 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 71.209999999999994 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.519999999999996 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 72.030000000000001 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 64.549999999999997 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.209999999999994 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.230000000000004 108.957 177.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.758 -0.163 . . . . 74.5 111.084 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 62.240000000000002 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.430000000000007 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.230000000000004 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.030000000000001 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.140000000000001 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 53.450000000000003 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.310000000000002 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.219999999999999 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 64.200000000000003 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.030000000000001 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.140000000000001 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 64.239999999999995 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 72.519999999999996 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.239999999999995 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.040000000000006 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.530000000000001 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.099999999999994 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 113' ' ' VAL . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 64.140000000000001 111.384 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.099999999999994 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.310000000000002 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 70.310000000000002 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 74.310000000000002 109.156 172.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 54.32 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 62.210000000000001 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 73.5 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.530000000000001 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 73.319999999999993 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 53.130000000000003 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.299999999999997 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.462 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.430000000000007 110.999 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.340000000000003 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 70.109999999999999 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.462 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.9 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.400000000000006 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.299999999999997 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 40.240000000000002 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.420000000000002 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.109999999999999 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 64.430000000000007 108.44 -179.821 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 CA--C 1.553 1.082 0 CA-C-O 118.771 -0.633 . . . . 65.230000000000004 111.322 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.319999999999993 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 73.230000000000004 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.409999999999997 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 70.040000000000006 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.239999999999995 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 62.420000000000002 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.030000000000001 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.420000000000002 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.100000000000001 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.420000000000002 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.549999999999997 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.450000000000003 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 64.319999999999993 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.010000000000005 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.517 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 53.0 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.129999999999995 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.340000000000003 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.340000000000003 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 65.299999999999997 110.224 174.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 11' ' ' THR . 1.4 m . . . . . 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.430000000000007 107.155 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.556 ' H ' HG22 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 71.549999999999997 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.319999999999993 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 53.229999999999997 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.010000000000005 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 64.150000000000006 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.030000000000001 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 55.439999999999998 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.109999999999999 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.200000000000003 111.822 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.329999999999998 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.240000000000002 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 64.030000000000001 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.549999999999997 109.107 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.349999999999994 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 65.040000000000006 110.659 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.450000000000003 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.310000000000002 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 45.450000000000003 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.099999999999994 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.519999999999996 110.525 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.239999999999995 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.530000000000001 112.928 -171.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 60.229999999999997 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.310000000000002 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.420000000000002 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 40' ' ' THR . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.319999999999993 108.82 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 33.32 110.283 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 63.100000000000001 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.230000000000004 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.129999999999995 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.349999999999994 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 61.140000000000001 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.150000000000006 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.439999999999998 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm . . . . . 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.120000000000005 110.624 -179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 112.725 0.639 . . . . 61.119999999999997 112.725 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.439999999999998 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.209999999999994 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.430000000000007 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.492 ' HG ' ' HE3' ' A' ' 58' ' ' MET . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.340000000000003 109.14 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.319999999999993 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.492 ' HE3' ' HG ' ' A' ' 56' ' ' LEU . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 73.230000000000004 109.939 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 73.150000000000006 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 64.519999999999996 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 73.329999999999998 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.439999999999998 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.530000000000001 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.310000000000002 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.400000000000006 112.465 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.140000000000001 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 63.340000000000003 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.120000000000005 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.219999999999999 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.019999999999996 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.140000000000001 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.400000000000006 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.120000000000005 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.310000000000002 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.299999999999997 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.010000000000005 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.430000000000007 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.209999999999994 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.400000000000006 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.140000000000001 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.209999999999994 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.25 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 . . . . . 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.209999999999994 111.046 -179.338 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.239999999999995 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.209999999999994 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 60.039999999999999 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.409999999999997 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.030000000000001 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 65.150000000000006 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.349999999999994 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 70.349999999999994 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 71.519999999999996 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 45.219999999999999 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.230000000000004 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 42.43 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.109999999999999 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 70.129999999999995 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.140000000000001 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.439999999999998 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 71.409999999999997 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.439999999999998 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.219999999999999 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 72.540000000000006 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.439999999999998 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.230000000000004 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.140000000000001 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.040000000000006 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.120000000000005 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.219999999999999 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 74.329999999999998 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.539999999999999 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.349999999999994 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.099999999999994 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.430000000000007 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.209999999999994 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 65.150000000000006 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 71.150000000000006 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.430000000000007 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.310000000000002 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.510000000000005 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 72.120000000000005 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 70.319999999999993 110.849 177.604 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 . . . . . 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 64.230000000000004 110.112 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 52.450000000000003 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.420000000000002 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 64.310000000000002 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HB3' HG22 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 41.329999999999998 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 61.240000000000002 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.437 ' HG3' HG11 ' A' ' 123' ' ' VAL . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 62.009999999999998 110.535 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 62.329999999999998 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 73.530000000000001 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.219999999999999 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 73.340000000000003 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 62.340000000000003 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 73.450000000000003 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 72.219999999999999 109.58 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.109999999999999 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.430000000000007 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.450000000000003 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.230000000000004 108.038 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.450000000000003 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.439999999999998 110.542 173.243 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 12' ' ' TYR . 11.4 m . . . . . 0 CA--C 1.544 0.741 0 N-CA-C 109.546 -0.538 . . . . 61.420000000000002 109.546 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.598 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 70.430000000000007 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 73.230000000000004 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 31.539999999999999 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 73.340000000000003 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.319999999999993 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 64.430000000000007 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 70.109999999999999 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.340000000000003 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.150000000000006 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.420000000000002 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.448 ' HB ' ' HG3' ' A' ' 31' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 71.219999999999999 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.540000000000006 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.010000000000005 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.150000000000006 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 53.25 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.310000000000002 110.724 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.310000000000002 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 64.239999999999995 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.329999999999998 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 54.210000000000001 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.120000000000005 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 65.239999999999995 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.209999999999994 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.409999999999997 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.409999999999997 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.450000000000003 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.582 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 55.109999999999999 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 73.129999999999995 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 65.209999999999994 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.239999999999995 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.409999999999997 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 72.319999999999993 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.140000000000001 110.39 -178.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 112.349 0.5 . . . . 74.420000000000002 112.349 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 72.340000000000003 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.439999999999998 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.140000000000001 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 54.340000000000003 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 72.140000000000001 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.230000000000004 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 64.519999999999996 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.481 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 72.230000000000004 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 74.129999999999995 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 65.030000000000001 111.292 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.310000000000002 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 53.109999999999999 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 71.420000000000002 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 62.100000000000001 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.140000000000001 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 62.039999999999999 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.349999999999994 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 74.209999999999994 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.150000000000006 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.219999999999999 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.540000000000006 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.409999999999997 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.129999999999995 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.439999999999998 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.549999999999997 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 45.43 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 65.430000000000007 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 54.109999999999999 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 72.109999999999999 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 65.310000000000002 109.949 177.14 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.215 -0.661 . . . . 75.510000000000005 109.215 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.400000000000006 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.109999999999999 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.319999999999993 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 62.5 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 73.25 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.040000000000006 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 63.130000000000003 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 72.530000000000001 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.340000000000003 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 51.530000000000001 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 71.409999999999997 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.420000000000002 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 71.329999999999998 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.450000000000003 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.099999999999994 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.520000000000003 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.340000000000003 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 71.019999999999996 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.549999999999997 110.722 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.150000000000006 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.140000000000001 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 109' ' ' VAL . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.120000000000005 109.259 175.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.530000000000001 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 63.140000000000001 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.140000000000001 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.120000000000005 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.150000000000006 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.120000000000005 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.439999999999998 113.383 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.019999999999996 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.299999999999997 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.509 HE21 ' HA2' ' A' ' 121' ' ' GLY . 29.2 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.229999999999997 110.903 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.409999999999997 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.519999999999996 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 52.030000000000001 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.239999999999995 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 122' ' ' TYR . 52.1 m-70 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.430000000000007 108.505 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.400000000000006 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.439999999999998 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 71.340000000000003 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 51.409999999999997 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' HB3' HG22 ' A' ' 123' ' ' VAL . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.340000000000003 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.329999999999998 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.400000000000006 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 65.019999999999996 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.209999999999994 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.310000000000002 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.420000000000002 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 72.230000000000004 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.230000000000004 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.420000000000002 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.340000000000003 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.239999999999995 108.562 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.409999999999997 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.319999999999993 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 152' ' ' ARG . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.430000000000007 108.499 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 51.210000000000001 111.604 -179.438 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 64.150000000000006 109.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 64.219999999999999 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.109999999999999 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.329999999999998 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.329999999999998 111.629 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.019999999999996 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.099999999999994 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 43.399999999999999 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.219999999999999 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.140000000000001 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 43.509999999999998 109.699 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.040000000000006 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.519999999999996 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.439999999999998 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 54.130000000000003 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 61.030000000000001 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.219999999999999 113.647 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.120000000000005 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.219999999999999 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 62.340000000000003 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 61.310000000000002 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.310000000000002 111.154 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 74.420000000000002 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.340000000000003 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 61.439999999999998 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.430000000000007 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.040000000000006 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.510000000000005 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.521 ' H ' HG13 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.019999999999996 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.439999999999998 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 73.510000000000005 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.409999999999997 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.109999999999999 109.91 171.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 65.319999999999993 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 72.099999999999994 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 65.200000000000003 110.351 174.45 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HD2' HD23 ' A' ' 47' ' ' LEU . 45.1 mmtm . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.430000000000007 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 61.509999999999998 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.430000000000007 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 74.040000000000006 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.200000000000003 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.540000000000006 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.340000000000003 110.169 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.329999999999998 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.512 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.019999999999996 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 70.430000000000007 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.219999999999999 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.120000000000005 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 63.240000000000002 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.496 HG13 ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 61.439999999999998 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.319999999999993 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.420000000000002 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.510000000000005 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 73.329999999999998 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 72.230000000000004 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 44.119999999999997 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 74.319999999999993 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.510000000000005 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.329999999999998 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 54.130000000000003 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 52.210000000000001 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 63.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 73.409999999999997 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.414 HG22 ' HE1' ' A' ' 84' ' ' PHE . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 72.209999999999994 111.354 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.040000000000006 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.230000000000004 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.420000000000002 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.209999999999994 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 73.549999999999997 109.677 178.714 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 21.3 mmm180 . . . . . 0 CA--C 1.548 0.881 0 N-CA-C 114.196 1.184 . . . . 73.209999999999994 114.196 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 73.25 110.052 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 70.439999999999998 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.43 ' HD1' HD12 ' A' ' 149' ' ' ILE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.049999999999997 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.340000000000003 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 71.239999999999995 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.129999999999995 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 64.120000000000005 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 64.439999999999998 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.140000000000001 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.209999999999994 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.400000000000006 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.430000000000007 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.319999999999993 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 63.329999999999998 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 51.119999999999997 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.420000000000002 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 148' ' ' ILE . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 71.200000000000003 108.353 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 60.420000000000002 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.030000000000001 110.741 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 44.340000000000003 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 53.310000000000002 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 72.349999999999994 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' VAL . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.349999999999994 109.784 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.209999999999994 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 73.099999999999994 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.439999999999998 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.109999999999999 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.340000000000003 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.536 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 53.240000000000002 111.088 174.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 73.310000000000002 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.450000000000003 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.536 HE21 ' HA2' ' A' ' 121' ' ' GLY . 24.4 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.420000000000002 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.430000000000007 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 62.409999999999997 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.430000000000007 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.019999999999996 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.430000000000007 109.252 177.216 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 . . . . . 0 CA--C 1.562 1.424 0 CA-C-O 119.135 -0.46 . . . . 70.150000000000006 111.331 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 74.340000000000003 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.349999999999994 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.149999999999999 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 50.100000000000001 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 61.229999999999997 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.229999999999997 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 72.439999999999998 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.409999999999997 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.200000000000003 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.219999999999999 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 72.310000000000002 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.400000000000006 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 65.439999999999998 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.230000000000004 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' HD1' ' A' ' 93' ' ' PHE . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 63.43 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 52.439999999999998 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 60.119999999999997 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.200000000000003 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt . . . . . 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 64.230000000000004 111.82 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 120.622 0.248 . . . . 64.349999999999994 111.416 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 65.310000000000002 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.329999999999998 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.150000000000006 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.109999999999999 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 64.329999999999998 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 65.540000000000006 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 66' ' ' VAL . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.340000000000003 110.022 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 63.219999999999999 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 65.329999999999998 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.400000000000006 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.230000000000004 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.430000000000007 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 65.420000000000002 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 61.409999999999997 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 64.25 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.120000000000005 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.509 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.310000000000002 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.541 HD12 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.140000000000001 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 52.439999999999998 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.299999999999997 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 64.209999999999994 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 42.229999999999997 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.530000000000001 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.120000000000005 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.100000000000001 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 65.150000000000006 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.419 ' H ' HG13 ' A' ' 38' ' ' VAL . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 64.140000000000001 111.338 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 65.129999999999995 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG3' HD22 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.0 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.319999999999993 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 61.43 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.567 HD12 HD21 ' A' ' 153' ' ' LEU . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.019999999999996 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 73.230000000000004 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.140000000000001 110.988 176.598 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 121.362 0.601 . . . . 74.5 110.407 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 70.340000000000003 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 70.439999999999998 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.420000000000002 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 71.530000000000001 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 63.310000000000002 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.409999999999997 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 65.099999999999994 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.239999999999995 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 63.100000000000001 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.329999999999998 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 63.119999999999997 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.439999999999998 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 17' ' ' ALA . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.019999999999996 110.15 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.510000000000005 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.030000000000001 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 54.240000000000002 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 73.349999999999994 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 71.200000000000003 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 73.129999999999995 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 70.420000000000002 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.450000000000003 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 62.310000000000002 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 71.5 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.040000000000006 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.219999999999999 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.340000000000003 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 80' ' ' ILE . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 72.319999999999993 110.945 -173.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 73.040000000000006 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.030000000000001 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 65.109999999999999 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.209999999999994 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 . . . . . 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 33.240000000000002 111.887 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 119.305 -0.378 . . . . 74.349999999999994 110.15 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.040000000000006 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 61.350000000000001 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.439999999999998 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 54.119999999999997 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 61.5 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.319999999999993 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.329999999999998 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 62.219999999999999 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.150000000000006 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 62.030000000000001 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.109999999999999 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.409999999999997 111.306 177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.420000000000002 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.140000000000001 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 30.329999999999998 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 51.030000000000001 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 74.230000000000004 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 71.209999999999994 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 113' ' ' VAL . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.439999999999998 110.744 -172.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.140000000000001 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.019999999999996 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 71.200000000000003 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 109' ' ' VAL . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 52.210000000000001 109.045 172.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.409999999999997 113.135 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 62.450000000000003 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.140000000000001 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.210000000000001 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.329999999999998 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.310000000000002 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.319999999999993 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.019999999999996 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 51.149999999999999 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 71.540000000000006 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.209999999999994 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 50.409999999999997 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.129999999999995 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.230000000000004 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 . . . . . 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 64.430000000000007 109.84 178.482 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.230000000000004 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 55.140000000000001 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 74.329999999999998 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.219999999999999 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 128' ' ' ASP . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.349999999999994 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 70.049999999999997 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.230000000000004 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.040000000000006 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.420000000000002 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 30.329999999999998 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.019999999999996 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 71.109999999999999 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 73.549999999999997 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 50.229999999999997 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.439999999999998 108.984 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 51.329999999999998 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.45 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.420000000000002 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.409999999999997 109.999 -176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 46' ' ' ILE . 55.5 mt . . . . . 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 64.329999999999998 110.831 176.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.128 0.49 . . . . 72.340000000000003 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.129999999999995 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.120000000000005 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.400000000000006 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 65.120000000000005 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.340000000000003 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.340000000000003 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 25.41 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.129999999999995 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.530000000000001 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.119999999999997 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.409999999999997 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.319999999999993 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.409999999999997 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 53.509999999999998 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 55.43 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 51.450000000000003 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 51.409999999999997 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.567 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.319999999999993 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.219999999999999 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.109999999999999 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.57 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.200000000000003 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.109999999999999 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 70.439999999999998 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.099999999999994 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.219999999999999 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.099999999999994 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 72.510000000000005 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 64.140000000000001 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.430000000000007 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.516 ' H ' HG13 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.510000000000005 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.411 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.510000000000005 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.340000000000003 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.239999999999995 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 22.329999999999998 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 62.539999999999999 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.519999999999996 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 53.43 110.405 175.764 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 112.206 0.447 . . . . 71.030000000000001 112.206 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 54.119999999999997 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 44.119999999999997 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 71.530000000000001 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 70.120000000000005 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.430000000000007 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 42.109999999999999 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 71.319999999999993 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.120000000000005 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 71.510000000000005 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.409999999999997 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.510000000000005 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 54.549999999999997 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.239999999999995 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.587 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.310000000000002 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.310000000000002 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.430000000000007 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.219999999999999 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.209999999999994 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.413 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.129999999999995 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 61.25 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.039999999999999 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 62.43 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 72.310000000000002 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 61.109999999999999 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.329999999999998 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 65.549999999999997 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.230000000000004 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 71.329999999999998 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 71.209999999999994 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.420000000000002 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.120000000000005 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.239999999999995 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 61.200000000000003 112.721 -173.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.450000000000003 109.698 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 50.210000000000001 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 45.530000000000001 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.509999999999998 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.430000000000007 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.409999999999997 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 41.149999999999999 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.209999999999994 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 72.549999999999997 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.209999999999994 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 63.439999999999998 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 51.539999999999999 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.239999999999995 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.230000000000004 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 71.310000000000002 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 62.43 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 55.039999999999999 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.099999999999994 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.120000000000005 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 72.319999999999993 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.129999999999995 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 63.409999999999997 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.430000000000007 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.109999999999999 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 62.420000000000002 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.299999999999997 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.200000000000003 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 65.420000000000002 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.340000000000003 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.299999999999997 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.140000000000001 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.310000000000002 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 64.420000000000002 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 61.030000000000001 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 65.409999999999997 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.230000000000004 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.299999999999997 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.040000000000006 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.329999999999998 110.414 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 . . . . . 0 CA--C 1.556 1.207 0 CA-C-O 119.032 -0.509 . . . . 75.540000000000006 110.225 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.450000000000003 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.319999999999993 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.505 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.310000000000002 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.019999999999996 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 72.540000000000006 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.340000000000003 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.209999999999994 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.329999999999998 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.310000000000002 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 63.119999999999997 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.230000000000004 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.140000000000001 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.519999999999996 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.530000000000001 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 60.240000000000002 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.409999999999997 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.230000000000004 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.329999999999998 109.743 167.611 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HD1' ' A' ' 12' ' ' TYR . 9.7 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 108.589 -0.893 . . . . 51.240000000000002 108.589 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 50.310000000000002 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.229999999999997 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 18' ' ' THR . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.040000000000006 112.218 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.230000000000004 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.209999999999994 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.109999999999999 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 14' ' ' SER . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.299999999999997 111.763 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 54.43 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 70.010000000000005 112.177 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 45.140000000000001 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 73.549999999999997 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 63.020000000000003 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.340000000000003 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.150000000000006 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 63.100000000000001 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.049999999999997 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.040000000000006 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.340000000000003 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 74.430000000000007 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 61.039999999999999 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.209999999999994 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 71.129999999999995 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.019999999999996 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 71.349999999999994 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 70.340000000000003 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 71.299999999999997 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 54.119999999999997 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.450000000000003 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.150000000000006 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.340000000000003 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 63.119999999999997 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.109999999999999 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.400000000000006 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.130000000000003 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.530000000000001 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm . . . . . 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 64.140000000000001 111.541 179.805 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm . . . . . 0 CA--C 1.558 1.257 0 CA-C-O 120.873 0.368 . . . . 64.519999999999996 111.504 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 63.43 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 72.329999999999998 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.530000000000001 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 65.109999999999999 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.433 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 63.130000000000003 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.239999999999995 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 73.439999999999998 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 58' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 52.409999999999997 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.349999999999994 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.230000000000004 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 61.549999999999997 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 50.210000000000001 112.115 -172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.420000000000002 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 72.349999999999994 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.420000000000002 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.049999999999997 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 54.229999999999997 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.329999999999998 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.299999999999997 110.187 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.109999999999999 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 70.5 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.230000000000004 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.319999999999993 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 71.400000000000006 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 62.43 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 60.130000000000003 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 52.420000000000002 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.019999999999996 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.319999999999993 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 64.439999999999998 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 73.219999999999999 110.243 176.624 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 119.029 -0.51 . . . . 71.230000000000004 110.926 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 71.540000000000006 112.568 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 55.450000000000003 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.468 ' HD2' ' HB2' ' A' ' 83' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.319999999999993 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.230000000000004 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.573 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 1.5 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.310000000000002 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.200000000000003 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.409999999999997 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 61.350000000000001 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.200000000000003 110.665 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 65.510000000000005 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.200000000000003 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 62.130000000000003 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 43.329999999999998 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.429 ' CG2' HD23 ' A' ' 112' ' ' LEU . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 54.130000000000003 109.36 -175.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 53.409999999999997 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 72.549999999999997 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.099999999999994 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.539999999999999 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 64.150000000000006 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.471 ' N ' HD12 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.439999999999998 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 63.439999999999998 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.230000000000004 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 64.329999999999998 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 41.030000000000001 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 72.519999999999996 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.521 ' O ' HG23 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 72.340000000000003 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.431 HE21 ' HD2' ' A' ' 141' ' ' PHE . 58.7 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.239999999999995 111.641 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.533 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 55.409999999999997 111.365 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.109999999999999 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 65.510000000000005 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.533 HE21 ' HA2' ' A' ' 121' ' ' GLY . 27.8 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 72.019999999999996 111.844 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 72.019999999999996 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 63.350000000000001 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.219999999999999 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.329999999999998 112.354 -174.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 . . . . . 0 CA--C 1.562 1.406 0 CA-C-O 118.777 -0.63 . . . . 64.239999999999995 110.779 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.420000000000002 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 73.129999999999995 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 51.329999999999998 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.329999999999998 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.521 ' HG3' HG11 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 63.039999999999999 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.499 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 63.240000000000002 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.319999999999993 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.420000000000002 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.109999999999999 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.573 HG21 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 73.340000000000003 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.219999999999999 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.510000000000005 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 63.310000000000002 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.468 HD12 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.530000000000001 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.140000000000001 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.099999999999994 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.230000000000004 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 63.329999999999998 112.807 178.764 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 108.62 -0.881 . . . . 61.5 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.010000000000005 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.010000000000005 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.540000000000006 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 71.540000000000006 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.519999999999996 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' MET . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.319999999999993 110.613 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 62.020000000000003 111.062 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 63.539999999999999 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 72.200000000000003 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.530000000000001 109.969 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.430000000000007 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 54.200000000000003 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 71.349999999999994 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 36' ' ' SER . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 74.310000000000002 108.202 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.140000000000001 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 72.239999999999995 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.510000000000005 111.675 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.400000000000006 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 71.400000000000006 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.129999999999995 111.199 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 33' ' ' VAL . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.030000000000001 110.117 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 32' ' ' ILE . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.209999999999994 107.44 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 64.430000000000007 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.129999999999995 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.451 ' H ' ' HE2' ' A' ' 24' ' ' TYR . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 55.310000000000002 109.453 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 64.25 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 62.130000000000003 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 64.019999999999996 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 64.549999999999997 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 63.539999999999999 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 72.349999999999994 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.310000000000002 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.510000000000005 111.477 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 61.100000000000001 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.200000000000003 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.439999999999998 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 62.039999999999999 113.106 -170.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.17 0.509 . . . . 63.25 110.83 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 62.25 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.439999999999998 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.219999999999999 109.365 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 64.409999999999997 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.420000000000002 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.430000000000007 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.099999999999994 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 71.450000000000003 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.310000000000002 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.040000000000006 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 72.140000000000001 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.310000000000002 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.329999999999998 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.030000000000001 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.520000000000003 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.439999999999998 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.329999999999998 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.109999999999999 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 71.219999999999999 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.430000000000007 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.340000000000003 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.530000000000001 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 63.219999999999999 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.540000000000006 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.219999999999999 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.450000000000003 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.140000000000001 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.109999999999999 111.85 -176.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 70.540000000000006 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.140000000000001 111.94 174.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.109999999999999 109.873 170.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.129999999999995 111.332 179.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 71.430000000000007 109.444 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 63.509999999999998 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 71.140000000000001 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HD1' HD12 ' A' ' 149' ' ' ILE . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 64.510000000000005 107.934 174.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 72.519999999999996 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 63.409999999999997 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 24.34 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 72.129999999999995 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 55.539999999999999 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 63.299999999999997 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 41.219999999999999 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 54.219999999999999 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.310000000000002 111.172 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 73.120000000000005 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 54.509999999999998 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.539999999999999 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.099999999999994 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 62.420000000000002 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 64.230000000000004 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 70.140000000000001 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.329999999999998 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 73.219999999999999 113.016 -177.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 73.420000000000002 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.409999999999997 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.120000000000005 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.450000000000003 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 62.409999999999997 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.319999999999993 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.522 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.010000000000005 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.099999999999994 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 43.240000000000002 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.239999999999995 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 34.020000000000003 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 27.6 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.450000000000003 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 63.310000000000002 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 45.240000000000002 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 74.129999999999995 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 61.530000000000001 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 37.3 m-70 . . . . . 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 63.030000000000001 110.906 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 . . . . . 0 CA--C 1.564 1.499 0 N-CA-C 112.212 0.449 . . . . 75.239999999999995 112.212 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD12 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.349999999999994 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.109999999999999 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 65.209999999999994 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.430000000000007 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.349999999999994 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 70.140000000000001 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.140000000000001 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 61.219999999999999 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.299999999999997 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 43.210000000000001 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 70.349999999999994 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 73.120000000000005 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.41 HD12 ' HD1' ' A' ' 93' ' ' PHE . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.109999999999999 109.175 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.319999999999993 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 72.129999999999995 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.120000000000005 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 62.340000000000003 109.744 170.85 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.652 0.739 . . . . 65.030000000000001 111.613 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 72.340000000000003 114.303 -163.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.530000000000001 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 53.009999999999998 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.239999999999995 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 74.239999999999995 110.896 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 65.019999999999996 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.350000000000001 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 64.340000000000003 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 54.32 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 64.140000000000001 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 43.399999999999999 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.200000000000003 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.548 HD12 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.109999999999999 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.230000000000004 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 72.340000000000003 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.667 HD21 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.040000000000006 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.329999999999998 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 62.530000000000001 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.409999999999997 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB2' HD21 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.420000000000002 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.239999999999995 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.513 HG13 HG12 ' A' ' 33' ' ' VAL . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 73.129999999999995 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 73.109999999999999 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.420000000000002 109.462 171.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 64.409999999999997 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.120000000000005 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.409999999999997 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 41' ' ' THR . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.209999999999994 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 44.020000000000003 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.437 ' H ' HG13 ' A' ' 38' ' ' VAL . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 70.299999999999997 111.423 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 54.530000000000001 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.140000000000001 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 32' ' ' ILE . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.140000000000001 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.530000000000001 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.319999999999993 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp . . . . . 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.430000000000007 111.142 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 26.7 mmtm . . . . . 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 70.209999999999994 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 61.140000000000001 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.099999999999994 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.420000000000002 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 65.010000000000005 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 55.310000000000002 110.425 -175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 43.439999999999998 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.129999999999995 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.329999999999998 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 72.349999999999994 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.420000000000002 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.510000000000005 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 74.329999999999998 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 73.010000000000005 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 64.049999999999997 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 74.540000000000006 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 63.109999999999999 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.349999999999994 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.540000000000006 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.329999999999998 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.519999999999996 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 53.539999999999999 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.340000000000003 109.602 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' THR . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 62.340000000000003 111.876 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 73.140000000000001 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 52.140000000000001 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.109999999999999 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 54.43 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.150000000000006 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.409999999999997 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 61.119999999999997 109.647 -177.563 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 119.476 -0.297 . . . . 70.349999999999994 110.345 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 62.229999999999997 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.540000000000006 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 73.120000000000005 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.129999999999995 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 61.25 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.549999999999997 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.400000000000006 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 63.340000000000003 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.049999999999997 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.450000000000003 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 55.149999999999999 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 62.100000000000001 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 61.310000000000002 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 55.329999999999998 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.239999999999995 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.150000000000006 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 64.340000000000003 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.239999999999995 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.129999999999995 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.319999999999993 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.329999999999998 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 62.0 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.420000000000002 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.329999999999998 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.310000000000002 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 72.219999999999999 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 55.409999999999997 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 62.310000000000002 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.498 HE21 ' H ' ' A' ' 141' ' ' PHE . 86.4 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 51.329999999999998 111.639 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.109999999999999 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.530000000000001 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 63.420000000000002 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.030000000000001 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.019999999999996 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.099999999999994 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 73.120000000000005 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 53.530000000000001 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 . . . . . 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 72.310000000000002 110.817 -176.937 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.549999999999997 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.230000000000004 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 71.219999999999999 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.329999999999998 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.409999999999997 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.540000000000006 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 34.109999999999999 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' H ' HE21 ' A' ' 120' ' ' GLN . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.129999999999995 109.242 172.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.340000000000003 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.310000000000002 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.140000000000001 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.400000000000006 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 71.329999999999998 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.299999999999997 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.030000000000001 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 70.219999999999999 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.109999999999999 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.415 HE21 HG22 ' A' ' 149' ' ' ILE . 93.4 mm-40 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 65.439999999999998 109.444 175.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.439999999999998 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.439999999999998 112.773 -178.47 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 11' ' ' THR . 1.6 m . . . . . 0 CA--C 1.559 1.322 0 N-CA-C 109.451 -0.574 . . . . 72.219999999999999 109.451 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.497 ' H ' HG22 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.120000000000005 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.409999999999997 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 64.010000000000005 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.519999999999996 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.340000000000003 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.109999999999999 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.140000000000001 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' CE2' ' A' ' 24' ' ' TYR . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 73.129999999999995 111.27 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 60.439999999999998 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.129999999999995 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.549999999999997 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 60.420000000000002 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.25 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 18' ' ' THR . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.239999999999995 108.589 169.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.430000000000007 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.209999999999994 110.458 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 73.010000000000005 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 64.030000000000001 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.030000000000001 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.109999999999999 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.409999999999997 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.400000000000006 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.409999999999997 111.517 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.510000000000005 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 44.5 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 62.140000000000001 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 40' ' ' THR . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 64.019999999999996 109.427 173.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.530000000000001 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 38' ' ' VAL . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 72.010000000000005 109.93 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.040000000000006 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 71.450000000000003 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.519999999999996 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.340000000000003 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 43.530000000000001 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.319999999999993 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 63.229999999999997 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.299999999999997 111.154 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp . . . . . 0 N--CA 1.478 0.972 0 CA-C-O 121.575 0.702 . . . . 73.510000000000005 111.727 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 71.409999999999997 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 33.020000000000003 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.219999999999999 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.230000000000004 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 62.229999999999997 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 61.420000000000002 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.209999999999994 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 61.240000000000002 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.209999999999994 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.140000000000001 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 74.109999999999999 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.540000000000006 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.439999999999998 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 73.219999999999999 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.099999999999994 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 73.439999999999998 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.239999999999995 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.230000000000004 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 72.519999999999996 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 60.039999999999999 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.420000000000002 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 73.099999999999994 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 64.230000000000004 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.129999999999995 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 55.420000000000002 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 70.519999999999996 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.209999999999994 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.540000000000006 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 72.519999999999996 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.299999999999997 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.409999999999997 110.766 -177.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 64.540000000000006 110.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 72.120000000000005 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 73.109999999999999 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 74.219999999999999 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 73.329999999999998 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 73.049999999999997 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.239999999999995 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.010000000000005 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.129999999999995 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.450000000000003 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.430000000000007 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.310000000000002 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.119999999999997 111.148 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.319999999999993 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.430000000000007 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.120000000000005 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.439999999999998 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 71.219999999999999 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 33.450000000000003 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 45.420000000000002 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.219999999999999 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.340000000000003 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 72.340000000000003 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 62.100000000000001 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 71.430000000000007 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 70.420000000000002 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.420000000000002 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.439999999999998 111.486 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 53.299999999999997 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.489 ' O ' HG23 ' A' ' 123' ' ' VAL . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.219999999999999 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 62.229999999999997 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.409999999999997 112.924 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.400000000000006 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 71.200000000000003 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.494 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 29.7 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 63.43 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 71.340000000000003 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.019999999999996 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.109999999999999 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 54.450000000000003 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 65.340000000000003 109.749 172.033 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.984 -0.532 . . . . 65.319999999999993 112.149 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.150000000000006 114.439 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 71.239999999999995 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 64.209999999999994 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 123' ' ' VAL . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.219999999999999 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.430000000000007 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 65.010000000000005 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 64.450000000000003 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 52.109999999999999 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.049999999999997 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 71.310000000000002 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.019999999999996 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 65.450000000000003 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 72.319999999999993 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 64.129999999999995 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.230000000000004 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' A' ' 56' ' ' LEU . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.310000000000002 108.56 171.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 61.329999999999998 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 64.5 111.506 -179.405 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 112.016 0.376 . . . . 62.240000000000002 112.016 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -77.95 -6.47 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 123.693 0.797 . . . . 72.430000000000007 111.306 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -55.88 150.13 29.85 Favored Pre-proline 0 N--CA 1.486 1.367 0 C-N-CA 124.616 1.167 . . . . 73.299999999999997 111.876 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.53 67.09 1.62 Allowed 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 123.756 2.97 . . . . 75.439999999999998 113.942 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.05 49.69 54.49 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 115.058 0.783 . . . . 44.520000000000003 115.058 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.82 89.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-O 121.42 0.629 . . . . 73.219999999999999 111.119 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -103.53 85.31 2.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.26 1.024 . . . . 65.230000000000004 109.744 178.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -162.77 147.22 11.67 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.77 1.228 . . . . 62.210000000000001 107.732 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB3' HE22 ' A' ' 151' ' ' GLN . 24.4 tp -68.94 118.14 11.49 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.496 -0.927 . . . . 63.350000000000001 108.496 172.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 p -77.18 174.56 10.58 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.748 1.219 . . . . 75.420000000000002 112.663 -172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.1 p -57.79 -56.13 25.89 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.529 1.131 . . . . 63.020000000000003 113.292 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -52.06 -37.15 52.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.735 0.814 . . . . 74.530000000000001 113.089 -175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.559 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.3 -37.78 71.8 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.659 0.783 . . . . 71.430000000000007 111.634 -177.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -79.13 -23.33 44.08 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.395 0.678 . . . . 41.32 111.216 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -72.67 -53.63 11.22 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.644 0.778 . . . . 64.409999999999997 109.741 175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.49 -23.02 67.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.856 0.862 . . . . 73.219999999999999 111.462 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.43 -53.6 15.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.922 -0.581 . . . . 51.520000000000003 111.322 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -69.98 -22.2 63.17 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.027 0.531 . . . . 64.340000000000003 111.411 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.84 -38.34 88.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.477 1.111 . . . . 63.310000000000002 109.558 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.6 tpp -70.56 -40.94 73.04 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.285 -0.87 . . . . 64.439999999999998 110.138 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.0 22.28 0.93 Allowed Glycine 0 C--N 1.353 1.508 0 O-C-N 123.554 0.533 . . . . 40.439999999999998 112.96 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -81.82 153.9 26.19 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.266 0.626 . . . . 74.450000000000003 111.044 177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 pt -119.58 159.28 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.621 0.769 . . . . 74.549999999999997 110.832 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -105.71 124.47 49.61 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.264 -1.013 . . . . 72.530000000000001 108.264 169.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.04 170.69 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.462 0.705 . . . . 44.329999999999998 109.867 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -92.8 -173.95 3.47 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.708 -0.479 . . . . 73.439999999999998 109.708 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 t -71.88 -14.75 62.03 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.165 0.586 . . . . 63.350000000000001 111.143 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -75.59 -60.96 2.08 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 108.718 -0.845 . . . . 75.329999999999998 108.718 167.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 143.96 -2.72 1.43 Allowed Glycine 0 C--N 1.344 0.996 0 CA-C-O 119.306 -0.719 . . . . 61.32 113.789 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.15 141.13 38.92 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.606 0.703 . . . . 74.420000000000002 110.292 177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.83 110.52 6.41 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.362 0.601 . . . . 71.140000000000001 110.603 -176.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.489 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 48.1 pt -75.22 -36.55 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.618 0.767 . . . . 61.009999999999998 111.108 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -161.54 136.77 1.56 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.182 -1.044 . . . . 72.030000000000001 108.182 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 26.5 p-10 -83.42 -33.7 25.66 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.681 0.792 . . . . 61.240000000000002 111.389 -174.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -124.28 145.42 49.4 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.919 0.888 . . . . 62.039999999999999 110.135 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -84.26 62.29 7.07 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.764 0.825 . . . . 72.040000000000006 109.541 173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -61.44 -57.23 13.03 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 115.248 -0.887 . . . . 72.409999999999997 109.682 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 40' ' ' THR . 5.8 p -161.36 147.39 4.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 CA-C-N 113.896 -1.502 . . . . 64.530000000000001 108.654 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -60.03 -23.79 64.0 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.455 1.102 . . . . 74.010000000000005 111.845 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.467 ' H ' HG22 ' A' ' 38' ' ' VAL . 75.1 p -68.7 -52.49 30.27 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.653 0.381 . . . . 53.039999999999999 110.501 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 m -58.86 -42.01 88.38 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.617 0.767 . . . . 75.439999999999998 110.973 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -62.31 -43.12 99.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.339 -1.301 . . . . 75.239999999999995 111.733 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.403 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 28.9 ttt180 -75.52 -37.39 60.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.099 0.56 . . . . 72.140000000000001 110.312 -174.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -68.55 -32.13 71.85 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.694 0.397 . . . . 71.519999999999996 110.474 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.47 -36.44 84.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.373 0.669 . . . . 35.420000000000002 111.052 176.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 80.8 mt -65.9 -47.56 84.99 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.376 1.071 . . . . 74.430000000000007 110.037 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.1 mt -74.71 -14.75 60.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.912 0.885 . . . . 74.030000000000001 112.86 -174.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -67.04 -38.45 85.87 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.136 0.574 . . . . 73.530000000000001 110.437 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -100.11 170.13 8.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.727 0.811 . . . . 74.25 110.139 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.34 31.71 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.363 0.665 . . . . 41.43 110.425 -176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.79 86.26 5.38 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.316 1.055 . . . . 44.310000000000002 109.738 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -85.99 77.21 9.7 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.58 -1.191 . . . . 71.310000000000002 112.586 -170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -158.21 145.58 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.475 1.11 . . . . 63.409999999999997 108.786 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . . . -104.25 158.04 16.72 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.703 0.801 . . . . 51.219999999999999 109.972 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.09 101.22 3.88 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.601 1.16 . . . . 73.420000000000002 108.472 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.5 tp -71.09 97.37 1.48 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.903 0.881 . . . . 54.240000000000002 109.59 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 85.9 t -87.03 119.88 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.283 -1.006 . . . . 72.439999999999998 108.283 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 ptp -134.17 170.76 15.21 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.408 1.083 . . . . 73.420000000000002 109.089 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.2 p30 -94.76 176.69 6.17 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.542 0.737 . . . . 63.229999999999997 109.657 170.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.505 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 29.8 tt0 -75.68 -26.84 57.96 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 111.925 0.343 . . . . 74.030000000000001 111.925 -176.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -68.32 -30.28 69.22 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.049 0.452 . . . . 65.340000000000003 110.059 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.2 m -66.71 -44.86 80.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.156 -0.929 . . . . 51.310000000000002 110.335 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -63.27 -32.47 73.88 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.228 -0.897 . . . . 64.420000000000002 112.179 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.505 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 69.5 mmtt -58.18 -27.35 63.76 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.797 0.439 . . . . 72.420000000000002 111.538 178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -84.52 -50.14 7.99 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.715 0.806 . . . . 75.25 110.741 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.559 HG13 ' HB1' ' A' ' 13' ' ' ALA . 70.2 t -57.22 -57.19 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 124.204 1.002 . . . . 62.219999999999999 111.831 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.404 ' HD1' HG21 ' A' ' 80' ' ' ILE . 92.0 t80 -52.07 -42.96 63.59 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.912 1.285 . . . . 63.130000000000003 112.106 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -68.67 -42.34 78.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.231 -0.895 . . . . 63.509999999999998 110.713 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.44 -33.56 75.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.814 0.846 . . . . 75.230000000000004 111.019 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.01 -57.68 11.59 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.836 0.454 . . . . 73.439999999999998 110.151 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 45.3 mt -64.66 -27.34 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 123.423 0.689 . . . . 75.109999999999999 111.602 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.75 -47.21 86.25 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.968 0.907 . . . . 61.43 109.574 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -73.46 -14.77 61.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.299 1.04 . . . . 64.409999999999997 111.658 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.8 t70 87.77 50.01 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.186 1.794 . . . . 75.319999999999993 110.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -111.75 92.56 4.08 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 105.419 -2.067 . . . . 70.530000000000001 105.419 171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.55 HG22 ' HG2' ' A' ' 79' ' ' GLU . 6.5 t -59.07 154.01 42.11 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.228 1.411 . . . . 71.299999999999997 112.621 -162.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.0 Cg_endo -53.92 -29.51 54.13 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 123.652 2.902 . . . . 31.52 112.844 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.983 0.802 . . . . 53.030000000000001 110.999 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' THR . 9.2 mm-40 -62.66 -53.04 60.57 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.144 0.497 . . . . 72.510000000000005 110.211 176.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.404 HG21 ' HD1' ' A' ' 67' ' ' TYR . 61.0 mt -57.52 -52.76 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 CA-C-N 113.916 -1.493 . . . . 74.409999999999997 111.6 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -68.33 -20.77 64.75 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.347 0.659 . . . . 75.430000000000007 112.123 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.2 t -73.82 -27.33 61.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.411 0.684 . . . . 62.409999999999997 111.304 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 71.5 m-85 -77.18 -12.14 59.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.474 0.31 . . . . 74.25 111.586 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -81.61 -13.69 57.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.018 0.527 . . . . 60.409999999999997 111.312 172.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -82.21 126.74 32.43 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.285 0.634 . . . . 70.25 110.669 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.688 HD22 ' HD3' ' A' ' 91' ' ' PRO . 27.5 t-20 -80.91 84.19 6.46 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.657 -0.868 . . . . 74.219999999999999 108.657 172.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -133.9 124.97 27.34 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.854 -0.795 . . . . 64.25 108.854 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.27 -55.07 4.94 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.087 -0.506 . . . . 74.010000000000005 112.053 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.1 -172.92 3.87 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.78 1.232 . . . . 71.299999999999997 108.593 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.451 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 96.9 mtt180 -62.03 156.53 57.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 C-N-CA 124.045 0.938 . . . . 54.0 112.099 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.688 ' HD3' HD22 ' A' ' 86' ' ' ASN . 31.6 Cg_exo -59.23 138.39 84.53 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.092 1.861 . . . . 62.140000000000001 112.122 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 68.9 t -79.23 -53.53 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.684 -0.858 . . . . 65.409999999999997 108.684 175.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 7.4 m-30 -89.83 111.94 23.11 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.615 -1.254 . . . . 72.040000000000006 107.615 171.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 91' ' ' PRO . 74.6 t -113.99 149.2 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.551 0.74 . . . . 71.209999999999994 109.882 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.492 ' HE3' HG21 ' A' ' 145' ' ' THR . 21.0 ptmt -145.33 163.62 33.96 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.526 0.73 . . . . 75.120000000000005 110.835 173.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.76 -153.59 25.45 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 110.53 -1.028 . . . . 70.140000000000001 110.53 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.2 t -72.85 177.37 4.9 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 109.04 -0.726 . . . . 64.409999999999997 109.04 168.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.88 -52.31 64.61 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 118.24 0.473 . . . . 72.109999999999999 110.894 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.8 mt-10 -70.21 -39.52 75.1 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.113 -0.949 . . . . 74.109999999999999 110.839 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -59.52 -49.24 78.53 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.444 0.698 . . . . 75.049999999999997 111.739 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.98 -26.3 66.74 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.066 -0.97 . . . . 73.439999999999998 111.07 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.464 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.03 -41.06 78.19 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.559 0.744 . . . . 52.240000000000002 110.818 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.3 mt-10 -69.66 -40.32 76.51 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.908 0.883 . . . . 73.420000000000002 111.39 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.402 ' O ' ' HD2' ' A' ' 91' ' ' PRO . 48.0 mt-30 -72.72 -41.3 65.37 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.69 -0.687 . . . . 73.409999999999997 111.128 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.46 -25.63 61.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.858 0.463 . . . . 74.200000000000003 110.976 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.66 17.71 61.39 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.756 -0.656 . . . . 75.25 113.834 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 148' ' ' ILE . 16.0 mt -81.1 150.67 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.865 0.866 . . . . 63.539999999999999 109.423 178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.0 111.52 2.53 Favored 'Isoleucine or valine' 0 C--O 1.252 1.187 0 N-CA-C 109.048 -0.723 . . . . 71.239999999999995 109.048 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.19 -49.78 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 114.777 -1.101 . . . . 70.209999999999994 111.286 -172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.6 t70 -55.25 -45.04 76.06 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.154 0.982 . . . . 71.310000000000002 111.991 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -62.26 -47.38 84.61 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 123.856 0.722 . . . . 72.349999999999994 111.43 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -76.73 -26.32 54.51 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 112.735 0.643 . . . . 74.5 112.735 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.58 -37.93 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.721 -0.844 . . . . 42.32 108.721 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 21.9 mm-40 -62.98 -56.68 15.03 Favored 'General case' 0 C--O 1.206 -1.21 0 N-CA-C 108.378 -0.971 . . . . 73.209999999999994 108.378 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 12.3 m -50.87 -38.97 52.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 114.412 1.264 . . . . 74.349999999999994 114.412 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 70.6 t -78.07 -37.6 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.164 0.586 . . . . 72.319999999999993 110.991 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -77.84 -22.62 49.65 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 118.47 0.577 . . . . 64.530000000000001 110.921 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -69.91 -52.79 21.66 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.628 -1.619 . . . . 72.439999999999998 106.628 171.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 123' ' ' VAL . 81.3 t80 -55.61 -66.05 0.49 Allowed 'General case' 0 C--N 1.358 0.942 0 O-C-N 125.16 1.538 . . . . 74.439999999999998 110.312 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -59.47 -25.32 64.32 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.77 0.828 . . . . 74.049999999999997 112.269 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.95 -44.74 29.38 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 123.36 0.412 . . . . 52.240000000000002 112.723 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -84.76 -18.4 35.22 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.374 0.509 . . . . 73.439999999999998 112.374 -175.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.4 t -61.8 -57.58 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 N-CA-C 109.419 -0.585 . . . . 72.129999999999995 109.419 174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -71.32 -15.76 62.42 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.396 -0.82 . . . . 63.340000000000003 111.852 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 14.7 t70 -78.85 -27.5 44.14 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.412 0.685 . . . . 71.340000000000003 110.668 171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 91.79 -21.6 35.48 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 116.166 -0.47 . . . . 73.209999999999994 114.023 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.577 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 41.3 t60 -101.75 112.18 24.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 108.915 -0.772 . . . . 64.219999999999999 108.915 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.64 171.4 13.31 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.385 0.612 . . . . 62.140000000000001 111.858 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -143.79 9.53 1.54 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.629 1.172 . . . . 64.239999999999995 108.891 175.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.9 p-10 -108.34 75.79 1.0 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.563 1.145 . . . . 70.019999999999996 109.29 -177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 66.99 1.9 2.5 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.985 1.314 . . . . 75.349999999999994 113.685 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.24 51.66 1.32 Allowed Glycine 0 C--N 1.347 1.159 0 CA-C-N 117.792 0.269 . . . . 50.310000000000002 112.915 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.532 ' HD2' HD23 ' A' ' 138' ' ' LEU . 58.0 ttm-85 -89.82 140.7 29.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.597 0.759 . . . . 75.530000000000001 109.955 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 11.9 t70 -73.14 142.3 82.18 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 122.934 0.493 . . . . 53.130000000000003 110.527 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.541 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.2 Cg_endo -42.09 -38.01 4.94 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 124.756 3.637 . . . . 62.43 115.651 175.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -73.14 -20.04 61.0 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 112.032 0.382 . . . . 63.43 112.032 -176.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.529 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 84.9 m-85 -93.68 -20.28 20.31 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.42 0.688 . . . . 72.430000000000007 110.707 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -65.01 126.92 29.54 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.417 0.687 . . . . 60.200000000000003 109.8 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -146.73 114.91 6.61 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.872 0.869 . . . . 73.099999999999994 109.846 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -62.99 143.53 57.68 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 117.82 0.282 . . . . 64.120000000000005 110.47 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 59.6 m-85 -65.35 100.9 0.51 Allowed 'General case' 0 C--O 1.24 0.556 0 O-C-N 124.132 0.895 . . . . 75.420000000000002 109.836 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -93.93 121.49 35.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.2 0.6 . . . . 70.200000000000003 110.187 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.23 142.46 4.4 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.181 -1.168 . . . . 73.420000000000002 110.181 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -64.06 -27.15 68.91 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.813 0.845 . . . . 75.329999999999998 110.989 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.492 HG21 ' HE3' ' A' ' 95' ' ' LYS . 24.1 m -106.9 121.83 45.21 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.848 0.859 . . . . 72.099999999999994 111.536 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -90.37 122.82 33.59 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.392 1.077 . . . . 65.230000000000004 109.268 169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -98.24 114.14 26.3 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.43 -0.582 . . . . 61.310000000000002 109.43 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 107' ' ' ILE . 52.2 mt -104.77 109.04 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 108.918 -0.771 . . . . 74.430000000000007 108.918 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.507 HG21 HD22 ' A' ' 9' ' ' LEU . 35.1 mm -98.76 112.25 30.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 109.522 -0.547 . . . . 75.540000000000006 109.522 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -64.26 107.5 1.34 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.775 0.83 . . . . 62.240000000000002 110.172 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.627 HE22 ' HB3' ' A' ' 9' ' ' LEU . 83.1 mm-40 -94.44 99.09 11.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.238 -0.892 . . . . 74.109999999999999 108.855 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -81.21 178.52 8.35 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.469 -0.787 . . . . 71.319999999999993 109.257 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.49 178.46 1.6 Allowed 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 120.862 0.363 . . . . 74.120000000000005 111.163 173.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 154' ' ' GLU . 2.7 mp0 -63.37 -62.99 1.31 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.743 1.217 . . . . 73.409999999999997 109.773 -168.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -83.32 132.15 35.03 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.068 -0.969 . . . . 63.32 108.691 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.0 p-80 -170.21 177.84 4.05 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.153 0.981 . . . . 62.020000000000003 109.049 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -69.69 139.8 53.49 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.226 0.536 . . . . 64.340000000000003 110.701 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -144.27 162.51 36.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.569 1.148 . . . . 73.140000000000001 109.453 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -69.92 112.9 6.66 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.782 -0.821 . . . . 64.0 108.782 175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 . . . . . 0 C--O 1.251 1.138 0 C-N-CA 125.119 1.368 . . . . 42.240000000000002 109.717 -175.621 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptm . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 111.78 0.289 . . . . 64.150000000000006 111.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.3 m -102.49 12.47 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 122.985 0.514 . . . . 64.329999999999998 111.2 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.99 148.31 98.4 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 123.18 0.592 . . . . 74.140000000000001 110.645 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -51.27 157.04 4.84 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 123.2 2.6 . . . . 60.409999999999997 113.804 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.73 80.35 0.12 Allowed Glycine 0 C--N 1.348 1.22 0 O-C-N 123.7 0.625 . . . . 73.310000000000002 112.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.8 m -117.28 142.62 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.472 1.109 . . . . 74.010000000000005 109.264 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 132.57 41.16 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 122.756 0.423 . . . . 72.310000000000002 110.893 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 4.0 tppp? -74.31 -14.8 60.94 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.302 0.641 . . . . 74.109999999999999 110.12 171.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.7 tp -54.82 124.39 16.39 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.391 1.076 . . . . 72.530000000000001 110.939 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 11' ' ' THR . 1.3 m -135.12 -174.55 3.64 Favored 'General case' 0 CA--C 1.562 1.418 0 N-CA-C 108.115 -1.068 . . . . 74.310000000000002 108.115 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.561 ' H ' HG22 ' A' ' 10' ' ' THR . 36.1 p -64.77 -22.03 66.9 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.765 1.024 . . . . 73.530000000000001 113.765 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 40.1 p90 -53.31 -40.9 65.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.281 0.633 . . . . 74.310000000000002 111.408 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.54 -32.15 65.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.421 -0.809 . . . . 64.120000000000005 111.601 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 57.8 p -83.95 -33.7 24.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.078 0.551 . . . . 64.0 111.871 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.67 -44.71 16.77 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.398 0.679 . . . . 71.329999999999998 111.416 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -63.88 -33.65 76.17 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.366 -0.379 . . . . 75.530000000000001 110.319 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.81 -54.15 50.34 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 123.778 0.674 . . . . 63.32 111.204 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 35' ' ' GLU . 40.1 p -66.34 -28.06 68.38 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.333 0.653 . . . . 74.120000000000005 112.029 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -64.27 -44.45 91.68 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 123.967 0.792 . . . . 65.420000000000002 110.559 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.562 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 61.8 mtm -81.92 -32.98 30.61 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.52 0.728 . . . . 52.5 111.892 -176.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.91 74.11 0.01 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.209 -0.357 . . . . 55.530000000000001 112.209 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -148.35 164.39 34.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.556 0.742 . . . . 51.310000000000002 109.744 173.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.5 pt -134.65 149.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.765 0.826 . . . . 70.109999999999999 109.779 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.568 ' HE2' HD21 ' A' ' 37' ' ' ASN . 86.4 m-85 -98.9 118.36 35.49 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.036 -1.098 . . . . 72.430000000000007 108.036 170.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 30' ' ' ASP . 22.3 m -112.55 -174.29 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 124.298 1.039 . . . . 64.25 108.531 171.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -123.69 -167.8 1.68 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 109.161 -0.681 . . . . 60.25 109.161 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.3 t -70.2 -7.69 43.96 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 112.984 0.735 . . . . 62.140000000000001 112.984 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -89.97 -49.52 6.55 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.048 -0.723 . . . . 72.099999999999994 109.048 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.34 17.37 2.97 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.677 -0.692 . . . . 74.450000000000003 112.691 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.0 m-20 -74.16 121.15 20.73 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.404 -0.961 . . . . 63.140000000000001 108.404 173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -56.58 98.1 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.67 -0.863 . . . . 74.409999999999997 108.67 165.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.688 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 26.5 pt -72.55 -30.96 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.31 -0.859 . . . . 75.25 109.884 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG21 ' HB3' ' A' ' 37' ' ' ASN . 7.4 p -168.89 139.43 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 125.299 1.44 . . . . 53.149999999999999 107.99 171.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.94 -66.13 0.68 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.915 -0.772 . . . . 60.399999999999999 108.915 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.593 ' HB3' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -158.19 -177.95 6.93 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.341 -1.3 . . . . 73.219999999999999 109.47 -174.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.4 t 51.7 70.27 0.57 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.206 1.002 . . . . 71.239999999999995 110.969 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.568 HD21 ' HE2' ' A' ' 24' ' ' TYR . 4.4 p30 -142.02 128.28 19.87 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.43 -0.804 . . . . 70.329999999999998 109.833 -172.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.3 p -78.59 165.44 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-N 115.324 -0.853 . . . . 74.430000000000007 108.783 171.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -52.78 -33.15 47.32 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.344 0.658 . . . . 64.409999999999997 111.652 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -63.13 -47.28 83.42 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.921 0.888 . . . . 70.140000000000001 110.816 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 56.3 m -62.99 -50.15 71.88 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.441 0.697 . . . . 61.299999999999997 110.665 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.37 -43.95 97.99 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.355 1.035 . . . . 73.129999999999995 111.096 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 46.0 ttp180 -66.75 -57.26 7.46 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.601 0.76 . . . . 65.219999999999999 110.159 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -58.71 -32.71 69.44 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.042 0.937 . . . . 51.439999999999998 111.835 -177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.688 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.89 -46.09 89.47 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.735 -0.666 . . . . 63.420000000000002 110.705 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.9 mt -67.09 -39.23 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.896 0.879 . . . . 63.409999999999997 111.153 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 66.5 mt -61.5 -32.45 72.48 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.169 0.588 . . . . 65.120000000000005 110.309 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -76.01 -25.58 55.85 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.057 0.943 . . . . 62.32 111.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 80.4 mm-40 -74.85 161.57 29.44 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.84 0.456 . . . . 75.409999999999997 111.549 -175.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.23 63.7 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 115.309 -0.86 . . . . 72.340000000000003 111.405 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -111.09 170.77 7.89 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.105 0.962 . . . . 65.099999999999994 109.374 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -125.18 23.95 7.55 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 120.901 0.381 . . . . 71.120000000000005 111.617 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 152' ' ' ARG . 8.0 p -141.8 146.98 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 122.796 0.438 . . . . 63.140000000000001 110.184 170.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.84 168.94 8.73 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.436 -0.802 . . . . 64.450000000000003 109.917 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -144.43 119.86 10.31 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.023 0.929 . . . . 74.329999999999998 109.273 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 tp -82.2 101.72 10.65 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.901 0.88 . . . . 73.540000000000006 110.294 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.7 t -89.06 119.58 36.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.975 -0.75 . . . . 61.130000000000003 108.975 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.6 ptp -132.62 177.18 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.441 1.096 . . . . 74.430000000000007 108.994 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 21.3 t70 -102.18 168.26 9.47 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.51 -0.922 . . . . 64.019999999999996 108.51 169.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 34.6 tt0 -68.17 -26.82 65.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 122.702 0.401 . . . . 73.030000000000001 111.427 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -55.96 -49.13 74.42 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.612 0.765 . . . . 74.329999999999998 111.144 171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.4 m -64.78 -37.45 87.66 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.874 -1.057 . . . . 75.400000000000006 110.319 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.4 t-105 -68.87 -30.31 68.79 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-N 115.207 -0.906 . . . . 74.430000000000007 112.38 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.9 mmtt -55.3 -37.21 67.04 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 119.063 0.847 . . . . 70.439999999999998 110.995 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.562 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 31.1 mmmt -75.18 -50.06 17.48 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.446 -1.252 . . . . 73.230000000000004 110.336 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.5 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.8 t -58.03 -50.62 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.844 0.858 . . . . 73.129999999999995 111.478 -177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -52.14 -45.44 64.99 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.685 1.594 . . . . 74.299999999999997 111.62 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.94 -44.36 93.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.496 -0.775 . . . . 75.120000000000005 110.533 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 92.3 mt -64.83 -29.91 70.89 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.972 0.909 . . . . 72.319999999999993 111.428 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 92.9 mt -64.61 -55.89 17.42 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.059 0.544 . . . . 52.299999999999997 109.682 176.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.6 mt -67.93 -28.94 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.517 0.727 . . . . 65.329999999999998 111.002 -177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.87 -44.54 80.68 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.763 0.825 . . . . 64.019999999999996 109.604 176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.0 -13.05 60.46 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.991 0.916 . . . . 75.420000000000002 111.854 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.0 t70 92.58 68.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.221 1.808 . . . . 72.540000000000006 109.893 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' LYS . 52.3 t80 -136.69 94.41 2.99 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 106.251 -1.759 . . . . 51.32 106.251 175.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 79' ' ' GLU . 5.8 t -56.11 148.76 38.92 Favored Pre-proline 0 CA--C 1.561 1.383 0 O-C-N 124.379 1.05 . . . . 72.349999999999994 111.874 -166.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -56.15 -28.82 72.4 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.212 2.608 . . . . 52.340000000000003 112.751 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -64.04 -42.75 96.96 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.575 1.15 . . . . 71.409999999999997 110.636 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' H ' HG23 ' A' ' 76' ' ' THR . 23.7 mm-40 -65.15 -46.37 81.15 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.184 0.594 . . . . 74.450000000000003 110.669 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.0 mt -55.21 -54.99 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 124.368 1.043 . . . . 70.209999999999994 110.682 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -70.72 -20.12 62.68 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.833 0.853 . . . . 73.299999999999997 111.638 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.3 t -71.62 -32.65 68.2 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.472 0.709 . . . . 72.209999999999994 111.005 177.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -80.31 2.14 25.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.529 0.566 . . . . 74.150000000000006 112.529 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -91.9 -17.61 24.96 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.086 0.554 . . . . 73.420000000000002 110.867 170.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 27.1 mm-40 -70.22 113.19 7.15 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.026 0.53 . . . . 75.340000000000003 110.529 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -99.39 91.1 4.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.276 1.03 . . . . 71.329999999999998 108.881 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 85' ' ' GLU . 49.6 mtmt -127.1 -72.68 0.63 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.793 0.837 . . . . 64.120000000000005 109.972 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -96.29 -38.46 4.53 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 110.907 -0.877 . . . . 73.450000000000003 110.907 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -109.95 159.06 17.59 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.388 1.075 . . . . 63.210000000000001 109.95 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 47.1 mtm105 -74.87 145.66 81.68 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.029 -1.1 . . . . 71.519999999999996 108.029 166.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.0 Cg_exo -60.94 128.59 25.92 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.195 1.93 . . . . 71.430000000000007 112.281 -174.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.3 -36.41 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.73 -0.841 . . . . 65.209999999999994 108.73 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -110.92 116.92 32.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.932 -1.507 . . . . 73.540000000000006 106.932 168.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 91' ' ' PRO . 15.7 t -110.62 155.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 108.729 -0.841 . . . . 44.439999999999998 108.729 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -150.45 176.49 10.89 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.262 0.553 . . . . 71.109999999999999 111.464 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.7 -143.97 14.97 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 114.792 -1.095 . . . . 73.120000000000005 110.453 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.0 t -77.51 171.44 14.89 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.219 -0.659 . . . . 62.340000000000003 109.219 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 51.2 tp -59.45 -47.35 85.83 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.005 0.522 . . . . 73.239999999999995 110.868 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.0 mt-10 -75.59 -40.14 57.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.061 -0.972 . . . . 71.329999999999998 111.469 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -61.01 -46.31 91.25 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.455 0.702 . . . . 74.230000000000004 111.165 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.91 -30.6 70.79 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.157 -0.929 . . . . 31.34 111.066 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -62.97 -45.24 93.35 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.532 0.733 . . . . 53.520000000000003 111.214 175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.6 mt-10 -67.61 -39.45 84.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.333 -0.849 . . . . 75.010000000000005 111.659 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -70.65 -35.61 72.97 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.291 0.636 . . . . 75.129999999999995 111.467 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.465 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -80.2 -23.0 41.27 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.223 0.609 . . . . 60.310000000000002 111.665 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.56 24.84 52.66 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.364 -0.38 . . . . 71.239999999999995 113.132 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.417 ' CG2' HD23 ' A' ' 112' ' ' LEU . 22.3 mt -93.76 151.01 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.853 0.861 . . . . 54.100000000000001 109.1 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.5 110.71 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 109.928 -0.397 . . . . 74.400000000000006 109.928 178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.5 t -52.98 -58.38 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.806 1.242 . . . . 64.450000000000003 111.473 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.94 -37.75 77.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.445 0.698 . . . . 75.510000000000005 111.951 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -65.89 -48.81 70.24 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.03 0.532 . . . . 53.329999999999998 111.605 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.0 pp -73.14 -30.6 63.72 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 112.131 0.419 . . . . 72.239999999999995 112.131 -178.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.424 ' N ' HD12 ' A' ' 112' ' ' LEU . 67.5 t -60.86 -39.9 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 109.022 -0.733 . . . . 73.349999999999994 109.022 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -59.87 -57.44 12.87 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.022 0.826 . . . . 75.219999999999999 110.677 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -31.09 71.65 Favored 'General case' 0 CA--C 1.561 1.4 0 C-N-CA 122.929 0.492 . . . . 72.150000000000006 112.242 -170.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.6 t -78.32 -45.78 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.623 0.769 . . . . 44.520000000000003 110.945 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.05 -25.9 61.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 110.599 -0.149 . . . . 71.519999999999996 110.599 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.14 -40.77 67.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.441 0.696 . . . . 74.530000000000001 109.543 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 123' ' ' VAL . 51.4 t80 -56.65 -61.21 2.58 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 124.12 0.887 . . . . 55.240000000000002 109.308 171.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -57.67 -29.48 64.66 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.123 0.969 . . . . 74.140000000000001 111.912 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.643 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -64.63 -46.03 91.2 Favored Glycine 0 C--N 1.344 1.006 0 O-C-N 123.955 0.784 . . . . 72.040000000000006 112.226 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.5 p90 -85.87 -18.09 33.78 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.748 0.648 . . . . 74.019999999999996 112.748 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.546 HG22 ' HB3' ' A' ' 138' ' ' LEU . 50.9 t -61.59 -53.89 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.77 0.428 . . . . 63.240000000000002 109.889 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.643 HE21 ' HA2' ' A' ' 121' ' ' GLY . 28.2 pt20 -67.6 -22.03 65.38 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.85 -0.614 . . . . 75.430000000000007 110.869 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.1 -27.66 35.52 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 122.939 0.496 . . . . 75.239999999999995 110.586 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.58 25.84 66.8 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 114.498 0.559 . . . . 70.439999999999998 114.498 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.542 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.3 t60 -149.72 112.13 4.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.488 -0.931 . . . . 73.099999999999994 108.488 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.08 171.12 12.5 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.179 0.514 . . . . 74.310000000000002 111.973 -173.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -149.19 29.42 0.8 Allowed 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.849 0.859 . . . . 63.439999999999998 109.536 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.71 -89.23 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.978 0.511 . . . . 75.099999999999994 111.339 -172.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -118.58 0.99 11.65 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.089 0.556 . . . . 63.119999999999997 110.643 -168.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.71 116.45 0.74 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.301 -0.72 . . . . 71.510000000000005 111.301 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.488 ' HD3' ' H ' ' A' ' 134' ' ' ASP . 14.7 tpp180 -161.02 137.69 8.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.989 0.516 . . . . 73.129999999999995 110.213 178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' H ' ' HD3' ' A' ' 133' ' ' ARG . 3.1 m-20 -56.98 134.88 80.09 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.843 1.257 . . . . 70.230000000000004 110.788 176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -52.78 -25.07 25.66 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 123.091 2.528 . . . . 73.430000000000007 113.938 174.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.57 -30.04 70.72 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.133 0.573 . . . . 74.010000000000005 111.691 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.15 -12.16 25.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.371 0.668 . . . . 71.25 111.598 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.546 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.8 mt -73.65 109.23 7.0 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.863 -0.792 . . . . 73.239999999999995 108.863 174.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -138.74 122.13 17.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.45 0.7 . . . . 72.040000000000006 109.405 -177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.08 153.26 38.06 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.663 0.602 . . . . 73.239999999999995 111.578 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.442 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 58.9 m-85 -73.6 103.54 4.24 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.31 -0.859 . . . . 54.119999999999997 108.804 168.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -136.2 94.65 3.06 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 121.709 0.766 . . . . 71.420000000000002 111.208 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.7 15.81 0.04 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.056 -0.975 . . . . 70.329999999999998 112.4 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 64.28 7.47 3.56 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.131 1.372 . . . . 70.299999999999997 113.955 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 55.3 m -148.74 123.37 9.81 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.941 0.496 . . . . 61.149999999999999 110.051 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -96.48 148.31 22.94 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.833 0.853 . . . . 74.219999999999999 110.538 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -125.87 127.28 45.79 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.313 1.045 . . . . 73.420000000000002 108.944 173.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 53.3 mt -115.42 112.22 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 109.204 -0.665 . . . . 72.129999999999995 109.204 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 24.6 mm -101.46 124.59 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 108.954 -0.758 . . . . 64.319999999999993 108.954 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.4 107.02 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.848 0.459 . . . . 72.230000000000004 110.108 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -96.84 99.91 11.46 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.955 -0.757 . . . . 64.519999999999996 108.955 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.419 ' HA ' HG23 ' A' ' 53' ' ' VAL . 29.4 mmt180 -77.16 176.03 9.11 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.348 0.659 . . . . 63.020000000000003 110.55 177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.31 156.23 22.83 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.728 0.411 . . . . 65.200000000000003 111.031 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.434 ' HG3' ' CD2' ' A' ' 155' ' ' HIS . 7.0 pt-20 -60.33 -29.09 68.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.154 0.981 . . . . 72.230000000000004 113.36 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.434 ' CD2' ' HG3' ' A' ' 154' ' ' GLU . 90.2 m-70 -83.59 79.07 9.56 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.733 0.778 . . . . 75.319999999999993 111.712 -174.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -135.68 140.29 44.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.627 1.171 . . . . 70.219999999999999 108.319 169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -128.16 147.14 50.54 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.741 0.816 . . . . 63.43 109.195 -175.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -73.68 108.7 6.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.781 0.433 . . . . 74.219999999999999 109.868 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -69.56 140.95 53.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.869 0.868 . . . . 64.439999999999998 111.285 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.546 1.138 . . . . 61.539999999999999 108.038 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.652 ' HG3' HG11 ' A' ' 53' ' ' VAL . 24.6 ttt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.689 0.281 . . . . 63.340000000000003 110.517 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.33 92.26 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.359 -0.978 . . . . 52.140000000000001 108.359 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 5' ' ' GLY . 6.1 mt-10 -73.63 156.3 88.64 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.078 0.551 . . . . 73.209999999999994 111.198 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.09 -13.42 23.62 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.672 2.248 . . . . 63.229999999999997 111.57 161.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' A' ' 3' ' ' GLU . . . 94.31 56.11 1.4 Allowed Glycine 0 C--N 1.349 1.29 0 CA-C-N 115.762 -0.653 . . . . 64.019999999999996 112.235 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.86 -48.84 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.032 0.533 . . . . 53.509999999999998 110.142 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 47.25 33.41 2.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.252 1.421 . . . . 23.239999999999998 112.476 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -72.57 88.59 1.26 Allowed 'General case' 0 C--N 1.358 0.966 0 CA-C-O 121.945 0.878 . . . . 75.209999999999994 110.475 -173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.62 HD22 HG21 ' A' ' 149' ' ' ILE . 57.0 tp -149.58 123.1 9.11 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 105.841 -1.911 . . . . 74.540000000000006 105.841 171.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.8 p -65.99 145.47 55.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.219 0.608 . . . . 75.200000000000003 111.374 -172.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.455 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.9 p -61.39 -47.39 86.06 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.147 0.979 . . . . 75.010000000000005 111.869 -172.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -55.92 -41.13 74.09 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.718 0.407 . . . . 71.209999999999994 111.032 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -71.6 -35.03 70.36 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.261 0.624 . . . . 55.439999999999998 111.335 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.4 m -67.2 -41.34 86.01 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.406 0.683 . . . . 61.210000000000001 110.889 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 11' ' ' THR . 64.8 mmtt -85.49 -29.81 23.97 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.82 -0.627 . . . . 55.030000000000001 112.176 -173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.27 -38.04 89.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.428 -0.582 . . . . 62.549999999999997 109.428 170.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.79 -52.35 65.84 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 123.831 0.707 . . . . 52.240000000000002 110.869 177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.1 p -64.67 -31.45 72.67 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.024 0.53 . . . . 71.019999999999996 112.079 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.85 -32.31 71.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.31 -0.859 . . . . 74.439999999999998 110.798 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 67.1 mtm -91.5 12.6 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.067 0.947 . . . . 54.530000000000001 111.597 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.08 8.51 41.57 Favored Glycine 0 C--N 1.356 1.642 0 N-CA-C 115.092 0.797 . . . . 63.310000000000002 115.092 166.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.45 150.1 38.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.348 0.574 . . . . 61.439999999999998 110.162 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.4 pt -119.0 151.5 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 122.781 0.432 . . . . 61.109999999999999 111.043 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -100.01 118.18 35.85 Favored 'General case' 0 C--O 1.246 0.875 0 N-CA-C 109.203 -0.666 . . . . 71.239999999999995 109.203 171.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 m -115.66 -176.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.579 1.151 . . . . 64.400000000000006 108.155 169.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -121.56 -168.48 1.7 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.066 -0.716 . . . . 61.329999999999998 109.066 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -70.67 -10.94 60.53 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 113.133 0.79 . . . . 32.100000000000001 113.133 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -80.62 -50.31 10.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 166.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.03 4.84 11.11 Favored Glycine 0 N--CA 1.473 1.134 0 CA-C-O 119.739 -0.478 . . . . 75.140000000000001 113.798 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.43 146.67 31.32 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 122.843 0.457 . . . . 54.420000000000002 110.336 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.7 ttm-85 -60.65 114.02 2.77 Favored 'General case' 0 CA--C 1.548 0.867 0 O-C-N 123.9 0.75 . . . . 61.119999999999997 109.73 173.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 32.9 pt -83.39 -28.59 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.664 0.386 . . . . 64.329999999999998 111.151 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 p -154.85 152.79 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.132 0 C-N-CA 123.592 0.757 . . . . 75.329999999999998 109.909 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -60.02 -40.83 90.63 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.475 1.11 . . . . 64.239999999999995 112.46 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -163.94 -176.35 4.51 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.96 1.304 . . . . 72.299999999999997 107.907 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.411 ' OG ' ' HD2' ' A' ' 15' ' ' LYS . 15.4 t -85.58 87.93 7.46 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.902 -0.777 . . . . 43.439999999999998 108.902 173.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -70.09 -58.52 3.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.734 -0.666 . . . . 53.539999999999999 109.848 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 41' ' ' THR . 8.3 p -159.82 156.5 3.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 114.773 -1.103 . . . . 72.510000000000005 109.01 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -48.67 -41.98 33.22 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 71.239999999999995 112.066 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m -61.32 -50.41 73.05 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 123.672 0.607 . . . . 71.209999999999994 111.056 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.46 ' H ' HG13 ' A' ' 38' ' ' VAL . 24.7 m -66.18 -37.55 85.89 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.418 0.687 . . . . 63.229999999999997 111.087 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.63 -51.24 63.67 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.999 0.92 . . . . 63.310000000000002 110.856 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' HD22 ' A' ' 153' ' ' LEU . 56.5 ttp180 -57.49 -47.63 81.4 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.919 0.888 . . . . 75.230000000000004 110.228 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -66.49 -33.19 75.13 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.177 -0.919 . . . . 64.420000000000002 111.854 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -64.71 -31.41 72.62 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.992 0.517 . . . . 74.209999999999994 110.966 178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 52' ' ' LYS . 66.6 mt -81.5 -35.68 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 C-N-CA 124.466 1.106 . . . . 72.319999999999993 110.283 176.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.443 HD23 ' HE2' ' A' ' 52' ' ' LYS . 93.9 mt -70.62 -24.94 62.83 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.82 0.848 . . . . 63.350000000000001 111.536 178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -66.17 -30.09 70.5 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.289 1.036 . . . . 71.409999999999997 110.078 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.26 161.02 16.62 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.817 -1.083 . . . . 73.439999999999998 109.606 171.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.72 -22.97 49.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.176 -0.676 . . . . 50.049999999999997 109.176 165.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.88 98.59 3.02 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.782 1.233 . . . . 65.120000000000005 109.249 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HA ' HG22 ' A' ' 46' ' ' ILE . 1.2 mptm? -86.9 54.94 3.35 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 122.496 1.141 . . . . 71.319999999999993 109.873 178.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.652 HG11 ' HG3' ' A' ' 1' ' ' MET . 3.1 p -158.65 126.16 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 113.451 -1.704 . . . . 74.5 108.483 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.89 159.47 16.23 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.55 0.74 . . . . 64.409999999999997 109.613 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -135.13 113.07 11.02 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.745 0.818 . . . . 75.040000000000006 108.994 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.2 tp -85.61 104.12 15.06 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.29 -0.868 . . . . 64.310000000000002 109.022 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.79 121.7 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.667 0.787 . . . . 75.400000000000006 109.481 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -134.1 169.49 17.07 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.821 0.848 . . . . 74.430000000000007 109.934 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.2 p-10 -85.13 176.16 8.55 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.658 0.783 . . . . 71.439999999999998 109.366 168.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 33.4 tt0 -68.53 -30.89 69.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.788 0.662 . . . . 74.239999999999995 112.788 -175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 142' ' ' GLU . 2.0 mpt_? -71.75 -46.09 59.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 118.319 0.509 . . . . 75.140000000000001 109.976 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.2 m -63.15 -31.98 73.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.433 -0.803 . . . . 75.129999999999995 110.244 175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -66.64 -46.49 75.61 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 115.743 -0.662 . . . . 75.310000000000002 111.52 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 70.7 mmtt -53.08 -35.04 59.13 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.568 0.347 . . . . 72.140000000000001 111.514 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -69.1 -45.21 70.78 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 123.944 0.777 . . . . 74.219999999999999 111.309 176.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.558 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.4 t -61.15 -59.87 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.232 0.613 . . . . 64.25 110.11 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -47.51 -43.03 24.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.862 1.665 . . . . 72.120000000000005 112.342 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.8 -56.05 18.37 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 123.823 0.702 . . . . 71.329999999999998 110.124 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.0 mt -59.47 -33.82 71.78 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.18 0.925 . . . . 74.420000000000002 111.876 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 96.1 mt -56.35 -58.43 8.03 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 123.965 0.791 . . . . 72.450000000000003 109.843 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.0 mt -67.77 -30.85 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.955 0.902 . . . . 65.129999999999995 110.956 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.65 -43.61 88.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.057 0.943 . . . . 72.319999999999993 109.624 -174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -85.03 -65.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 121.988 0.115 . . . . 64.439999999999998 110.703 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 179.76 98.0 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.984 0.914 . . . . 72.010000000000005 109.771 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -174.26 104.19 0.11 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 106.559 -1.645 . . . . 74.140000000000001 106.559 173.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 79' ' ' GLU . 6.1 m -60.19 132.61 90.2 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 123.582 0.753 . . . . 55.420000000000002 110.678 -175.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.02 -33.63 83.96 Favored 'Trans proline' 0 C--N 1.381 2.24 0 C-N-CA 122.68 2.253 . . . . 60.32 111.66 175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.46 -43.42 83.96 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 124.493 1.12 . . . . 73.310000000000002 111.091 174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 76' ' ' THR . 49.9 mt-10 -67.46 -44.41 78.69 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 75.200000000000003 111.462 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.98 -48.61 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.598 0.759 . . . . 71.25 110.831 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.4 ptmm? -72.33 -20.28 61.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.47 0.708 . . . . 63.140000000000001 111.5 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.5 m -74.86 -21.15 59.42 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.813 0.445 . . . . 54.530000000000001 111.615 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.29 -15.21 57.44 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.559 0.343 . . . . 72.040000000000006 111.393 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 82.5 m-85 -83.69 -13.22 54.61 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.798 0.439 . . . . 71.129999999999995 110.997 171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -76.3 142.1 41.42 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.079 0.552 . . . . 75.109999999999999 110.18 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -77.18 79.01 3.71 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.097 -0.705 . . . . 53.140000000000001 109.097 177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -127.97 157.07 41.59 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.091 0.956 . . . . 74.239999999999995 110.126 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.56 -82.95 0.47 Allowed Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.159 -0.777 . . . . 60.210000000000001 111.159 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -132.15 -49.86 0.94 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.315 1.046 . . . . 74.420000000000002 109.38 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' NH1' ' HA3' ' A' ' 106' ' ' GLY . 29.4 ttm180 -157.31 146.02 14.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.713 0.805 . . . . 62.109999999999999 109.8 -170.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 90' ' ' ARG . 32.2 Cg_exo -56.59 118.04 4.81 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.497 2.132 . . . . 54.43 111.198 169.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.26 -43.36 91.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.664 0.745 . . . . 71.519999999999996 109.11 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 2.0 m-30 -95.95 116.56 29.12 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.197 -1.038 . . . . 73.010000000000005 108.197 175.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.44 152.36 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 123.419 0.688 . . . . 62.149999999999999 109.911 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -144.37 175.2 10.28 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.538 0.735 . . . . 71.230000000000004 111.476 176.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.41 -145.57 17.49 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.026 -1.23 . . . . 24.210000000000001 110.026 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -76.4 172.67 12.54 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.736 -0.838 . . . . 63.340000000000003 108.736 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.45 -51.16 71.02 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.075 0.464 . . . . 73.030000000000001 110.744 176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 45.3 mt-10 -67.77 -42.2 82.07 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.583 -1.19 . . . . 62.219999999999999 111.419 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -61.84 -51.23 69.08 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.367 0.667 . . . . 53.450000000000003 111.528 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.06 -24.89 66.81 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.087 -0.961 . . . . 73.549999999999997 111.453 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.08 -44.92 75.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.588 0.755 . . . . 63.0 111.096 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 37.8 mt-10 -63.84 -46.4 85.21 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.406 -0.816 . . . . 74.109999999999999 111.401 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -67.87 -33.24 74.35 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.32 -0.855 . . . . 65.209999999999994 111.707 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -81.03 -25.56 37.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.284 0.634 . . . . 62.340000000000003 111.042 176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' HA3' ' NH1' ' A' ' 90' ' ' ARG . . . 84.34 31.92 23.97 Favored Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.81 -0.632 . . . . 74.109999999999999 113.309 178.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.492 HD11 HG21 ' A' ' 148' ' ' ILE . 7.1 mt -91.47 146.94 5.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 108.387 -0.968 . . . . 55.240000000000002 108.387 173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.7 105.82 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 108.339 -0.986 . . . . 71.120000000000005 108.339 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.1 t -54.15 -48.16 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 114.454 -1.248 . . . . 71.150000000000006 111.234 -172.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.15 -41.38 83.65 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.184 -0.916 . . . . 71.200000000000003 110.982 -177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.13 -46.91 79.04 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.519 0.512 . . . . 71.409999999999997 111.594 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.1 pp -75.23 -24.27 57.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 112.928 0.714 . . . . 72.430000000000007 112.928 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 t -65.55 -39.57 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 108.23 -1.026 . . . . 71.109999999999999 108.23 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -65.48 -50.51 65.07 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.045 0.841 . . . . 74.239999999999995 108.969 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 55.0 m -53.82 -43.1 69.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.013 1.325 . . . . 73.129999999999995 112.869 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.1 t -84.09 -39.02 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 123.276 0.63 . . . . 72.310000000000002 111.649 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -70.59 -31.44 68.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.841 0.746 . . . . 75.129999999999995 110.504 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -79.39 -34.48 41.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.523 0.729 . . . . 70.430000000000007 109.851 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 65.0 t80 -54.43 -58.39 7.63 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 123.907 0.754 . . . . 74.349999999999994 109.063 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -62.75 -28.46 69.98 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.519 -1.218 . . . . 74.129999999999995 111.307 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.465 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.28 -45.09 72.06 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 124.233 0.958 . . . . 74.239999999999995 112.415 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HE2' ' HB2' ' A' ' 130' ' ' ASP . 2.3 p90 -82.85 -18.76 39.24 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 112.221 0.452 . . . . 75.420000000000002 112.221 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 138' ' ' LEU . 25.6 t -60.8 -59.58 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 122.928 0.491 . . . . 72.040000000000006 109.852 171.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.465 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -74.26 -16.15 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.763 0.825 . . . . 75.299999999999997 111.53 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.55 -24.7 64.65 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.479 0.711 . . . . 72.109999999999999 110.333 172.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 76.18 22.14 74.29 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.774 -0.648 . . . . 73.310000000000002 112.797 -177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -165.09 129.55 2.46 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 107.837 -1.171 . . . . 63.210000000000001 107.837 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -75.9 142.17 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 123.342 0.401 . . . . 62.509999999999998 110.959 -178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -112.34 -53.74 2.68 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 72.299999999999997 108.751 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' HB2' ' HE2' ' A' ' 122' ' ' TYR . 5.7 m-20 -88.87 76.26 7.96 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.108 -1.071 . . . . 73.439999999999998 108.108 175.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 19.8 p90 22.53 72.25 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 127.044 2.138 . . . . 74.239999999999995 114.164 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -100.12 -114.04 3.6 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.292 -0.867 . . . . 74.140000000000001 111.37 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -167.19 -169.92 1.38 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.43 1.092 . . . . 73.140000000000001 109.672 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HB2' ' HD2' ' A' ' 137' ' ' TYR . 4.8 m-20 -53.71 144.04 36.56 Favored Pre-proline 0 N--CA 1.494 1.757 0 C-N-CA 124.003 0.921 . . . . 72.430000000000007 112.404 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.421 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 28.1 Cg_endo -58.69 -26.4 79.43 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.66 2.906 . . . . 74.040000000000006 113.828 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -68.61 -25.93 65.1 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.777 0.431 . . . . 74.120000000000005 111.366 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.405 ' HD2' ' HB2' ' A' ' 134' ' ' ASP . 68.5 m-85 -94.79 -26.33 16.28 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.887 0.875 . . . . 73.120000000000005 110.454 175.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 123' ' ' VAL . 83.8 mt -69.6 115.57 9.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.608 -0.724 . . . . 73.239999999999995 109.156 172.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -145.25 138.93 26.77 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.593 -0.891 . . . . 65.219999999999999 108.593 174.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -66.07 153.92 40.96 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.326 -0.62 . . . . 72.340000000000003 109.326 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 93.8 m-85 -64.63 92.99 0.1 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.817 0.698 . . . . 62.210000000000001 109.498 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' O ' ' HD3' ' A' ' 61' ' ' ARG . 43.2 mt-10 -73.28 96.7 2.33 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.172 -0.677 . . . . 72.400000000000006 109.172 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.98 145.11 4.11 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 110.518 -1.033 . . . . 75.310000000000002 110.518 -175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -75.18 -58.31 3.36 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.237 0.615 . . . . 71.400000000000006 110.321 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.6 m -78.25 130.56 36.4 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.008 0.923 . . . . 72.409999999999997 111.163 -177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -96.07 149.45 21.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.148 0.979 . . . . 64.140000000000001 110.269 171.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -125.6 132.97 52.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.951 1.3 . . . . 71.299999999999997 107.729 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 107' ' ' ILE . 52.5 mt -125.48 114.73 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.601 -0.889 . . . . 75.030000000000001 108.601 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.62 HG21 HD22 ' A' ' 9' ' ' LEU . 26.7 mm -105.69 120.45 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 122.905 0.482 . . . . 74.030000000000001 109.778 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -71.37 127.47 32.69 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.638 1.175 . . . . 74.310000000000002 110.459 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -136.11 101.08 4.6 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.866 -1.161 . . . . 64.510000000000005 107.866 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.414 ' HG2' HG23 ' A' ' 53' ' ' VAL . 14.4 mtm180 -88.82 159.56 17.67 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.935 -0.395 . . . . 64.510000000000005 109.935 174.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' A' ' 43' ' ' ARG . 88.5 mt -60.64 159.16 11.16 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 63.539999999999999 112.204 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -64.93 157.08 29.05 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.74 0.781 . . . . 64.219999999999999 111.44 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -116.82 95.6 5.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.842 -1.072 . . . . 73.409999999999997 108.125 -168.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -85.28 95.26 9.14 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.687 -0.688 . . . . 75.120000000000005 109.4 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -124.99 129.13 49.72 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.043 0.937 . . . . 61.409999999999997 109.998 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -80.61 70.64 7.38 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.026 -0.731 . . . . 74.439999999999998 109.026 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -164.81 173.04 12.19 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.842 1.657 . . . . 61.210000000000001 109.01 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 109.011 -0.737 . . . . 73.140000000000001 109.011 176.329 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 119.896 -0.097 . . . . 72.530000000000001 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 m -74.91 -7.98 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.153 0.581 . . . . 71.340000000000003 111.738 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -64.19 149.92 93.35 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.655 1.182 . . . . 73.0 110.759 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -84.59 21.12 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.949 2.432 . . . . 73.420000000000002 112.896 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.84 -68.77 0.29 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.623 -0.991 . . . . 73.219999999999999 110.623 -173.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.5 t 71.43 -59.49 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 126.14 1.776 . . . . 72.349999999999994 112.671 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.92 121.22 10.01 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.203 1.001 . . . . 42.340000000000003 113.233 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.1 134.67 33.22 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.819 0.848 . . . . 71.239999999999995 109.39 174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 tt -82.5 122.47 28.09 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.914 0.486 . . . . 52.149999999999999 109.944 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.8 m -110.3 151.31 27.55 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.772 0.829 . . . . 74.030000000000001 109.122 172.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 39.9 p -58.0 -18.86 26.66 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 115.089 1.515 . . . . 62.109999999999999 115.089 -171.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 22.0 p90 -47.6 -44.7 26.71 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.739 0.816 . . . . 73.329999999999998 112.981 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -68.75 -35.41 77.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.672 0.789 . . . . 73.040000000000006 111.701 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.5 p -79.97 -21.11 44.1 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.119 0.568 . . . . 72.209999999999994 111.675 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 11' ' ' THR . 71.6 mmtt -83.62 -40.78 18.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.896 0.478 . . . . 71.519999999999996 110.768 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 84.9 mm-40 -57.91 -34.79 70.2 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.958 0.503 . . . . 72.030000000000001 109.879 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.92 79.86 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 114.705 -1.134 . . . . 63.009999999999998 112.352 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.3 p -69.85 -32.44 70.83 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.866 0.466 . . . . 71.540000000000006 111.713 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -61.09 -48.18 82.89 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.589 0.556 . . . . 72.5 111.206 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.511 ' SD ' ' HG3' ' A' ' 65' ' ' LYS . 67.5 mtm -75.24 -34.75 61.45 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.9 -0.591 . . . . 63.450000000000003 111.537 -176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.3 80.63 0.04 OUTLIER Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.368 -0.293 . . . . 64.519999999999996 112.368 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.59 151.49 28.9 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.777 0.831 . . . . 65.120000000000005 109.768 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -121.65 148.51 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 123.751 0.82 . . . . 52.140000000000001 110.38 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 64.4 m-85 -97.79 119.15 35.88 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.737 -0.838 . . . . 75.549999999999997 108.737 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.0 m -112.9 165.6 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.086 0.954 . . . . 74.530000000000001 110.398 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 39.5 p30 -95.57 -168.39 1.77 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.827 0.451 . . . . 72.439999999999998 111.097 177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -69.29 -14.53 62.99 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.725 0.81 . . . . 74.319999999999993 112.305 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -92.03 -49.52 6.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.207 -0.664 . . . . 52.200000000000003 109.207 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.73 -1.04 1.49 Allowed Glycine 0 C--O 1.22 -0.726 0 CA-C-O 119.05 -0.861 . . . . 52.109999999999999 113.284 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.93 121.11 14.78 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 117.809 0.805 . . . . 72.420000000000002 110.807 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.725 ' HD2' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -61.67 90.71 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.765 0.793 . . . . 74.409999999999997 109.855 172.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.447 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 20.1 pt -67.81 -19.23 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.492 1.117 . . . . 71.340000000000003 112.991 -173.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.0 139.38 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 122.854 0.462 . . . . 64.430000000000007 109.969 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -67.65 -40.4 84.56 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.614 1.165 . . . . 73.109999999999999 112.106 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.469 ' HB2' HH11 ' A' ' 133' ' ' ARG . 14.0 tp10 -161.47 145.35 12.88 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.217 1.407 . . . . 75.510000000000005 108.102 -173.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 20.9 t -81.15 68.65 7.53 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 109.101 -0.703 . . . . 72.430000000000007 109.101 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -66.02 -41.79 90.52 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.747 -1.115 . . . . 74.299999999999997 109.995 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 41' ' ' THR . 10.8 p -142.13 152.99 18.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 C-N-CA 124.073 0.949 . . . . 74.239999999999995 109.033 172.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -57.77 -30.11 65.38 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.896 0.878 . . . . 74.510000000000005 111.993 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.8 m -66.13 -49.39 67.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.562 0.745 . . . . 62.240000000000002 111.307 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.469 ' H ' HG13 ' A' ' 38' ' ' VAL . 23.4 m -61.48 -39.16 89.9 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.876 0.47 . . . . 73.129999999999995 110.845 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -67.74 -43.44 79.89 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.353 -0.84 . . . . 62.210000000000001 111.033 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 51.0 ttm-85 -65.86 -48.31 72.01 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.168 0.587 . . . . 75.219999999999999 111.334 -175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -68.09 -30.34 69.49 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.677 0.391 . . . . 71.239999999999995 111.399 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -62.2 -34.83 77.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.958 0.503 . . . . 73.129999999999995 110.928 172.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 54' ' ' ALA . 60.6 mt -75.79 -37.48 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.96 0.904 . . . . 64.140000000000001 110.939 173.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 94.9 mt -65.85 -21.06 66.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.493 0.717 . . . . 51.340000000000003 111.354 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -60.12 -35.38 75.12 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.025 0.93 . . . . 73.400000000000006 111.784 171.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 46' ' ' ILE . 1.8 mp0 -77.15 151.53 35.28 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.362 0.665 . . . . 72.540000000000006 111.155 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.33 -65.14 0.72 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.338 -0.846 . . . . 53.210000000000001 108.734 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.01 119.29 19.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.386 -0.968 . . . . 72.140000000000001 108.386 170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -74.08 85.61 1.83 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.422 0.63 . . . . 74.219999999999999 111.96 -171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -151.09 153.5 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 CA-C-N 115.098 -0.955 . . . . 64.239999999999995 110.936 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.521 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -136.52 128.91 30.16 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.008 1.323 . . . . 63.200000000000003 107.758 168.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -87.47 159.22 18.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.176 0.591 . . . . 64.400000000000006 109.527 174.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 tp -125.13 101.94 7.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.354 0.662 . . . . 73.230000000000004 109.433 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.4 t -88.08 127.65 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.321 -0.622 . . . . 70.329999999999998 109.321 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -147.41 174.78 11.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.46 1.104 . . . . 61.039999999999999 108.886 -178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 17.6 t70 -97.95 168.01 10.56 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.174 -1.047 . . . . 61.329999999999998 108.174 163.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 42.9 tt0 -64.18 -20.95 66.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.517 1.127 . . . . 74.109999999999999 112.044 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -55.5 -47.03 76.85 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.596 0.758 . . . . 72.519999999999996 111.103 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 m -66.54 -36.47 82.75 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.471 -1.241 . . . . 75.010000000000005 110.478 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 68.9 t-105 -68.8 -30.64 69.25 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.84 0.856 . . . . 65.209999999999994 112.657 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -54.99 -29.8 57.96 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.339 0.59 . . . . 72.140000000000001 110.726 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' HG3' ' SD ' ' A' ' 20' ' ' MET . 30.4 mmmt -88.14 -46.34 9.37 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-N 114.606 -1.179 . . . . 73.140000000000001 111.205 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.484 HG13 ' HB1' ' A' ' 13' ' ' ALA . 95.3 t -59.63 -55.11 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 C-N-CA 122.799 0.439 . . . . 70.049999999999997 110.75 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -50.41 -44.75 55.21 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.92 1.288 . . . . 75.040000000000006 112.028 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.18 -56.74 14.17 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 124.285 0.991 . . . . 74.120000000000005 111.008 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.4 mt -59.86 -33.54 71.94 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 124.325 1.05 . . . . 53.049999999999997 111.435 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 89.6 mt -58.86 -58.52 8.24 Favored 'General case' 0 C--N 1.354 0.764 0 O-C-N 123.531 0.52 . . . . 70.549999999999997 110.318 176.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.61 -45.28 97.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 121.162 0.506 . . . . 74.439999999999998 111.244 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -56.01 -39.14 71.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.257 1.423 . . . . 64.219999999999999 110.375 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -79.48 -60.55 2.31 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.197 -0.456 . . . . 74.019999999999996 111.703 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -170.59 -39.91 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.659 0.614 . . . . 72.340000000000003 112.659 -161.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.551 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 9.2 t80 -73.53 110.32 7.73 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.636 . . . . 65.0 110.441 -168.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 78' ' ' GLU . 33.4 m -54.63 135.16 63.87 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 125.074 1.349 . . . . 74.120000000000005 111.913 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.35 -31.08 83.68 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 123.477 2.785 . . . . 53.109999999999999 112.655 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.496 ' H ' HG22 ' A' ' 76' ' ' THR . 39.6 mt-10 -68.88 -33.53 73.94 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.431 1.092 . . . . 53.210000000000001 111.278 178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 31.5 mm-40 -72.75 -37.74 67.6 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.754 0.422 . . . . 74.239999999999995 111.015 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 75.0 mt -59.73 -55.26 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.842 0.857 . . . . 62.229999999999997 110.311 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.552 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 15.8 ptmt -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.673 -1.149 . . . . 74.120000000000005 111.082 -175.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 48.4 t -58.96 -27.95 65.83 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.141 0.976 . . . . 61.32 112.369 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' HB3' ' H ' ' A' ' 93' ' ' PHE . 37.1 m-85 -79.4 -30.17 42.31 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.057 0.543 . . . . 71.239999999999995 111.182 177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 77.9 m-85 -76.47 -29.59 56.97 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.916 0.486 . . . . 74.510000000000005 110.287 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.2 mm-40 -72.28 -30.83 65.21 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.41 0.684 . . . . 72.420000000000002 109.532 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.0 t30 57.15 66.59 1.13 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.656 1.582 . . . . 74.409999999999997 111.154 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -91.44 3.58 54.6 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.694 -1.139 . . . . 72.340000000000003 110.365 170.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -84.93 -101.76 0.65 Allowed Glycine 0 C--N 1.359 1.836 0 N-CA-C 111.111 -0.796 . . . . 74.120000000000005 111.111 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -143.96 -61.69 0.39 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.032 0.933 . . . . 72.430000000000007 109.404 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -121.0 133.31 24.12 Favored Pre-proline 0 C--O 1.245 0.825 0 N-CA-C 106.061 -1.829 . . . . 73.510000000000005 106.061 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.83 123.49 13.65 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.134 1.89 . . . . 72.219999999999999 111.821 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.4 t -72.69 -51.57 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.552 -0.907 . . . . 72.409999999999997 108.552 176.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.434 ' H ' ' HB3' ' A' ' 83' ' ' PHE . 10.2 m-30 -91.14 108.42 19.86 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.654 -1.157 . . . . 74.120000000000005 108.124 172.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.37 155.34 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.648 0.779 . . . . 75.319999999999993 109.209 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -152.28 174.78 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.079 0.552 . . . . 72.530000000000001 111.529 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.03 -152.5 20.37 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.113 -1.195 . . . . 64.239999999999995 110.113 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 9.5 t -74.02 174.84 8.04 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.956 -0.757 . . . . 71.450000000000003 108.956 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 tp -60.7 -40.43 92.2 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 118.324 0.511 . . . . 74.140000000000001 110.444 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 36.9 mt-10 -70.67 -48.68 53.62 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.132 -0.94 . . . . 71.510000000000005 110.974 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -57.69 -50.1 74.32 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.58 0.752 . . . . 62.140000000000001 111.961 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.51 -29.92 70.62 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.147 -0.933 . . . . 74.409999999999997 111.334 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -67.41 -45.79 75.1 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.564 0.745 . . . . 75.230000000000004 111.279 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 35.1 mt-10 -62.28 -47.26 85.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.859 -1.064 . . . . 70.519999999999996 111.29 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -69.75 -29.4 66.75 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.149 -0.932 . . . . 74.329999999999998 111.557 -178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.61 -15.13 46.64 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.979 0.512 . . . . 54.350000000000001 111.367 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.21 14.5 78.84 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 116.178 -0.465 . . . . 34.0 113.582 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 148' ' ' ILE . 6.7 mt -87.33 151.92 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.866 0.866 . . . . 75.510000000000005 109.196 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.3 t -65.44 103.84 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 N-CA-C 109.671 -0.492 . . . . 72.140000000000001 109.671 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG22 ' HB3' ' A' ' 102' ' ' ALA . 93.7 t -47.63 -51.87 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.56 1.144 . . . . 71.239999999999995 111.424 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 15.2 t70 -56.56 -44.61 81.11 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.097 0.873 . . . . 73.439999999999998 111.349 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -69.93 -40.09 75.71 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 123.978 0.799 . . . . 72.239999999999995 112.693 -174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.2 pp -77.84 -24.01 48.77 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.22 0.463 . . . . 73.109999999999999 111.628 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.4 t -67.8 -38.79 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.254 -0.647 . . . . 74.040000000000006 109.254 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.4 mm-40 -62.81 -52.95 61.18 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.982 -0.748 . . . . 55.549999999999997 108.982 173.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.725 HG23 ' HD2' ' A' ' 31' ' ' ARG . 1.4 m -52.44 -42.8 64.44 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.713 1.205 . . . . 74.140000000000001 113.082 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.2 t -82.73 -37.14 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 119.153 -0.451 . . . . 64.099999999999994 111.668 -176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.03 -30.59 61.12 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 119.142 0.883 . . . . 74.430000000000007 110.8 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.35 -35.67 40.6 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.576 0.75 . . . . 70.120000000000005 109.467 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.508 ' O ' HG23 ' A' ' 123' ' ' VAL . 52.9 t80 -58.41 -62.33 1.92 Allowed 'General case' 0 C--N 1.357 0.917 0 O-C-N 123.759 0.662 . . . . 74.530000000000001 109.297 171.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -57.6 -29.37 64.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.505 1.122 . . . . 71.25 111.764 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.63 -47.22 50.65 Favored Glycine 0 C--N 1.346 1.13 0 O-C-N 123.792 0.683 . . . . 55.119999999999997 111.77 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -79.41 -16.17 56.63 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.167 0.432 . . . . 75.120000000000005 112.167 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' A' ' 138' ' ' LEU . 54.5 t -60.96 -56.31 18.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 N-CA-C 109.624 -0.509 . . . . 71.5 109.624 171.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -71.64 -22.9 61.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.421 -0.809 . . . . 74.450000000000003 112.135 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -75.1 -26.26 59.14 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 120.563 0.221 . . . . 60.009999999999998 110.594 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 135' ' ' PRO . . . 73.56 42.7 39.49 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.952 -0.567 . . . . 32.539999999999999 113.539 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.591 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.3 t60 -167.25 119.65 0.93 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.348 0.659 . . . . 71.340000000000003 109.758 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.41 167.64 20.11 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.873 0.469 . . . . 74.230000000000004 111.639 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -126.99 3.33 6.54 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.225 0.61 . . . . 74.329999999999998 111.907 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -168.25 92.3 0.33 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.08 0.552 . . . . 63.100000000000001 110.874 -176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 35.6 p90 44.73 22.75 0.06 Allowed 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 125.742 1.617 . . . . 75.420000000000002 115.017 175.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -71.5 -118.34 0.05 OUTLIER Glycine 0 C--N 1.347 1.182 0 O-C-N 123.463 0.477 . . . . 64.340000000000003 112.734 -173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.469 HH11 ' HB2' ' A' ' 35' ' ' GLU . 26.1 ptt180 -171.04 -177.92 2.33 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 117.373 0.587 . . . . 72.510000000000005 110.819 -174.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.67 143.2 98.0 Favored Pre-proline 0 CA--C 1.551 1.008 0 O-C-N 123.912 0.757 . . . . 53.350000000000001 110.979 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.415 ' HB3' ' HA2' ' A' ' 126' ' ' GLY . 5.5 Cg_exo -36.72 -36.61 0.26 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 125.28 3.987 . . . . 71.099999999999994 116.253 170.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -70.35 -22.94 62.74 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.977 0.353 . . . . 75.409999999999997 111.607 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -98.1 -22.57 16.15 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.893 0.877 . . . . 72.319999999999993 110.628 175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.668 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.5 mt -77.87 119.84 21.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.726 0.81 . . . . 51.299999999999997 109.581 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -145.83 131.57 18.99 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 118.193 0.451 . . . . 70.430000000000007 110.033 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -64.27 140.75 58.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.517 0.511 . . . . 73.25 110.642 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.422 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 46.1 m-85 -69.98 89.71 0.61 Allowed 'General case' 0 C--N 1.355 0.82 0 N-CA-C 108.818 -0.808 . . . . 74.439999999999998 108.818 174.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -109.12 136.75 48.1 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.694 -0.685 . . . . 74.400000000000006 109.489 -177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 161.86 -105.29 0.26 Allowed Glycine 0 C--O 1.237 0.342 0 N-CA-C 111.048 -0.821 . . . . 61.109999999999999 111.048 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.61 -40.38 0.26 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.851 0.686 . . . . 64.209999999999994 112.851 -170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 93.8 m -147.07 134.82 21.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.417 0.287 . . . . 74.519999999999996 110.794 -166.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -87.27 133.81 33.63 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.36 0.664 . . . . 73.019999999999996 110.144 175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.77 138.17 51.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.9 0.88 . . . . 74.120000000000005 109.609 174.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 107' ' ' ILE . 57.6 mt -124.66 108.62 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.589 -0.893 . . . . 72.450000000000003 108.589 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.69 133.79 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.481 0.712 . . . . 64.420000000000002 109.115 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.37 106.91 19.0 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.045 0.538 . . . . 71.540000000000006 110.787 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -98.89 106.79 19.09 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.778 0.831 . . . . 74.420000000000002 109.087 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -85.88 168.78 13.92 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.905 -0.776 . . . . 61.049999999999997 108.905 171.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.448 ' HG ' HG21 ' A' ' 46' ' ' ILE . 36.9 mt -71.07 171.61 10.6 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 120.814 0.34 . . . . 73.340000000000003 110.624 166.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.4 126.21 27.54 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.472 -0.786 . . . . 72.25 111.304 -176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.1 m170 71.7 8.04 6.05 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.677 1.591 . . . . 75.439999999999998 112.378 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -85.26 64.92 8.94 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 122.619 1.199 . . . . 72.450000000000003 108.566 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -98.8 64.53 1.47 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.358 -1.292 . . . . 74.310000000000002 107.746 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -76.91 137.25 38.99 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.567 -1.197 . . . . 74.120000000000005 110.213 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -166.55 163.81 17.02 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.359 0.664 . . . . 74.010000000000005 109.818 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 107.897 -1.149 . . . . 74.040000000000006 107.897 170.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ptm . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 109.651 -0.5 . . . . 73.319999999999993 109.651 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.2 t -122.32 90.02 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.059 -1.83 . . . . 74.409999999999997 106.059 169.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 67.41 162.03 0.14 Allowed Pre-proline 0 N--CA 1.486 1.356 0 C-N-CA 125.419 1.487 . . . . 75.319999999999993 111.561 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -56.66 167.84 2.65 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 122.32 2.013 . . . . 72.409999999999997 112.674 164.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.95 71.31 1.95 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.32 -0.4 . . . . 73.109999999999999 112.839 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.41 68.01 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.044 0.937 . . . . 74.230000000000004 110.444 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.22 144.52 44.68 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.561 -0.745 . . . . 62.299999999999997 110.86 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -85.54 8.06 20.68 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.045 0.938 . . . . 72.129999999999995 110.841 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 HD21 HE22 ' A' ' 151' ' ' GLN . 56.0 tp -59.28 113.92 2.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.355 1.062 . . . . 71.200000000000003 110.996 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.3 m -121.97 162.9 20.26 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 107.618 -1.253 . . . . 62.109999999999999 107.618 172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 m -57.28 -21.01 31.63 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 114.439 1.274 . . . . 74.019999999999996 114.439 -168.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -53.08 -41.62 65.06 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.675 0.79 . . . . 75.209999999999994 111.768 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.593 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -70.54 -35.73 73.29 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.86 0.864 . . . . 43.030000000000001 110.612 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -74.98 -26.13 59.35 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 114.383 -1.28 . . . . 73.019999999999996 111.785 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -65.35 -48.29 73.49 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.621 0.768 . . . . 63.240000000000002 110.543 176.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -68.22 -33.11 73.81 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.497 -0.774 . . . . 75.299999999999997 111.071 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -60.82 -51.91 67.31 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.125 -0.489 . . . . 60.039999999999999 110.91 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.9 p -66.55 -24.39 66.35 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.807 -0.633 . . . . 63.439999999999998 112.059 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.66 -38.06 88.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.4 0.68 . . . . 63.109999999999999 110.579 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -72.3 -15.03 61.89 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.614 0.366 . . . . 51.539999999999999 111.665 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.99 19.88 7.04 Favored Glycine 0 C--N 1.347 1.155 0 O-C-N 123.142 0.276 . . . . 75.099999999999994 112.983 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -74.33 137.09 42.61 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 109.963 -0.384 . . . . 65.129999999999995 109.963 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.8 pt -100.14 152.92 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 122.84 0.456 . . . . 75.349999999999994 110.482 -176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -99.96 120.71 40.22 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.242 -0.651 . . . . 75.109999999999999 109.242 170.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -112.18 -174.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.281 -1.007 . . . . 54.350000000000001 108.281 168.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 5.0 p30 -121.13 -171.1 2.13 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.057 -0.72 . . . . 75.549999999999997 109.057 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -68.22 -6.52 24.04 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 112.642 0.608 . . . . 72.409999999999997 112.642 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.3 mmtt -93.39 -36.29 12.58 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.15 0.58 . . . . 74.140000000000001 110.394 169.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.35 6.95 26.99 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.817 -0.435 . . . . 74.430000000000007 113.079 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.32 123.55 24.81 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.509 -0.923 . . . . 63.009999999999998 108.509 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -59.21 106.08 0.4 Allowed 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.827 0.704 . . . . 70.109999999999999 109.592 173.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.654 HG22 HE21 ' A' ' 49' ' ' GLN . 24.9 pt -74.37 -34.55 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 115.503 -0.771 . . . . 65.109999999999999 110.241 -177.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 32' ' ' ILE . 13.2 p -164.53 137.69 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.379 -1.341 . . . . 74.120000000000005 107.379 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.484 HD22 ' HD2' ' A' ' 131' ' ' PHE . 10.7 p30 -83.68 -2.85 57.07 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.159 0.429 . . . . 63.100000000000001 112.159 -174.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -154.61 151.3 28.66 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.033 0.933 . . . . 71.049999999999997 108.927 -172.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 t -87.21 57.27 4.38 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.868 -0.79 . . . . 73.140000000000001 108.868 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.79 -51.61 69.0 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.558 1.143 . . . . 72.420000000000002 111.386 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.93 142.23 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.764 -0.828 . . . . 73.109999999999999 108.764 175.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -62.27 -25.12 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.881 0.873 . . . . 71.319999999999993 111.404 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -66.74 -55.87 13.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.288 0.635 . . . . 72.439999999999998 110.879 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.7 m -58.94 -42.57 90.09 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.385 0.674 . . . . 72.129999999999995 110.949 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 31.1 t80 -57.84 -43.16 85.64 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.096 1.358 . . . . 72.310000000000002 111.478 176.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -77.76 -44.63 27.03 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.327 0.651 . . . . 74.519999999999996 111.069 -172.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -66.1 -25.77 67.16 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 123.217 0.323 . . . . 64.400000000000006 110.726 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.36 -37.87 80.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.953 0.501 . . . . 62.119999999999997 111.195 173.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 69.9 mt -68.06 -41.8 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 123.177 0.591 . . . . 71.349999999999994 110.306 174.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.05 -24.0 65.94 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.517 0.727 . . . . 74.040000000000006 111.176 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm -70.58 -36.63 73.67 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.803 0.841 . . . . 71.439999999999998 110.645 175.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.654 HE21 HG22 ' A' ' 32' ' ' ILE . 10.6 mm-40 -81.82 177.87 8.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.485 0.714 . . . . 64.099999999999994 110.963 -175.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.26 -54.84 14.85 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.555 0.742 . . . . 40.240000000000002 111.426 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -92.32 161.2 14.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.484 -0.78 . . . . 64.219999999999999 110.933 -175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.471 ' HB3' HD12 ' A' ' 153' ' ' LEU . 29.2 mmtp -105.9 32.76 4.15 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.102 0.961 . . . . 63.229999999999997 110.962 -176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -139.36 135.73 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.75 0.82 . . . . 74.540000000000006 109.145 175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -104.29 163.85 12.14 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.986 0.915 . . . . 72.299999999999997 108.923 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -139.68 115.06 9.86 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.197 -0.668 . . . . 71.430000000000007 109.197 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 17' ' ' ALA . 24.3 tp -84.54 102.59 12.97 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.118 -0.946 . . . . 74.430000000000007 109.422 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -87.85 116.96 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 123.796 0.838 . . . . 64.120000000000005 108.945 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ptp -133.06 179.07 6.41 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.19 0.996 . . . . 74.319999999999993 109.269 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.94 -177.19 3.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.18 0.992 . . . . 74.310000000000002 108.809 171.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -70.41 -41.07 73.44 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.536 0.569 . . . . 74.219999999999999 112.536 -175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -64.31 -41.41 96.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.546 0.339 . . . . 72.519999999999996 110.724 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 61.2 m -64.19 -41.08 97.24 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.659 -0.701 . . . . 75.409999999999997 111.122 173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -61.12 -36.33 79.45 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 115.674 -0.694 . . . . 74.420000000000002 111.671 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -54.5 -34.85 62.37 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.012 0.375 . . . . 71.530000000000001 112.012 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.401 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 28.1 mmmt -77.7 -39.45 44.63 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.741 0.651 . . . . 73.049999999999997 111.084 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.593 HG13 ' HB1' ' A' ' 13' ' ' ALA . 51.7 t -61.66 -40.65 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.472 0.653 . . . . 64.400000000000006 109.534 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -63.73 -37.85 88.89 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.404 1.482 . . . . 70.219999999999999 110.631 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -59.48 -54.94 40.8 Favored 'General case' 0 C--N 1.36 1.04 0 O-C-N 123.793 0.683 . . . . 63.509999999999998 109.306 174.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.4 mt -59.59 -39.63 84.78 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.773 -1.103 . . . . 51.409999999999997 112.504 -173.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 95.1 mt -58.85 -56.07 26.96 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.99 0.806 . . . . 63.43 110.323 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.6 mt -69.06 -33.06 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.547 0.739 . . . . 73.340000000000003 110.94 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 -47.07 79.43 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.139 0.976 . . . . 72.209999999999994 109.782 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -75.09 -62.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.317 0.386 . . . . 52.399999999999999 109.983 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.8 t70 170.06 89.92 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.637 1.175 . . . . 71.230000000000004 108.697 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 3.9 t80 -176.66 91.92 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.48 -0.933 . . . . 74.349999999999994 108.48 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.569 HG22 ' HG3' ' A' ' 79' ' ' GLU . 1.5 t -64.0 149.94 92.69 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.135 0.974 . . . . 73.219999999999999 111.035 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -52.79 -29.88 44.57 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 123.586 2.857 . . . . 72.019999999999996 114.121 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.61 -39.06 93.04 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.034 0.834 . . . . 72.340000000000003 112.089 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG3' HG22 ' A' ' 76' ' ' THR . 42.5 mt-10 -67.53 -49.98 60.83 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 63.119999999999997 110.51 177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.1 mt -51.86 -55.16 10.3 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 O-C-N 124.653 1.221 . . . . 74.439999999999998 111.38 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 13.9 ptmm? -65.48 -27.54 68.56 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.8 -0.637 . . . . 51.109999999999999 111.938 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.7 t -70.86 -27.98 64.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.097 0.559 . . . . 55.030000000000001 111.886 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.22 -11.73 59.96 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.64 0.237 . . . . 73.519999999999996 111.64 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 93.5 m-85 -85.33 -43.28 13.84 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 109.087 -0.709 . . . . 75.310000000000002 109.087 165.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -95.97 42.68 1.09 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.795 1.238 . . . . 74.439999999999998 109.791 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -71.11 90.27 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.576 0.75 . . . . 71.150000000000006 110.009 -173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -87.38 76.76 9.03 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.61 -0.723 . . . . 74.230000000000004 109.496 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.18 -52.32 0.26 Allowed Glycine 0 C--N 1.336 0.58 0 N-CA-C 110.882 -0.887 . . . . 44.100000000000001 110.882 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.77 -176.81 3.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.827 0.851 . . . . 71.129999999999995 110.414 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -73.94 133.15 79.19 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 123.401 0.68 . . . . 75.129999999999995 109.863 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.2 Cg_exo -54.35 124.7 16.7 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.614 2.209 . . . . 72.129999999999995 112.659 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.6 t -74.27 -44.15 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.834 -0.802 . . . . 41.509999999999998 108.834 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -97.46 114.09 25.88 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.708 -1.219 . . . . 72.400000000000006 107.708 170.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 91' ' ' PRO . 48.3 t -113.6 150.06 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.346 0.659 . . . . 63.340000000000003 109.805 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.93 171.34 15.93 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.606 0.762 . . . . 73.340000000000003 110.987 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.07 -151.86 20.18 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.491 -1.043 . . . . 74.439999999999998 110.491 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 44.0 t -71.19 168.4 17.32 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.978 -0.749 . . . . 65.450000000000003 108.978 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.58 -38.16 80.43 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 120.906 0.384 . . . . 75.510000000000005 110.451 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.8 mp0 -75.98 -46.16 31.01 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.514 -0.766 . . . . 75.140000000000001 110.555 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 m -59.61 -48.7 80.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.754 0.822 . . . . 64.230000000000004 111.199 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.31 -28.04 68.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.657 -1.156 . . . . 61.140000000000001 111.384 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.23 -47.17 71.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.267 0.627 . . . . 53.5 110.926 176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.2 mt-10 -61.77 -43.55 98.64 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.053 -0.976 . . . . 63.539999999999999 111.058 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.81 -36.64 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.423 -0.808 . . . . 75.219999999999999 111.722 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.64 -13.67 58.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.969 0.508 . . . . 55.140000000000001 111.571 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.97 51.37 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.379 0.425 . . . . 75.299999999999997 113.056 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.0 mt -103.23 154.41 5.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 124.071 0.948 . . . . 73.140000000000001 109.23 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 41.2 t -67.98 105.27 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.185 0 N-CA-C 109.015 -0.735 . . . . 73.0 109.015 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 57.7 t -52.84 -45.62 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.014 1.326 . . . . 72.319999999999993 110.879 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -51.4 -50.58 59.35 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.866 1.266 . . . . 73.519999999999996 111.467 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -68.08 -47.27 68.74 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.491 -0.777 . . . . 73.040000000000006 112.159 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.592 ' HA ' HG22 ' A' ' 115' ' ' THR . 3.6 pp -71.47 -33.49 69.37 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.607 0.595 . . . . 73.129999999999995 112.607 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.466 ' N ' HD12 ' A' ' 112' ' ' LEU . 68.1 t -61.84 -39.89 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.08 -0.711 . . . . 71.540000000000006 109.08 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -62.91 -53.61 51.39 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 123.718 0.637 . . . . 64.150000000000006 111.553 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.2 t -68.6 -26.38 65.34 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.115 0.413 . . . . 72.420000000000002 112.115 -173.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -84.41 -36.96 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.341 0.656 . . . . 74.340000000000003 111.499 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -75.67 -37.68 59.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 122.097 -0.377 . . . . 62.520000000000003 110.325 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -68.7 -38.15 80.06 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 109.001 -0.74 . . . . 74.439999999999998 109.001 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.528 ' O ' HG23 ' A' ' 123' ' ' VAL . 34.2 t80 -50.93 -60.81 2.69 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 124.48 1.112 . . . . 62.020000000000003 109.878 172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -64.59 -20.87 66.51 Favored 'General case' 0 CA--C 1.551 0.993 0 O-C-N 123.613 0.571 . . . . 63.240000000000002 112.222 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.482 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.82 -46.05 40.03 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.563 0.539 . . . . 73.0 112.748 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 3.9 p90 -86.13 -16.63 37.33 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 113.112 0.782 . . . . 74.230000000000004 113.112 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 140' ' ' GLN . 48.3 t -57.3 -56.62 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 123.478 0.486 . . . . 74.310000000000002 109.824 170.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.482 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.5 pt20 -71.05 -20.01 62.43 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.228 -0.897 . . . . 72.010000000000005 111.6 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.0 -26.1 60.26 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.907 0.483 . . . . 73.219999999999999 110.569 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.6 14.28 78.4 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.324 -0.398 . . . . 74.310000000000002 113.552 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 28.6 t60 -138.73 113.98 9.52 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.219 -1.03 . . . . 72.230000000000004 108.219 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.43 166.72 23.16 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.321 0.581 . . . . 62.240000000000002 111.338 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -143.99 15.6 1.73 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.51 1.124 . . . . 71.120000000000005 108.099 175.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -64.44 -76.11 0.07 Allowed 'General case' 0 C--N 1.365 1.262 0 C-N-CA 124.102 0.961 . . . . 72.200000000000003 109.111 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.484 ' HD2' HD22 ' A' ' 34' ' ' ASN . 75.8 m-85 -153.42 17.48 0.54 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.464 1.506 . . . . 71.420000000000002 108.794 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.86 50.37 4.67 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 116.035 -0.529 . . . . 74.030000000000001 113.051 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HD3' ' HB2' ' A' ' 137' ' ' TYR . 3.0 ptp180 -79.42 -176.13 5.09 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.284 0.633 . . . . 61.43 109.912 172.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.465 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.1 t70 -90.77 143.7 29.25 Favored Pre-proline 0 N--CA 1.483 1.197 0 N-CA-C 109.053 -0.721 . . . . 70.239999999999995 109.053 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.99 -18.33 27.86 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.053 2.502 . . . . 73.450000000000003 115.051 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -75.84 -21.99 56.72 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 118.235 0.471 . . . . 73.239999999999995 111.584 178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 90.3 m-85 -85.39 -13.03 50.67 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.403 0.681 . . . . 64.310000000000002 111.569 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 123' ' ' VAL . 84.1 mt -67.67 96.37 0.55 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.478 0.711 . . . . 72.219999999999999 110.007 171.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -123.72 118.82 28.08 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.179 0.992 . . . . 64.209999999999994 109.074 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.575 ' HG3' HG11 ' A' ' 123' ' ' VAL . 86.0 mt-30 -70.37 142.54 52.1 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.172 0.589 . . . . 71.409999999999997 110.111 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.433 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 79.5 m-85 -69.3 93.89 0.67 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.068 -0.716 . . . . 74.129999999999995 109.068 175.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.21 96.69 7.93 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.632 0.729 . . . . 74.129999999999995 110.76 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.59 150.11 5.63 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.327 -0.851 . . . . 42.329999999999998 111.566 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.55 -37.71 62.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.172 0.589 . . . . 71.409999999999997 110.549 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.0 m -90.26 115.4 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.177 0.591 . . . . 75.299999999999997 111.339 -178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -89.8 146.38 24.5 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.424 1.089 . . . . 73.109999999999999 109.935 170.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -119.05 115.12 23.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.0 0.92 . . . . 74.450000000000003 108.664 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.3 mt -104.4 116.1 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.867 -0.79 . . . . 74.5 108.867 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.52 123.85 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.753 0.821 . . . . 64.430000000000007 109.758 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -74.19 123.05 23.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.445 0.698 . . . . 64.230000000000004 110.467 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.456 HE22 HD21 ' A' ' 9' ' ' LEU . 24.2 mm-40 -115.17 100.17 7.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.118 0.967 . . . . 73.430000000000007 108.821 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -89.56 148.47 23.36 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.31 0.644 . . . . 74.120000000000005 109.94 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -66.72 143.35 57.0 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.174 0.297 . . . . 64.409999999999997 110.346 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -72.46 167.38 20.7 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.506 0.669 . . . . 71.319999999999993 111.563 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -159.56 -28.18 0.07 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.542 -1.208 . . . . 74.349999999999994 110.117 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -142.87 106.73 4.67 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.189 0.595 . . . . 73.109999999999999 110.806 172.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -157.58 103.05 1.91 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.716 1.206 . . . . 65.409999999999997 108.908 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -83.1 -27.66 30.04 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.248 0.619 . . . . 73.430000000000007 110.794 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -167.11 -164.33 0.61 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.723 0.809 . . . . 74.040000000000006 110.444 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 CA--C 1.554 1.115 0 CA-C-O 117.829 -1.081 . . . . 73.200000000000003 109.626 177.325 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.055 -0.721 . . . . 71.430000000000007 109.055 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.4 m -154.93 69.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.45 1.5 . . . . 53.340000000000003 107.936 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -87.13 158.36 52.75 Favored Pre-proline 0 N--CA 1.481 1.084 0 CA-C-N 114.902 -1.045 . . . . 73.109999999999999 109.874 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -52.56 163.18 1.92 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.908 2.405 . . . . 73.400000000000006 113.817 170.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.91 69.3 1.26 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 112.086 -0.406 . . . . 74.099999999999994 112.086 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 m -85.87 74.3 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 122.783 1.278 . . . . 74.430000000000007 110.251 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' HB3' ' NH2' ' A' ' 152' ' ' ARG . . . -149.76 76.57 1.3 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.453 -1.249 . . . . 50.25 110.034 -172.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -133.73 -179.99 5.88 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.928 -1.033 . . . . 73.25 109.197 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD11 HD21 ' A' ' 70' ' ' LEU . 43.4 tp -139.32 140.32 37.52 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 107.566 -1.272 . . . . 74.25 107.566 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -58.28 138.92 56.01 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.837 0.855 . . . . 73.120000000000005 111.07 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 m -61.39 -36.96 81.74 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 123.996 0.81 . . . . 72.450000000000003 112.142 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' GLN . 24.0 p90 -57.56 -40.69 79.47 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 122.549 0.34 . . . . 71.120000000000005 110.785 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.99 -40.92 68.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.609 0.763 . . . . 72.140000000000001 111.05 -173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 p -72.93 -30.11 63.63 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.088 -0.96 . . . . 74.340000000000003 111.408 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.07 -35.82 41.86 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.167 0.587 . . . . 62.350000000000001 111.957 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 12' ' ' TYR . 8.9 mm100 -70.5 -29.67 66.24 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.056 0.222 . . . . 73.120000000000005 110.926 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.16 -52.71 64.16 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 123.722 0.639 . . . . 63.310000000000002 109.943 174.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -72.27 -24.42 61.35 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.577 0.751 . . . . 75.519999999999996 112.545 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.11 -43.65 70.6 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.387 0.675 . . . . 74.340000000000003 110.569 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 71.0 mtm -83.83 -39.35 20.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.753 -0.658 . . . . 75.430000000000007 110.767 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.65 84.84 0.05 OUTLIER Glycine 0 C--N 1.346 1.126 0 O-C-N 123.449 0.468 . . . . 51.43 113.515 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.417 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.2 169.16 25.16 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.734 0.814 . . . . 73.129999999999995 110.26 173.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.0 pt -127.34 150.71 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.738 0.815 . . . . 74.120000000000005 109.98 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -100.03 120.82 40.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.866 -1.161 . . . . 74.120000000000005 107.866 169.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 55' ' ' TYR . 19.8 m -112.79 178.35 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.268 0.627 . . . . 75.530000000000001 109.815 174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.695 HD21 ' HB3' ' A' ' 30' ' ' ASP . 9.5 p30 -114.56 -168.26 1.34 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.991 0.516 . . . . 72.319999999999993 110.356 176.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.4 p -60.92 -18.73 58.4 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.545 1.138 . . . . 53.109999999999999 113.401 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -92.5 -30.16 15.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.073 0.549 . . . . 71.129999999999995 110.33 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.03 1.47 31.73 Favored Glycine 0 N--CA 1.47 0.95 0 CA-C-N 116.487 -0.324 . . . . 73.219999999999999 112.911 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.695 ' HB3' HD21 ' A' ' 26' ' ' ASN . 12.3 t70 -73.99 129.27 37.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 71.519999999999996 108.936 174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.38 110.33 1.89 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.475 0.31 . . . . 73.319999999999993 110.577 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -72.88 -32.93 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.29 0.636 . . . . 72.209999999999994 111.603 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -148.59 139.87 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.997 0.919 . . . . 71.340000000000003 108.882 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.686 HD22 ' HD3' ' A' ' 133' ' ' ARG . 15.8 p-10 -63.69 -32.77 74.36 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.393 1.477 . . . . 63.350000000000001 113.187 -173.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -162.59 -163.57 0.91 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.605 0.762 . . . . 73.439999999999998 110.31 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.2 m -57.46 -66.02 0.53 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.985 0.914 . . . . 55.340000000000003 111.896 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 56.75 -88.51 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.17 1.388 . . . . 64.530000000000001 112.726 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.33 156.39 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.853 0.861 . . . . 72.420000000000002 109.16 -175.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -59.19 -28.31 66.51 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.443 0.697 . . . . 72.209999999999994 111.896 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.7 m -66.68 -54.42 23.28 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 123.834 0.709 . . . . 65.319999999999993 111.258 -175.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -65.67 -22.42 66.64 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 122.709 0.404 . . . . 71.140000000000001 111.894 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -78.25 -63.67 1.34 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.684 0.793 . . . . 72.299999999999997 110.135 176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -61.11 -46.93 88.6 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.664 1.185 . . . . 72.209999999999994 111.342 -172.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -68.16 -27.69 66.64 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.879 0.872 . . . . 65.400000000000006 111.739 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -71.68 -33.06 68.51 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.733 0.413 . . . . 52.210000000000001 110.774 174.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.57 -37.83 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.729 0.811 . . . . 72.209999999999994 109.219 174.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.596 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 96.0 mt -70.91 -27.41 63.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.063 0.945 . . . . 73.239999999999995 111.165 178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -74.91 -38.76 61.75 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.295 0.638 . . . . 54.219999999999999 109.947 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -72.01 144.01 48.97 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.343 -0.614 . . . . 64.030000000000001 109.343 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.01 78.0 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.695 0.798 . . . . 53.219999999999999 110.853 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -81.44 131.11 35.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.323 0.649 . . . . 64.030000000000001 110.443 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.0 mmtm -94.08 66.87 3.59 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.197 0.999 . . . . 64.200000000000003 110.282 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.49 143.58 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 113.807 -1.542 . . . . 54.229999999999997 109.865 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -129.26 127.27 40.85 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.221 1.009 . . . . 60.450000000000003 109.123 175.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.473 ' HB3' HG23 ' A' ' 148' ' ' ILE . 68.7 m-85 -100.96 107.8 19.38 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.828 0.851 . . . . 73.439999999999998 109.24 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -75.36 105.41 6.37 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.392 0.677 . . . . 73.109999999999999 110.128 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.451 HG22 HG12 ' A' ' 148' ' ' ILE . 60.4 t -97.79 124.5 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.356 0.662 . . . . 70.549999999999997 109.938 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -139.32 -179.62 5.98 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 124.048 0.939 . . . . 60.25 108.714 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.2 p-10 -96.03 170.41 9.3 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.969 0.908 . . . . 73.349999999999994 109.833 172.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.9 tt0 -65.99 -31.69 72.73 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.16 0.43 . . . . 73.409999999999997 112.16 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.18 -36.91 80.33 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.835 0.454 . . . . 72.239999999999995 110.523 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.1 m -74.88 -34.96 62.3 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.147 0.579 . . . . 72.150000000000006 110.276 173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.5 t-105 -65.89 -34.03 77.2 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 118.842 -0.599 . . . . 74.439999999999998 111.744 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.497 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.2 mmtt -48.8 -44.53 39.25 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.363 0.601 . . . . 74.140000000000001 110.898 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 27.7 mmmt -72.97 -43.42 62.29 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.729 -1.578 . . . . 61.329999999999998 111.024 -175.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 62.3 t -58.67 -41.84 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.319 0.648 . . . . 64.349999999999994 110.375 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -66.78 -35.1 79.3 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 124.811 1.244 . . . . 75.209999999999994 110.958 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.55 -49.05 74.99 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.047 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 93.6 mt -59.16 -39.6 82.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 124.555 1.142 . . . . 73.230000000000004 111.597 -174.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD21 HD11 ' A' ' 9' ' ' LEU . 85.4 mt -58.66 -55.95 28.53 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.406 1.066 . . . . 72.120000000000005 110.5 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.6 mt -70.86 -25.85 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.827 0.851 . . . . 62.130000000000003 111.323 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -69.1 -45.45 70.23 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.57 1.148 . . . . 64.140000000000001 109.906 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -80.98 -62.39 1.68 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 109.567 -0.531 . . . . 71.310000000000002 109.567 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.5 t70 171.78 102.95 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.998 1.319 . . . . 74.049999999999997 108.908 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.408 ' HD2' HD22 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -172.73 120.23 0.38 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.387 -0.968 . . . . 75.129999999999995 108.387 174.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.46 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 28.9 m -71.65 130.11 87.63 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.157 0.983 . . . . 55.210000000000001 110.546 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.13 -34.41 47.72 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.732 2.955 . . . . 64.219999999999999 113.257 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.77 -40.05 91.07 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.248 1.019 . . . . 74.120000000000005 112.016 177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.9 mm-40 -80.75 -23.88 39.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.022 -0.535 . . . . 73.109999999999999 111.446 -178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.5 mt -72.37 -50.41 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.191 0.596 . . . . 74.209999999999994 109.714 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.3 ptmt -70.55 -25.52 63.13 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.547 -0.751 . . . . 63.100000000000001 112.312 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.6 p -66.63 -24.59 66.32 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.2 0.6 . . . . 71.430000000000007 111.828 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.81 -7.23 57.66 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.054 0.542 . . . . 72.120000000000005 111.786 175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.486 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 92.7 m-85 -91.13 -30.36 16.75 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.379 0.672 . . . . 70.010000000000005 110.906 172.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -80.76 105.02 11.68 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 115.336 -0.847 . . . . 62.450000000000003 110.649 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.443 HD22 ' HD3' ' A' ' 91' ' ' PRO . 26.0 t-20 -74.55 92.36 2.38 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.798 0.839 . . . . 74.329999999999998 109.014 174.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -120.5 26.62 9.05 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.211 1.004 . . . . 72.430000000000007 111.438 -173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.43 -44.81 0.62 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 111.492 -0.643 . . . . 62.439999999999998 111.492 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 89' ' ' LYS . 8.5 mmpt? -122.16 172.18 8.45 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.968 0.907 . . . . 73.150000000000006 110.55 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -57.94 134.57 83.63 Favored Pre-proline 0 CA--C 1.544 0.747 0 O-C-N 124.66 1.225 . . . . 74.219999999999999 110.881 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HD3' HD22 ' A' ' 86' ' ' ASN . 32.9 Cg_endo -64.71 125.84 15.61 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 121.748 1.632 . . . . 75.329999999999998 110.558 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.58 -47.14 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-O 121.66 0.743 . . . . 73.140000000000001 109.209 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -97.17 115.02 26.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.283 -1.377 . . . . 62.329999999999998 107.283 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.0 t -111.71 153.66 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 63.399999999999999 108.818 -177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -148.97 173.88 12.87 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.657 0.783 . . . . 74.310000000000002 110.615 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.17 -147.55 19.13 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.523 -1.031 . . . . 52.219999999999999 110.523 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.5 t -81.55 173.8 12.03 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.986 -0.746 . . . . 75.239999999999995 108.986 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.99 -49.3 77.29 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.929 0.492 . . . . 71.25 111.373 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.1 mt-10 -78.25 -35.65 47.92 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.527 -0.761 . . . . 70.219999999999999 111.859 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -66.39 -49.58 66.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.677 0.791 . . . . 72.239999999999995 110.952 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.66 -29.28 70.53 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.944 -1.026 . . . . 54.200000000000003 110.919 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.61 -44.3 82.46 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.247 0.619 . . . . 44.299999999999997 111.074 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.0 mt-10 -64.25 -43.1 95.94 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.304 -0.862 . . . . 74.209999999999994 110.781 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.49 -36.7 76.76 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.566 0.747 . . . . 73.340000000000003 111.805 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.38 -20.46 60.07 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.265 0.626 . . . . 64.510000000000005 111.011 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.41 30.96 47.83 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 116.105 -0.498 . . . . 51.310000000000002 112.591 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.4 mt -93.87 161.01 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.142 0.977 . . . . 53.43 109.147 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.1 t -70.7 100.83 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.539 -0.911 . . . . 71.0 108.539 170.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.8 t -55.72 -52.72 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 113.907 -1.497 . . . . 74.099999999999994 111.966 -170.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.36 -35.44 75.7 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.907 0.883 . . . . 73.299999999999997 111.285 -173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -69.88 -42.55 73.32 Favored 'General case' 0 C--O 1.244 0.813 0 O-C-N 123.439 0.462 . . . . 74.430000000000007 111.825 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.0 pp -72.89 -27.52 61.94 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 120.113 -0.635 . . . . 73.540000000000006 112.046 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 109' ' ' VAL . 77.3 t -62.83 -40.96 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.234 -0.654 . . . . 71.150000000000006 109.234 172.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -59.93 -53.33 59.14 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 123.943 0.777 . . . . 72.049999999999997 110.745 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 112' ' ' LEU . 7.6 t -64.6 -37.86 89.02 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 111.872 0.323 . . . . 70.109999999999999 111.872 -173.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 79.0 t -74.58 -39.85 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 122.941 0.496 . . . . 72.340000000000003 111.215 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -74.0 -33.69 63.9 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 117.928 0.331 . . . . 72.230000000000004 110.912 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -67.18 -45.66 76.3 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.994 -0.743 . . . . 75.409999999999997 108.994 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 123' ' ' VAL . 54.1 t80 -52.82 -59.81 4.04 Favored 'General case' 0 C--N 1.356 0.862 0 O-C-N 124.929 1.393 . . . . 71.040000000000006 109.654 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -59.52 -33.01 70.84 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.202 0.939 . . . . 63.229999999999997 111.987 -178.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -64.23 -51.47 52.49 Favored Glycine 0 C--N 1.35 1.315 0 O-C-N 123.947 0.78 . . . . 74.200000000000003 113.266 176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.402 ' HA ' ' HB3' ' A' ' 125' ' ' ASP . 8.6 p90 -82.53 -18.91 39.82 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.516 0.561 . . . . 72.140000000000001 112.516 -175.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 138' ' ' LEU . 13.3 t -62.68 -54.38 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.654 0.782 . . . . 71.150000000000006 110.643 175.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.475 ' HB3' HE22 ' A' ' 140' ' ' GLN . 21.7 pt20 -75.39 -18.59 59.9 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.806 -0.633 . . . . 72.25 111.377 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 32.0 t70 -75.88 -26.17 56.82 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 123.348 0.659 . . . . 63.039999999999999 110.361 173.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.94 -27.4 16.54 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 116.507 -0.315 . . . . 72.209999999999994 113.174 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -80.27 112.85 17.99 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 117.405 0.602 . . . . 72.239999999999995 109.814 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -70.88 153.25 42.87 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.502 0.721 . . . . 73.030000000000001 111.145 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -126.33 -73.59 0.62 Allowed 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.785 -1.561 . . . . 71.230000000000004 106.785 170.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 12.4 m-20 24.05 -88.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 126.013 2.07 . . . . 71.239999999999995 113.183 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -143.63 11.88 1.68 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 125.403 1.481 . . . . 75.109999999999999 109.359 171.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 93.32 104.06 1.66 Allowed Glycine 0 C--N 1.353 1.505 0 N-CA-C 111.857 -0.497 . . . . 74.230000000000004 111.857 -176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.686 ' HD3' HD22 ' A' ' 34' ' ' ASN . 28.1 ptt180 -152.99 -175.17 5.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.729 0.812 . . . . 74.329999999999998 110.592 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.94 143.58 70.95 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.095 0.558 . . . . 74.230000000000004 111.097 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.07 -12.57 32.95 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 123.336 2.691 . . . . 61.219999999999999 113.465 174.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -70.66 -24.18 62.64 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.816 0.446 . . . . 51.509999999999998 111.529 177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.444 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 96.5 m-85 -88.1 -18.57 28.55 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.373 0.669 . . . . 74.219999999999999 111.508 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB3' HG22 ' A' ' 123' ' ' VAL . 72.6 mt -68.46 106.76 2.65 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.354 0.661 . . . . 72.200000000000003 110.142 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -141.32 140.96 33.9 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.852 -0.796 . . . . 64.150000000000006 108.852 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' A' ' 124' ' ' GLN . 19.5 mp0 -81.73 160.15 23.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.806 0.443 . . . . 65.349999999999994 109.988 176.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 69.1 m-85 -81.63 151.06 27.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.049 0.54 . . . . 75.140000000000001 110.299 177.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -73.27 98.0 2.57 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.186 0.594 . . . . 71.510000000000005 109.398 171.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.01 78.37 0.52 Allowed Glycine 0 C--N 1.347 1.185 0 CA-C-N 115.298 -0.865 . . . . 55.049999999999997 112.248 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -127.31 -53.98 1.37 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.906 1.282 . . . . 64.329999999999998 107.671 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 19.7 m -149.85 119.8 7.16 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 114.266 -1.334 . . . . 54.049999999999997 108.89 177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -89.35 131.12 35.58 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.582 0.753 . . . . 75.349999999999994 110.177 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.571 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 19.8 m-85 -108.43 133.66 52.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.099 0.959 . . . . 70.310000000000002 109.884 175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.473 HG23 ' HB3' ' A' ' 55' ' ' TYR . 53.5 mt -122.0 108.49 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 124.195 0.998 . . . . 75.319999999999993 108.972 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.402 HG21 HD22 ' A' ' 9' ' ' LEU . 37.1 mm -100.02 103.07 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.681 0.793 . . . . 71.409999999999997 109.421 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -68.17 119.79 13.31 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.396 0.678 . . . . 75.340000000000003 110.801 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -122.89 101.95 7.73 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.324 1.05 . . . . 72.230000000000004 109.187 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.431 ' NH2' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -84.19 158.3 21.35 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.17 -0.678 . . . . 74.150000000000006 109.17 173.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 52' ' ' LYS . 73.1 mt -62.59 146.2 52.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 123.74 0.65 . . . . 70.310000000000002 112.651 -176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -45.76 68.51 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.476 1.511 . . . . 73.25 111.887 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -74.46 93.48 2.46 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 122.248 1.023 . . . . 74.129999999999995 109.539 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -79.96 163.99 23.84 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.717 -1.128 . . . . 74.209999999999994 111.179 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 35.8 m170 59.07 45.69 14.35 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.875 0.87 . . . . 63.229999999999997 108.817 -168.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -63.7 118.8 8.79 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-N 115.208 -0.905 . . . . 72.129999999999995 112.122 -169.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -101.51 10.04 40.74 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.649 1.179 . . . . 75.010000000000005 109.802 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.204 -1.776 . . . . 74.439999999999998 106.204 163.459 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 111.245 0.091 . . . . 64.299999999999997 111.245 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -130.92 60.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.292 -1.003 . . . . 75.219999999999999 108.292 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -110.36 165.09 13.33 Favored Pre-proline 0 N--CA 1.481 1.108 0 CA-C-N 114.831 -1.077 . . . . 62.530000000000001 109.096 175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.63 -174.86 2.18 Favored 'Trans proline' 0 C--N 1.383 2.345 0 C-N-CA 121.777 1.651 . . . . 70.450000000000003 111.664 170.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.5 61.79 4.57 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-N 116.613 -0.267 . . . . 73.140000000000001 112.561 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 ' HB ' ' HE3' ' A' ' 8' ' ' LYS . 28.8 m -125.15 141.98 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.884 0.874 . . . . 63.539999999999999 109.575 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . . . -159.8 109.96 1.88 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.145 0.578 . . . . 74.010000000000005 109.836 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HE3' ' HB ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -164.42 178.8 7.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.308 1.043 . . . . 74.409999999999997 109.291 -178.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' HB2' HG21 ' A' ' 149' ' ' ILE . 37.0 tp -111.69 150.87 29.57 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.012 -0.736 . . . . 70.109999999999999 109.012 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 64.2 p -60.81 132.23 53.22 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.39 0.676 . . . . 74.329999999999998 110.227 173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 45.6 p -60.21 -35.27 75.04 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 118.609 -0.71 . . . . 73.409999999999997 112.046 -174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -58.79 -37.85 77.25 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.229 0.455 . . . . 63.310000000000002 112.229 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.546 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -77.35 -35.39 54.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.589 -0.732 . . . . 61.229999999999997 110.309 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.407 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 49.6 m -70.37 -31.13 68.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.979 0.911 . . . . 64.019999999999996 112.219 -178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.54 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.9 mmtt -67.65 -47.44 69.54 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.076 0.55 . . . . 72.310000000000002 110.179 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -76.12 -25.92 55.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.715 -1.129 . . . . 74.519999999999996 110.974 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.61 -52.56 51.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.259 0.624 . . . . 63.420000000000002 110.12 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 35' ' ' GLU . 24.2 p -67.75 -36.97 81.5 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.975 -0.557 . . . . 52.130000000000003 111.575 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.5 -34.36 73.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.644 0.778 . . . . 71.420000000000002 110.52 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 26.1 tpp -70.08 -36.71 75.13 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.624 0.77 . . . . 63.450000000000003 110.635 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 152.83 -7.63 0.49 Allowed Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.529 -0.595 . . . . 70.209999999999994 113.702 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.432 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -68.54 157.02 36.9 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.446 0.623 . . . . 72.329999999999998 111.868 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.9 pt -130.26 154.48 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.912 0.885 . . . . 71.010000000000005 109.959 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' HE2' ' HB3' ' A' ' 36' ' ' SER . 59.7 m-85 -101.29 121.65 42.27 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.889 -0.782 . . . . 62.43 108.889 169.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -112.93 175.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.717 0.807 . . . . 73.209999999999994 108.917 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' ND2' HE21 ' A' ' 49' ' ' GLN . 33.4 p-10 -105.95 -170.38 1.73 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.945 0.498 . . . . 72.120000000000005 109.663 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 34.1 t -69.44 -5.28 22.78 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.738 0.815 . . . . 71.299999999999997 112.207 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 33.8 mmtp -94.43 -35.4 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.473 0.709 . . . . 75.510000000000005 110.28 171.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 110.13 -0.91 29.85 Favored Glycine 0 N--CA 1.47 0.952 0 CA-C-O 120.057 -0.301 . . . . 73.349999999999994 112.873 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.95 119.91 15.75 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.068 0.947 . . . . 70.109999999999999 109.114 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.706 ' HD2' ' HB3' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -56.97 112.0 1.2 Allowed 'General case' 0 CA--C 1.547 0.863 0 O-C-N 124.01 0.819 . . . . 75.400000000000006 110.239 174.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.7 pt -78.79 -32.88 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.801 0.84 . . . . 74.109999999999999 111.053 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -154.76 148.32 12.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 N-CA-C 107.927 -1.138 . . . . 65.450000000000003 107.927 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -57.88 -59.37 5.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.511 0.725 . . . . 75.030000000000001 110.349 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 18' ' ' THR . 61.2 mt-10 -142.72 176.24 9.2 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.067 -0.969 . . . . 73.329999999999998 110.91 -173.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HE2' ' A' ' 24' ' ' TYR . 35.0 p -89.14 47.17 1.46 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 74.439999999999998 110.341 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -52.89 -48.33 67.25 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.355 1.062 . . . . 64.420000000000002 111.828 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG22 ' H ' ' A' ' 40' ' ' THR . 5.9 p -156.17 146.23 12.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 123.678 0.791 . . . . 74.439999999999998 109.189 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -62.27 -23.45 66.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.781 0.832 . . . . 72.109999999999999 112.475 -176.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.46 ' H ' HG22 ' A' ' 38' ' ' VAL . 68.7 p -62.77 -59.85 4.3 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 123.531 0.519 . . . . 73.409999999999997 110.317 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.8 t -67.84 -28.46 67.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.725 0.41 . . . . 72.420000000000002 111.567 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -69.71 -54.91 11.6 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.397 0.679 . . . . 74.420000000000002 111.194 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -63.75 -43.87 95.18 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.259 0.623 . . . . 62.229999999999997 109.513 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.9 -30.51 71.59 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.004 0.815 . . . . 64.319999999999993 111.564 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.73 -42.2 91.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.824 0.45 . . . . 55.119999999999997 111.134 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.9 mt -68.62 -40.93 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.309 0.576 . . . . 75.099999999999994 109.848 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 96.2 mt -72.82 -17.96 61.51 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.933 0.893 . . . . 63.229999999999997 111.676 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.85 -32.87 52.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.157 0.983 . . . . 72.310000000000002 109.954 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 11.3 mm100 -80.41 153.49 28.25 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.548 -0.751 . . . . 74.150000000000006 109.824 177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.56 66.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.412 -0.813 . . . . 61.240000000000002 109.472 168.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.31 115.72 20.01 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.339 1.056 . . . . 74.019999999999996 109.007 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 34.1 mmtp -97.26 43.5 1.07 Allowed 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.872 0.844 . . . . 72.519999999999996 110.283 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -151.95 127.35 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.0 -1.455 . . . . 43.0 108.15 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.37 163.89 12.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.086 0.955 . . . . 53.549999999999997 109.046 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 110.09 5.94 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.909 -0.774 . . . . 74.239999999999995 108.909 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -80.59 101.37 9.14 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 109.197 -0.668 . . . . 74.349999999999994 109.197 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.47 126.93 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.792 0.837 . . . . 63.109999999999999 109.864 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.52 175.51 9.55 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.891 0.876 . . . . 70.310000000000002 109.571 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -94.55 173.75 7.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.822 0.849 . . . . 74.439999999999998 109.248 169.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.3 tt0 -73.0 -29.34 62.96 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 119.115 -0.469 . . . . 74.019999999999996 111.8 -175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -66.47 -38.96 88.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.592 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 64.8 m -67.8 -41.42 83.18 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 115.608 -0.724 . . . . 51.210000000000001 109.976 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.506 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 58.8 t-105 -61.63 -32.09 72.21 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-O 118.508 -0.758 . . . . 75.340000000000003 111.812 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 72.9 mmtt -51.65 -46.66 63.81 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 118.253 0.479 . . . . 73.340000000000003 109.931 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 25.9 mmmt -75.84 -36.81 59.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.875 -1.057 . . . . 71.319999999999993 111.366 -175.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG13 ' HB1' ' A' ' 13' ' ' ALA . 94.2 t -58.37 -46.55 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.21 0.604 . . . . 53.130000000000003 109.652 173.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -70.07 -31.94 69.79 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.729 1.612 . . . . 71.420000000000002 110.641 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.12 -55.26 36.04 Favored 'General case' 0 C--N 1.363 1.183 0 O-C-N 123.604 0.565 . . . . 73.439999999999998 109.603 171.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 78.3 mt -61.29 -38.37 86.55 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 124.628 1.205 . . . . 74.140000000000001 111.659 -173.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 84.9 mt -56.44 -60.42 3.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.226 0.954 . . . . 65.239999999999995 109.895 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.494 HD13 ' HD3' ' A' ' 77' ' ' PRO . 46.4 mt -66.06 -31.47 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.547 0.739 . . . . 64.420000000000002 111.234 -176.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.66 -55.33 18.08 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.303 1.041 . . . . 74.329999999999998 110.331 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -83.33 -60.24 2.2 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 116.151 -0.477 . . . . 74.25 110.314 -172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -166.32 85.19 0.3 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-O 120.734 0.302 . . . . 72.409999999999997 111.74 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -171.97 -177.76 1.99 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.064 1.746 . . . . 74.5 108.406 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.529 HG22 ' HG2' ' A' ' 79' ' ' GLU . 5.5 t -153.3 152.08 27.0 Favored Pre-proline 0 CA--C 1.557 1.231 0 N-CA-C 107.826 -1.176 . . . . 64.519999999999996 107.826 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.494 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.2 Cg_endo -47.17 -42.87 26.43 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 123.733 2.955 . . . . 71.510000000000005 114.165 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.37 -30.87 71.5 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.877 0.736 . . . . 71.340000000000003 112.507 -176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' HG22 ' A' ' 76' ' ' THR . 21.5 mm-40 -76.8 -46.54 24.57 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.961 0.41 . . . . 55.25 111.254 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.0 mt -63.32 -43.2 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 114.994 -1.003 . . . . 52.039999999999999 110.454 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.439 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 17.0 ptmt -72.55 -24.03 61.06 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.664 -0.698 . . . . 54.439999999999998 111.606 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.4 t -67.15 -26.81 66.85 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.507 0.723 . . . . 61.539999999999999 111.173 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -74.2 -26.42 60.26 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.047 0.539 . . . . 74.310000000000002 111.521 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 95.9 m-85 -76.54 -28.2 56.24 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.057 0.543 . . . . 73.209999999999994 110.341 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -75.08 101.72 4.63 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.963 0.505 . . . . 74.209999999999994 110.538 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.83 143.37 45.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.906 0.882 . . . . 55.109999999999999 109.712 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -108.54 -36.29 6.24 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.064 0.945 . . . . 70.409999999999997 110.04 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.08 -44.96 0.02 OUTLIER Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.382 -0.826 . . . . 62.020000000000003 111.171 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -72.26 140.77 48.79 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.711 -0.478 . . . . 63.350000000000001 109.711 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -59.48 135.15 88.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.376 1.071 . . . . 64.140000000000001 111.624 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' HG22 ' A' ' 94' ' ' VAL . 56.8 Cg_endo -69.77 137.41 35.38 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.118 1.879 . . . . 61.450000000000003 111.693 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.5 t -70.0 -43.59 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-O 121.754 0.787 . . . . 73.019999999999996 109.206 175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -97.75 112.68 24.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.907 -1.146 . . . . 54.43 107.907 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.522 HG22 ' HG2' ' A' ' 91' ' ' PRO . 30.1 t -112.9 153.81 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.836 0.854 . . . . 75.030000000000001 109.308 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -154.15 175.38 13.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.906 0.482 . . . . 75.0 111.297 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 139.63 -137.38 8.46 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.898 -1.281 . . . . 75.049999999999997 109.898 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.4 t -84.93 179.12 7.37 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.06 -0.719 . . . . 61.130000000000003 109.06 165.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.89 -50.88 71.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.666 0.387 . . . . 71.5 110.265 177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 42.8 mt-10 -69.46 -45.2 69.6 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.264 -0.88 . . . . 74.340000000000003 111.014 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.9 m -59.1 -51.53 69.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.893 0.877 . . . . 74.420000000000002 111.367 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.24 69.72 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.254 -0.885 . . . . 74.200000000000003 111.419 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -69.46 -42.13 75.32 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.359 0.664 . . . . 55.240000000000002 110.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.9 mt-10 -66.26 -41.52 89.78 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.649 0.779 . . . . 53.409999999999997 110.627 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -69.71 -34.7 74.25 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.394 -0.821 . . . . 74.340000000000003 111.124 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.38 -11.13 56.83 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.179 0.592 . . . . 73.319999999999993 111.644 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.96 28.01 67.6 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.286 0.366 . . . . 74.430000000000007 113.484 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.2 mt -93.54 156.32 3.08 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 124.041 0.936 . . . . 74.519999999999996 108.61 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.1 t -70.21 104.03 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.084 0 N-CA-C 108.973 -0.751 . . . . 71.200000000000003 108.973 173.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.9 t -55.61 -44.4 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 114.308 -1.314 . . . . 75.340000000000003 110.818 -175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -56.94 -45.59 82.66 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.217 1.007 . . . . 72.0 111.745 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' LYS . 41.1 mt-10 -73.25 -39.96 65.03 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.41 0.443 . . . . 72.340000000000003 111.685 -176.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.5 pp -72.96 -25.58 61.07 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 118.197 0.453 . . . . 54.229999999999997 111.769 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.2 t -68.8 -36.22 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 109.012 -0.736 . . . . 74.239999999999995 109.012 174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -64.06 -50.37 68.66 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 109.041 -0.725 . . . . 72.400000000000006 109.041 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.511 HG23 ' HD3' ' A' ' 31' ' ' ARG . 45.7 m -53.43 -43.7 68.22 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.319 1.448 . . . . 75.209999999999994 112.832 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.8 t -83.71 -40.25 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.542 0.737 . . . . 63.140000000000001 111.558 -178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -70.88 -34.57 71.73 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.806 0.73 . . . . 73.5 110.877 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -77.69 -37.22 50.09 Favored 'General case' 0 C--N 1.344 0.353 0 O-C-N 123.916 0.76 . . . . 75.109999999999999 109.307 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.523 ' O ' HG23 ' A' ' 123' ' ' VAL . 59.5 t80 -55.35 -63.34 1.2 Allowed 'General case' 0 C--N 1.364 1.212 0 O-C-N 124.154 0.909 . . . . 73.219999999999999 109.398 171.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -57.24 -33.83 67.96 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.204 1.002 . . . . 65.430000000000007 111.382 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.03 -40.75 93.28 Favored Glycine 0 C--N 1.342 0.875 0 O-C-N 124.12 0.887 . . . . 51.299999999999997 112.539 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -86.42 -19.26 29.93 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.527 0.566 . . . . 74.409999999999997 112.527 -179.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 119' ' ' TYR . 14.8 t -60.17 -52.35 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.747 0.819 . . . . 53.210000000000001 111.054 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -61.58 -26.12 67.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.912 0.757 . . . . 73.230000000000004 111.858 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -84.32 -22.95 30.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.696 0.798 . . . . 72.540000000000006 111.59 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 72.14 43.62 47.27 Favored Glycine 0 C--N 1.346 1.128 0 O-C-N 123.217 0.323 . . . . 75.340000000000003 112.636 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 53.8 t60 -150.39 101.79 3.0 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.359 0.663 . . . . 74.549999999999997 109.377 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.81 155.69 38.76 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.166 0.508 . . . . 55.140000000000001 111.786 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -129.14 -56.73 1.17 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.303 1.041 . . . . 73.019999999999996 109.197 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.706 ' HB3' ' HD2' ' A' ' 31' ' ' ARG . 45.4 m-20 -84.77 54.82 3.19 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.843 0.857 . . . . 71.219999999999999 110.694 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 25.3 p90 38.92 60.97 1.32 Allowed 'General case' 0 C--N 1.359 1.002 0 C-N-CA 125.501 1.52 . . . . 74.349999999999994 112.675 -177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.78 -158.92 25.71 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.773 -1.103 . . . . 64.120000000000005 112.18 -177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.508 ' HD2' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -97.33 -178.23 4.09 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.906 -0.776 . . . . 64.129999999999995 108.906 175.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.678 ' HB3' ' HD1' ' A' ' 137' ' ' TYR . 13.2 t70 -56.75 140.98 74.86 Favored Pre-proline 0 N--CA 1.482 1.143 0 CA-C-O 118.113 -0.946 . . . . 72.349999999999994 109.967 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.498 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.4 Cg_exo -36.83 -45.76 1.26 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 125.001 3.8 . . . . 73.439999999999998 115.372 174.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.1 ptpp? -74.22 -27.71 60.91 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.428 0.291 . . . . 73.209999999999994 111.66 -177.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.678 ' HD1' ' HB3' ' A' ' 134' ' ' ASP . 87.9 m-85 -89.57 -13.98 36.05 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.357 0.663 . . . . 75.200000000000003 111.311 177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' HB3' HG22 ' A' ' 123' ' ' VAL . 63.1 mt -60.92 112.79 2.2 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 109.011 -0.737 . . . . 73.239999999999995 109.011 172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -134.83 136.17 42.29 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 108.878 -0.786 . . . . 70.230000000000004 108.878 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -67.47 148.79 51.06 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.645 0.591 . . . . 54.43 110.305 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.432 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 72.9 m-85 -65.61 135.24 54.8 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 108.519 -0.919 . . . . 63.32 108.519 169.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.09 107.6 1.97 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.346 -0.983 . . . . 72.519999999999996 108.346 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.23 65.67 3.0 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.598 -0.728 . . . . 74.340000000000003 111.942 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.24 -44.57 1.88 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.255 1.022 . . . . 73.109999999999999 109.058 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 28.1 m -151.97 135.37 16.02 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.573 -0.899 . . . . 74.239999999999995 108.573 171.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -105.52 151.29 24.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.329999999999998 110.234 172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -127.68 140.33 52.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.902 1.281 . . . . 72.310000000000002 108.411 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.6 mt -129.75 111.82 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.3 -1.0 . . . . 74.319999999999993 108.3 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.515 HG21 ' HB2' ' A' ' 9' ' ' LEU . 29.3 mm -99.82 108.53 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 N-CA-C 109.487 -0.56 . . . . 71.310000000000002 109.487 -178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.27 120.25 13.5 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.536 1.134 . . . . 73.510000000000005 111.411 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.456 ' NE2' HG22 ' A' ' 149' ' ' ILE . 25.1 mm-40 -114.37 115.26 27.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.334 1.454 . . . . 74.150000000000006 108.638 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.607 ' HD3' ' HB3' ' A' ' 7' ' ' ALA . 2.4 mpt_? -92.64 175.52 6.79 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.635 0.652 . . . . 73.5 109.45 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 69.6 mt -73.87 179.15 4.43 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.417 0.627 . . . . 54.420000000000002 111.108 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -71.4 -178.39 2.1 Favored 'General case' 0 C--O 1.246 0.892 0 CA-C-N 115.245 -0.889 . . . . 75.319999999999993 111.483 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -63.11 115.56 4.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.935 -0.765 . . . . 71.209999999999994 108.935 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -60.75 -33.12 72.45 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.943 0.897 . . . . 74.319999999999993 110.272 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -131.27 134.1 46.06 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.628 1.171 . . . . 71.109999999999999 108.308 167.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -78.44 81.99 4.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.707 0.765 . . . . 71.310000000000002 110.314 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -159.59 102.46 1.53 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.82 1.248 . . . . 72.239999999999995 109.039 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 CA--C 1.562 1.423 0 C-N-CA 124.875 1.27 . . . . 72.329999999999998 110.75 179.647 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 121.079 0.466 . . . . 71.5 110.101 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.8 t -125.36 126.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 107.752 -1.203 . . . . 70.219999999999999 107.752 169.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.08 160.65 48.72 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.71 0.804 . . . . 74.299999999999997 109.856 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.545 ' HG2' HG13 ' A' ' 6' ' ' VAL . 94.6 Cg_endo -84.53 -165.76 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.425 2.084 . . . . 72.150000000000006 111.659 175.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.57 55.38 5.02 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 121.942 -0.17 . . . . 72.299999999999997 112.83 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG13 ' HG2' ' A' ' 4' ' ' PRO . 12.8 m -70.75 128.7 34.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 123.669 0.788 . . . . 55.219999999999999 111.02 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.03 -175.44 5.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.839 0.855 . . . . 73.319999999999993 110.269 -173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt 59.82 90.49 0.06 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.701 1.2 . . . . 73.239999999999995 111.759 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp 57.92 74.19 0.44 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.595 1.158 . . . . 64.319999999999993 110.299 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 11' ' ' THR . 1.9 m -98.67 -174.77 2.88 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 108.436 -0.949 . . . . 71.099999999999994 108.436 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 10' ' ' THR . 74.1 p -55.96 -36.86 68.28 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.144 0.978 . . . . 70.230000000000004 113.564 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -47.85 -39.8 19.63 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.218 1.007 . . . . 65.030000000000001 112.637 -176.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.33 71.27 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.285 -0.87 . . . . 65.329999999999998 111.405 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.1 p -79.84 -32.93 40.56 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.539 -0.755 . . . . 54.329999999999998 112.845 -175.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 11' ' ' THR . 68.5 mmtt -82.7 -42.09 18.51 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.658 0.266 . . . . 75.219999999999999 110.993 -171.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 19' ' ' ASP . 12.5 mm100 -67.85 -33.32 74.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.995 -0.548 . . . . 75.010000000000005 110.043 175.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -52.4 -49.03 65.29 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.453 0.644 . . . . 73.439999999999998 111.115 171.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 m -68.96 -28.18 66.4 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 114.591 -1.186 . . . . 72.319999999999993 110.866 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.414 ' HB3' ' O ' ' A' ' 16' ' ' GLN . 22.7 t70 -62.84 -51.79 65.66 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.887 0.875 . . . . 72.219999999999999 111.391 175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -76.6 -30.48 56.98 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 112.573 0.583 . . . . 54.119999999999997 112.573 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.54 76.83 0.02 OUTLIER Glycine 0 C--N 1.345 1.061 0 C-N-CA 121.343 -0.456 . . . . 73.019999999999996 112.664 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -145.39 151.96 39.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.544 0.738 . . . . 65.319999999999993 109.326 172.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 pt -117.97 149.12 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.363 0.665 . . . . 60.210000000000001 110.273 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HB3' HD11 ' A' ' 32' ' ' ILE . 64.2 m-85 -97.84 117.8 32.96 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.851 -0.796 . . . . 74.420000000000002 108.851 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.3 172.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.716 0.806 . . . . 72.439999999999998 109.302 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -96.5 -169.46 1.9 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 109.74 -0.467 . . . . 73.140000000000001 109.74 172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.1 p -66.59 -10.14 42.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.046 0.938 . . . . 64.430000000000007 112.932 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.34 -50.26 5.32 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.595 -0.52 . . . . 72.420000000000002 109.595 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.82 0.2 3.99 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 116.121 -0.49 . . . . 52.200000000000003 112.77 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -66.87 135.2 53.51 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.53 0.732 . . . . 74.420000000000002 110.24 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 34' ' ' ASN . 56.8 ttm-85 -63.0 99.47 0.16 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.961 -0.755 . . . . 63.229999999999997 108.961 169.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.538 HD11 ' HB3' ' A' ' 24' ' ' TYR . 31.6 pt -68.07 -42.35 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 115.077 -0.965 . . . . 73.219999999999999 110.542 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.441 HG12 HG13 ' A' ' 32' ' ' ILE . 9.6 p -156.78 154.24 6.25 Favored 'Isoleucine or valine' 0 C--O 1.246 0.902 0 C-N-CA 124.14 0.976 . . . . 74.319999999999993 108.495 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' HA ' HH11 ' A' ' 31' ' ' ARG . 15.4 p-10 -66.41 -54.55 23.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.406 0.682 . . . . 64.219999999999999 111.156 175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -146.44 -160.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.322 1.449 . . . . 73.430000000000007 108.149 -167.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.4 m -126.65 89.46 3.0 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.409 -0.589 . . . . 64.129999999999995 109.409 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -69.7 -36.78 76.24 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.119 -0.697 . . . . 74.200000000000003 109.119 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.463 HG13 ' H ' ' A' ' 41' ' ' THR . 11.8 p -153.58 155.65 6.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 124.937 1.295 . . . . 70.120000000000005 108.513 169.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -58.68 -27.95 65.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.159 0.583 . . . . 73.420000000000002 111.659 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.3 m -68.62 -39.06 80.98 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.427 0.691 . . . . 74.099999999999994 110.919 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.463 ' H ' HG13 ' A' ' 38' ' ' VAL . 57.5 m -65.18 -39.94 93.59 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.047 0.539 . . . . 63.140000000000001 110.823 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.2 -39.02 93.12 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.398 -0.819 . . . . 72.040000000000006 110.5 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 42.0 ttm180 -62.85 -50.43 70.94 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.637 0.775 . . . . 71.019999999999996 109.921 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -65.17 -27.18 68.53 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.277 0.631 . . . . 54.409999999999997 111.743 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -65.13 -35.37 80.9 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.435 0.694 . . . . 54.119999999999997 111.436 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.573 HG22 ' HD3' ' A' ' 52' ' ' LYS . 20.3 mm -79.74 -33.24 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 CA-C-N 116.074 -0.512 . . . . 74.209999999999994 109.966 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 83.2 mt -67.29 -25.76 66.2 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.635 0.774 . . . . 70.230000000000004 110.896 175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -61.12 -37.39 82.61 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.521 1.129 . . . . 70.25 110.488 174.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -98.6 165.7 11.69 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.656 -1.156 . . . . 65.319999999999993 110.16 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.36 -61.07 2.11 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.663 0.785 . . . . 63.350000000000001 111.182 -176.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.16 132.95 36.0 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.039 0.447 . . . . 61.509999999999998 110.207 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HD3' HG22 ' A' ' 46' ' ' ILE . 44.2 mmtm -97.69 70.08 2.18 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.927 0.891 . . . . 62.310000000000002 112.435 -164.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 152' ' ' ARG . 4.9 p -159.2 145.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.991 0.916 . . . . 61.539999999999999 109.996 171.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.566 ' HB2' HD11 ' A' ' 46' ' ' ILE . . . -107.14 161.92 14.33 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.823 0.849 . . . . 60.409999999999997 110.315 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -137.87 113.05 9.24 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.708 -1.219 . . . . 72.430000000000007 107.708 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 17' ' ' ALA . 51.2 tp -83.32 100.53 10.71 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.456 0.703 . . . . 74.310000000000002 109.479 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.35 121.48 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.314 0.646 . . . . 72.400000000000006 109.302 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.4 ptp -134.86 176.37 8.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.735 1.214 . . . . 62.119999999999997 108.847 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 19.6 t70 -101.05 167.38 10.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.33 -0.989 . . . . 74.400000000000006 108.33 167.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 34.9 tt0 -65.82 -23.99 66.8 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.599 0.76 . . . . 75.409999999999997 111.862 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -60.02 -44.09 94.83 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.33 0.586 . . . . 74.140000000000001 110.481 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.1 m -67.96 -39.14 83.44 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.655 -1.157 . . . . 53.340000000000003 110.372 176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -61.62 -32.62 72.76 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.548 0.739 . . . . 75.219999999999999 112.172 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.97 -38.32 67.65 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.334 0.588 . . . . 64.049999999999997 110.251 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -79.87 -40.04 29.21 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 114.534 -1.212 . . . . 63.340000000000003 111.317 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 58.4 t -66.16 -53.27 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.434 0.693 . . . . 74.25 110.439 -178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' HA ' HD12 ' A' ' 70' ' ' LEU . 55.4 t80 -51.31 -40.41 58.97 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.771 1.228 . . . . 73.519999999999996 111.376 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.97 -52.04 61.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.148 -0.933 . . . . 71.150000000000006 110.635 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.2 mt -56.15 -38.05 70.33 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.148 0.979 . . . . 70.150000000000006 111.322 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 67' ' ' TYR . 96.9 mt -57.36 -56.99 14.7 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 124.156 0.91 . . . . 73.209999999999994 110.397 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.3 mt -72.98 -22.02 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.372 0.669 . . . . 73.349999999999994 111.458 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.07 -42.83 62.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.687 0.795 . . . . 72.129999999999995 110.155 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -78.29 -62.49 1.66 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.274 -0.421 . . . . 75.310000000000002 109.865 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.6 t70 162.37 98.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.035 1.734 . . . . 70.230000000000004 107.402 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -179.51 84.56 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 106.709 -1.589 . . . . 74.120000000000005 106.709 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.0 t -52.53 154.05 4.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.25 1.42 . . . . 73.140000000000001 112.09 -174.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -54.76 -28.66 58.52 Favored 'Trans proline' 0 C--N 1.383 2.346 0 C-N-CA 123.491 2.794 . . . . 73.420000000000002 111.717 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -63.3 -37.96 89.29 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.088 1.355 . . . . 73.310000000000002 112.408 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -70.02 -48.26 58.75 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 122.379 0.272 . . . . 61.340000000000003 110.291 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.5 -56.67 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 O-C-N 124.503 1.127 . . . . 71.239999999999995 110.896 -175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -64.35 -24.73 67.75 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.973 -1.012 . . . . 72.420000000000002 111.622 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.2 t -75.99 -24.9 55.36 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.246 0.618 . . . . 71.209999999999994 111.57 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -78.64 -12.19 60.01 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 119.735 -0.174 . . . . 72.519999999999996 111.323 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -82.93 -47.17 12.08 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.873 -0.788 . . . . 75.409999999999997 108.873 164.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -85.86 61.97 7.17 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.807 1.243 . . . . 75.219999999999999 110.6 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -98.86 121.67 41.11 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.113 -0.699 . . . . 73.439999999999998 109.113 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 114.23 27.57 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.058 0.943 . . . . 71.099999999999994 109.683 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.94 13.57 60.54 Favored Glycine 0 C--N 1.346 1.111 0 O-C-N 123.374 0.421 . . . . 74.439999999999998 113.468 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 1.3 tpmt? -160.0 157.0 27.97 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.975 0.91 . . . . 71.219999999999999 108.727 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -59.8 131.23 88.85 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 123.227 0.611 . . . . 74.430000000000007 110.743 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -61.18 125.22 16.45 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 121.992 1.795 . . . . 63.350000000000001 111.139 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.1 t -67.55 -42.66 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 109.326 -0.62 . . . . 52.5 109.326 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -97.96 107.88 20.46 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.886 -0.783 . . . . 64.319999999999993 108.886 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.2 t -111.86 152.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.945 0.898 . . . . 61.0 109.136 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -144.55 171.52 14.26 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.205 0.602 . . . . 51.100000000000001 111.034 175.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.77 -147.56 19.12 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.318 -1.113 . . . . 70.109999999999999 110.318 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.6 t -76.86 173.08 12.14 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.975 -0.75 . . . . 71.140000000000001 108.975 166.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 61.7 tp -61.28 -53.8 52.15 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 117.93 0.332 . . . . 64.439999999999998 110.898 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.4 mp0 -65.43 -42.75 92.13 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.165 0.586 . . . . 75.310000000000002 110.647 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -62.08 -49.42 76.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.784 0.834 . . . . 62.409999999999997 112.131 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.79 -27.71 69.07 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.594 -0.73 . . . . 62.030000000000001 110.941 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' HG22 ' A' ' 109' ' ' VAL . . . -70.65 -40.45 73.05 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 123.584 0.754 . . . . 52.200000000000003 111.163 177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.0 mt-10 -63.78 -44.83 92.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.164 0.586 . . . . 64.319999999999993 110.487 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.15 -28.13 67.88 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.259 -0.882 . . . . 55.119999999999997 111.855 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.93 -10.37 34.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.245 0.618 . . . . 70.129999999999995 111.485 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.39 80.2 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.357 0.503 . . . . 60.219999999999999 114.357 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 12.1 mt -81.53 153.98 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.125 0.97 . . . . 64.430000000000007 108.814 177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.71 100.74 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-O 121.453 0.644 . . . . 75.230000000000004 109.841 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 102' ' ' ALA . 61.5 t -47.67 -50.69 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.888 1.675 . . . . 74.140000000000001 111.388 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -52.14 -38.79 58.66 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.345 1.458 . . . . 74.420000000000002 112.405 -176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -75.41 -55.94 5.19 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.033 -0.53 . . . . 75.319999999999993 111.402 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.52 -24.08 64.61 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.534 0.939 . . . . 74.129999999999995 113.534 -172.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.14 -37.51 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.341 0.656 . . . . 73.340000000000003 109.998 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -68.83 -45.8 70.23 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.503 0.668 . . . . 73.319999999999993 109.447 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 98.9 m -57.75 -39.07 76.5 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.37 -1.286 . . . . 74.109999999999999 112.728 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.9 t -83.91 -38.43 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.562 0.745 . . . . 75.319999999999993 111.774 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -71.95 -37.43 69.96 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.985 0.357 . . . . 54.229999999999997 110.716 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -77.14 -29.69 54.74 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.389 0.676 . . . . 44.240000000000002 109.717 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.478 ' O ' HG23 ' A' ' 123' ' ' VAL . 35.2 t80 -57.43 -60.5 3.55 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.898 -0.779 . . . . 65.109999999999999 108.898 170.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -61.14 -25.12 66.78 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 123.821 0.7 . . . . 72.230000000000004 111.249 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -68.75 -44.57 69.47 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.598 0.561 . . . . 72.129999999999995 112.498 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.1 p90 -85.0 -18.91 33.0 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 117.318 0.559 . . . . 74.140000000000001 112.153 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 62.5 t -66.76 -52.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 122.792 0.437 . . . . 43.140000000000001 110.513 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -66.78 -38.22 86.13 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 122.332 0.253 . . . . 53.240000000000002 111.506 -174.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.74 -15.05 59.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.512 0.725 . . . . 72.120000000000005 110.831 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 69.89 36.86 74.34 Favored Glycine 0 C--N 1.348 1.225 0 O-C-N 123.692 0.62 . . . . 75.010000000000005 113.21 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 68.2 t60 -150.74 105.88 3.33 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.917 -1.142 . . . . 75.109999999999999 107.917 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB2' HD11 ' A' ' 138' ' ' LEU . 8.8 t70 -63.88 146.18 54.47 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.657 0.783 . . . . 53.130000000000003 111.709 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.76 -29.5 6.75 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.414 1.086 . . . . 72.299999999999997 110.744 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -125.47 61.6 1.22 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.647 0.379 . . . . 72.219999999999999 111.738 -167.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 44.4 p90 44.76 26.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 126.117 1.767 . . . . 75.140000000000001 114.85 172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.27 -90.77 0.03 OUTLIER Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.513 -0.635 . . . . 51.310000000000002 111.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -173.28 -176.27 1.31 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.607 0.763 . . . . 74.239999999999995 109.691 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.46 140.82 97.81 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 123.397 0.679 . . . . 75.420000000000002 110.836 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.507 ' HA ' HD12 ' A' ' 138' ' ' LEU . 4.8 Cg_exo -32.64 -46.8 0.29 Allowed 'Trans proline' 0 C--N 1.383 2.388 1 C-N-CA 125.633 4.222 . . . . 73.049999999999997 115.737 173.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -65.46 -33.31 75.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.434 0.293 . . . . 72.239999999999995 111.564 -175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -88.75 -23.1 23.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.369 0.668 . . . . 74.310000000000002 111.199 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 71.9 mt -59.33 126.68 28.65 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.336 0.655 . . . . 64.239999999999995 109.856 175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -143.58 125.66 15.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.165 0.586 . . . . 75.209999999999994 109.938 -174.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -71.4 157.74 37.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.466 0.706 . . . . 64.030000000000001 111.143 176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 56.2 m-85 -71.82 88.84 1.03 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.829 -0.804 . . . . 75.129999999999995 108.829 166.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -85.3 97.37 9.92 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.274 0.559 . . . . 73.430000000000007 110.319 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.51 -136.07 3.72 Favored Glycine 0 C--O 1.241 0.56 0 CA-C-N 115.849 -0.614 . . . . 45.009999999999998 111.98 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -145.79 -55.96 0.3 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.882 0.873 . . . . 74.299999999999997 109.76 -170.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 m -93.01 116.82 29.41 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.849 0.86 . . . . 64.030000000000001 110.975 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -89.77 145.17 25.38 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.965 0.906 . . . . 70.200000000000003 111.015 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -117.16 137.45 52.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.154 0.982 . . . . 74.200000000000003 109.231 170.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.0 mt -118.92 112.61 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.578 -0.897 . . . . 65.200000000000003 108.578 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.4 mm -100.87 111.53 30.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.034 0.933 . . . . 72.129999999999995 108.903 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.92 106.16 2.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.961 0.505 . . . . 73.010000000000005 110.076 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -108.82 101.24 10.37 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.549 -0.908 . . . . 74.129999999999995 108.549 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HA ' HG23 ' A' ' 53' ' ' VAL . 10.5 tpp180 -71.54 170.04 14.19 Favored 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 108.909 -0.775 . . . . 52.200000000000003 108.909 175.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 153' ' ' LEU . 14.1 mt -67.59 171.9 5.74 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 121.602 0.715 . . . . 60.43 110.81 167.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -59.82 -29.46 68.26 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.404 -1.271 . . . . 55.229999999999997 109.671 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -59.61 99.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.387 -1.279 . . . . 71.439999999999998 108.935 162.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.46 89.09 2.13 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.375 0.67 . . . . 63.130000000000003 110.614 -173.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.0 m170 -94.64 90.02 5.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.746 0.819 . . . . 63.210000000000001 109.671 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -116.34 39.42 3.12 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.839 0.828 . . . . 61.509999999999998 109.096 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -166.57 -41.57 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 115.132 -0.94 . . . . 71.409999999999997 109.406 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 106.715 -1.587 . . . . 71.120000000000005 106.715 -173.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 111.265 0.098 . . . . 73.209999999999994 111.265 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.9 m -112.49 108.34 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.927 0.87 . . . . 62.229999999999997 108.998 173.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -77.98 155.62 80.07 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 124.204 1.002 . . . . 65.530000000000001 109.903 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -51.86 147.68 24.71 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.846 2.364 . . . . 75.209999999999994 111.976 174.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.84 92.03 0.02 OUTLIER Glycine 0 C--N 1.346 1.097 0 O-C-N 124.177 0.923 . . . . 72.109999999999999 112.549 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.1 m -65.14 158.07 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.154 0.982 . . . . 74.310000000000002 110.682 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.86 -173.87 4.54 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.022 0.439 . . . . 71.409999999999997 111.086 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HE2' ' HB2' ' A' ' 152' ' ' ARG . 13.6 ptpt -71.46 169.35 15.58 Favored 'General case' 0 C--O 1.245 0.852 0 CA-C-N 115.243 -0.889 . . . . 72.420000000000002 109.973 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.89 129.14 39.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.945 -0.761 . . . . 65.019999999999996 108.945 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -58.76 130.79 48.61 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.811 0.844 . . . . 63.219999999999999 109.965 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.501 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 57.2 p -51.18 -38.97 55.26 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.98 1.474 . . . . 74.129999999999995 114.98 -161.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -57.43 -35.15 69.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.899 0.48 . . . . 74.109999999999999 111.797 -175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.574 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.31 -38.61 68.66 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.073 0.949 . . . . 55.009999999999998 111.162 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.8 p -76.07 -26.36 56.45 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.503 -0.771 . . . . 70.329999999999998 111.38 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' THR . 73.8 mmtt -64.9 -49.59 69.85 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.955 0.502 . . . . 71.109999999999999 110.361 174.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -70.24 -27.94 64.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.182 -0.917 . . . . 61.100000000000001 111.839 -176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -68.5 -51.01 47.92 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.457 0.473 . . . . 71.450000000000003 110.899 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.6 p -66.12 -33.69 76.34 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.037 -0.529 . . . . 63.539999999999999 111.431 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.13 -40.8 98.64 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.197 -0.91 . . . . 72.319999999999993 110.54 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.8 tpp -65.12 -31.1 72.13 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.181 -0.918 . . . . 62.530000000000001 110.558 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 139' ' ' HIS . . . 121.2 55.4 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 111.292 -0.723 . . . . 64.120000000000005 111.292 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.73 141.19 50.68 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.974 0.91 . . . . 72.340000000000003 109.236 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.4 pt -86.77 142.56 12.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.328 0.651 . . . . 75.150000000000006 110.793 -177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.08 118.93 36.94 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.501 -1.296 . . . . 73.540000000000006 107.501 169.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.72 161.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.106 0.962 . . . . 71.530000000000001 110.012 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -93.04 -170.98 2.55 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 123.145 0.578 . . . . 74.430000000000007 109.756 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.1 t -67.9 -11.63 59.08 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.596 0.758 . . . . 42.329999999999998 111.576 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.31 -46.21 12.88 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.472 -0.566 . . . . 71.230000000000004 109.472 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.24 12.89 9.44 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 112.658 -0.177 . . . . 73.319999999999993 112.658 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -81.67 133.74 35.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.072 0.949 . . . . 73.349999999999994 109.558 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 91.29 0.1 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.946 0.879 . . . . 72.450000000000003 110.58 176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 39.0 pt -60.89 -35.17 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 115.055 -0.975 . . . . 62.530000000000001 112.192 -173.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.44 HG12 HG13 ' A' ' 32' ' ' ILE . 14.0 p -150.46 152.92 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 C-N-CA 123.809 0.843 . . . . 65.530000000000001 109.548 -178.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -51.03 -53.31 34.67 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.836 0.854 . . . . 74.129999999999995 111.438 172.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -157.72 155.67 30.33 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.489 -1.232 . . . . 74.439999999999998 109.338 -168.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.7 p -84.94 41.75 0.89 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.357 0.663 . . . . 74.430000000000007 110.617 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -52.73 -46.84 67.58 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.783 1.233 . . . . 73.340000000000003 110.334 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -132.05 145.68 34.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.3 -0.864 . . . . 73.209999999999994 108.866 172.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -58.63 -25.99 63.26 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.678 0.791 . . . . 72.120000000000005 111.865 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.413 ' H ' HG22 ' A' ' 38' ' ' VAL . 6.5 m -64.03 -52.82 57.62 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.189 0.996 . . . . 61.299999999999997 111.004 -176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.475 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -69.98 -27.82 65.03 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.93 0.492 . . . . 51.350000000000001 110.843 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -65.5 -47.42 76.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.174 0.989 . . . . 75.400000000000006 110.31 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -68.8 -49.7 56.39 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.758 -0.655 . . . . 72.540000000000006 110.716 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -60.56 -36.04 77.51 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.906 0.754 . . . . 71.510000000000005 111.051 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -61.25 -43.69 98.47 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.415 -0.811 . . . . 63.229999999999997 111.577 176.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.459 HD12 HD23 ' A' ' 153' ' ' LEU . 74.2 mt -71.66 -38.86 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 124.361 1.064 . . . . 74.400000000000006 111.497 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 94.9 mt -67.36 -27.27 66.98 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.949 0.5 . . . . 60.409999999999997 110.866 178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -74.51 -19.04 60.51 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.534 1.134 . . . . 74.450000000000003 111.474 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 66.7 mm-40 -87.24 159.06 18.96 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.348 0.659 . . . . 63.329999999999998 110.16 178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.96 96.77 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.015 0.926 . . . . 74.109999999999999 110.571 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -88.92 173.68 8.36 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.0 -1.0 . . . . 70.329999999999998 109.905 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 47' ' ' LEU . 32.6 mmtp -134.73 50.8 2.14 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.306 0.642 . . . . 75.540000000000006 111.104 -174.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.75 141.77 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.317 0.647 . . . . 72.239999999999995 109.576 175.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.42 115.72 24.67 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.631 0.373 . . . . 23.02 111.351 -176.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -81.72 157.22 24.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.065 -0.717 . . . . 70.450000000000003 109.065 169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 17' ' ' ALA . 41.4 tp -123.65 110.31 14.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.105 -1.072 . . . . 72.319999999999993 108.105 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 148' ' ' ILE . 46.3 t -97.21 109.23 22.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.589 -0.893 . . . . 75.239999999999995 108.589 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -117.49 173.78 6.52 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.688 0.795 . . . . 61.119999999999997 109.384 173.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.7 p-10 -98.92 -177.49 3.65 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.597 0.759 . . . . 73.319999999999993 109.856 171.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -62.98 -44.6 95.6 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 124.258 0.974 . . . . 71.510000000000005 112.033 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HD3' ' HG3' ' A' ' 142' ' ' GLU . 8.4 mpt_? -67.18 -42.28 84.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.819 0.447 . . . . 55.32 110.387 -174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.6 m -63.76 -36.57 84.32 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 123.895 0.747 . . . . 71.239999999999995 110.672 173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -65.21 -39.81 93.3 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.207 0.603 . . . . 73.540000000000006 111.167 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -55.85 -35.6 66.61 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.053 0.454 . . . . 71.340000000000003 110.061 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.0 mmmt -73.65 -49.66 24.85 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 114.578 -1.192 . . . . 54.329999999999998 110.798 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.574 HG13 ' HB1' ' A' ' 13' ' ' ALA . 87.9 t -60.6 -55.42 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.107 0.963 . . . . 72.200000000000003 110.89 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -50.42 -42.08 53.32 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.854 1.662 . . . . 73.010000000000005 111.822 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.33 -47.05 83.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.908 0.755 . . . . 71.299999999999997 111.084 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.1 mt -63.58 -38.69 92.1 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.706 0.802 . . . . 75.25 111.294 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 97.0 mt -58.77 -53.67 55.8 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.033 0.833 . . . . 44.210000000000001 109.855 178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.2 mt -67.56 -33.41 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 115.523 -0.762 . . . . 55.149999999999999 111.417 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.0 -39.36 90.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.52 0.728 . . . . 74.409999999999997 110.046 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -73.56 -62.16 1.58 Allowed 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.044 -0.525 . . . . 75.409999999999997 110.745 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -178.39 -18.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.657 0.598 . . . . 72.439999999999998 112.395 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 1.2 t80 -77.54 97.26 4.98 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.27 0.557 . . . . 74.340000000000003 110.076 -172.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.579 ' HB ' ' HG2' ' A' ' 79' ' ' GLU . 42.7 m -55.0 137.48 66.17 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 125.93 1.692 . . . . 63.409999999999997 112.484 -177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -55.24 -33.89 86.25 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 123.848 3.032 . . . . 63.200000000000003 112.68 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 39.5 mt-10 -64.46 -34.55 78.46 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.612 1.195 . . . . 72.519999999999996 111.155 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 15.0 mm-40 -81.73 -37.91 26.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.25 0.22 . . . . 72.439999999999998 110.506 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.1 mt -57.88 -48.93 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.64 0.776 . . . . 74.329999999999998 110.476 177.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -70.05 -21.66 63.15 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.231 -0.895 . . . . 74.109999999999999 112.174 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.7 t -67.89 -29.49 68.61 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.343 0.657 . . . . 62.229999999999997 111.093 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -74.1 -18.8 60.76 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.802 0.441 . . . . 74.420000000000002 111.703 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.433 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 83.6 m-85 -76.31 -30.76 57.85 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 120.983 0.42 . . . . 70.549999999999997 110.159 171.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.6 9.55 41.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.802 0.841 . . . . 60.229999999999997 111.511 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -65.36 96.45 0.24 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.429 0.691 . . . . 63.219999999999999 110.046 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -101.82 -15.79 16.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.795 0.838 . . . . 75.329999999999998 111.478 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.45 -42.99 54.91 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.619 0.574 . . . . 74.230000000000004 112.467 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.88 -79.94 0.56 Allowed 'General case' 0 C--O 1.246 0.871 0 N-CA-C 108.36 -0.978 . . . . 61.350000000000001 108.36 173.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 178.17 142.15 0.27 Allowed Pre-proline 0 C--O 1.246 0.879 0 N-CA-C 106.919 -1.511 . . . . 64.329999999999998 106.919 -175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 94' ' ' VAL . 50.6 Cg_exo -53.84 110.17 0.47 Allowed 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.05 1.833 . . . . 70.239999999999995 112.431 177.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 150' ' ' GLU . 57.3 t -69.03 -38.61 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 115.413 -0.812 . . . . 72.140000000000001 108.938 172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -100.97 112.71 25.22 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.368 -1.287 . . . . 74.230000000000004 107.899 173.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 91' ' ' PRO . 45.6 t -118.66 157.11 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.642 0.777 . . . . 74.310000000000002 109.658 -177.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -152.28 174.11 14.19 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.445 0.698 . . . . 73.549999999999997 111.696 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.99 -147.23 19.09 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 114.799 -1.091 . . . . 65.349999999999994 110.722 175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.3 t -72.47 174.68 7.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.193 -0.669 . . . . 70.120000000000005 109.193 169.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 113' ' ' VAL . 58.2 tp -62.05 -48.99 77.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.374 -0.232 . . . . 74.25 110.374 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 3.2 mp0 -71.64 -41.68 68.52 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.853 -0.612 . . . . 75.420000000000002 110.474 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.8 m -56.84 -53.01 62.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.456 0.702 . . . . 73.409999999999997 111.688 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.17 -29.08 70.11 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.301 -0.863 . . . . 74.400000000000006 111.23 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -70.2 -45.48 66.54 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.535 0.734 . . . . 64.219999999999999 111.293 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 41.7 mt-10 -61.17 -46.69 89.45 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.096 0.958 . . . . 73.430000000000007 110.696 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -70.78 -32.04 69.02 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 114.946 -1.024 . . . . 73.030000000000001 111.899 -177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.17 -17.63 45.59 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.889 0.476 . . . . 71.420000000000002 111.313 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.98 43.46 40.71 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 123.226 0.329 . . . . 53.32 112.582 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 148' ' ' ILE . 14.1 mt -110.77 157.28 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.565 1.146 . . . . 64.329999999999998 108.605 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 t -70.69 106.02 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.252 1.19 0 N-CA-C 109.339 -0.615 . . . . 43.420000000000002 109.339 176.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.37 -47.48 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 114.011 -1.45 . . . . 62.340000000000003 110.772 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -52.31 -47.16 66.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.967 1.307 . . . . 70.439999999999998 111.612 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -64.43 -54.09 38.17 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 123.92 0.762 . . . . 74.120000000000005 111.219 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.28 -22.76 62.82 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.267 0.84 . . . . 73.239999999999995 113.267 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.442 ' HA ' HD21 ' A' ' 98' ' ' LEU . 38.4 t -68.25 -41.99 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.779 -0.452 . . . . 64.150000000000006 109.779 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -66.67 -47.06 73.66 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.535 0.683 . . . . 75.299999999999997 109.293 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 36.3 m -56.15 -41.97 76.23 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 113.864 -1.516 . . . . 71.329999999999998 112.49 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 52.3 t -80.3 -38.38 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.338 0.655 . . . . 64.430000000000007 111.859 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -31.22 63.62 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 120.76 0.314 . . . . 72.140000000000001 111.39 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -83.51 -25.57 30.95 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.656 0.782 . . . . 63.119999999999997 109.74 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.485 ' O ' HG23 ' A' ' 123' ' ' VAL . 83.4 t80 -60.98 -62.18 2.04 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 108.823 -0.806 . . . . 73.409999999999997 108.823 170.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.62 -27.38 67.72 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.195 -0.911 . . . . 72.349999999999994 110.806 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -58.87 -59.42 10.81 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 124.141 0.901 . . . . 42.409999999999997 113.328 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 22.1 p90 -70.16 -27.55 64.62 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.591 0.695 . . . . 73.239999999999995 111.28 -177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 119' ' ' TYR . 89.5 t -62.68 -45.15 99.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 CA-C-N 116.376 -0.374 . . . . 73.019999999999996 110.63 176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -79.47 -16.57 55.86 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 111.416 0.154 . . . . 71.510000000000005 111.416 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -74.07 -25.25 59.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 110.258 -0.275 . . . . 74.109999999999999 110.258 168.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.96 46.4 16.93 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 112.949 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -168.13 143.39 3.66 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.13 0.572 . . . . 73.329999999999998 109.571 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HB3' ' O ' ' A' ' 133' ' ' ARG . 7.6 p-10 -69.37 137.63 52.99 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.602 0.761 . . . . 60.530000000000001 111.888 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -141.57 26.17 1.96 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.456 1.102 . . . . 64.209999999999994 108.849 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -132.11 22.82 4.5 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.638 -1.165 . . . . 52.0 110.788 -172.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 8.0 p90 47.7 32.66 2.67 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.226 1.01 . . . . 64.230000000000004 111.797 -171.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -106.77 -106.0 3.08 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.571 -0.741 . . . . 62.399999999999999 113.422 -169.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' ASP . 0.0 OUTLIER -149.86 171.13 17.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.745 0.418 . . . . 70.299999999999997 111.664 -164.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 135' ' ' PRO . 15.0 t70 -60.96 145.27 89.41 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.581 -1.191 . . . . 74.200000000000003 112.032 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.0 Cg_exo -34.51 -38.31 0.14 Allowed 'Trans proline' 0 C--N 1.384 2.426 1 C-N-CA 126.02 4.48 . . . . 72.200000000000003 116.953 170.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -77.01 -0.1 23.23 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 112.467 0.543 . . . . 75.109999999999999 112.467 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.38 5.9 9.63 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.026 0.93 . . . . 73.019999999999996 110.619 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 135' ' ' PRO . 88.9 mt -89.27 148.74 23.41 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.279 0.632 . . . . 74.439999999999998 110.641 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 21' ' ' GLY . 37.2 t-80 -146.34 109.87 4.81 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.633 0.773 . . . . 75.409999999999997 110.037 -173.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.434 ' HG3' HG11 ' A' ' 123' ' ' VAL . 90.8 mt-30 -71.73 150.43 44.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.937 0.495 . . . . 72.299999999999997 109.918 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 67.6 m-85 -70.28 118.81 13.56 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.747 -0.66 . . . . 74.329999999999998 110.029 174.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.437 ' HG3' ' HD3' ' A' ' 61' ' ' ARG . 8.9 pt-20 -116.96 155.57 28.91 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.359 0.664 . . . . 54.439999999999998 111.19 -177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 99.43 -12.18 61.57 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 115.694 -0.685 . . . . 51.210000000000001 112.966 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 73.36 -25.18 0.19 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.262 1.425 . . . . 73.420000000000002 113.37 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 24.6 m -84.9 107.83 17.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.971 0.508 . . . . 62.439999999999998 110.089 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -90.04 138.26 31.66 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.002 0.921 . . . . 63.399999999999999 110.036 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 39.1 m-85 -112.73 136.46 52.3 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.192 -1.04 . . . . 65.430000000000007 108.192 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.472 HG12 HG22 ' A' ' 57' ' ' VAL . 46.1 mt -125.82 109.94 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 108.778 -0.823 . . . . 63.43 108.778 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 12.0 mm -105.8 141.57 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 108.477 -0.935 . . . . 73.230000000000004 108.477 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.521 ' HB3' HG13 ' A' ' 92' ' ' VAL . 34.2 tt0 -93.11 119.87 32.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.894 0.478 . . . . 75.349999999999994 110.707 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 8' ' ' LYS . 1.3 mp0 -118.27 144.22 45.97 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.546 0.738 . . . . 74.109999999999999 109.047 173.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.476 ' HB2' ' HE2' ' A' ' 8' ' ' LYS . 2.9 mpt_? -103.04 177.26 4.89 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 107.504 -1.295 . . . . 75.420000000000002 107.504 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 46' ' ' ILE . 61.5 mt -54.35 119.75 5.62 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.621 -0.511 . . . . 74.129999999999995 109.621 176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -44.97 -36.8 3.58 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.979 1.425 . . . . 72.530000000000001 112.819 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -163.33 139.41 6.9 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.273 -0.876 . . . . 74.150000000000006 109.737 173.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -102.11 174.12 6.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.057 0.943 . . . . 75.510000000000005 109.023 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -162.97 160.1 24.3 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.916 0.886 . . . . 73.230000000000004 109.021 173.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 63.19 92.57 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.599 1.16 . . . . 61.140000000000001 111.597 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -165.23 160.0 18.02 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.428 0.691 . . . . 62.049999999999997 109.456 170.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 81.3 t60 . . . . . 0 CA--C 1.554 1.127 0 CA-C-O 118.966 -0.54 . . . . 72.239999999999995 109.91 179.737 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 109.735 -0.468 . . . . 61.109999999999999 109.735 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p -152.31 152.81 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.34 0.656 . . . . 73.430000000000007 110.671 -174.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -69.83 157.75 88.89 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 123.801 0.84 . . . . 75.019999999999996 110.761 175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.74 26.32 0.32 Allowed 'Trans proline' 0 C--N 1.383 2.39 0 C-N-CA 123.072 2.515 . . . . 33.219999999999999 115.116 -177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.41 54.1 5.72 Favored Glycine 0 C--N 1.35 1.312 0 N-CA-C 112.383 -0.287 . . . . 35.299999999999997 112.383 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.2 m -85.92 14.18 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 C-N-CA 123.541 0.736 . . . . 72.329999999999998 111.624 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.28 102.62 11.3 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.884 0.874 . . . . 72.019999999999996 111.506 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -162.06 132.02 4.7 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.125 0.97 . . . . 61.530000000000001 108.494 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD22 ' H ' ' A' ' 10' ' ' THR . 2.1 tm? -94.39 154.32 17.53 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.278 -0.638 . . . . 75.519999999999996 109.278 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.573 ' H ' HD22 ' A' ' 9' ' ' LEU . 76.1 p -72.22 165.64 24.01 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.067 1.347 . . . . 74.439999999999998 113.066 -173.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.2 p -80.69 -43.43 20.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.635 -0.711 . . . . 63.210000000000001 111.6 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -57.05 -37.49 71.86 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -72.89 -39.77 66.13 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.628 0.771 . . . . 52.229999999999997 110.812 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 50.0 m -72.79 -26.69 61.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.805 -1.089 . . . . 73.409999999999997 111.525 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -61.55 -58.64 7.33 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.953 0.901 . . . . 73.109999999999999 110.464 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -67.27 -37.82 84.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.239 -0.891 . . . . 75.239999999999995 111.29 -172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.79 -49.99 67.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.599 0.76 . . . . 64.040000000000006 111.311 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.4 p -69.68 -35.67 75.32 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.466 -0.788 . . . . 52.039999999999999 111.293 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.58 -44.57 81.17 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.744 0.818 . . . . 61.350000000000001 112.258 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -73.91 -38.83 64.22 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.597 0.18 . . . . 64.230000000000004 111.234 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.22 75.07 0.02 OUTLIER Glycine 0 C--N 1.347 1.161 0 C-N-CA 121.812 -0.232 . . . . 63.420000000000002 112.694 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.39 148.72 43.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.859 0.864 . . . . 71.25 109.053 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -122.79 152.22 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.173 0.589 . . . . 73.530000000000001 110.791 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' OH ' ' HB3' ' A' ' 14' ' ' SER . 68.3 m-85 -100.34 126.69 46.72 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.027 0.531 . . . . 74.439999999999998 109.795 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 m -119.21 155.95 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 123.748 0.819 . . . . 64.519999999999996 109.289 171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -82.09 -176.16 6.01 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.917 -0.772 . . . . 71.209999999999994 108.917 168.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.4 t -71.57 -0.02 9.64 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 111.882 0.327 . . . . 65.209999999999994 111.882 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 75.6 mmtt -81.23 -49.68 10.48 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.602 -0.518 . . . . 70.510000000000005 109.602 162.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 111.05 23.11 5.95 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.865 -0.494 . . . . 54.219999999999999 111.865 -173.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.18 128.8 42.3 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.307 -0.997 . . . . 64.519999999999996 108.307 172.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.49 101.78 0.08 Allowed 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 121.736 0.779 . . . . 72.030000000000001 110.535 174.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.444 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.8 pt -80.05 -29.27 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 CA-C-N 115.793 -0.639 . . . . 63.32 111.697 -174.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 32' ' ' ILE . 12.2 p -156.31 149.97 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.427 0.691 . . . . 74.099999999999994 109.351 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -56.66 -54.65 43.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.335 1.054 . . . . 52.130000000000003 111.426 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -161.52 176.28 11.22 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.142 -0.935 . . . . 62.439999999999998 110.716 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.8 p -92.45 48.39 1.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.822 0.849 . . . . 70.109999999999999 110.995 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.62 -48.3 72.39 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.47 0.652 . . . . 71.099999999999994 109.881 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 41' ' ' THR . 14.7 p -128.19 149.92 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 114.765 -1.107 . . . . 73.340000000000003 108.056 166.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -63.39 -28.75 70.2 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.156 0.582 . . . . 74.150000000000006 111.303 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.436 ' H ' HG22 ' A' ' 38' ' ' VAL . 5.4 m -66.51 -45.25 80.15 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.168 0.987 . . . . 72.230000000000004 111.891 -171.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 ' H ' HG13 ' A' ' 38' ' ' VAL . 12.7 t -66.13 -31.2 71.92 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.703 0.401 . . . . 60.350000000000001 110.728 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -74.37 -44.04 53.93 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.909 0.884 . . . . 74.409999999999997 110.846 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 77.5 ttt-85 -67.65 -48.74 65.83 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.497 0.719 . . . . 72.230000000000004 109.877 -175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -65.48 -27.72 68.69 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.135 0.897 . . . . 71.099999999999994 111.222 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -63.14 -41.93 99.38 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.962 0.505 . . . . 64.0 110.934 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 54' ' ' ALA . 54.5 mt -66.91 -41.64 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.332 0.653 . . . . 74.319999999999993 110.213 175.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 88.8 mt -66.43 -24.01 66.38 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.203 -0.908 . . . . 64.430000000000007 111.556 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -81.31 -27.86 34.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.714 0.806 . . . . 72.420000000000002 111.004 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 85.4 mm-40 -84.42 154.34 22.85 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.06 0.544 . . . . 72.329999999999998 111.051 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.66 -36.75 65.39 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.345 -0.843 . . . . 65.430000000000007 109.888 173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.26 112.52 14.04 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.541 -0.911 . . . . 73.140000000000001 108.541 172.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.493 ' HE2' HD11 ' A' ' 153' ' ' LEU . 8.2 tptm -92.48 40.31 1.05 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.638 0.732 . . . . 73.049999999999997 111.485 -167.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.601 ' HB ' ' HD3' ' A' ' 152' ' ' ARG . 2.6 p -157.78 136.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 C-N-CA 124.535 1.134 . . . . 75.109999999999999 109.457 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 46' ' ' ILE . . . -106.84 165.42 11.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.765 0.826 . . . . 60.549999999999997 110.356 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -144.7 112.82 6.43 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.343 1.057 . . . . 72.349999999999994 109.852 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 tp -79.04 103.37 8.93 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.19 0.996 . . . . 74.439999999999998 110.087 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 48.7 t -87.99 115.11 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.082 -0.71 . . . . 55.219999999999999 109.082 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -135.79 177.18 8.03 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.801 0.84 . . . . 74.219999999999999 108.884 172.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.0 p-10 -99.57 -179.83 4.32 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.515 0.726 . . . . 75.239999999999995 110.537 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 31.7 tt0 -73.35 -32.28 64.43 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.164 0.586 . . . . 65.420000000000002 111.938 -175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -72.18 -37.49 69.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.538 0.335 . . . . 75.430000000000007 110.4 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.8 m -69.31 -34.87 75.34 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.542 0.737 . . . . 55.530000000000001 110.12 172.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -64.25 -34.59 78.46 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.477 0.711 . . . . 73.319999999999993 111.253 174.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 68.7 mmtt -58.48 -23.71 58.52 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 118.308 0.504 . . . . 64.450000000000003 111.465 177.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -84.67 -49.63 8.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.461 0.704 . . . . 72.540000000000006 110.616 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.572 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.4 t -64.26 -55.03 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.204 1.001 . . . . 72.409999999999997 111.468 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -47.02 -44.17 20.2 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.419 1.488 . . . . 72.310000000000002 111.94 172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.1 -46.68 86.21 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 123.98 0.8 . . . . 73.219999999999999 110.567 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.73 -31.39 72.36 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.613 0.765 . . . . 61.439999999999998 111.85 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 98.6 mt -61.75 -53.52 54.91 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.392 -0.596 . . . . 65.120000000000005 109.392 174.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -66.59 -33.42 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.278 -0.874 . . . . 71.400000000000006 111.317 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.9 -42.45 81.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.39 1.076 . . . . 72.439999999999998 109.376 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -83.59 -65.68 0.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.403 0.439 . . . . 73.519999999999996 110.602 -171.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 178.6 64.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.9 0.88 . . . . 72.200000000000003 111.134 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -159.07 101.82 1.6 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.73 -0.841 . . . . 70.450000000000003 108.73 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 78' ' ' GLU . 86.3 m -62.63 137.54 96.52 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.376 1.071 . . . . 75.420000000000002 111.06 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -51.85 -31.33 42.15 Favored 'Trans proline' 0 C--N 1.39 2.723 0 C-N-CA 123.525 2.816 . . . . 75.329999999999998 112.889 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.457 ' H ' HG22 ' A' ' 76' ' ' THR . 46.3 mt-10 -65.23 -45.97 82.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.136 0.897 . . . . 73.439999999999998 111.121 176.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.81 -30.77 71.79 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.877 0.471 . . . . 73.310000000000002 111.305 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 70.9 mt -71.82 -51.6 30.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.259 0.623 . . . . 71.430000000000007 110.358 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 11.7 ptmm? -70.48 -19.52 62.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.352 0.661 . . . . 75.420000000000002 112.182 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.1 p -69.5 -24.18 63.72 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.478 0.711 . . . . 75.319999999999993 112.196 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -76.19 -24.06 54.69 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.319 0.248 . . . . 75.150000000000006 111.409 176.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 91.5 m-85 -77.29 -10.51 59.48 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.855 0.462 . . . . 73.400000000000006 111.07 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -86.98 35.89 0.71 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.743 0.817 . . . . 75.439999999999998 111.014 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -62.17 -50.46 71.73 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.97 0.908 . . . . 72.319999999999993 112.014 -175.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? 49.42 27.49 2.01 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.227 1.411 . . . . 64.340000000000003 113.179 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.33 55.08 0.15 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.258 -0.737 . . . . 73.329999999999998 111.258 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -166.7 159.19 13.73 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.177 0.991 . . . . 64.430000000000007 108.539 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -75.84 114.81 40.45 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.985 -0.746 . . . . 70.25 108.985 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -76.58 145.66 26.44 Favored 'Trans proline' 0 C--N 1.372 1.79 0 C-N-CA 122.5 2.133 . . . . 73.200000000000003 111.362 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.45 -34.39 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.916 -0.772 . . . . 53.409999999999997 108.916 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -115.97 112.01 21.22 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.443 -0.947 . . . . 73.109999999999999 108.443 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.1 t -111.24 150.53 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.626 0.77 . . . . 51.200000000000003 109.223 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -148.81 176.69 10.18 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.292 0.568 . . . . 73.010000000000005 111.414 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 124.09 -151.32 17.12 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 110.534 -1.027 . . . . 71.329999999999998 110.534 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 t -71.32 166.86 20.73 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 109.26 -0.644 . . . . 63.420000000000002 109.26 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -56.85 -48.53 77.86 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 118.104 0.411 . . . . 74.340000000000003 111.093 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.0 mt-10 -72.3 -39.36 68.33 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.25 -0.887 . . . . 74.120000000000005 111.36 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 59.0 m -62.72 -49.62 74.32 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.366 0.667 . . . . 55.020000000000003 111.698 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.41 -29.51 70.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.825 -1.08 . . . . 55.329999999999998 111.046 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -66.21 -46.37 77.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.471 0.709 . . . . 71.420000000000002 111.182 176.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 40.4 mt-10 -61.12 -45.79 93.22 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.056 0.848 . . . . 62.310000000000002 110.853 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -66.58 -39.38 88.41 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.717 0.807 . . . . 54.399999999999999 111.534 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.98 -20.61 57.74 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.18 0.592 . . . . 73.099999999999994 111.565 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.11 38.42 15.41 Favored Glycine 0 C--N 1.349 1.287 0 O-C-N 123.468 0.48 . . . . 32.5 112.723 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.4 mt -109.85 149.34 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.115 0.966 . . . . 63.119999999999997 109.126 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 47.8 t -69.66 106.42 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 109.377 -0.601 . . . . 73.140000000000001 109.377 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.3 t -50.98 -41.33 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.637 1.175 . . . . 72.329999999999998 111.249 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -55.91 -48.15 76.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.851 1.26 . . . . 74.439999999999998 111.818 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -71.33 -48.61 49.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 123.7 0.625 . . . . 73.450000000000003 111.501 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.53 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.79 -36.77 75.97 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.546 0.573 . . . . 53.420000000000002 112.546 -173.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.9 t -62.79 -39.06 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.785 -0.45 . . . . 64.040000000000006 109.785 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -58.88 -57.42 13.14 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.794 0.684 . . . . 74.299999999999997 110.458 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 112' ' ' LEU . 9.3 t -65.8 -24.24 66.87 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 112.278 0.473 . . . . 72.099999999999994 112.278 -174.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.21 -45.86 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.289 0.636 . . . . 54.409999999999997 110.867 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -73.61 -29.56 62.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 117.914 0.325 . . . . 63.130000000000003 110.991 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.96 -44.7 65.49 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.278 -0.638 . . . . 75.230000000000004 109.278 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.2 t80 -53.58 -60.66 3.02 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 124.403 1.064 . . . . 75.230000000000004 109.483 174.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -57.79 -27.41 63.07 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.216 0.947 . . . . 72.519999999999996 112.431 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.97 -54.38 8.27 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.857 0.723 . . . . 74.120000000000005 112.735 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 1.9 p90 -74.63 -19.88 60.12 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.607 0.595 . . . . 62.329999999999998 112.607 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.9 t -61.09 -49.97 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.544 0.527 . . . . 74.109999999999999 110.023 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.438 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 13.9 pt20 -79.03 -18.32 53.75 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.301 -0.409 . . . . 73.530000000000001 112.045 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -74.47 -23.56 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.662 0.385 . . . . 52.140000000000001 110.791 169.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 82.0 40.1 10.87 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.231 0.332 . . . . 75.540000000000006 113.42 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.525 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 47.5 t60 -165.92 114.71 0.97 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.893 0.877 . . . . 63.240000000000002 108.709 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.563 ' HB3' HD11 ' A' ' 138' ' ' LEU . 7.4 p-10 -71.13 152.35 43.53 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.014 0.37 . . . . 63.210000000000001 110.608 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -112.84 -58.45 2.15 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.954 0.502 . . . . 72.400000000000006 109.923 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -85.72 80.44 8.97 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 116.176 -0.466 . . . . 71.209999999999994 110.433 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 27.6 p90 40.48 38.86 0.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 125.591 1.556 . . . . 71.0 114.247 171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.56 -113.5 0.25 Allowed Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.46 -0.791 . . . . 53.299999999999997 112.749 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -169.7 -174.68 1.92 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.695 0.798 . . . . 63.310000000000002 109.477 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -54.7 141.27 56.8 Favored Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 73.25 111.692 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.14 -28.01 68.3 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.638 2.892 . . . . 74.150000000000006 113.72 178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -69.13 -25.54 64.44 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.404 0.682 . . . . 65.010000000000005 111.066 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -101.12 -17.02 16.86 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.783 0.833 . . . . 72.400000000000006 111.072 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 79.3 mt -68.98 132.25 46.37 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.242 -0.651 . . . . 70.120000000000005 109.242 172.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -146.61 129.64 16.43 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.497 0.719 . . . . 73.200000000000003 109.58 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.438 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -78.61 156.09 29.27 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 110.084 -0.339 . . . . 65.129999999999995 110.084 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 72.0 m-85 -65.84 121.46 15.1 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.176 -0.92 . . . . 74.0 111.116 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -79.36 156.94 27.76 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.622 1.169 . . . . 73.409999999999997 111.884 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.76 -153.32 51.45 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 115.801 -0.636 . . . . 54.539999999999999 112.843 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -118.12 -36.09 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.573 0.749 . . . . 71.109999999999999 111.028 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.0 m -83.3 115.81 22.16 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 122.6 0.36 . . . . 65.120000000000005 111.332 -172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -91.47 136.63 32.98 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.901 0.88 . . . . 62.43 109.602 173.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -109.34 112.67 24.94 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.59 0.756 . . . . 74.140000000000001 109.308 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.0 mt -100.59 115.38 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.993 0.917 . . . . 74.540000000000006 108.752 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.5 mm -103.61 122.15 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 123.656 0.783 . . . . 63.049999999999997 109.704 -174.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -73.52 121.88 21.3 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 122.927 0.491 . . . . 74.340000000000003 110.68 177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -115.01 100.13 7.96 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.246 -1.02 . . . . 71.040000000000006 108.246 165.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' HD3' ' HB ' ' A' ' 53' ' ' VAL . 3.1 tpp180 -78.85 174.6 11.32 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 124.064 0.946 . . . . 72.349999999999994 108.469 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.493 HD11 ' HE2' ' A' ' 52' ' ' LYS . 36.9 mt -70.29 169.32 14.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.81 -0.556 . . . . 70.450000000000003 110.543 167.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -67.21 147.11 53.48 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.47 -0.786 . . . . 63.219999999999999 110.435 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -105.49 142.0 36.0 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.121 0.968 . . . . 63.140000000000001 109.519 -170.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -77.21 168.84 19.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.851 0.861 . . . . 75.329999999999998 111.481 -174.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -67.69 94.05 0.41 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.507 -0.769 . . . . 62.149999999999999 109.848 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -84.8 53.5 2.73 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.216 1.407 . . . . 72.209999999999994 111.846 -176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -173.59 126.8 0.4 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 74.129999999999995 110.276 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.019 0.928 . . . . 51.310000000000002 109.972 171.242 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 110.197 -0.297 . . . . 73.450000000000003 110.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.75 -24.71 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 123.518 0.727 . . . . 72.239999999999995 111.522 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' HB2' ' HD2' ' A' ' 4' ' ' PRO . 4.7 pm0 -62.72 162.39 21.49 Favored Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 123.969 0.908 . . . . 70.310000000000002 110.774 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.445 ' HD2' ' HB2' ' A' ' 3' ' ' GLU . 56.5 Cg_endo -65.5 179.91 1.46 Allowed 'Trans proline' 0 C--N 1.386 2.511 0 C-N-CA 122.362 2.042 . . . . 65.239999999999995 112.733 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.93 76.05 0.88 Allowed Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.83 -0.623 . . . . 60.219999999999999 112.564 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.57 165.75 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.868 0.867 . . . . 63.229999999999997 110.143 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.77 115.63 11.5 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.081 0.552 . . . . 72.25 110.624 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -69.15 -41.96 76.6 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.978 -0.749 . . . . 72.209999999999994 108.978 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.5 tp -71.61 85.26 0.88 Allowed 'General case' 0 C--N 1.354 0.768 0 N-CA-C 108.251 -1.018 . . . . 74.019999999999996 108.251 169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -89.44 156.25 18.79 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.532 -1.213 . . . . 31.129999999999999 108.231 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.616 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 62.0 p -54.95 -20.87 9.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.859 1.429 . . . . 55.119999999999997 114.859 -170.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -47.98 -36.74 13.16 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.013 0.925 . . . . 72.409999999999997 112.354 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -62.98 -43.27 99.24 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 124.325 1.05 . . . . 73.319999999999993 111.352 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.6 p -83.39 -26.08 30.75 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.626 0.77 . . . . 52.119999999999997 111.676 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.616 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 72.8 mmtt -69.98 -49.12 54.81 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.532 -0.544 . . . . 71.25 109.532 177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -66.26 -25.18 66.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.113 -0.949 . . . . 72.349999999999994 111.227 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.98 -50.75 30.93 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.497 0.719 . . . . 54.240000000000002 111.429 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 35' ' ' GLU . 42.6 p -66.51 -33.92 76.75 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 121.027 0.442 . . . . 71.120000000000005 111.057 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -70.91 -20.39 62.49 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.528 1.131 . . . . 54.219999999999999 110.79 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.435 ' HB3' HG23 ' A' ' 62' ' ' THR . 27.5 tpp -83.78 -39.98 19.35 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.493 0.717 . . . . 63.109999999999999 110.415 175.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.93 78.19 0.07 OUTLIER Glycine 0 C--N 1.344 0.998 0 N-CA-C 109.873 -1.291 . . . . 64.439999999999998 109.873 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.11 152.08 22.11 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.264 1.026 . . . . 64.239999999999995 108.984 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.9 pt -119.04 153.61 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.247 0.619 . . . . 64.140000000000001 110.43 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.645 ' HE2' ' HB2' ' A' ' 36' ' ' SER . 60.9 m-85 -100.28 129.11 46.24 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.846 -0.798 . . . . 71.230000000000004 108.846 170.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.566 HG11 HG21 ' A' ' 115' ' ' THR . 28.9 m -122.85 167.95 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.907 0.883 . . . . 71.310000000000002 108.684 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 30' ' ' ASP . 10.1 p30 -99.46 -165.8 1.27 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 109.961 -0.385 . . . . 63.340000000000003 109.961 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.0 t -63.48 -15.59 58.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.286 1.035 . . . . 64.519999999999996 113.577 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -92.85 -65.35 1.01 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.304 -0.999 . . . . 63.200000000000003 108.304 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 144.45 35.47 0.07 OUTLIER Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.472 -0.786 . . . . 41.009999999999998 111.536 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 4.0 m-20 -94.2 136.07 34.9 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.504 -0.925 . . . . 73.420000000000002 108.504 176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.603 ' H ' ' NE ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -69.11 94.06 0.64 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.98 -1.119 . . . . 61.299999999999997 107.98 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.573 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 43.0 pt -72.18 -31.52 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 115.961 -0.563 . . . . 61.420000000000002 110.294 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 p -164.97 141.05 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 C-N-CA 124.261 1.024 . . . . 72.420000000000002 108.859 171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 24.9 p-10 -68.88 -35.91 77.45 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.89 0.876 . . . . 75.120000000000005 111.742 -176.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 32.1 tt0 -154.62 148.68 25.8 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.908 1.283 . . . . 75.230000000000004 108.474 -172.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.645 ' HB2' ' HE2' ' A' ' 24' ' ' TYR . 19.1 t -77.33 77.25 3.86 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.485 0.659 . . . . 65.120000000000005 109.586 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.11 -53.12 15.7 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.802 -1.09 . . . . 74.400000000000006 109.334 176.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.18 142.52 22.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 CA-C-N 115.088 -0.96 . . . . 60.109999999999999 108.515 175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -63.05 -26.12 68.69 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.387 0.675 . . . . 74.109999999999999 112.329 -174.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.4 p -63.69 -49.27 73.82 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.034 0.534 . . . . 75.329999999999998 111.0 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.5 m -62.03 -43.6 98.5 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.169 0.988 . . . . 61.140000000000001 111.103 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.86 -43.2 99.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.543 1.137 . . . . 70.140000000000001 111.175 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 ttt85 -74.72 -49.7 20.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 111.059 -170.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.416 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.8 OUTLIER -66.08 -23.82 66.6 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 123.747 0.654 . . . . 74.150000000000006 111.467 -175.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -70.09 -38.08 75.57 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.345 0.658 . . . . 24.5 110.877 174.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -71.78 -36.18 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.802 0.841 . . . . 75.540000000000006 110.144 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 97.0 mt -69.81 -30.02 67.44 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.785 0.834 . . . . 52.310000000000002 110.716 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -67.71 -37.03 81.69 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.69 0.796 . . . . 72.310000000000002 110.537 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HG3' ' H ' ' A' ' 51' ' ' ASP . 58.4 tp60 -80.98 144.01 32.14 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.619 -0.719 . . . . 53.539999999999999 109.599 176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.67 91.99 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.588 0.755 . . . . 65.230000000000004 110.208 175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.519 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 9.9 m-20 -79.71 112.7 17.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.994 -1.003 . . . . 65.329999999999998 109.389 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 46.2 mmtm -86.5 70.19 10.44 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.612 0.72 . . . . 73.219999999999999 109.766 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -158.06 142.01 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.325 -1.307 . . . . 33.039999999999999 109.786 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.71 17.82 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.654 0.782 . . . . 73.219999999999999 109.038 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -90.35 121.23 32.15 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.739 0.815 . . . . 71.129999999999995 109.595 177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ILE . 56.5 tp -85.83 105.94 16.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.089 -0.959 . . . . 71.109999999999999 109.407 -178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.9 t -88.4 125.26 41.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.531 -0.915 . . . . 63.32 108.531 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.517 ' SD ' HG12 ' A' ' 149' ' ' ILE . 11.5 ptm -158.88 162.93 36.98 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.052 0.941 . . . . 74.420000000000002 109.179 -170.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 141' ' ' PHE . 24.2 t70 -99.25 169.2 9.54 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 108.444 -0.947 . . . . 63.409999999999997 108.444 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.524 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 30.7 tt0 -64.37 -22.63 67.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.021 0.928 . . . . 75.420000000000002 110.861 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -47.8 -54.59 11.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.072 1.349 . . . . 72.120000000000005 110.981 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 20' ' ' MET . 48.6 m -67.84 -40.51 83.7 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.513 1.125 . . . . 74.200000000000003 110.631 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 67.6 t-105 -59.44 -32.43 70.2 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.989 0.916 . . . . 75.129999999999995 113.33 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 73.7 mmtt -51.95 -39.84 59.88 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.416 0.627 . . . . 75.109999999999999 110.881 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.5 mmmt -78.22 -46.59 20.01 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.0 -1.0 . . . . 74.329999999999998 110.894 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG13 ' HB1' ' A' ' 13' ' ' ALA . 98.8 t -58.22 -54.19 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.571 0.748 . . . . 75.129999999999995 111.393 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -47.54 -45.76 27.04 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.344 1.457 . . . . 63.5 111.836 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.75 -46.64 78.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 115.219 -0.9 . . . . 73.129999999999995 110.557 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 97.3 mt -63.8 -31.56 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.02 0.928 . . . . 74.049999999999997 111.33 -177.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 79.2 mt -60.72 -56.73 17.73 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.406 0.683 . . . . 73.209999999999994 109.913 176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.9 mt -67.84 -31.12 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 C-N-CA 123.818 0.847 . . . . 44.039999999999999 110.847 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.79 -43.22 89.42 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.144 0.978 . . . . 55.329999999999998 110.096 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -80.07 -64.53 1.17 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.938 -0.393 . . . . 72.019999999999996 109.938 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.9 t70 169.54 93.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.959 1.304 . . . . 54.420000000000002 109.078 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.558 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 6.1 t80 -172.78 91.32 0.1 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 106.918 -1.512 . . . . 61.32 106.918 176.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.1 t -63.73 149.98 91.72 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 123.347 0.659 . . . . 75.430000000000007 110.798 -171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -54.81 -30.05 65.85 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.983 2.455 . . . . 71.439999999999998 113.149 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -57.61 -36.88 72.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 123.866 0.729 . . . . 71.400000000000006 111.461 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -70.44 -53.99 14.17 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.488 0.492 . . . . 75.319999999999993 110.098 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.6 mt -53.16 -55.57 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 124.809 1.318 . . . . 71.209999999999994 111.506 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 20.8 ptmt -62.49 -31.97 72.8 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 124.25 0.969 . . . . 75.519999999999996 111.502 -178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -73.2 -18.83 61.21 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 123.749 0.82 . . . . 72.030000000000001 111.957 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.54 -29.0 59.27 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 118.008 0.367 . . . . 64.549999999999997 110.757 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.476 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 63.5 m-85 -78.68 -38.51 39.17 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.366 -0.605 . . . . 71.209999999999994 109.366 172.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -95.82 44.3 1.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.867 1.267 . . . . 74.230000000000004 108.957 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -69.58 117.45 11.21 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.002 -0.999 . . . . 75.140000000000001 111.617 -168.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -107.7 -17.05 14.19 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.31 1.044 . . . . 44.43 109.558 172.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.69 59.2 4.98 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.365 -0.834 . . . . 62.439999999999998 112.251 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt 67.77 -79.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.576 1.55 . . . . 75.109999999999999 112.462 176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -118.59 140.49 28.42 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.813 0.845 . . . . 74.5 111.084 -169.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.13 153.66 28.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.824 2.349 . . . . 62.240000000000002 113.248 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.2 t -101.6 -45.37 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.526 -0.916 . . . . 74.430000000000007 108.526 167.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -98.34 120.59 39.01 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.445 -0.798 . . . . 73.230000000000004 108.893 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.35 150.52 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.651 0.78 . . . . 73.030000000000001 109.139 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.3 ptmt -145.55 174.78 10.86 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.389 0.675 . . . . 75.140000000000001 111.362 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.27 -131.33 6.2 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.212 -1.155 . . . . 53.450000000000003 110.212 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.7 t -89.43 172.66 8.85 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.796 -0.816 . . . . 52.310000000000002 108.796 168.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.93 -51.6 68.99 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.122 0.569 . . . . 74.219999999999999 110.249 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 43.5 mt-10 -67.7 -41.27 83.85 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.324 -0.853 . . . . 75.5 111.156 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.6 m -58.41 -51.79 68.36 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.249 0.62 . . . . 64.200000000000003 110.905 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.15 -28.95 70.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.978 -1.01 . . . . 74.030000000000001 111.103 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -67.03 -47.35 71.65 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.11 0.964 . . . . 75.140000000000001 111.308 177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.079 0.862 . . . . 64.239999999999995 110.569 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -67.44 -35.61 79.56 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.222 -0.899 . . . . 72.519999999999996 111.718 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.56 -11.54 45.33 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.061 0.545 . . . . 74.239999999999995 111.581 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 81.39 20.85 63.49 Favored Glycine 0 C--N 1.358 1.776 0 N-CA-C 114.253 0.461 . . . . 74.040000000000006 114.253 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 148' ' ' ILE . 4.2 mt -87.75 149.3 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 124.257 1.023 . . . . 72.530000000000001 109.476 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.25 102.97 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.323 -0.621 . . . . 74.099999999999994 109.323 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 113' ' ' VAL . 91.4 t -52.85 -41.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 114.56 -1.2 . . . . 64.140000000000001 111.384 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.24 -40.3 93.84 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.581 0.752 . . . . 70.099999999999994 111.844 -174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -73.12 -41.09 64.38 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.209 0.603 . . . . 72.310000000000002 111.651 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.5 pp -74.9 -31.42 61.56 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.185 0.439 . . . . 70.310000000000002 112.185 -178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.9 t -58.03 -37.78 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.156 -0.683 . . . . 74.310000000000002 109.156 172.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -62.69 -60.77 3.04 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 123.866 0.729 . . . . 54.32 111.102 174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 112' ' ' LEU . 14.6 t -59.56 -30.63 68.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 112.762 0.653 . . . . 62.210000000000001 112.762 -173.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.49 -42.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.1 0.56 . . . . 73.5 110.438 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -75.0 -23.88 58.31 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 118.247 0.476 . . . . 72.530000000000001 111.278 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -79.49 -36.23 38.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.54 0.736 . . . . 73.319999999999993 109.218 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.47 ' O ' HG23 ' A' ' 123' ' ' VAL . 84.0 t80 -59.92 -61.65 2.46 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 124.083 0.864 . . . . 53.130000000000003 108.756 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -61.42 -26.57 67.95 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.296 1.039 . . . . 71.299999999999997 111.781 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.462 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -71.65 -47.41 34.02 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 124.116 0.885 . . . . 75.430000000000007 110.999 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -74.87 -20.62 59.65 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 111.871 0.322 . . . . 74.340000000000003 111.871 -177.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 119' ' ' TYR . 54.2 t -67.04 -56.39 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.408 0.683 . . . . 70.109999999999999 110.752 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.462 HE21 ' HA2' ' A' ' 121' ' ' GLY . 26.9 pt20 -71.71 -16.71 62.24 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.785 0.434 . . . . 74.400000000000006 111.239 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -75.81 -24.52 55.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.186 0.594 . . . . 75.299999999999997 110.494 172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 73.41 26.15 70.88 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.703 -0.68 . . . . 40.240000000000002 113.143 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 45.5 t60 -157.88 115.02 2.95 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.04 -1.096 . . . . 74.420000000000002 108.04 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.7 149.34 48.15 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 123.82 0.7 . . . . 71.109999999999999 109.895 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -108.25 -59.5 1.85 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.44 -0.948 . . . . 64.430000000000007 108.44 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -100.61 88.76 3.7 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.664 -0.698 . . . . 64.200000000000003 110.629 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 10.7 p90 42.13 33.27 0.37 Allowed 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.056 1.742 . . . . 71.400000000000006 115.066 169.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.94 -105.18 0.07 OUTLIER Glycine 0 C--N 1.35 1.344 0 O-C-N 123.377 0.423 . . . . 61.340000000000003 112.05 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.32 -175.75 1.46 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.771 0.828 . . . . 73.329999999999998 110.703 177.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -57.93 143.05 78.34 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 124.869 1.267 . . . . 65.230000000000004 111.322 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 138' ' ' LEU . 1.3 Cg_endo -42.98 -35.05 4.2 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 124.731 3.621 . . . . 73.319999999999993 115.423 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.01 -30.74 65.53 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.519 0.328 . . . . 73.230000000000004 111.304 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -96.14 -1.63 48.08 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 63.409999999999997 111.479 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 135' ' ' PRO . 77.1 mt -80.7 129.09 34.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.984 0.514 . . . . 70.040000000000006 109.935 175.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -147.15 135.81 22.01 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.742 0.817 . . . . 74.239999999999995 109.505 175.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.416 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.8 mp0 -73.44 155.45 39.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.886 0.474 . . . . 62.420000000000002 111.079 176.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 34.9 m-85 -72.72 98.15 2.33 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.116 -1.439 . . . . 74.030000000000001 107.116 164.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -68.11 97.21 0.68 Allowed 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.619 -0.882 . . . . 73.420000000000002 108.619 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -61.07 85.71 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 O-C-N 124.588 1.18 . . . . 61.100000000000001 114.605 -165.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -92.38 -55.59 3.35 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.608 -1.256 . . . . 65.420000000000002 107.608 168.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 42.2 m -151.3 119.1 6.15 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.228 -0.896 . . . . 64.549999999999997 108.998 176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.86 129.1 35.31 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.143 0.497 . . . . 74.450000000000003 110.284 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -107.29 152.29 24.33 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.562 1.145 . . . . 64.319999999999993 109.849 173.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.459 HG21 HD11 ' A' ' 107' ' ' ILE . 63.5 mt -134.45 109.01 11.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.237 -1.023 . . . . 74.010000000000005 108.237 172.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.517 HG12 ' SD ' ' A' ' 58' ' ' MET . 36.0 mm -97.02 115.57 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.474 0.71 . . . . 53.0 109.35 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.72 112.65 6.33 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.064 0.546 . . . . 74.129999999999995 109.777 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -118.87 101.28 7.94 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.028 0.931 . . . . 63.340000000000003 108.72 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 -96.56 171.75 8.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.308 0.643 . . . . 72.340000000000003 110.072 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.42 172.65 3.85 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.981 -0.554 . . . . 65.299999999999997 110.224 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -62.56 173.71 1.18 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 121.514 0.673 . . . . 75.430000000000007 111.011 -175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -81.54 78.0 8.34 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.45 -0.796 . . . . 74.030000000000001 109.185 -171.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -96.09 27.77 3.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.804 1.241 . . . . 71.140000000000001 110.023 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -54.27 -33.63 59.06 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.811 1.244 . . . . 70.129999999999995 112.956 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -73.11 88.17 1.43 Allowed 'General case' 0 C--N 1.361 1.068 0 CA-C-O 121.852 0.834 . . . . 75.349999999999994 110.287 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -132.53 -16.31 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.369 -1.287 . . . . 72.530000000000001 109.555 168.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 124.132 0.973 . . . . 71.299999999999997 108.675 176.612 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.437 -0.579 . . . . 54.450000000000003 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.15 -46.74 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 N-CA-C 108.438 -0.949 . . . . 72.120000000000005 108.438 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.32 145.26 82.58 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 114.671 -1.15 . . . . 73.099999999999994 111.149 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.73 -174.25 2.2 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 123.044 2.496 . . . . 51.130000000000003 112.541 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.28 78.32 1.13 Allowed Glycine 0 C--N 1.347 1.191 0 CA-C-N 116.365 -0.38 . . . . 34.539999999999999 112.722 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.3 11.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.923 0.889 . . . . 73.239999999999995 110.43 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.17 32.91 1.11 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.045 0.938 . . . . 33.109999999999999 112.555 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 65.51 82.51 0.18 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.143 1.377 . . . . 53.219999999999999 110.918 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.8 tp 63.16 107.2 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.495 1.518 . . . . 73.349999999999994 111.187 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 11' ' ' THR . 1.4 m -141.69 -164.47 1.79 Allowed 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 107.155 -1.424 . . . . 72.430000000000007 107.155 -175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.556 ' H ' HG22 ' A' ' 10' ' ' THR . 17.7 p -62.01 -21.23 64.71 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.174 1.176 . . . . 71.549999999999997 114.174 -177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -54.58 -35.9 63.81 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.569 0.748 . . . . 73.319999999999993 112.823 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.86 -35.73 50.65 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.485 0.714 . . . . 53.229999999999997 111.423 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.3 p -83.49 -37.92 22.48 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.492 0.717 . . . . 73.010000000000005 112.07 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -63.92 -56.63 13.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.968 0.907 . . . . 64.150000000000006 111.026 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -67.09 -31.58 72.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.535 -0.757 . . . . 72.030000000000001 110.75 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.71 89.18 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-N 115.507 -0.769 . . . . 55.439999999999998 111.388 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -74.38 -29.22 61.45 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.929 0.491 . . . . 63.32 111.89 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -61.34 -42.49 98.77 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.612 0.57 . . . . 73.109999999999999 110.431 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 75.8 mtm -83.17 -29.33 28.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.454 -0.794 . . . . 74.200000000000003 111.822 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.53 88.71 0.17 Allowed Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.076 -0.41 . . . . 64.329999999999998 112.076 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -156.63 146.98 21.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.171 0.988 . . . . 63.240000000000002 110.148 175.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.4 pt -122.5 152.76 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.638 0.775 . . . . 64.030000000000001 110.581 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -101.21 117.91 35.93 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.107 -0.701 . . . . 73.549999999999997 109.107 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.66 161.97 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.247 0.619 . . . . 72.349999999999994 111.232 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.611 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 28.3 p-10 -89.8 -177.46 5.25 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.298 0.639 . . . . 65.040000000000006 110.659 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -64.89 -13.52 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.518 0.727 . . . . 73.450000000000003 111.921 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 111' ' ' GLU . 74.8 mmtt -81.37 -59.65 2.55 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.982 -0.747 . . . . 74.310000000000002 108.982 169.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 136.62 23.93 0.5 Allowed Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.175 0.43 . . . . 45.450000000000003 114.175 175.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -113.57 152.26 30.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.686 0.794 . . . . 64.409999999999997 108.921 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' NH2' ' HA ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER -65.43 114.53 4.9 Favored 'General case' 0 CA--C 1.549 0.94 0 O-C-N 123.43 0.456 . . . . 74.099999999999994 110.811 -176.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.586 HG22 HE21 ' A' ' 49' ' ' GLN . 29.6 pt -76.65 -27.77 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.25 0.62 . . . . 74.519999999999996 110.525 172.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 p -144.23 136.2 22.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.795 0 N-CA-C 107.264 -1.384 . . . . 74.239999999999995 107.264 169.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 7.3 p30 -68.79 -28.8 67.09 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.765 0.826 . . . . 72.530000000000001 112.928 -171.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -159.79 171.88 18.68 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.352 -0.84 . . . . 60.229999999999997 108.867 -169.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.7 t -78.01 79.8 4.46 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.361 0.6 . . . . 73.310000000000002 109.416 173.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -78.65 -64.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.175 -0.92 . . . . 71.420000000000002 109.398 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 40' ' ' THR . 7.4 p -160.06 146.7 6.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 C-N-CA 124.33 1.052 . . . . 74.319999999999993 108.82 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -68.79 -19.03 64.29 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.397 0.679 . . . . 73.25 111.781 -176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.442 ' H ' HG22 ' A' ' 38' ' ' VAL . 74.1 p -68.64 -56.12 9.24 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 123.034 0.533 . . . . 33.32 110.283 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 41.8 m -59.7 -37.75 79.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.024 0.93 . . . . 63.100000000000001 111.057 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' O ' HG13 ' A' ' 46' ' ' ILE . 32.2 t80 -65.23 -40.92 94.73 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.377 -0.829 . . . . 74.230000000000004 111.067 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -65.22 -48.68 72.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.438 0.695 . . . . 74.129999999999995 109.786 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -64.11 -29.2 70.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.451 -0.795 . . . . 74.349999999999994 111.299 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.28 -30.85 70.83 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.772 0.429 . . . . 61.140000000000001 111.623 177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 42' ' ' PHE . 51.1 mt -84.5 -26.37 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.281 0 C-N-CA 124.021 0.928 . . . . 73.150000000000006 110.234 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.3 mt -84.86 -17.79 36.86 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.393 0.677 . . . . 72.439999999999998 112.089 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -102.27 -37.26 8.17 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.879 0.872 . . . . 75.120000000000005 110.624 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.586 HE21 HG22 ' A' ' 32' ' ' ILE . 24.2 tt0 -141.28 -172.28 3.47 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.8 -1.185 . . . . 73.420000000000002 107.8 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.611 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 83.02 -7.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 124.53 1.132 . . . . 54.039999999999999 113.121 168.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 63.43 35.4 12.13 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.839 0.855 . . . . 73.420000000000002 110.77 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 66.36 14.11 9.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.358 1.463 . . . . 61.119999999999997 112.725 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.66 119.81 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 121.907 0.86 . . . . 72.439999999999998 111.042 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.59 142.2 35.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.489 -0.93 . . . . 64.209999999999994 108.489 172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB3' HG23 ' A' ' 148' ' ' ILE . 87.2 m-85 -118.49 113.06 20.74 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.45 0.7 . . . . 75.430000000000007 109.604 -176.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.492 ' HG ' ' HE3' ' A' ' 58' ' ' MET . 50.5 tp -85.79 105.35 16.24 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.14 -0.689 . . . . 74.340000000000003 109.14 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HG12 ' A' ' 148' ' ' ILE . 40.1 t -100.28 124.64 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.763 0.825 . . . . 71.319999999999993 109.9 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.492 ' HE3' ' HG ' ' A' ' 56' ' ' LEU . 1.7 pmm? -137.7 178.32 7.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.928 0.891 . . . . 73.230000000000004 109.939 176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -93.25 163.02 13.77 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.107 -0.701 . . . . 73.150000000000006 109.107 167.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.8 tt0 -61.28 -29.83 70.1 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.225 1.01 . . . . 64.519999999999996 112.349 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -53.84 -40.9 66.85 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.778 0.831 . . . . 73.329999999999998 111.516 174.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 -38.27 55.06 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.106 0.963 . . . . 75.439999999999998 109.812 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -60.53 -33.72 73.06 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 123.946 0.779 . . . . 73.530000000000001 112.041 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.1 mmtt -50.91 -41.54 58.66 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 120.937 0.398 . . . . 73.310000000000002 110.709 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -81.68 -33.49 31.23 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.844 -1.071 . . . . 75.400000000000006 112.465 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 67.3 t -64.46 -55.16 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 109.658 -0.497 . . . . 73.140000000000001 109.658 177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -48.11 -45.36 32.76 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.6 1.56 . . . . 63.340000000000003 111.968 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -60.37 -45.83 92.11 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.718 -1.128 . . . . 73.120000000000005 111.25 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.63 -39.68 88.39 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.82 0.848 . . . . 74.219999999999999 111.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 96.0 mt -55.8 -55.71 29.21 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.69 0.619 . . . . 73.019999999999996 109.464 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.78 -42.1 93.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 124.074 0.859 . . . . 74.140000000000001 111.335 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.34 -40.67 90.01 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.947 0.899 . . . . 75.400000000000006 111.073 -174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -82.76 -48.78 10.45 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 119.283 -0.389 . . . . 74.5 111.566 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -157.63 -41.33 0.07 Allowed 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 113.947 1.091 . . . . 71.120000000000005 113.947 -172.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -68.26 178.72 1.81 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.029 0.919 . . . . 73.310000000000002 112.97 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.3 t -138.35 151.38 69.26 Favored Pre-proline 0 CA--C 1.554 1.116 0 CA-C-N 114.176 -1.374 . . . . 75.299999999999997 107.292 174.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -47.86 -40.36 32.2 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.702 2.935 . . . . 75.010000000000005 113.904 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.99 -44.35 96.91 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.408 1.067 . . . . 74.430000000000007 112.711 -173.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.93 -36.27 64.67 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 123.064 0.227 . . . . 73.209999999999994 111.271 -175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.3 mt -64.45 -48.15 86.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.75 0.82 . . . . 74.25 110.339 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 19.0 ptmt -70.66 -25.78 63.15 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.72 -0.673 . . . . 75.400000000000006 110.943 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.6 t -66.13 -24.81 66.74 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.388 0.675 . . . . 75.140000000000001 111.377 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -76.13 -25.1 55.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.923 0.489 . . . . 73.209999999999994 111.841 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.421 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 82.6 m-85 -74.85 -39.47 61.58 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.249 0.547 . . . . 74.25 110.443 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -94.26 12.63 26.11 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.957 -1.02 . . . . 70.209999999999994 111.046 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.707 HD21 ' HB2' ' A' ' 89' ' ' LYS . 54.5 t30 -67.59 99.23 0.75 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.524 0.73 . . . . 51.210000000000001 109.887 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -88.7 -36.26 16.29 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.754 0.822 . . . . 64.140000000000001 110.787 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.75 -50.26 54.73 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 124.124 0.89 . . . . 55.119999999999997 112.511 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.707 ' HB2' HD21 ' A' ' 86' ' ' ASN . 30.0 mmmt -108.4 -176.62 3.1 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.925 -0.769 . . . . 72.430000000000007 108.925 174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -68.12 132.85 91.76 Favored Pre-proline 0 N--CA 1.474 0.742 0 N-CA-C 109.118 -0.697 . . . . 73.239999999999995 109.118 175.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 94' ' ' VAL . 51.2 Cg_exo -55.34 112.18 0.97 Allowed 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 121.512 1.475 . . . . 73.209999999999994 111.092 168.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.87 -38.47 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-O 121.821 0.819 . . . . 60.039999999999999 109.703 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -112.55 114.5 27.18 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.308 -0.997 . . . . 74.409999999999997 108.308 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.536 HG22 ' HB2' ' A' ' 91' ' ' PRO . 99.4 t -110.24 152.2 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.315 1.046 . . . . 75.030000000000001 108.673 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.49 ' HE3' HG21 ' A' ' 145' ' ' THR . 19.4 ptmt -148.36 169.77 19.43 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.862 0.465 . . . . 65.150000000000006 110.943 175.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.88 -155.46 24.95 Favored Glycine 0 C--N 1.334 0.46 0 CA-C-N 115.012 -0.995 . . . . 72.349999999999994 110.907 174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.9 t -75.38 163.82 27.04 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.17 -1.048 . . . . 70.349999999999994 108.17 170.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -50.7 -45.25 58.24 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.634 0.774 . . . . 71.519999999999996 112.775 -172.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 37.6 mt-10 -80.49 -40.4 26.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.478 -0.783 . . . . 45.219999999999999 110.78 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.3 m -56.89 -49.91 74.11 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.951 0.9 . . . . 64.230000000000004 111.285 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.08 -31.3 72.45 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.851 -1.068 . . . . 42.43 111.213 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -65.19 -45.27 85.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.615 0.766 . . . . 74.230000000000004 111.194 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.8 mt-10 -64.07 -42.36 97.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.813 -1.085 . . . . 75.109999999999999 110.943 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -70.94 -29.68 65.77 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.07 -0.968 . . . . 70.129999999999995 111.752 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.15 25.26 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.069 0.547 . . . . 74.140000000000001 111.961 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 50.87 2.9 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.047 -0.421 . . . . 70.439999999999998 112.047 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 148' ' ' ILE . 1.8 mt -125.07 157.52 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.338 1.055 . . . . 71.409999999999997 108.361 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.5 t -79.07 108.87 13.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 N-CA-C 109.493 -0.558 . . . . 72.439999999999998 109.493 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.0 t -51.05 -48.43 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.795 1.238 . . . . 73.219999999999999 111.654 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.0 -39.34 68.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.737 1.215 . . . . 72.540000000000006 111.863 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 28' ' ' LYS . 25.9 mm-40 -69.52 -57.82 4.74 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.668 0.605 . . . . 74.439999999999998 110.858 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 3.9 pp -70.6 -23.79 62.64 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.277 1.214 . . . . 73.230000000000004 114.277 -170.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.64 -39.54 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.692 -0.485 . . . . 74.140000000000001 109.692 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -67.41 -46.79 72.17 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.713 -0.676 . . . . 70.040000000000006 109.264 174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 53.7 m -51.99 -49.54 63.08 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 114.26 -1.336 . . . . 75.120000000000005 111.948 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.3 t -78.08 -40.2 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.505 0.722 . . . . 75.219999999999999 111.861 -174.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -72.94 -36.63 67.23 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 118.158 0.436 . . . . 74.329999999999998 110.99 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -71.46 -40.54 70.24 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.457 -0.572 . . . . 63.539999999999999 109.457 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.545 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.2 t80 -51.53 -62.15 1.8 Allowed 'General case' 0 C--N 1.365 1.275 0 O-C-N 124.868 1.355 . . . . 75.349999999999994 109.52 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -57.25 -36.99 71.63 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 124.609 1.193 . . . . 74.099999999999994 111.696 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -57.66 -47.35 89.1 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.907 0.754 . . . . 75.430000000000007 113.597 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 11.1 p90 -86.32 -19.22 30.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 112.668 0.618 . . . . 75.209999999999994 112.668 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 138' ' ' LEU . 52.7 t -59.1 -56.91 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.317 -0.623 . . . . 65.150000000000006 109.317 171.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -70.95 -22.34 62.23 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.391 -0.822 . . . . 71.150000000000006 111.352 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -73.24 -25.55 60.76 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.326 0.651 . . . . 73.430000000000007 110.767 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.06 38.67 34.6 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.964 -0.562 . . . . 74.310000000000002 112.669 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.433 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 24.2 t60 -145.72 127.12 14.96 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.718 -0.845 . . . . 74.510000000000005 108.718 176.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -77.6 156.26 30.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.3 0.64 . . . . 72.120000000000005 111.45 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -147.03 0.87 0.74 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.282 0.633 . . . . 70.319999999999993 110.849 177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.474 ' HA ' ' NH2' ' A' ' 31' ' ' ARG . 6.0 m-20 -69.4 -81.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.452 0.701 . . . . 73.549999999999997 110.988 -174.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -145.9 12.78 1.28 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.815 1.246 . . . . 55.119999999999997 109.134 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.29 104.01 2.24 Favored Glycine 0 C--N 1.352 1.445 0 O-C-N 123.532 0.52 . . . . 61.399999999999999 112.205 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -162.17 -179.54 7.14 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.283 1.033 . . . . 74.209999999999994 109.758 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -94.29 146.82 32.25 Favored Pre-proline 0 CA--C 1.564 1.509 0 CA-C-O 119.051 -0.5 . . . . 64.230000000000004 110.112 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -53.46 -23.26 23.99 Favored 'Trans proline' 0 C--N 1.392 2.857 0 C-N-CA 123.896 3.064 . . . . 52.450000000000003 115.492 177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -64.49 -29.13 70.18 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 118.158 0.435 . . . . 75.420000000000002 111.21 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -84.64 -23.75 29.37 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.076 0.95 . . . . 64.310000000000002 111.735 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HB3' HG22 ' A' ' 123' ' ' VAL . 80.0 mt -67.73 110.87 3.95 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.679 -0.691 . . . . 41.329999999999998 109.239 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -126.96 129.43 48.13 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.564 0.746 . . . . 61.240000000000002 109.689 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.437 ' HG3' HG11 ' A' ' 123' ' ' VAL . 93.1 mt-30 -78.48 157.49 28.89 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.667 0.746 . . . . 62.009999999999998 110.535 174.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 42.2 m-85 -86.44 152.7 22.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.998 -1.001 . . . . 62.329999999999998 108.552 165.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -90.57 163.17 14.68 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.626 0.251 . . . . 73.530000000000001 110.479 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.19 67.13 2.92 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.971 -0.559 . . . . 62.219999999999999 112.69 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.78 -78.44 0.58 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.838 0.455 . . . . 73.340000000000003 110.336 172.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 92.7 m -151.86 128.74 10.96 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.585 0.754 . . . . 62.340000000000003 110.32 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -88.48 122.75 32.3 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.937 0.495 . . . . 73.450000000000003 110.742 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.4 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 21.0 m-85 -101.23 146.19 27.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.214 1.006 . . . . 72.219999999999999 109.58 171.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 107' ' ' ILE . 48.1 mt -134.8 122.06 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.743 -0.836 . . . . 62.109999999999999 108.743 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 23.8 mm -103.39 127.77 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.284 0.634 . . . . 74.430000000000007 109.879 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -71.97 109.26 5.67 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.891 0.877 . . . . 75.450000000000003 109.608 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -116.3 102.64 9.73 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.038 -1.097 . . . . 73.230000000000004 108.038 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -121.22 130.89 53.91 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.54 0.736 . . . . 73.450000000000003 110.384 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 72.8 mt -73.5 179.65 3.95 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.402 -0.817 . . . . 72.439999999999998 110.542 173.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 52.53 13.34 0.3 Allowed 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 126.723 2.009 . . . . 72.310000000000002 113.915 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -144.81 46.13 1.36 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.141 1.377 . . . . 71.319999999999993 108.136 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -63.37 123.67 19.32 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.427 -0.806 . . . . 73.340000000000003 111.177 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 59.85 32.93 21.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.037 1.335 . . . . 72.510000000000005 112.315 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -65.21 103.0 0.71 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.641 0.734 . . . . 64.109999999999999 110.781 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -115.19 48.1 1.21 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-O 121.784 0.802 . . . . 72.409999999999997 110.14 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-N 115.317 -0.856 . . . . 52.219999999999999 110.437 178.045 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.697 -0.483 . . . . 74.030000000000001 109.697 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.97 145.15 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 108.621 -0.881 . . . . 75.25 108.621 175.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.67 152.49 44.76 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.734 0.814 . . . . 71.319999999999993 109.366 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.49 -155.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.101 2.534 . . . . 74.439999999999998 113.002 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.81 65.59 2.52 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 111.775 -0.53 . . . . 63.439999999999998 111.775 174.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 m -80.64 -8.13 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.798 1.239 . . . . 74.129999999999995 110.728 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HA ' ' HE1' ' A' ' 75' ' ' PHE . . . -69.38 83.93 0.39 Allowed 'General case' 0 C--N 1.354 0.784 0 C-N-CA 123.575 0.75 . . . . 73.25 109.517 171.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -92.67 43.17 1.12 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.073 0.94 . . . . 65.319999999999993 109.792 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.7 tp -71.43 86.13 0.84 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.131 -1.063 . . . . 64.230000000000004 108.131 171.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 12' ' ' TYR . 11.4 m -89.51 157.48 18.07 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.253 -0.885 . . . . 61.420000000000002 109.546 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.598 ' HB ' ' HE2' ' A' ' 15' ' ' LYS . 37.6 p -55.65 -23.13 26.33 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.877 1.436 . . . . 70.430000000000007 114.877 -170.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CD2' ' HB ' ' A' ' 10' ' ' THR . 42.5 p90 -53.61 -40.01 65.38 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.276 0.631 . . . . 73.230000000000004 111.924 -178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.36 -32.48 74.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.001 0.92 . . . . 31.539999999999999 111.258 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.7 m -78.18 -38.36 43.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.622 -1.172 . . . . 73.340000000000003 111.076 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.598 ' HE2' ' HB ' ' A' ' 11' ' ' THR . 70.9 mmtt -70.46 -40.3 73.77 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.454 0.645 . . . . 75.319999999999993 109.869 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -73.71 -24.54 59.94 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 114.457 -1.247 . . . . 64.430000000000007 112.018 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -65.68 -49.64 67.84 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 109.772 172.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' ALA . 1.7 p -71.55 -15.9 62.3 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.289 -0.869 . . . . 70.109999999999999 112.457 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -62.3 -40.28 95.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.231 0.612 . . . . 75.340000000000003 110.881 174.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -85.18 2.19 44.78 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.04 0.536 . . . . 74.5 112.429 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.03 57.59 1.38 Allowed Glycine 0 C--N 1.348 1.243 0 O-C-N 123.043 0.214 . . . . 74.150000000000006 112.651 175.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 18' ' ' THR . . . -100.1 171.2 7.96 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.83 0.852 . . . . 72.420000000000002 109.927 173.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.736 HG22 HH12 ' A' ' 133' ' ' ARG . 31.3 pt -120.33 142.22 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 122.799 0.44 . . . . 71.219999999999999 110.975 -177.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -98.88 118.94 36.78 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.422 -1.325 . . . . 74.540000000000006 107.422 166.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 m -112.0 169.65 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.252 0.621 . . . . 73.010000000000005 109.689 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -95.62 -172.13 2.54 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.105 0.562 . . . . 73.150000000000006 110.016 175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.6 t -65.88 -14.62 61.83 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.684 0.794 . . . . 53.25 111.952 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -85.74 -39.05 17.59 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.925 0.393 . . . . 64.109999999999999 110.104 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.56 64.43 0.73 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.724 -0.95 . . . . 64.310000000000002 110.724 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -148.43 144.09 27.21 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.908 0.883 . . . . 75.310000000000002 109.011 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 23' ' ' ILE . 1.4 mpp_? -64.8 103.34 0.69 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.728 0.811 . . . . 64.239999999999995 111.225 -171.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.5 pt -78.56 -22.99 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.03 0.532 . . . . 75.329999999999998 111.021 174.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -162.44 145.08 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 123.797 0.839 . . . . 54.210000000000001 109.358 173.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -78.29 -102.87 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.566 0 C-N-CA 123.952 0.901 . . . . 74.120000000000005 111.037 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -73.4 158.8 34.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.827 0.851 . . . . 65.239999999999995 110.699 171.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.8 p -84.42 66.88 9.66 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 114.94 -1.027 . . . . 64.209999999999994 108.874 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -61.9 -39.89 93.55 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.281 -0.872 . . . . 72.409999999999997 110.641 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG13 ' H ' ' A' ' 41' ' ' THR . 10.9 p -155.16 149.25 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 108.882 170.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -59.37 -28.22 66.67 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.152 0.581 . . . . 75.409999999999997 111.237 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.554 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.6 m -62.67 -49.86 73.47 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.198 0.936 . . . . 73.450000000000003 111.31 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.582 ' H ' HG13 ' A' ' 38' ' ' VAL . 14.3 t -64.79 -31.96 73.42 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.634 0.374 . . . . 55.109999999999999 111.402 -177.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -68.69 -49.62 57.5 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.418 0.687 . . . . 73.129999999999995 110.504 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -63.62 -45.33 90.77 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.482 0.713 . . . . 65.209999999999994 110.594 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -60.33 -42.55 95.85 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.681 0.792 . . . . 71.239999999999995 110.305 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.86 -36.62 79.64 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.134 0.896 . . . . 71.409999999999997 111.999 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 74.1 mt -67.58 -45.28 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 110.457 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 76.4 mt -69.89 -27.95 65.23 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.471 -0.786 . . . . 72.319999999999993 111.005 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -77.75 -36.54 50.6 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.824 1.65 . . . . 75.140000000000001 110.39 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -68.95 155.59 40.03 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.705 -1.134 . . . . 75.049999999999997 110.434 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.36 -58.81 6.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.171 0.988 . . . . 60.25 110.757 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.38 173.38 12.66 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.57 0.748 . . . . 54.219999999999999 110.533 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 28.4 mmtm -128.0 19.04 6.57 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.38 1.072 . . . . 74.420000000000002 112.349 -170.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.94 130.67 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 121.594 0.712 . . . . 72.340000000000003 110.054 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.35 169.32 8.52 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.795 -1.093 . . . . 74.439999999999998 109.663 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -146.22 111.28 5.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.367 1.067 . . . . 73.140000000000001 108.942 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 17' ' ' ALA . 36.6 tp -81.6 103.49 11.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 54.340000000000003 109.497 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.48 HG22 HG12 ' A' ' 148' ' ' ILE . 52.5 t -98.13 127.85 50.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-N 115.41 -0.813 . . . . 72.140000000000001 109.748 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.452 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -140.71 175.85 9.28 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.418 0.687 . . . . 70.230000000000004 109.838 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 6.8 p-10 -88.35 165.43 14.97 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.508 1.123 . . . . 64.519999999999996 109.378 170.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.481 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.9 tt0 -68.53 -28.65 67.17 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 118.834 -0.603 . . . . 72.230000000000004 112.537 -175.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.5 mmt-85 -60.78 -46.32 90.95 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.916 -0.772 . . . . 74.129999999999995 108.916 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -65.78 -36.27 83.05 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.061 -1.427 . . . . 65.030000000000001 111.292 177.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -64.84 -35.68 81.9 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 118.956 -0.545 . . . . 75.310000000000002 111.744 177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.3 mmtt -54.91 -28.45 50.91 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.193 0.452 . . . . 53.109999999999999 111.633 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -80.8 -45.73 16.49 Favored 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.838 0.711 . . . . 71.420000000000002 111.031 175.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 HG13 ' HB1' ' A' ' 13' ' ' ALA . 78.2 t -60.17 -55.07 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.409 0.684 . . . . 62.100000000000001 110.789 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -51.02 -44.79 61.06 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.273 1.429 . . . . 75.140000000000001 111.876 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.82 -50.13 74.67 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 114.958 -1.019 . . . . 62.039999999999999 110.427 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.5 mt -65.08 -31.24 72.36 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 124.268 1.027 . . . . 75.349999999999994 111.982 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.461 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 88.9 mt -58.62 -56.87 16.61 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.869 0.731 . . . . 74.209999999999994 109.98 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -67.16 -32.54 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.171 -0.922 . . . . 73.150000000000006 110.824 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.23 -44.32 96.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.075 0.95 . . . . 74.219999999999999 110.214 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -83.78 -67.81 0.76 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 118.681 -0.676 . . . . 74.540000000000006 110.939 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 179.39 84.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 124.822 1.249 . . . . 65.409999999999997 108.868 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HE1' ' HA ' ' A' ' 7' ' ' ALA . 5.2 t80 -171.82 91.77 0.13 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.254 -1.017 . . . . 74.140000000000001 108.254 175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.2 t -68.43 151.74 97.03 Favored Pre-proline 0 CA--C 1.564 1.481 0 C-N-CA 124.333 1.053 . . . . 75.129999999999995 110.829 -168.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.9 -36.98 85.18 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 123.25 2.633 . . . . 72.439999999999998 113.87 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.81 -33.35 72.87 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.968 0.793 . . . . 75.329999999999998 111.648 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 24.7 mm-40 -69.48 -53.34 19.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.633 0.373 . . . . 75.549999999999997 110.993 174.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 50.9 mt -52.84 -47.54 51.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.226 1.01 . . . . 45.43 111.691 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -73.23 -19.51 61.06 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.749 -0.66 . . . . 65.430000000000007 112.439 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.3 m -67.82 -30.23 69.59 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 54.109999999999999 111.795 175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -77.68 -12.35 59.96 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.616 0.367 . . . . 72.109999999999999 111.978 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -80.2 -21.74 42.63 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.836 0.454 . . . . 75.25 110.309 170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -87.23 90.45 8.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.899 0.88 . . . . 65.310000000000002 109.949 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -85.37 100.08 11.6 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.745 0.784 . . . . 64.329999999999998 111.547 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -123.17 -38.08 2.63 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.806 -0.634 . . . . 72.540000000000006 110.228 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.25 -76.78 0.5 Allowed Glycine 0 C--N 1.351 1.401 0 O-C-N 123.855 0.722 . . . . 72.530000000000001 111.999 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -114.64 -82.95 0.61 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.943 -0.762 . . . . 75.25 108.943 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 22.3 mtm180 -143.59 168.02 13.99 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.554 1.141 . . . . 75.510000000000005 109.215 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 94' ' ' VAL . 42.8 Cg_endo -74.33 114.93 4.15 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 120.87 1.046 . . . . 74.400000000000006 110.479 174.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.73 -34.31 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.666 -0.697 . . . . 64.109999999999999 109.91 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -112.69 111.95 23.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.885 -1.154 . . . . 71.319999999999993 107.885 171.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.537 HG21 ' HB2' ' A' ' 105' ' ' ALA . 7.0 t -111.43 155.65 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 108.715 -0.846 . . . . 62.5 108.715 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.02 177.39 10.84 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.52 0.728 . . . . 73.25 111.476 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.12 -153.77 17.13 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 110.022 -1.231 . . . . 73.040000000000006 110.022 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.2 t -72.12 167.58 19.97 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 117.562 0.681 . . . . 63.130000000000003 109.554 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 56.4 tp -54.44 -55.2 31.3 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.609 0.764 . . . . 72.530000000000001 111.243 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.527 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.4 mt-10 -68.68 -36.3 78.33 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.132 -0.94 . . . . 72.340000000000003 111.492 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.0 m -61.23 -49.87 75.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.049 0.94 . . . . 51.530000000000001 111.07 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.44 -27.96 68.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.908 -1.042 . . . . 71.409999999999997 111.059 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -70.55 -38.59 74.18 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.559 0.744 . . . . 63.420000000000002 111.242 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 44.2 mt-10 -68.42 -44.35 75.2 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.471 0.708 . . . . 71.329999999999998 111.085 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -64.92 -39.45 93.53 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.314 -0.857 . . . . 75.450000000000003 111.669 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -79.94 -20.14 46.33 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.823 0.449 . . . . 71.099999999999994 111.011 175.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 76.09 26.57 63.96 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.175 -0.466 . . . . 61.520000000000003 113.516 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.6 159.59 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.105 0.962 . . . . 64.340000000000003 108.969 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.1 t -67.3 98.92 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.037 0 N-CA-C 109.283 -0.636 . . . . 71.019999999999996 109.283 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 113' ' ' VAL . 61.7 t -55.28 -42.92 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 114.616 -1.174 . . . . 64.549999999999997 110.722 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.81 -42.93 98.64 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.538 -0.756 . . . . 73.239999999999995 111.707 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -65.92 -49.95 66.16 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.312 0.383 . . . . 73.150000000000006 111.05 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.4 pp -72.51 -31.97 65.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.549 0.944 . . . . 73.140000000000001 113.549 -172.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 109' ' ' VAL . 54.8 t -58.62 -45.57 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 N-CA-C 109.259 -0.645 . . . . 73.120000000000005 109.259 175.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -62.05 -54.46 41.16 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.329 1.018 . . . . 73.530000000000001 109.598 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER -63.44 -28.09 69.73 Favored 'General case' 0 CA--C 1.559 1.289 0 N-CA-C 112.22 0.452 . . . . 63.140000000000001 112.22 -170.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.7 t -82.53 -43.45 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.548 0.739 . . . . 74.140000000000001 111.303 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -74.28 -27.84 60.92 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 122.12 -0.363 . . . . 75.120000000000005 110.712 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.75 -42.91 63.54 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 108.719 -0.845 . . . . 72.25 108.719 174.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 123' ' ' VAL . 29.8 t80 -49.54 -60.33 2.96 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 125.048 1.467 . . . . 75.150000000000006 109.694 174.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.49 -34.48 70.96 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.301 1.001 . . . . 73.120000000000005 112.266 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -57.86 -48.18 83.88 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.948 0.78 . . . . 65.439999999999998 113.383 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 12.4 p90 -87.12 -18.47 30.39 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 112.917 0.71 . . . . 73.019999999999996 112.917 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 119' ' ' TYR . 24.2 t -59.31 -52.89 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 123.226 0.611 . . . . 74.299999999999997 110.15 174.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.509 HE21 ' HA2' ' A' ' 121' ' ' GLY . 29.2 pt20 -67.26 -25.6 66.15 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.085 -0.961 . . . . 63.229999999999997 110.903 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 26.0 t70 -77.61 -25.1 49.57 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.337 1.055 . . . . 60.409999999999997 111.063 177.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 95.03 -28.58 11.23 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.936 -0.369 . . . . 73.519999999999996 113.73 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 62.2 t60 -85.34 122.94 30.23 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.27 0.628 . . . . 52.030000000000001 109.883 -177.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -75.12 175.22 8.44 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.037 0.446 . . . . 71.239999999999995 111.324 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 122' ' ' TYR . 52.1 m-70 -152.95 21.28 0.58 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.312 1.045 . . . . 75.430000000000007 108.505 176.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -149.67 97.53 2.63 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.773 0.797 . . . . 75.319999999999993 109.963 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 68.53 15.64 9.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.805 1.242 . . . . 73.040000000000006 113.794 166.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.05 40.68 29.25 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 111.46 -0.656 . . . . 23.100000000000001 111.46 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.736 HH12 HG22 ' A' ' 23' ' ' ILE . 39.6 ttt180 -67.36 133.43 49.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.315 1.046 . . . . 75.349999999999994 110.233 -177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.72 141.16 87.15 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-O 118.974 -0.536 . . . . 74.400000000000006 109.715 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.404 ' HA ' HD12 ' A' ' 138' ' ' LEU . 12.2 Cg_endo -56.97 -12.73 10.05 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 123.296 2.664 . . . . 74.439999999999998 113.83 172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -79.15 -33.65 43.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.715 0.406 . . . . 71.340000000000003 110.872 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -93.02 -14.65 27.11 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.993 0.917 . . . . 51.409999999999997 112.046 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.573 HD23 ' HD3' ' A' ' 133' ' ' ARG . 55.5 mt -65.31 100.46 0.47 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.461 -0.94 . . . . 70.340000000000003 108.461 169.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -124.36 115.95 21.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.488 0.715 . . . . 74.329999999999998 110.179 -173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.89 133.21 45.29 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.205 -0.665 . . . . 73.400000000000006 109.205 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.488 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 27.4 m-85 -79.62 132.33 36.22 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.337 -0.986 . . . . 65.019999999999996 108.337 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.84 121.16 15.42 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.555 -0.906 . . . . 75.209999999999994 108.555 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.58 61.45 4.47 Favored Glycine 0 C--N 1.352 1.439 0 O-C-N 124.175 0.922 . . . . 71.310000000000002 112.945 -168.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -122.31 -62.34 1.39 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.997 -1.112 . . . . 72.420000000000002 107.997 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 27.9 m -134.49 108.55 8.18 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.281 -0.872 . . . . 72.230000000000004 110.504 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -92.04 150.18 21.12 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.357 1.063 . . . . 72.230000000000004 110.285 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.452 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 28.6 m-85 -121.57 139.11 53.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.468 1.107 . . . . 71.420000000000002 108.783 171.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.48 HG12 HG22 ' A' ' 57' ' ' VAL . 47.9 mt -124.68 113.14 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.911 -0.774 . . . . 74.340000000000003 108.911 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 27.3 mm -97.92 114.26 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.562 -0.903 . . . . 74.239999999999995 108.562 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.01 106.32 1.02 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.85 0.719 . . . . 73.409999999999997 109.693 175.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -99.86 99.84 10.68 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.024 -1.102 . . . . 71.319999999999993 108.024 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 152' ' ' ARG . 27.4 ttp-105 -108.71 152.71 24.47 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.499 -0.926 . . . . 72.430000000000007 108.499 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.28 159.64 5.88 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.603 0.761 . . . . 51.210000000000001 111.604 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -73.64 172.46 11.36 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.736 0.815 . . . . 75.319999999999993 111.742 -170.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.0 m170 65.98 23.48 11.19 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.954 1.302 . . . . 74.409999999999997 111.32 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -124.76 149.24 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.494 1.118 . . . . 71.200000000000003 108.996 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 85.2 t60 65.65 16.22 10.4 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.709 1.204 . . . . 74.209999999999994 110.638 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -74.94 132.55 41.51 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 108.829 -0.804 . . . . 71.310000000000002 108.829 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -148.53 148.32 30.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.895 0.478 . . . . 73.530000000000001 110.159 -174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 67.2 m80 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 123.96 0.904 . . . . 74.200000000000003 108.609 173.597 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.617 -0.512 . . . . 54.240000000000002 109.617 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.55 95.41 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 109.062 -0.718 . . . . 71.319999999999993 109.062 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -137.56 149.21 64.37 Favored Pre-proline 0 N--CA 1.472 0.639 0 C-N-CA 124.804 1.241 . . . . 74.109999999999999 109.182 -173.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.32 -174.66 1.06 Allowed 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.272 1.981 . . . . 74.540000000000006 111.955 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.87 52.68 4.25 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.726 -0.215 . . . . 63.539999999999999 112.733 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -106.04 132.02 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.896 1.278 . . . . 64.030000000000001 109.351 -177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.36 94.15 0.52 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.164 0.586 . . . . 73.540000000000006 110.069 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -129.8 138.72 51.18 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.212 0.605 . . . . 64.230000000000004 110.975 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.5 tp -111.69 96.61 6.18 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.049 1.34 . . . . 74.319999999999993 107.465 172.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.1 m -105.2 164.11 12.08 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.47 -0.567 . . . . 64.150000000000006 109.47 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 54.9 p -54.34 -19.17 4.97 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.475 1.51 . . . . 64.219999999999999 114.946 -172.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -52.85 -38.75 61.87 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 118.713 0.688 . . . . 71.109999999999999 111.56 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.0 -44.37 85.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.538 0.735 . . . . 74.329999999999998 110.672 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.409 ' HB3' ' OH ' ' A' ' 24' ' ' TYR . 31.6 m -69.07 -33.18 73.14 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.497 -1.228 . . . . 74.329999999999998 111.629 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -68.79 -45.63 70.79 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.278 1.031 . . . . 74.019999999999996 111.553 -176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 123.306 0.378 . . . . 75.099999999999994 111.259 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.26 -49.42 27.8 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.057 -0.52 . . . . 43.399999999999999 110.257 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.8 p -68.53 -28.79 67.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.497 0.719 . . . . 73.219999999999999 111.587 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -66.39 -37.04 84.35 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.724 0.81 . . . . 64.140000000000001 109.755 175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 27.9 tpp -64.9 -39.35 93.39 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.586 -0.734 . . . . 43.509999999999998 109.699 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.38 12.37 0.82 Allowed Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.18 -0.918 . . . . 74.040000000000006 113.746 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.812 0.445 . . . . 71.519999999999996 111.478 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.1 pt -106.83 152.94 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 110.843 -174.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 49.5 m-85 -100.12 128.1 46.25 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 109.519 -0.548 . . . . 74.439999999999998 109.519 169.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 35.8 m -115.63 -176.47 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.398 1.079 . . . . 54.130000000000003 108.376 167.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 54' ' ' ALA . 7.8 p30 -123.7 -166.37 1.47 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.932 -0.48 . . . . 61.030000000000001 109.747 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 51' ' ' ASP . 33.4 t -62.0 -20.81 64.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 113.647 0.98 . . . . 63.219999999999999 113.647 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 71.3 mmtt -87.94 -33.71 18.36 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.275 -0.639 . . . . 75.120000000000005 109.275 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 100.01 26.13 8.59 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 112.303 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -78.51 136.72 37.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.969 -0.752 . . . . 73.219999999999999 108.969 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -56.34 102.89 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 O-C-N 124.46 1.1 . . . . 75.349999999999994 110.419 170.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 pt -96.61 -166.53 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 107.726 -1.213 . . . . 62.340000000000003 107.726 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' TYR . 14.0 p -50.65 128.87 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 C-N-CA 123.146 0.578 . . . . 61.310000000000002 110.845 -178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.02 -48.39 73.45 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.393 0.677 . . . . 75.310000000000002 111.154 -172.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.47 161.36 23.7 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.319 0.58 . . . . 74.420000000000002 111.151 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.5 p -81.17 67.92 7.27 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.312 -0.996 . . . . 71.340000000000003 108.312 170.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -52.87 -58.37 7.15 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.928 1.291 . . . . 61.439999999999998 110.413 -174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' H ' ' A' ' 41' ' ' THR . 7.2 p -130.53 151.61 36.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.151 0 N-CA-C 107.24 -1.392 . . . . 74.430000000000007 107.24 168.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -51.51 -35.3 39.88 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.309 0.644 . . . . 74.040000000000006 110.917 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.1 m -62.7 -54.69 35.43 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.161 0.984 . . . . 72.510000000000005 111.598 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.521 ' H ' HG13 ' A' ' 38' ' ' VAL . 35.8 m -62.41 -43.46 98.77 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.136 0.575 . . . . 75.019999999999996 111.227 -177.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.56 -51.55 55.27 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.326 -0.852 . . . . 75.439999999999998 111.067 -176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 62.3 ttt180 -58.6 -49.05 78.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.287 1.035 . . . . 73.510000000000005 110.957 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -70.01 -24.87 63.36 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.087 0.555 . . . . 73.409999999999997 111.531 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -65.62 -44.49 86.35 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.91 -0.404 . . . . 73.109999999999999 109.91 171.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.35 -38.54 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.827 0.851 . . . . 65.319999999999993 110.509 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.548 HD23 ' HD2' ' A' ' 52' ' ' LYS . 72.0 mt -72.02 -22.87 61.34 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.344 0.657 . . . . 72.099999999999994 111.397 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -82.93 -7.0 59.71 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.75 0.82 . . . . 65.200000000000003 110.351 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 45' ' ' ALA . 27.3 mm-40 -101.36 166.66 10.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.923 0.889 . . . . 70.219999999999999 111.105 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.09 -70.54 0.19 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.496 1.118 . . . . 71.109999999999999 111.647 -175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 27' ' ' SER . 7.0 m-20 -86.52 147.87 25.77 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.71 -0.478 . . . . 63.32 109.71 176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.548 ' HD2' HD23 ' A' ' 47' ' ' LEU . 45.1 mmtm -95.86 64.78 2.48 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 122.044 0.926 . . . . 75.430000000000007 111.198 -173.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 p -158.99 135.73 2.13 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 113.919 -1.491 . . . . 61.509999999999998 109.511 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . . . -106.39 169.47 8.5 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.201 1.0 . . . . 64.430000000000007 109.819 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.4 m-85 -146.79 117.15 7.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.106 0.962 . . . . 74.040000000000006 109.494 -175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.7 tp -85.82 113.24 21.82 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.389 0.676 . . . . 72.200000000000003 109.65 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 54.4 t -105.35 124.24 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.351 0.661 . . . . 64.540000000000006 109.498 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -140.9 171.74 13.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 72.340000000000003 110.169 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.1 p30 -84.05 169.54 14.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.305 1.042 . . . . 64.329999999999998 109.829 171.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.512 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 41.0 tt0 -67.85 -28.67 67.74 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.433 0.531 . . . . 74.019999999999996 112.433 -177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -66.52 -33.35 75.5 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 120.775 0.321 . . . . 70.430000000000007 110.901 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 50.2 m -72.13 -34.88 68.89 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.529 -0.759 . . . . 70.5 110.316 173.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -67.82 -30.7 70.18 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.924 -0.58 . . . . 75.219999999999999 111.596 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 71.8 mmtt -56.41 -28.89 60.68 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.3 0.571 . . . . 73.120000000000005 110.935 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 26.8 mmmt -81.2 -55.02 5.02 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.537 -1.21 . . . . 63.240000000000002 109.459 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.496 HG13 ' HB1' ' A' ' 13' ' ' ALA . 90.9 t -57.69 -53.98 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.116 0.967 . . . . 61.439999999999998 111.636 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -52.9 -40.28 63.42 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 125.042 1.337 . . . . 72.319999999999993 111.521 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -63.13 -51.77 65.19 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.435 -0.802 . . . . 75.420000000000002 110.299 178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 75.7 mt -60.75 -34.18 74.05 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.868 0.867 . . . . 75.510000000000005 111.591 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 90.2 mt -60.7 -57.31 13.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.408 0.683 . . . . 73.329999999999998 110.32 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.09 -28.02 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.379 -0.828 . . . . 72.230000000000004 110.696 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.36 -41.0 63.94 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.981 0.912 . . . . 44.119999999999997 110.513 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -82.15 -66.39 0.89 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 119.505 -0.283 . . . . 74.319999999999993 110.508 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 175.46 68.8 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.412 1.085 . . . . 74.510000000000005 110.041 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 10.9 t80 -164.35 80.57 0.39 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.978 -1.119 . . . . 74.329999999999998 107.978 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.652 HG22 ' HG2' ' A' ' 79' ' ' GLU . 1.4 t -63.37 155.45 74.64 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 125.058 1.343 . . . . 54.130000000000003 111.546 -170.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 11.7 Cg_endo -52.76 -29.26 41.61 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 123.797 2.998 . . . . 52.210000000000001 113.586 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.94 -43.12 99.5 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.672 0.789 . . . . 63.0 110.759 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG2' HG22 ' A' ' 76' ' ' THR . 13.9 mm-40 -68.88 -49.38 58.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.75 -0.659 . . . . 73.409999999999997 110.241 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.414 HG22 ' HE1' ' A' ' 84' ' ' PHE . 27.2 mt -56.8 -50.46 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 124.373 1.045 . . . . 72.209999999999994 111.354 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -67.59 -24.24 65.47 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.494 0.718 . . . . 74.040000000000006 111.767 -175.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 27.2 t -65.62 -36.18 82.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.191 0.597 . . . . 74.230000000000004 110.885 177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -83.4 -4.0 58.07 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.404 0.52 . . . . 74.420000000000002 112.404 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.432 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 61.3 m-85 -78.81 -36.88 42.03 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.851 -0.426 . . . . 73.209999999999994 109.851 166.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.19 101.86 11.5 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.626 -0.715 . . . . 73.549999999999997 109.677 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -66.16 86.95 0.1 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.551 0.74 . . . . 52.439999999999998 109.13 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -99.52 81.81 2.56 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.935 0.894 . . . . 73.319999999999993 108.899 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 63.61 13.43 50.97 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.538 -0.755 . . . . 24.32 114.067 177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -160.03 143.01 13.73 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.533 0.733 . . . . 73.299999999999997 109.238 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 21.3 mmm180 -41.78 133.55 2.3 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.977 1.711 . . . . 73.209999999999994 114.196 -173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 90' ' ' ARG . 21.7 Cg_endo -82.64 105.55 1.41 Allowed 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.549 2.166 . . . . 73.25 110.052 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.1 t -64.78 -35.88 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 115.893 -0.594 . . . . 70.439999999999998 110.373 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.43 ' HD1' HD12 ' A' ' 149' ' ' ILE . 25.2 m-85 -115.91 110.04 18.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.914 -0.773 . . . . 74.049999999999997 108.914 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 38.8 t -111.76 153.71 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 108.947 -0.76 . . . . 71.340000000000003 108.947 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -149.42 173.48 13.51 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 121.446 0.641 . . . . 71.239999999999995 111.344 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.08 -149.89 20.42 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 109.416 -1.474 . . . . 72.129999999999995 109.416 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.8 t -74.26 175.5 7.54 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.764 0.782 . . . . 64.120000000000005 109.554 168.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 116' ' ' VAL . 58.7 tp -54.1 -49.44 69.1 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.439 0.638 . . . . 64.439999999999998 110.95 176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 30.1 mt-10 -80.23 -37.75 32.43 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.684 -1.143 . . . . 62.140000000000001 111.436 -176.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.9 m -63.12 -48.76 77.14 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.301 0.641 . . . . 71.209999999999994 111.39 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.52 -28.84 70.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.284 -0.871 . . . . 65.400000000000006 110.939 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 112' ' ' LEU . . . -71.55 -41.49 69.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.331 0.652 . . . . 75.430000000000007 111.16 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 46.1 mt-10 -66.18 -40.87 90.79 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.231 0.612 . . . . 73.319999999999993 110.618 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.16 -34.9 71.4 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.459 -0.791 . . . . 63.329999999999998 111.168 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.47 -7.81 59.48 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.806 0.442 . . . . 51.119999999999997 111.497 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.76 31.77 76.58 Favored Glycine 0 C--N 1.345 1.066 0 O-C-N 123.14 0.275 . . . . 73.420000000000002 113.054 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 148' ' ' ILE . 10.5 mt -92.59 156.34 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.353 -0.98 . . . . 71.200000000000003 108.353 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 60.4 t -69.89 97.98 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.028 0 CA-C-O 121.899 0.857 . . . . 60.420000000000002 108.932 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 113' ' ' VAL . 38.2 t -56.65 -42.68 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 113.84 -1.527 . . . . 74.030000000000001 110.741 -176.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -54.78 -40.76 69.76 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.496 -1.229 . . . . 44.340000000000003 111.898 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -77.72 -48.05 17.63 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.81 0.444 . . . . 53.310000000000002 111.636 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.524 HD21 ' HB1' ' A' ' 102' ' ' ALA . 4.6 pp -68.3 -27.81 66.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.067 0.766 . . . . 72.349999999999994 113.067 -173.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 109' ' ' VAL . 67.0 t -66.03 -39.18 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.784 -0.45 . . . . 70.349999999999994 109.784 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -63.89 -53.59 48.15 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 108.643 -0.873 . . . . 74.209999999999994 108.643 172.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 18.5 m -50.74 -42.03 57.09 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.053 1.341 . . . . 73.25 113.053 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 98' ' ' LEU . 70.8 t -78.8 -39.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 122.925 0.49 . . . . 73.099999999999994 111.018 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -77.64 -23.86 49.64 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 118.633 0.651 . . . . 71.0 111.783 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -77.02 -36.56 56.13 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.78 0.832 . . . . 70.439999999999998 108.968 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 123' ' ' VAL . 43.1 t80 -58.12 -59.06 5.87 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 114.809 -1.087 . . . . 72.109999999999999 109.198 169.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.31 -22.83 66.36 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.08 0.952 . . . . 75.340000000000003 111.588 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.536 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -69.97 -53.5 14.8 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 124.087 0.867 . . . . 53.240000000000002 111.088 174.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -74.0 -19.4 60.66 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 111.908 0.336 . . . . 73.310000000000002 111.908 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 138' ' ' LEU . 41.7 t -64.21 -53.11 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.196 0.598 . . . . 74.450000000000003 110.605 175.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.536 HE21 ' HA2' ' A' ' 121' ' ' GLY . 24.4 pt20 -69.72 -20.48 63.53 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 122.68 0.392 . . . . 74.420000000000002 111.725 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -73.6 -24.07 60.01 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 75.430000000000007 110.802 170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.02 62.21 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.734 0.646 . . . . 62.409999999999997 112.104 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -152.43 108.75 3.41 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.109 -0.7 . . . . 73.430000000000007 109.109 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.08 154.58 41.36 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.385 0.674 . . . . 74.019999999999996 111.072 177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -124.13 -60.5 1.42 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.416 0.686 . . . . 74.430000000000007 109.252 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.08 82.21 5.07 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.105 -0.952 . . . . 75.120000000000005 110.89 -169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 35.16 45.69 0.2 Allowed 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.87 1.668 . . . . 74.129999999999995 112.901 171.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.58 -106.57 0.7 Allowed Glycine 0 C--N 1.348 1.224 0 CA-C-N 114.651 -1.159 . . . . 65.340000000000003 111.852 -173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.2 -177.77 2.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.397 1.079 . . . . 74.439999999999998 108.717 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.535 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 12.5 t70 -53.54 138.3 50.83 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.976 0.91 . . . . 70.150000000000006 111.331 -176.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.488 ' HA ' HD12 ' A' ' 138' ' ' LEU . 5.8 Cg_exo -36.15 -42.2 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.445 1 C-N-CA 125.335 4.023 . . . . 74.340000000000003 115.739 174.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -68.0 -30.58 69.87 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 111.915 0.339 . . . . 72.349999999999994 111.915 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.535 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 85.9 m-85 -87.31 -21.25 25.85 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.355 0.662 . . . . 63.149999999999999 110.899 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.567 ' HB3' HG22 ' A' ' 123' ' ' VAL . 96.9 mt -60.98 117.74 5.86 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 108.748 -0.834 . . . . 50.100000000000001 108.748 169.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -146.27 132.06 19.01 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.35 -0.611 . . . . 61.229999999999997 109.35 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.45 HE22 ' HB3' ' A' ' 124' ' ' GLN . 21.5 mp0 -65.73 142.62 57.94 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.471 0.482 . . . . 63.229999999999997 109.746 177.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.53 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 56.5 m-85 -67.42 90.7 0.24 Allowed 'General case' 0 C--O 1.244 0.779 0 O-C-N 123.651 0.595 . . . . 72.439999999999998 109.817 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.06 94.24 4.63 Favored 'General case' 0 C--N 1.349 0.578 0 N-CA-C 108.572 -0.899 . . . . 72.409999999999997 108.572 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.95 98.1 0.17 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.265 -1.534 . . . . 74.200000000000003 109.265 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -63.81 -21.41 66.41 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.886 0.875 . . . . 74.219999999999999 111.385 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 32.6 m -77.01 94.44 3.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.988 -0.745 . . . . 72.310000000000002 108.988 170.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -90.06 146.05 24.62 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.199 1.0 . . . . 72.400000000000006 110.574 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -117.74 137.69 52.53 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.561 1.144 . . . . 65.439999999999998 108.797 171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.407 HG23 ' HB3' ' A' ' 55' ' ' TYR . 56.8 mt -122.27 108.06 21.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 124.007 0.923 . . . . 75.230000000000004 109.031 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD12 ' HD1' ' A' ' 93' ' ' PHE . 12.4 mm -94.76 106.44 18.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.692 -0.855 . . . . 63.43 108.692 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -66.13 123.22 19.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.204 0.602 . . . . 52.439999999999998 111.311 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.75 101.8 10.39 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.26 1.024 . . . . 60.119999999999997 109.019 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -86.29 164.04 17.35 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.705 -0.48 . . . . 74.200000000000003 109.705 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 52' ' ' LYS . 89.2 mt -61.78 155.66 22.41 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.382 0.673 . . . . 64.230000000000004 111.82 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -52.33 -44.61 65.24 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.337 1.055 . . . . 73.209999999999994 112.03 -175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -128.79 137.44 51.53 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.302 -0.863 . . . . 75.430000000000007 108.878 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -146.79 133.47 19.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.231 0.613 . . . . 74.439999999999998 110.051 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -127.07 77.32 1.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.875 -1.158 . . . . 74.209999999999994 107.875 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -153.02 112.26 3.82 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.454 -1.314 . . . . 74.329999999999998 107.454 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -88.05 143.41 27.1 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.519 0.728 . . . . 74.219999999999999 110.671 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 t60 . . . . . 0 C--O 1.256 1.447 0 N-CA-C 107.404 -1.332 . . . . 74.400000000000006 107.404 172.446 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.5 mtp . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.874 -0.417 . . . . 42.530000000000001 109.874 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 44.6 t 58.15 86.2 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 124.501 1.125 . . . . 75.510000000000005 109.207 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.8 mp0 76.52 149.06 0.12 Allowed Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 125.741 1.616 . . . . 74.209999999999994 110.736 -171.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.65 42.98 0.86 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 123.72 2.947 . . . . 54.340000000000003 113.546 175.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 65.08 34.0 88.6 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 122.787 0.232 . . . . 72.230000000000004 113.057 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 3' ' ' GLU . 28.5 m -87.16 153.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 122.867 0.467 . . . . 60.119999999999997 110.712 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.53 113.85 19.85 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.508 -0.769 . . . . 74.540000000000006 109.538 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -96.18 82.33 3.45 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 123.246 0.618 . . . . 74.329999999999998 109.599 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.551 HD22 HG21 ' A' ' 149' ' ' ILE . 38.6 tp -141.65 153.61 44.83 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.13 0.972 . . . . 75.219999999999999 109.418 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.3 p -90.98 162.88 14.54 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.226 1.01 . . . . 64.349999999999994 111.416 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.6 m -73.46 -41.18 63.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.403 0.681 . . . . 65.310000000000002 111.951 -175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -58.86 -34.46 71.64 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 112.244 0.461 . . . . 64.329999999999998 112.244 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.78 -43.53 83.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.598 0.759 . . . . 75.150000000000006 110.902 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 70.5 p -75.63 -35.57 60.45 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.395 0.678 . . . . 73.109999999999999 111.664 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.99 -50.24 69.31 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.783 0.833 . . . . 64.329999999999998 111.691 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -80.98 -21.53 40.23 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.07 -0.513 . . . . 65.540000000000006 111.446 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB2' HG22 ' A' ' 66' ' ' VAL . . . -67.07 -50.22 62.48 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.399 0.437 . . . . 75.340000000000003 110.022 172.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 41.4 p -65.55 -42.21 92.13 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.688 -0.687 . . . . 63.219999999999999 110.757 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -53.47 -37.53 62.74 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.863 1.265 . . . . 72.0 110.922 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 25.2 tpp -70.9 -38.38 73.01 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.916 0.886 . . . . 75.0 111.015 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.14 -8.4 0.32 Allowed Glycine 0 C--N 1.355 1.602 0 CA-C-O 119.429 -0.651 . . . . 65.329999999999998 114.245 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -65.97 147.05 53.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.107 0.563 . . . . 73.400000000000006 112.391 -175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.71 165.11 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.065 0.946 . . . . 60.32 110.659 -175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.45 ' HE1' ' HG3' ' A' ' 151' ' ' GLN . 66.1 m-85 -110.79 133.33 53.44 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.157 0.583 . . . . 71.230000000000004 110.391 171.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.415 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 33.1 m -128.89 150.14 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.404 1.082 . . . . 75.430000000000007 108.943 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 32' ' ' ILE . 27.9 p-10 -77.41 -171.63 2.19 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.501 0.32 . . . . 65.420000000000002 110.463 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.3 -9.87 59.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.157 0.583 . . . . 64.409999999999997 111.827 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 43.3 mmtm -87.09 -27.35 23.18 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.034 0.534 . . . . 61.409999999999997 110.573 168.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 88.4 59.85 1.6 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.553 -0.619 . . . . 64.25 111.553 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -135.96 152.7 51.23 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.423 0.689 . . . . 74.120000000000005 110.386 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.509 HH22 ' HA ' ' A' ' 34' ' ' ASN . 14.2 mmm180 -62.71 97.6 0.1 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.089 0.955 . . . . 74.310000000000002 110.717 176.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.541 HD12 HG12 ' A' ' 46' ' ' ILE . 20.4 pt -92.78 -44.05 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.144 0.577 . . . . 75.140000000000001 111.51 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 p -146.46 156.94 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.784 0.834 . . . . 52.439999999999998 109.047 -177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' HA ' HH22 ' A' ' 31' ' ' ARG . 16.2 p30 -55.27 -48.58 73.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.357 0.663 . . . . 64.299999999999997 111.757 176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 13.2 pt-20 -177.65 -162.79 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.186 0.994 . . . . 64.209999999999994 109.963 -173.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.9 p -84.95 20.94 1.71 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.129 0.972 . . . . 42.229999999999997 111.739 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.54 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 50.3 t-20 -35.09 -57.92 0.55 Allowed 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 126.341 1.857 . . . . 74.530000000000001 112.316 -174.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 40' ' ' THR . 5.1 p -147.36 142.74 20.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.937 -1.134 . . . . 75.120000000000005 107.937 174.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -56.43 -27.19 55.91 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.886 0.875 . . . . 63.100000000000001 111.851 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.482 ' H ' HG22 ' A' ' 38' ' ' VAL . 58.7 p -67.27 -60.59 2.47 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 122.758 0.423 . . . . 65.150000000000006 110.44 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.419 ' H ' HG13 ' A' ' 38' ' ' VAL . 47.7 m -61.81 -32.56 72.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.213 0.605 . . . . 64.140000000000001 111.338 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.96 -52.69 58.48 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.915 0.886 . . . . 65.129999999999995 110.594 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HG3' HD22 ' A' ' 153' ' ' LEU . 37.1 ttm180 -70.35 -49.9 44.52 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.286 0.634 . . . . 73.0 110.931 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -59.15 -31.35 68.89 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.709 0.804 . . . . 74.319999999999993 111.997 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.34 84.93 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.701 0.626 . . . . 61.43 110.863 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.567 HD12 HD21 ' A' ' 153' ' ' LEU . 35.1 mt -77.03 -29.76 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 CA-C-N 115.283 -0.871 . . . . 75.019999999999996 110.291 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 78.4 mt -73.05 -26.63 61.36 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.579 0.751 . . . . 73.230000000000004 111.139 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -61.75 -26.85 68.32 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.521 0.728 . . . . 71.140000000000001 110.988 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -113.55 161.77 16.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.298 1.039 . . . . 70.319999999999993 109.771 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.03 75.03 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.517 0.727 . . . . 73.439999999999998 111.926 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.81 119.02 11.15 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.971 0.909 . . . . 72.349999999999994 109.512 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -107.81 30.81 5.98 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.582 0.753 . . . . 74.5 110.407 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 p -145.94 134.27 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 115.308 -0.86 . . . . 70.340000000000003 110.171 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.74 169.05 8.67 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.851 1.26 . . . . 70.439999999999998 109.455 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -141.8 108.25 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.317 1.047 . . . . 75.420000000000002 108.437 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.34 102.64 8.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.38 -0.827 . . . . 72.140000000000001 109.276 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG22 HG12 ' A' ' 148' ' ' ILE . 43.1 t -95.59 120.03 44.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.855 0.862 . . . . 71.530000000000001 109.355 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.464 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.7 pmm? -130.41 171.5 12.9 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.663 0.785 . . . . 63.310000000000002 109.859 175.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 5.5 p-10 -91.45 177.3 6.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.511 0.724 . . . . 74.409999999999997 109.799 169.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 45.0 tt0 -65.85 -35.14 79.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.668 0.787 . . . . 65.099999999999994 112.391 -177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -71.45 -38.09 71.34 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.364 0.266 . . . . 74.239999999999995 110.694 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.8 m -65.55 -38.15 88.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.748 0.419 . . . . 63.100000000000001 110.031 172.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -63.66 -32.97 74.62 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.642 0.777 . . . . 72.329999999999998 111.496 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 67.6 mmtt -58.41 -19.74 38.7 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.1 0.407 . . . . 63.119999999999997 112.1 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.4 mmmt -100.84 -31.71 11.03 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 118.408 -0.806 . . . . 71.439999999999998 112.482 172.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' A' ' 17' ' ' ALA . 57.9 t -63.98 -57.93 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.258 0.936 . . . . 71.019999999999996 110.15 177.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -52.35 -40.6 62.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.135 1.374 . . . . 71.510000000000005 111.552 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -61.65 -57.75 10.77 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 114.551 -1.204 . . . . 64.030000000000001 110.519 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 96.8 mt -59.21 -36.1 74.8 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.673 1.233 . . . . 54.240000000000002 111.724 -175.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . 85.9 mt -53.96 -56.78 14.65 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.873 0.733 . . . . 73.349999999999994 110.098 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.6 mt -72.01 -32.0 42.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.409 0.684 . . . . 71.200000000000003 111.238 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.04 -44.04 93.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.385 1.074 . . . . 73.129999999999995 109.935 -174.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -83.03 -64.54 1.15 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.273 -0.64 . . . . 70.420000000000002 109.273 176.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.9 t70 170.59 99.02 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.622 1.169 . . . . 73.450000000000003 109.204 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 70' ' ' LEU . 30.1 t80 178.05 91.21 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 106.563 -1.643 . . . . 62.310000000000002 106.563 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 t -57.09 150.27 41.33 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.763 1.225 . . . . 71.5 111.664 -169.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -56.73 -28.56 76.49 Favored 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 123.128 2.552 . . . . 74.040000000000006 112.336 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -58.32 -42.32 86.48 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.713 1.258 . . . . 74.219999999999999 110.956 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -62.77 -56.15 20.16 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.928 0.768 . . . . 64.340000000000003 110.856 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 80' ' ' ILE . 34.2 mt -55.81 -52.97 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 124.971 1.42 . . . . 72.319999999999993 110.945 -173.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -67.66 -29.66 69.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.898 -1.046 . . . . 73.040000000000006 111.337 -174.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 t -68.13 -29.39 68.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.261 0.624 . . . . 75.030000000000001 111.969 -175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 93' ' ' PHE . 90.8 m-85 -68.4 -31.01 70.06 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 110.373 -0.232 . . . . 65.109999999999999 110.373 174.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.422 ' HD2' ' HA ' ' A' ' 81' ' ' LYS . 98.1 m-85 -75.29 -32.48 61.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.979 0.512 . . . . 74.209999999999994 110.396 176.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 81' ' ' LYS . 10.4 mm-40 -73.21 -19.65 61.04 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.122 0.569 . . . . 33.240000000000002 111.887 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.462 HD21 ' HB2' ' A' ' 89' ' ' LYS . 57.9 t30 -51.33 126.68 17.62 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.534 1.134 . . . . 72.120000000000005 112.043 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -99.21 -71.36 0.7 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.832 0.853 . . . . 73.299999999999997 111.599 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.56 -42.83 93.32 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.771 0.669 . . . . 52.340000000000003 114.081 -171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HB2' HD21 ' A' ' 86' ' ' ASN . 3.5 mppt? -94.8 171.79 8.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.105 0.562 . . . . 72.409999999999997 109.996 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -69.73 131.09 89.73 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.347 -0.842 . . . . 74.349999999999994 110.15 175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 47.3 Cg_exo -59.07 127.68 25.08 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.324 2.016 . . . . 72.040000000000006 111.487 167.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.7 t -71.67 -41.49 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 108.4 -0.963 . . . . 61.350000000000001 108.4 171.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.445 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 1.4 m-85 -98.71 108.18 20.8 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.908 -1.145 . . . . 71.439999999999998 107.908 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 91' ' ' PRO . 40.5 t -111.29 155.04 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.009 0.923 . . . . 54.119999999999997 109.594 -177.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -145.22 176.37 9.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.012 0.925 . . . . 61.5 110.683 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.71 -160.81 23.92 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 111.229 -0.748 . . . . 71.319999999999993 111.229 174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.1 t -74.5 175.48 7.73 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 109.38 -0.6 . . . . 74.329999999999998 109.38 170.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -45.5 87.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.655 0.382 . . . . 62.219999999999999 111.123 -175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.497 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 46.7 mt-10 -72.7 -47.54 46.33 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.603 -0.726 . . . . 75.150000000000006 110.518 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.5 m -54.84 -50.76 67.84 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.151 0.98 . . . . 62.030000000000001 111.945 -174.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.61 -32.56 74.27 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.09 -0.959 . . . . 75.109999999999999 111.283 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.38 -38.99 81.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.483 0.713 . . . . 74.409999999999997 111.306 177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 36.8 mt-10 -70.89 -35.44 72.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.646 0.778 . . . . 75.420000000000002 111.241 -178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -74.95 -37.97 61.84 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.487 0.715 . . . . 74.140000000000001 111.168 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -80.78 -13.62 58.81 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.979 0.512 . . . . 30.329999999999998 111.488 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.71 24.01 71.1 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 113.847 0.299 . . . . 51.030000000000001 113.847 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.3 mt -88.55 154.6 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.772 0.829 . . . . 74.230000000000004 108.9 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 48.2 t -67.37 104.05 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 109.032 -0.729 . . . . 71.209999999999994 109.032 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 113' ' ' VAL . 39.2 t -56.74 -50.77 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 113.913 -1.494 . . . . 75.439999999999998 110.744 -172.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.73 -37.25 73.25 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.277 1.031 . . . . 60.140000000000001 111.839 -174.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -74.4 -41.25 61.25 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 119.287 -0.387 . . . . 72.019999999999996 111.873 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.403 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.1 pp -75.08 -23.57 58.04 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.459 0.572 . . . . 71.200000000000003 112.256 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 109' ' ' VAL . 53.4 t -67.16 -37.54 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 109.045 -0.724 . . . . 52.210000000000001 109.045 172.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -63.14 -52.4 62.62 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.575 -0.898 . . . . 71.109999999999999 108.575 173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.1 m -49.78 -46.18 50.48 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.998 1.319 . . . . 74.409999999999997 113.135 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.8 t -80.48 -35.28 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.314 0.645 . . . . 62.450000000000003 111.679 -175.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.29 -31.9 60.84 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 118.803 0.729 . . . . 71.140000000000001 110.646 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -72.91 -40.57 65.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.803 -0.814 . . . . 54.210000000000001 108.803 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 123' ' ' VAL . 85.6 t80 -56.01 -64.14 0.95 Allowed 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.341 1.026 . . . . 74.329999999999998 109.38 174.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -60.19 -26.93 66.73 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.702 0.801 . . . . 73.310000000000002 111.927 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -41.84 30.35 Favored Glycine 0 C--N 1.348 1.237 0 O-C-N 124.006 0.816 . . . . 72.319999999999993 111.995 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -82.84 -20.5 35.51 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.782 0.291 . . . . 71.019999999999996 111.63 -177.237 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 119' ' ' TYR . 35.0 t -64.52 -57.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.975 0.91 . . . . 51.149999999999999 110.171 174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.464 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 14.1 pt20 -69.15 -23.41 63.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.391 -0.822 . . . . 71.540000000000006 111.353 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.68 -25.6 61.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.764 0.426 . . . . 72.209999999999994 110.946 178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.8 44.57 19.52 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 115.714 -0.676 . . . . 50.409999999999997 112.451 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 85.0 t60 -166.66 117.72 0.95 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.679 0.792 . . . . 75.129999999999995 109.317 174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.513 ' HB3' HD11 ' A' ' 138' ' ' LEU . 5.6 p-10 -78.5 154.99 30.04 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.449 0.568 . . . . 75.230000000000004 110.763 176.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.84 -60.19 1.73 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.649 0.78 . . . . 64.430000000000007 109.84 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -96.42 63.45 2.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.604 -0.726 . . . . 64.349999999999994 111.226 -170.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 28.5 p90 36.34 51.04 0.8 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.731 1.612 . . . . 72.409999999999997 113.116 172.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -86.26 -65.83 1.41 Allowed Glycine 0 C--N 1.341 0.859 0 CA-C-N 115.376 -0.829 . . . . 34.100000000000001 111.577 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -178.23 158.47 1.17 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.926 1.29 . . . . 71.329999999999998 108.657 -172.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -57.06 140.75 77.47 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 118.842 -0.599 . . . . 74.230000000000004 110.897 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' HD12 ' A' ' 138' ' ' LEU . 11.1 Cg_endo -53.67 -28.01 44.75 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.769 2.979 . . . . 55.140000000000001 114.03 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -75.03 -20.99 59.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.387 0.675 . . . . 74.329999999999998 111.478 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -113.78 -6.23 13.28 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.508 0.723 . . . . 75.219999999999999 111.304 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 128' ' ' ASP . 17.8 mt -63.0 129.9 42.36 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.066 0.547 . . . . 74.349999999999994 110.351 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -145.96 131.9 19.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.558 0.743 . . . . 70.049999999999997 109.992 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 21.9 mp0 -72.0 158.53 35.82 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.176 0.512 . . . . 74.230000000000004 111.339 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.607 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 64.1 m-85 -70.92 105.45 3.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.601 -1.181 . . . . 74.040000000000006 109.392 171.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -96.08 95.47 8.2 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.347 -0.612 . . . . 75.420000000000002 109.347 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 157.65 117.44 0.52 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.642 -0.983 . . . . 30.329999999999998 110.642 -176.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.55 -34.29 76.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.428 0.691 . . . . 74.019999999999996 111.686 -177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.0 m -80.96 108.76 14.91 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.145 -0.48 . . . . 72.129999999999995 109.71 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -88.72 155.43 19.58 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.974 0.91 . . . . 71.109999999999999 109.48 170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.464 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 62.6 m-85 -127.39 134.32 49.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.752 1.221 . . . . 73.549999999999997 107.886 173.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 57' ' ' VAL . 50.8 mt -123.81 112.18 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 108.695 -0.854 . . . . 50.229999999999997 108.695 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.551 HG21 HD22 ' A' ' 9' ' ' LEU . 24.0 mm -100.98 121.12 51.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.984 -0.747 . . . . 71.439999999999998 108.984 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -64.19 135.39 56.26 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.09 -0.707 . . . . 51.329999999999998 109.09 173.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.45 ' HG3' ' HE1' ' A' ' 24' ' ' TYR . 24.2 mm-40 -133.57 101.5 5.15 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.721 1.208 . . . . 75.420000000000002 109.212 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 37.0 mmt180 -90.06 144.1 26.19 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.965 0.906 . . . . 75.409999999999997 109.999 -176.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 46' ' ' ILE . 55.5 mt -71.64 104.73 3.43 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 123.585 0.553 . . . . 64.329999999999998 110.831 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 55.38 -159.68 0.19 Allowed 'General case' 0 N--CA 1.481 1.123 0 O-C-N 124.79 1.306 . . . . 75.0 113.388 161.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -110.12 97.78 7.2 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.074 0.949 . . . . 73.099999999999994 109.668 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -86.38 72.07 10.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.138 -0.69 . . . . 70.010000000000005 109.138 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -71.37 -15.53 62.38 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.389 1.076 . . . . 73.129999999999995 112.672 -169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -60.39 -23.58 64.44 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.323 0.249 . . . . 44.329999999999998 110.664 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -123.9 157.31 34.54 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.353 1.061 . . . . 42.32 109.181 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 11.6 p80 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 109.311 -0.626 . . . . 73.430000000000007 109.311 175.239 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.249 -0.649 . . . . 74.420000000000002 109.249 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.5 m -131.74 -175.61 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.461 1.104 . . . . 75.230000000000004 109.134 175.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.11 152.45 29.63 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 123.048 0.539 . . . . 73.400000000000006 112.089 174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.32 173.24 0.13 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.488 2.792 . . . . 63.100000000000001 114.407 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.65 68.93 1.51 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 116.246 -0.434 . . . . 32.43 112.331 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.24 9.22 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.264 1.026 . . . . 70.439999999999998 110.292 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -76.65 -171.69 1.96 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.994 0.918 . . . . 70.209999999999994 110.588 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? 61.38 83.67 0.14 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.947 0.899 . . . . 72.409999999999997 109.594 -175.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.4 tp -72.51 146.14 47.02 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.316 -0.624 . . . . 40.009999999999998 109.316 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.6 p -52.07 102.7 0.05 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.274 1.43 . . . . 72.340000000000003 112.114 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 48.5 p -68.79 -35.07 76.58 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.499 -0.773 . . . . 72.129999999999995 111.701 -174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -60.06 -33.85 72.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.778 0.431 . . . . 75.120000000000005 111.357 176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.587 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -66.79 -39.94 87.96 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 123.554 0.741 . . . . 74.400000000000006 110.652 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.4 p -71.67 -37.55 70.75 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.763 -0.653 . . . . 65.120000000000005 111.223 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.8 mmtt -60.12 -53.2 60.53 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.865 0.728 . . . . 71.340000000000003 111.272 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -68.12 -38.3 82.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.344 -0.844 . . . . 72.340000000000003 111.184 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.93 -53.07 62.56 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.664 0.602 . . . . 25.41 111.236 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 35' ' ' GLU . 36.5 p -68.6 -37.4 79.76 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 111.87 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -54.37 -50.82 66.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.653 1.181 . . . . 64.129999999999995 110.993 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 64.1 mtm -79.68 -26.66 40.9 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.177 -0.92 . . . . 74.530000000000001 111.169 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.41 87.77 0.09 OUTLIER Glycine 0 C--N 1.349 1.28 0 O-C-N 123.345 0.403 . . . . 63.119999999999997 112.665 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.478 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -157.06 149.63 23.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.456 0.703 . . . . 74.409999999999997 110.374 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.08 171.68 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.879 0.871 . . . . 73.319999999999993 110.661 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -118.06 124.98 49.4 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.081 0.553 . . . . 72.409999999999997 110.858 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' HA2' ' A' ' 29' ' ' GLY . 27.5 m -120.2 143.52 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 123.818 0.847 . . . . 53.509999999999998 109.006 167.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -76.35 -174.15 2.73 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.259 0.623 . . . . 55.43 111.27 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 t -70.93 -11.88 61.22 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.596 0.358 . . . . 51.450000000000003 111.86 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -77.11 -64.52 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.485 -1.302 . . . . 51.409999999999997 107.485 163.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.567 ' HA2' ' HB ' ' A' ' 25' ' ' VAL . . . 125.04 63.3 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.975 -0.85 . . . . 73.319999999999993 110.975 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.99 153.18 50.6 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.006 0.922 . . . . 74.219999999999999 108.839 -174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.29 73.83 0.97 Allowed 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 122.148 0.975 . . . . 72.109999999999999 110.453 177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.57 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 31.9 pt -72.03 -35.23 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 121.741 -0.599 . . . . 74.200000000000003 111.067 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 p -156.32 136.19 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.564 1.146 . . . . 75.109999999999999 108.128 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -61.04 -44.46 97.36 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.178 0.991 . . . . 70.439999999999998 112.653 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 12.8 pt-20 -160.81 -170.2 2.65 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.476 -0.783 . . . . 70.099999999999994 110.357 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -83.66 47.17 1.24 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.833 0.853 . . . . 71.219999999999999 110.205 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -57.43 -38.66 74.75 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.999 0.92 . . . . 75.099999999999994 111.999 -175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG13 ' H ' ' A' ' 41' ' ' THR . 7.5 p -169.47 144.72 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 125.375 1.47 . . . . 72.510000000000005 107.884 174.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -57.97 -28.43 64.36 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.534 0.734 . . . . 64.140000000000001 111.584 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 38' ' ' VAL . 8.3 m -67.4 -58.84 4.04 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.423 1.089 . . . . 65.430000000000007 111.105 -175.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.516 ' H ' HG13 ' A' ' 38' ' ' VAL . 86.3 m -57.61 -41.69 81.77 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.918 0.887 . . . . 72.510000000000005 111.252 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.411 ' HZ ' ' HB3' ' A' ' 151' ' ' GLN . 32.7 t80 -58.76 -49.3 78.17 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.568 -1.196 . . . . 73.510000000000005 111.477 177.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 15.4 ttm180 -68.18 -39.23 82.56 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.097 0.559 . . . . 74.340000000000003 110.808 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -64.55 -31.05 72.09 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.146 0.578 . . . . 73.239999999999995 110.704 178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' A' ' 32' ' ' ILE . . . -67.98 -34.18 76.05 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.348 0.659 . . . . 22.329999999999998 111.263 177.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.1 mt -74.18 -42.52 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 123.721 0.809 . . . . 62.539999999999999 110.128 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.99 -27.97 65.14 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.965 0.906 . . . . 75.519999999999996 111.04 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -66.77 -37.75 85.22 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.605 1.162 . . . . 53.43 110.405 175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -92.74 147.48 22.83 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.053 -0.976 . . . . 72.349999999999994 111.278 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.0 83.81 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.108 0.963 . . . . 73.519999999999996 112.36 -176.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.27 -21.24 64.81 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 113.782 1.03 . . . . 51.399999999999999 113.782 -170.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm 60.52 42.66 13.96 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.529 1.132 . . . . 71.030000000000001 112.206 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -157.05 133.67 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.986 0.422 . . . . 54.119999999999997 110.884 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.74 168.03 9.38 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.884 0.874 . . . . 44.119999999999997 109.071 173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' A' ' 148' ' ' ILE . 97.6 m-85 -142.84 120.4 11.76 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.559 . . . . 71.530000000000001 109.621 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.8 tp -82.8 104.46 13.05 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 123.938 0.773 . . . . 70.120000000000005 109.379 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -95.85 120.42 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.523 0.729 . . . . 75.430000000000007 109.724 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 147' ' ' TYR . 1.8 pmm? -132.7 176.7 8.22 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.612 0.765 . . . . 42.109999999999999 109.481 171.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 4.4 p30 -94.51 -179.44 4.9 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.202 0.601 . . . . 71.319999999999993 109.871 171.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 38.6 tt0 -70.0 -37.66 75.74 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.548 0.739 . . . . 73.120000000000005 112.34 -173.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 tpt180 -66.73 -42.59 86.05 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.019 0.528 . . . . 71.510000000000005 110.071 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.9 m -64.46 -33.85 76.83 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 122.708 0.403 . . . . 63.409999999999997 110.364 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -67.29 -38.49 85.09 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-O 118.785 -0.626 . . . . 75.510000000000005 111.776 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.5 mmtt -54.45 -33.63 59.93 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.564 0.62 . . . . 54.549999999999997 111.363 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.437 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 32.0 mmmt -72.62 -51.71 18.46 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.044 -0.98 . . . . 75.239999999999995 110.459 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.587 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.1 t -56.11 -57.2 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.715 0.806 . . . . 74.310000000000002 111.16 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -47.53 -44.05 25.5 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.022 1.729 . . . . 52.310000000000002 112.557 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.09 -43.3 78.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.428 0.691 . . . . 75.430000000000007 111.038 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 90.2 mt -63.04 -36.47 83.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.291 1.036 . . . . 73.219999999999999 111.139 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 80.9 mt -56.59 -56.97 14.65 Favored 'General case' 0 C--N 1.354 0.781 0 O-C-N 124.141 0.901 . . . . 74.209999999999994 109.567 178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.413 HD13 ' HD3' ' A' ' 77' ' ' PRO . 49.1 mt -68.14 -31.44 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 CA-C-N 115.045 -0.98 . . . . 75.129999999999995 110.936 -176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.85 -47.89 76.29 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.519 0.728 . . . . 61.25 110.702 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -84.34 -62.81 1.47 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 111.734 0.272 . . . . 63.039999999999999 111.734 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -164.45 87.03 0.46 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.447 0.299 . . . . 62.43 111.324 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -177.08 172.8 1.91 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.86 1.664 . . . . 72.310000000000002 108.412 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.594 HG22 ' HG2' ' A' ' 79' ' ' GLU . 4.1 t -144.7 151.24 49.42 Favored Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 107.159 -1.423 . . . . 61.109999999999999 107.159 169.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HD13 ' A' ' 71' ' ' ILE . 6.6 Cg_endo -48.29 -35.2 26.7 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.631 2.887 . . . . 64.329999999999998 114.2 -177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -62.07 -41.26 97.98 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.803 0.841 . . . . 65.549999999999997 111.782 178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 76' ' ' THR . 57.4 mm-40 -66.51 -48.95 68.15 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.77 0.428 . . . . 73.230000000000004 111.086 178.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.2 mt -62.62 -46.93 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.208 -0.906 . . . . 71.329999999999998 110.954 -173.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.71 -25.55 65.72 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.833 -0.621 . . . . 71.209999999999994 111.354 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 -30.97 71.41 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.039 0.536 . . . . 71.420000000000002 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.18 -26.73 61.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.033 -0.53 . . . . 72.120000000000005 111.417 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -74.95 -38.9 61.6 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.637 0.375 . . . . 75.239999999999995 110.024 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.16 26.0 0.92 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.44 0.696 . . . . 61.200000000000003 112.721 -173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -74.29 94.9 2.57 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.307 -0.627 . . . . 75.25 109.307 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -95.58 83.82 3.85 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.624 0.769 . . . . 74.219999999999999 110.752 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 147.55 -49.39 0.61 Allowed Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.829 -0.508 . . . . 70.430000000000007 111.829 176.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -94.46 -178.83 4.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.745 -0.835 . . . . 73.340000000000003 108.745 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -77.1 125.67 86.4 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 109.698 -0.482 . . . . 64.450000000000003 109.698 177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HB2' HG22 ' A' ' 94' ' ' VAL . 24.1 Cg_exo -64.23 130.85 28.28 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.248 1.965 . . . . 50.210000000000001 111.31 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 85.7 t -68.08 -41.05 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.503 0.668 . . . . 45.530000000000001 109.586 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.48 111.68 24.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 108.12 -1.067 . . . . 62.509999999999998 108.12 172.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.56 HG22 ' HB2' ' A' ' 91' ' ' PRO . 21.5 t -111.9 155.05 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.451 0.701 . . . . 72.430000000000007 109.461 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -147.03 172.92 12.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.349 0.66 . . . . 75.409999999999997 111.543 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.95 -154.0 21.16 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.775 -1.33 . . . . 41.149999999999999 109.775 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.1 t -71.01 168.07 17.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.472 0.636 . . . . 64.209999999999994 109.786 168.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.1 tp -53.47 -42.45 67.24 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.142 0.577 . . . . 72.549999999999997 110.782 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 38.0 mt-10 -81.64 -40.33 23.08 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.148 -0.933 . . . . 73.209999999999994 111.507 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 m -61.35 -52.05 66.25 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.385 0.674 . . . . 63.439999999999998 111.24 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.74 -28.24 69.29 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.034 0.933 . . . . 51.539999999999999 111.517 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -66.16 -47.32 74.39 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.78 -0.646 . . . . 72.239999999999995 110.92 176.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.9 mt-10 -63.29 -40.87 98.59 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.608 0.763 . . . . 74.230000000000004 111.06 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -69.52 -33.43 72.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.092 0.957 . . . . 71.310000000000002 111.855 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -83.51 -22.35 32.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.111 0.564 . . . . 62.43 111.489 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.33 52.35 5.65 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.812 -0.515 . . . . 55.039999999999999 111.812 -176.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -113.3 151.31 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 107.947 -1.131 . . . . 70.099999999999994 107.947 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.6 t -71.77 105.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 108.287 -1.005 . . . . 72.120000000000005 108.287 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.3 t -56.94 -48.57 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 114.675 -1.148 . . . . 72.319999999999993 111.518 -171.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.96 -42.38 80.01 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.786 0.834 . . . . 72.129999999999995 111.689 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -60.17 -55.98 27.14 Favored 'General case' 0 C--O 1.243 0.759 0 O-C-N 123.66 0.6 . . . . 63.409999999999997 111.247 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.488 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.3 pp -69.36 -36.84 77.25 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.48 -0.295 . . . . 65.430000000000007 111.67 -173.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.35 -39.52 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 109.836 -0.431 . . . . 75.109999999999999 109.836 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -62.57 -59.87 4.32 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 123.377 0.423 . . . . 62.420000000000002 110.69 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.488 HG22 ' HA ' ' A' ' 112' ' ' LEU . 13.2 t -65.81 -22.69 66.58 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 112.741 0.645 . . . . 75.299999999999997 112.741 -172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.0 t -84.35 -43.35 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.09 0.556 . . . . 64.200000000000003 111.02 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -72.8 -32.5 65.61 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.279 0.49 . . . . 65.420000000000002 110.508 -178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -76.14 -33.13 59.41 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.707 0.803 . . . . 54.43 109.523 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.484 ' O ' HG23 ' A' ' 123' ' ' VAL . 60.1 t80 -55.83 -59.75 4.43 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.215 0.947 . . . . 74.340000000000003 108.512 167.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -59.78 -21.38 60.72 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.033 0.933 . . . . 75.299999999999997 112.116 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.66 -61.67 3.27 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.649 -0.705 . . . . 70.140000000000001 111.916 174.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 2.2 p90 -68.35 -18.17 64.42 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 112.711 0.634 . . . . 72.310000000000002 112.711 -176.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 38.3 t -62.53 -50.15 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 123.486 0.714 . . . . 64.420000000000002 110.848 172.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -76.09 -20.8 57.37 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.351 0.26 . . . . 61.030000000000001 111.34 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -70.51 -23.98 62.75 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.036 0.534 . . . . 65.409999999999997 110.719 168.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 80.31 41.73 11.38 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-N 115.591 -0.732 . . . . 74.230000000000004 112.979 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 66.3 t60 -161.6 116.68 2.02 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 65.299999999999997 110.479 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.449 ' HB3' HD11 ' A' ' 138' ' ' LEU . 3.6 p-10 -72.89 148.79 44.03 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 109.732 -0.47 . . . . 74.040000000000006 109.732 175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -102.2 -47.79 4.41 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.733 0.413 . . . . 70.329999999999998 110.414 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -118.72 95.4 4.83 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.588 0.355 . . . . 71.400000000000006 110.478 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 14.5 p90 41.09 31.5 0.14 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.19 1.796 . . . . 60.140000000000001 114.431 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -68.54 -95.57 0.05 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.343 -0.703 . . . . 72.310000000000002 111.343 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -178.14 -174.5 0.42 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.977 0.911 . . . . 75.200000000000003 110.076 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.505 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 13.0 t70 -59.6 140.47 89.04 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 123.52 0.728 . . . . 75.540000000000006 110.225 -178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 138' ' ' LEU . 6.2 Cg_endo -45.81 -35.58 13.79 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 124.346 3.364 . . . . 73.450000000000003 115.424 178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -69.85 -30.92 68.52 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 120.695 0.283 . . . . 75.319999999999993 111.023 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.505 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 63.4 m-85 -91.07 -19.21 23.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.097 0.559 . . . . 72.310000000000002 110.95 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 84.9 mt -66.34 113.06 4.34 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.717 -0.846 . . . . 74.25 108.717 170.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -132.52 149.68 52.28 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.237 0.615 . . . . 71.019999999999996 109.563 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -90.04 158.58 17.26 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.572 -0.74 . . . . 72.540000000000006 109.665 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 79.0 m-85 -76.27 94.3 3.55 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.269 -0.878 . . . . 71.340000000000003 109.343 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.27 94.9 7.42 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.653 -0.869 . . . . 74.209999999999994 108.653 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.15 151.2 8.35 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.175 -0.92 . . . . 73.329999999999998 111.099 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -78.9 -51.08 10.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.727 0.811 . . . . 65.310000000000002 109.911 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 31.2 m -89.41 124.03 34.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.273 -0.876 . . . . 63.119999999999997 110.746 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.88 148.15 22.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.667 0.787 . . . . 74.230000000000004 110.133 167.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HB2' ' SD ' ' A' ' 58' ' ' MET . 44.3 m-85 -121.24 124.6 45.03 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.266 1.026 . . . . 74.140000000000001 108.676 174.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 55' ' ' TYR . 44.5 mt -112.48 107.97 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 108.708 -0.849 . . . . 74.519999999999996 108.708 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.1 mm -100.29 113.8 37.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 115.707 -0.679 . . . . 73.530000000000001 109.641 -174.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.74 132.53 54.24 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.837 0.71 . . . . 60.240000000000002 111.29 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.411 ' HB3' ' HZ ' ' A' ' 42' ' ' PHE . 74.3 mm-40 -123.11 100.72 7.01 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.726 -1.213 . . . . 74.409999999999997 107.726 178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -96.88 167.24 11.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.135 0.574 . . . . 74.230000000000004 110.669 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.19 168.44 19.97 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.093 -0.958 . . . . 74.329999999999998 109.743 167.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.18 176.5 0.75 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.768 0.827 . . . . 72.400000000000006 111.925 178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.32 87.09 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 122.014 0.911 . . . . 73.120000000000005 112.141 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -111.26 -28.58 8.19 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.388 -0.824 . . . . 72.340000000000003 110.012 176.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -84.56 90.76 7.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.465 -0.939 . . . . 70.510000000000005 108.465 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -109.94 167.47 10.14 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.421 0.689 . . . . 72.140000000000001 111.167 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -153.11 132.93 13.19 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.009 0.924 . . . . 73.349999999999994 109.877 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 83.2 t60 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 123.695 0.798 . . . . 74.400000000000006 110.029 172.82 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.444 -0.576 . . . . 75.329999999999998 109.444 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.1 t -91.49 76.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 106.852 -1.536 . . . . 52.340000000000003 106.852 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 68.51 139.3 0.06 OUTLIER Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 125.482 1.513 . . . . 53.350000000000001 112.497 -172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HG2' HG22 ' A' ' 6' ' ' VAL . 72.7 Cg_endo -79.62 -168.17 0.6 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.397 2.065 . . . . 74.140000000000001 111.133 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.12 61.46 4.65 Favored Glycine 0 N--CA 1.469 0.836 0 C-N-CA 121.377 -0.439 . . . . 75.129999999999995 112.669 -178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 4' ' ' PRO . 15.1 m -133.87 72.06 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 CA-C-O 122.55 1.167 . . . . 61.119999999999997 109.857 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 73' ' ' HIS . . . -112.54 -5.67 14.01 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.136 -0.938 . . . . 73.430000000000007 111.209 175.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -70.47 -66.43 0.6 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.88 0.872 . . . . 65.530000000000001 108.974 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -155.66 114.04 3.44 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.464 -0.939 . . . . 74.040000000000006 108.464 173.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 9.7 m -140.2 173.0 11.95 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.189 0.996 . . . . 51.240000000000002 108.589 -176.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 10' ' ' THR . 40.0 p -53.44 -27.06 22.72 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.749 1.018 . . . . 50.310000000000002 113.749 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' HD1' ' HB ' ' A' ' 10' ' ' THR . 24.6 p90 -57.57 -41.32 80.84 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 118.309 0.504 . . . . 75.25 110.732 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.13 93.08 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.373 0.669 . . . . 54.229999999999997 111.15 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 18' ' ' THR . 42.5 p -84.13 -28.22 27.61 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.275 -0.875 . . . . 64.040000000000006 112.218 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.79 -31.21 24.04 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.924 0.49 . . . . 75.230000000000004 111.956 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -73.85 -15.51 61.16 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 110.169 -0.308 . . . . 75.209999999999994 110.169 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.4 -49.4 13.59 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.702 0.801 . . . . 71.109999999999999 110.363 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 14' ' ' SER . 81.4 p -64.65 -17.2 63.84 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.289 0.636 . . . . 74.299999999999997 111.763 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -52.88 -41.35 64.27 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.716 0.807 . . . . 54.43 111.449 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 mpp? -88.35 -20.54 25.2 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.047 0.539 . . . . 70.010000000000005 112.177 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.2 93.02 2.03 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.033 -0.827 . . . . 45.140000000000001 111.033 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.45 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -147.07 105.37 3.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.493 1.117 . . . . 73.549999999999997 109.108 -174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 pp -79.89 156.22 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 112.625 0.602 . . . . 63.020000000000003 112.625 -166.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -103.91 125.19 50.13 Favored 'General case' 0 C--O 1.246 0.912 0 C-N-CA 123.549 0.739 . . . . 74.340000000000003 110.125 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.14 160.37 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 108.375 -0.972 . . . . 73.150000000000006 108.375 167.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 32' ' ' ILE . 33.2 p-10 -90.61 -168.58 2.13 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 110.069 -0.345 . . . . 63.100000000000001 110.069 173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.8 p -62.38 -21.61 65.49 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.69 0.796 . . . . 72.049999999999997 111.681 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 74.8 mmtt -80.77 -37.84 29.63 Favored 'General case' 0 C--O 1.214 -0.811 0 C-N-CA 122.998 0.519 . . . . 73.040000000000006 110.71 174.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.36 12.69 26.41 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 111.743 -0.543 . . . . 73.340000000000003 111.743 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -86.93 136.38 32.96 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.422 1.089 . . . . 74.430000000000007 109.889 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.3 113.94 3.51 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 108.931 -0.766 . . . . 61.039999999999999 108.931 172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 26' ' ' ASN . 40.9 pt -98.68 -14.49 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 123.049 0.54 . . . . 74.209999999999994 112.348 -175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.26 164.02 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 123.572 0.749 . . . . 71.129999999999995 109.465 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -73.76 27.11 0.07 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.324 1.449 . . . . 72.019999999999996 112.894 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.67 -80.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.616 1.566 . . . . 71.349999999999994 111.055 -175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 t -117.72 134.4 54.95 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.294 0.638 . . . . 70.340000000000003 110.232 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.26 -61.74 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.684 1.194 . . . . 71.299999999999997 107.887 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -170.72 158.19 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.611 -1.177 . . . . 54.119999999999997 108.756 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -55.91 -34.09 65.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.814 0.846 . . . . 75.329999999999998 111.587 178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.0 m -65.0 -47.01 79.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.089 0.955 . . . . 74.450000000000003 111.373 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.1 m -63.75 -41.27 98.04 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 75.150000000000006 110.638 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' O ' HG13 ' A' ' 46' ' ' ILE . 19.9 t80 -70.02 -36.78 75.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.292 -0.867 . . . . 74.340000000000003 111.211 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 20.3 ttt180 -68.57 -48.42 64.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.38 0.672 . . . . 63.119999999999997 109.816 -177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -56.43 -34.67 67.03 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.087 0.955 . . . . 72.109999999999999 111.469 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.93 -39.26 93.74 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.408 0.683 . . . . 74.400000000000006 111.391 177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 42' ' ' PHE . 35.1 mt -81.21 -26.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 CA-C-N 115.675 -0.693 . . . . 62.130000000000003 110.55 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 95.0 mt -69.94 -32.71 71.12 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.956 0.502 . . . . 73.530000000000001 110.108 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.27 -35.14 80.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.662 0.785 . . . . 64.140000000000001 111.541 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.654 HE21 ' HB2' ' A' ' 51' ' ' ASP . 19.2 pt20 -86.64 143.56 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.835 -0.431 . . . . 64.420000000000002 109.835 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.75 -26.91 66.36 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.878 0.871 . . . . 64.109999999999999 111.724 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.654 ' HB2' HE21 ' A' ' 49' ' ' GLN . 5.4 m-20 -68.04 -36.21 79.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.717 1.207 . . . . 73.430000000000007 111.693 -173.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' H ' ' HG3' ' A' ' 49' ' ' GLN . 49.3 mmtm 61.02 33.4 19.69 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.15 0.98 . . . . 64.519999999999996 111.504 -177.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.8 p -145.07 124.28 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.374 0.67 . . . . 63.43 110.635 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 171.06 7.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.267 1.027 . . . . 72.329999999999998 109.075 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -141.83 123.62 15.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.318 1.047 . . . . 73.530000000000001 109.375 -174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 56.2 tp -89.04 107.27 18.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.046 0.938 . . . . 73.0 110.307 -178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.3 t -87.83 119.17 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 108.622 -0.881 . . . . 65.109999999999999 108.622 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.433 ' HB3' ' HB1' ' A' ' 22' ' ' ALA . 3.9 ptt? -138.58 177.18 8.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 63.130000000000003 110.528 175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 141' ' ' PHE . 3.6 p30 -98.54 176.17 5.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.226 1.01 . . . . 71.239999999999995 110.448 172.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 30.5 tt0 -75.59 -28.6 58.99 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -175.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttt85 -65.05 -41.43 95.19 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.441 0.638 . . . . 73.439999999999998 109.575 177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.43 HG22 ' SD ' ' A' ' 58' ' ' MET . 99.0 m -65.89 -35.39 80.5 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 114.738 -1.119 . . . . 52.409999999999997 110.893 174.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -68.45 -29.95 68.71 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.556 0.742 . . . . 75.349999999999994 112.526 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -55.49 -32.21 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.199 0.524 . . . . 74.230000000000004 111.137 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -74.69 -53.46 9.23 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.152 -0.931 . . . . 61.549999999999997 110.599 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.83 -52.5 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 124.158 0.983 . . . . 50.210000000000001 112.115 -172.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -54.01 -43.1 69.8 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.39 1.076 . . . . 71.420000000000002 111.264 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -65.99 -45.98 79.63 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.726 -1.124 . . . . 72.349999999999994 110.711 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.1 -40.37 95.62 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.804 0.841 . . . . 73.420000000000002 111.369 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 75' ' ' PHE . 98.4 mt -56.02 -54.24 47.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.387 0.675 . . . . 75.049999999999997 110.522 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.0 mt -66.67 -37.65 79.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-N 115.441 -0.799 . . . . 54.229999999999997 110.851 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.4 -35.86 82.27 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.532 1.133 . . . . 72.329999999999998 110.338 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.564 ' HB3' ' HB1' ' A' ' 7' ' ' ALA . 12.1 m-70 -83.37 -65.02 1.06 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 119.063 -0.494 . . . . 74.299999999999997 110.187 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.3 t70 169.77 80.09 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.113 1.365 . . . . 74.109999999999999 108.819 174.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HD2' ' HB3' ' A' ' 70' ' ' LEU . 28.2 t80 -165.13 82.85 0.36 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.9 -1.148 . . . . 70.5 107.9 178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.516 HG22 ' HG2' ' A' ' 79' ' ' GLU . 8.1 t -56.61 153.2 22.18 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 125.194 1.398 . . . . 74.230000000000004 111.241 -174.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 76' ' ' THR . 18.7 Cg_endo -55.39 -26.57 53.84 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.234 2.623 . . . . 72.319999999999993 113.198 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.71 -44.42 93.71 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.666 1.186 . . . . 71.400000000000006 110.853 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG2' HG22 ' A' ' 76' ' ' THR . 40.5 mm-40 -65.19 -51.03 63.54 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.129 -0.487 . . . . 62.43 110.426 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.0 mt -54.11 -49.03 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 124.438 1.086 . . . . 60.130000000000003 110.874 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -72.46 -29.37 63.61 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.306 -0.861 . . . . 52.420000000000002 111.652 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 69.1 m -71.71 -25.59 62.14 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 122.485 0.314 . . . . 75.019999999999996 110.97 176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 92' ' ' VAL . 27.5 m-85 -91.15 -7.66 50.89 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.027 0.531 . . . . 74.319999999999993 110.873 174.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 14.9 m-85 -79.73 -36.97 36.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.364 0.665 . . . . 64.439999999999998 109.648 163.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -78.35 167.62 21.07 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.869 -1.06 . . . . 73.219999999999999 110.243 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -148.23 135.92 20.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.749 -0.659 . . . . 72.030000000000001 110.023 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -132.11 72.98 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.082 -1.081 . . . . 61.240000000000002 108.082 177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.05 -45.19 3.48 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 111.883 -0.487 . . . . 65.519999999999996 111.883 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -81.45 139.43 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.714 0.806 . . . . 72.510000000000005 109.918 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttm-85 -66.04 140.02 96.86 Favored Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.546 1.138 . . . . 71.230000000000004 110.926 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.11 142.38 50.6 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.288 1.992 . . . . 71.540000000000006 112.568 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 83' ' ' PHE . 53.7 t -76.63 -55.64 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.464 0.706 . . . . 55.450000000000003 109.141 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.468 ' HD2' ' HB2' ' A' ' 83' ' ' PHE . 90.0 m-85 -85.56 116.38 23.82 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.42 -0.956 . . . . 73.319999999999993 108.42 173.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.6 t -117.84 140.25 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.896 0.878 . . . . 71.230000000000004 108.83 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.573 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.4 ptmt -140.53 160.31 40.29 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.381 0.672 . . . . 72.5 111.22 175.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.26 -158.81 27.84 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 114.861 -1.063 . . . . 1.5 110.503 176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 t -69.61 169.21 13.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.933 -0.766 . . . . 73.310000000000002 108.933 165.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' VAL . 56.2 tp -58.34 -44.36 88.68 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.564 0.346 . . . . 73.200000000000003 111.41 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 41.3 mt-10 -75.25 -35.78 61.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.865 0.866 . . . . 74.209999999999994 111.6 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.3 m -65.75 -46.17 79.85 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.797 0.839 . . . . 73.409999999999997 111.0 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.68 -23.46 63.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.485 -1.234 . . . . 61.350000000000001 110.782 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -69.48 -45.62 68.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.508 0.723 . . . . 74.200000000000003 110.665 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.3 mt-10 -59.51 -49.69 76.82 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.728 -1.124 . . . . 65.510000000000005 110.7 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -66.0 -32.95 74.72 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.222 -0.899 . . . . 74.200000000000003 111.936 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 -9.41 53.26 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.939 0.496 . . . . 62.130000000000003 111.589 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.58 7.39 87.17 Favored Glycine 0 C--N 1.353 1.492 0 O-C-N 123.32 0.388 . . . . 43.329999999999998 113.816 174.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.429 ' CG2' HD23 ' A' ' 112' ' ' LEU . 41.3 mt -80.94 145.74 8.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 124.212 1.005 . . . . 54.130000000000003 109.36 -175.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 35.1 t -60.51 105.83 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.251 0 N-CA-C 108.831 -0.803 . . . . 53.409999999999997 108.831 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.34 -51.87 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 113.93 -1.486 . . . . 72.549999999999997 111.665 -171.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -58.62 -39.33 80.16 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.779 0.674 . . . . 74.099999999999994 111.39 -176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -62.59 -53.42 54.84 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 123.495 0.497 . . . . 60.539999999999999 110.803 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.509 ' HA ' HG22 ' A' ' 115' ' ' THR . 4.2 pp -69.77 -34.77 74.22 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.232 0.456 . . . . 64.150000000000006 112.232 -177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.471 ' N ' HD12 ' A' ' 112' ' ' LEU . 53.5 t -61.59 -42.96 96.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.286 -0.635 . . . . 73.439999999999998 109.286 178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.487 ' HA ' ' HG2' ' A' ' 117' ' ' LYS . 85.3 mm-40 -66.08 -48.91 69.41 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.586 0.553 . . . . 63.439999999999998 111.853 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 112' ' ' LEU . 10.7 t -70.25 -18.73 63.15 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 117.964 0.347 . . . . 75.230000000000004 111.752 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.59 -39.44 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 123.613 0.765 . . . . 64.329999999999998 112.342 171.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.487 ' HG2' ' HA ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -79.58 -35.37 39.79 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.866 -0.521 . . . . 41.030000000000001 111.41 -174.782 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -77.39 -27.87 52.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.988 0.515 . . . . 72.519999999999996 109.907 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.521 ' O ' HG23 ' A' ' 123' ' ' VAL . 48.6 t80 -58.86 -62.42 1.89 Allowed 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.735 -0.839 . . . . 72.340000000000003 108.735 169.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.431 HE21 ' HD2' ' A' ' 141' ' ' PHE . 58.7 mt-30 -60.66 -24.94 65.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.819 0.847 . . . . 71.239999999999995 111.641 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.533 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -68.38 -43.52 78.21 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.365 -0.694 . . . . 55.409999999999997 111.365 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.522 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -85.28 -17.42 36.97 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.443 0.534 . . . . 73.109999999999999 112.443 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 138' ' ' LEU . 63.7 t -61.19 -51.21 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.124 0.57 . . . . 65.510000000000005 109.791 172.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.533 HE21 ' HA2' ' A' ' 121' ' ' GLY . 27.8 pt20 -76.03 -18.51 59.22 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.682 -0.69 . . . . 72.019999999999996 111.844 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.28 -25.51 36.49 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.647 0.379 . . . . 72.019999999999996 110.893 169.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 74.24 41.94 36.95 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.304 0.377 . . . . 63.350000000000001 113.688 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.9 t60 -164.47 113.71 1.15 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.211 0.604 . . . . 65.219999999999999 109.372 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -69.75 153.41 43.4 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.579 0.352 . . . . 61.43 110.267 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -113.43 -17.64 12.19 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.98 0.512 . . . . 73.329999999999998 112.354 -174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -149.41 82.05 1.41 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 75.209999999999994 109.861 -173.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 33.0 p90 40.85 28.07 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 126.629 1.972 . . . . 64.510000000000005 114.474 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -61.77 -76.82 0.22 Allowed Glycine 0 C--N 1.349 1.273 0 O-C-N 123.738 0.649 . . . . 73.329999999999998 113.309 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 174.58 156.75 0.15 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.665 0.786 . . . . 55.310000000000002 110.155 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 137' ' ' TYR . 10.6 t70 -60.47 136.47 92.09 Favored Pre-proline 0 CA--C 1.562 1.406 0 C-N-CA 123.544 0.738 . . . . 64.239999999999995 110.779 175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.551 ' HA ' HD12 ' A' ' 138' ' ' LEU . 2.1 Cg_endo -39.15 -47.38 3.02 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 124.773 3.649 . . . . 73.420000000000002 115.36 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.8 -23.56 64.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.114 0.413 . . . . 74.5 112.114 -173.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' HD2' ' HB3' ' A' ' 134' ' ' ASP . 58.7 m-85 -100.82 -12.08 19.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 73.129999999999995 111.414 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.589 ' HB3' HG22 ' A' ' 123' ' ' VAL . 36.3 mt -59.96 114.01 2.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.258 0.623 . . . . 51.329999999999998 109.993 175.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -121.88 121.29 36.81 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.897 0.879 . . . . 73.329999999999998 110.548 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.521 ' HG3' HG11 ' A' ' 123' ' ' VAL . 81.0 mt-30 -78.56 153.35 31.29 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.404 -0.591 . . . . 63.039999999999999 109.404 171.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.499 ' HB3' ' HB3' ' A' ' 59' ' ' ASP . 73.8 m-85 -77.98 94.89 4.69 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.447 0.641 . . . . 63.240000000000002 110.55 -175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -81.94 97.46 8.09 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 114.626 -1.17 . . . . 73.319999999999993 109.831 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 169.9 143.75 4.03 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 111.7 -0.56 . . . . 63.420000000000002 111.7 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -65.19 -21.7 66.8 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.788 0.835 . . . . 72.109999999999999 111.285 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.573 HG21 ' HE3' ' A' ' 95' ' ' LYS . 79.4 m -128.3 134.41 48.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.472 0.709 . . . . 73.340000000000003 111.528 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.71 143.45 26.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.827 1.251 . . . . 72.219999999999999 109.846 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -121.19 114.76 21.87 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.083 0.953 . . . . 75.510000000000005 109.449 175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 47.3 mt -100.01 112.12 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 123.988 0.915 . . . . 63.310000000000002 109.077 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.468 HD12 ' HD1' ' A' ' 93' ' ' PHE . 22.9 mm -102.22 111.49 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.576 0.751 . . . . 73.530000000000001 109.459 -174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.26 108.1 1.8 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.665 0.786 . . . . 75.140000000000001 109.675 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -113.85 100.63 8.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.661 1.184 . . . . 73.099999999999994 109.976 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 35.8 ttp-105 -100.47 157.62 16.51 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.266 1.026 . . . . 74.230000000000004 109.794 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.72 179.22 1.82 Allowed 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.924 0.869 . . . . 63.329999999999998 112.807 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.74 169.55 12.7 Favored 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 125.817 1.647 . . . . 73.030000000000001 110.891 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -145.04 -44.65 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.057 0.943 . . . . 74.200000000000003 110.734 -169.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -149.46 105.23 3.44 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.977 0.911 . . . . 73.510000000000005 108.891 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -58.05 87.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.409 1.484 . . . . 72.230000000000004 112.086 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.8 t60 53.95 34.36 19.4 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.433 1.093 . . . . 72.420000000000002 110.538 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -144.5 175.21 10.3 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.233 -0.894 . . . . 74.129999999999995 110.164 -169.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 31.7 t60 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.79 1.236 . . . . 64.400000000000006 107.857 173.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 mmt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.442 -0.577 . . . . 62.310000000000002 109.442 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.17 160.39 4.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.47 0.652 . . . . 70.209999999999994 110.322 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -83.17 159.54 62.08 Favored Pre-proline 0 CA--C 1.557 1.216 0 CA-C-N 115.116 -0.947 . . . . 72.019999999999996 109.112 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.76 34.67 0.45 Allowed 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.235 2.623 . . . . 63.420000000000002 115.574 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.98 -66.93 1.55 Allowed Glycine 0 C--N 1.344 0.977 0 O-C-N 121.967 -0.458 . . . . 53.130000000000003 112.136 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t 68.91 -61.94 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 125.209 1.403 . . . . 74.340000000000003 111.612 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.43 104.81 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.713 0.805 . . . . 61.509999999999998 108.862 169.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -89.14 -50.64 6.03 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.332 -0.988 . . . . 72.439999999999998 108.332 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -160.15 120.74 2.99 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.904 -1.147 . . . . 74.439999999999998 107.904 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.6 m -138.29 158.33 44.5 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.145 0.978 . . . . 61.5 108.62 -173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -53.35 -18.46 2.54 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.707 1.743 . . . . 71.010000000000005 115.707 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -54.7 -38.08 66.6 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 119.57 1.077 . . . . 73.010000000000005 111.663 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -64.05 -39.06 93.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.724 0.809 . . . . 72.540000000000006 110.717 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -78.01 -27.96 49.08 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.886 -1.052 . . . . 71.540000000000006 111.835 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -72.27 -48.42 42.64 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.186 0.994 . . . . 75.519999999999996 111.249 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.415 ' O ' ' HB2' ' A' ' 20' ' ' MET . 23.4 mm-40 -70.77 -22.41 62.39 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.659 -0.7 . . . . 75.319999999999993 110.613 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.59 -44.74 49.31 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.534 0.734 . . . . 62.020000000000003 111.062 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.6 p -68.98 -40.43 78.81 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.536 0.334 . . . . 63.539999999999999 110.747 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.51 -30.88 70.9 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.628 1.171 . . . . 72.200000000000003 110.402 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 16' ' ' GLN . 27.4 tpp -77.8 -38.03 47.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.787 0.835 . . . . 75.530000000000001 109.969 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.61 86.29 0.24 Allowed Glycine 0 C--N 1.347 1.141 0 CA-C-N 115.19 -0.914 . . . . 72.430000000000007 110.888 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' HA ' ' HE1' ' A' ' 141' ' ' PHE . . . -155.19 155.16 33.4 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.802 0.841 . . . . 54.200000000000003 110.518 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 37.4 pt -121.43 148.44 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.125 0.97 . . . . 71.349999999999994 110.776 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' HE2' ' H ' ' A' ' 36' ' ' SER . 92.1 m-85 -97.8 121.06 39.26 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.202 -1.036 . . . . 74.310000000000002 108.202 173.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.5 m -113.42 171.82 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.545 1.138 . . . . 75.140000000000001 108.749 173.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -101.09 -173.92 2.49 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.681 0.392 . . . . 72.239999999999995 110.015 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 51' ' ' ASP . 48.1 t -66.93 -15.35 63.62 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.579 0.751 . . . . 73.510000000000005 111.675 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' O ' ' HB ' ' A' ' 108' ' ' VAL . 44.9 mmtm -76.04 -48.82 19.44 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.529 -0.545 . . . . 73.5 109.529 165.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.37 3.09 15.03 Favored Glycine 0 N--CA 1.473 1.116 0 CA-C-O 120.062 -0.299 . . . . 73.400000000000006 112.987 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -79.32 140.91 37.39 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.354 -0.61 . . . . 71.400000000000006 109.354 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.419 ' H ' ' HG3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -62.3 109.14 1.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.505 0.669 . . . . 75.129999999999995 111.199 179.288 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 33' ' ' VAL . 31.0 pt -79.48 -35.41 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.592 -0.731 . . . . 74.030000000000001 110.117 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG12 HG13 ' A' ' 32' ' ' ILE . 13.3 p -162.31 135.77 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 107.44 -1.319 . . . . 74.209999999999994 107.44 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 43.9 t-20 -66.63 -48.7 68.64 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.757 0.789 . . . . 64.430000000000007 109.16 -175.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -145.96 141.46 27.75 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.943 -1.026 . . . . 74.129999999999995 109.015 176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.451 ' H ' ' HE2' ' A' ' 24' ' ' TYR . 24.2 p -70.43 91.85 0.78 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.735 0.814 . . . . 55.310000000000002 109.453 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -63.91 -43.99 94.26 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.397 -0.819 . . . . 64.25 109.951 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.32 149.77 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 124.708 1.203 . . . . 62.130000000000003 108.196 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -58.12 -27.75 64.02 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.729 0.812 . . . . 64.019999999999996 112.209 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.6 p -67.96 -51.52 46.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.278 0.631 . . . . 64.549999999999997 111.034 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 78.9 m -65.91 -35.45 80.65 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.433 0.693 . . . . 63.539999999999999 111.325 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.72 -49.25 73.79 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.768 0.827 . . . . 72.349999999999994 110.728 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 49.2 ttt180 -63.58 -43.76 96.03 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.561 -0.745 . . . . 70.310000000000002 109.828 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.53 -26.8 66.51 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.796 0.839 . . . . 71.510000000000005 111.477 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.29 -36.72 82.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.049 0.539 . . . . 61.100000000000001 110.558 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.5 mt -77.56 -27.43 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.336 1.054 . . . . 72.200000000000003 110.384 175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 52' ' ' LYS . 87.7 mt -83.13 -21.06 33.71 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.24 0.616 . . . . 74.439999999999998 111.279 177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.51 -35.93 82.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.019 0.927 . . . . 62.039999999999999 113.106 -170.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.43 -179.26 3.81 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.999 0.92 . . . . 63.350000000000001 108.907 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.33 90.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.147 0.979 . . . . 51.409999999999997 112.235 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 27' ' ' SER . 10.6 m-20 -67.54 122.79 18.76 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.514 1.126 . . . . 71.409999999999997 110.908 -172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 47' ' ' LEU . 24.6 mmtm -106.83 31.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.602 1.161 . . . . 63.25 110.83 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.04 133.18 10.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 124.2 1.0 . . . . 62.25 108.567 171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -105.61 170.49 7.86 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.275 1.03 . . . . 75.5 109.097 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.3 126.12 14.38 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.988 0.915 . . . . 73.439999999999998 108.776 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 tp -95.06 113.3 24.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.365 -0.606 . . . . 73.219999999999999 109.365 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG22 HG12 ' A' ' 148' ' ' ILE . 59.6 t -99.08 122.38 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.604 0.762 . . . . 64.409999999999997 109.551 -177.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -144.46 -173.36 4.01 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.187 0.995 . . . . 71.420000000000002 109.208 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -102.26 174.92 5.7 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.05 0.94 . . . . 73.430000000000007 110.288 171.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 35.8 tt0 -70.41 -25.69 63.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.53 0.732 . . . . 74.099999999999994 112.395 -174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 mtm105 -63.03 -47.81 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.657 0.741 . . . . 71.450000000000003 109.613 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.2 m -61.01 -37.39 82.38 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.121 -1.4 . . . . 74.310000000000002 110.943 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.8 t-105 -66.06 -36.78 84.14 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 119.258 -0.401 . . . . 74.040000000000006 111.81 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 72.7 mmtt -54.17 -29.17 44.68 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.086 0.469 . . . . 72.140000000000001 111.191 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 29.7 mmmt -81.3 -47.32 13.48 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.064 -0.971 . . . . 75.310000000000002 110.609 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 13' ' ' ALA . 72.5 t -62.3 -54.97 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 123.66 0.784 . . . . 75.329999999999998 111.494 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -47.59 -45.94 27.81 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.382 1.473 . . . . 73.030000000000001 111.564 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.02 -51.97 67.79 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.693 -1.139 . . . . 62.520000000000003 110.325 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 60.2 mt -57.88 -34.84 70.22 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.155 0.982 . . . . 74.439999999999998 112.656 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.6 mt -61.19 -52.55 64.35 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 116.053 -0.521 . . . . 65.329999999999998 110.282 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -73.63 -22.03 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.594 0.757 . . . . 74.109999999999999 111.032 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.69 -41.58 37.53 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.824 0.85 . . . . 71.219999999999999 108.806 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -84.62 -70.18 0.59 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 118.545 -0.741 . . . . 73.430000000000007 109.464 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -176.99 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 124.239 1.015 . . . . 65.340000000000003 109.751 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -175.03 109.09 0.11 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.771 -0.826 . . . . 62.530000000000001 108.771 175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.6 t -63.54 147.45 95.43 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.505 0.722 . . . . 63.219999999999999 110.717 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -55.35 -34.85 90.21 Favored 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 123.44 2.76 . . . . 75.540000000000006 112.626 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.01 -30.89 70.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.899 1.28 . . . . 75.219999999999999 112.377 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -71.12 -51.34 25.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.962 0.505 . . . . 74.450000000000003 110.862 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -59.13 -51.3 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 114.705 -1.134 . . . . 72.140000000000001 110.866 -173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HA ' ' HD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -69.09 -22.39 64.0 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.971 -1.013 . . . . 73.109999999999999 111.85 -176.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.6 t -76.38 -23.18 54.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.803 0.841 . . . . 70.540000000000006 111.068 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.427 ' HA ' ' HB2' ' A' ' 86' ' ' ASN . 54.6 m-85 -73.99 -20.93 60.18 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 111.94 0.348 . . . . 73.140000000000001 111.94 174.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.405 ' HD1' ' HA ' ' A' ' 81' ' ' LYS . 94.3 m-85 -76.11 -27.3 57.06 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.194 0.521 . . . . 71.109999999999999 109.873 170.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -99.16 12.15 36.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.313 1.045 . . . . 75.129999999999995 111.332 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.527 HD21 ' HB2' ' A' ' 89' ' ' LYS . 55.5 t30 -74.56 101.2 4.12 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.418 0.687 . . . . 70.530000000000001 110.498 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -91.18 -44.86 8.98 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.947 -1.024 . . . . 64.319999999999993 110.637 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.22 -32.4 82.45 Favored Glycine 0 C--N 1.353 1.484 0 O-C-N 123.692 0.62 . . . . 70.420000000000002 113.314 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.527 ' HB2' HD21 ' A' ' 86' ' ' ASN . 13.6 mmmm -125.52 -178.31 4.2 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.404 1.082 . . . . 72.329999999999998 109.039 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -72.6 135.12 81.42 Favored Pre-proline 0 C--O 1.242 0.703 0 N-CA-C 109.444 -0.576 . . . . 71.430000000000007 109.444 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.561 ' HB2' HG22 ' A' ' 94' ' ' VAL . 73.8 Cg_exo -50.85 110.85 0.44 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.17 1.913 . . . . 63.509999999999998 111.521 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.82 -29.68 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.699 -0.682 . . . . 71.140000000000001 110.101 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HD1' HD12 ' A' ' 149' ' ' ILE . 20.5 m-85 -117.15 108.24 15.44 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.934 -1.135 . . . . 64.510000000000005 107.934 174.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 91' ' ' PRO . 41.2 t -110.35 147.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.491 0.716 . . . . 72.519999999999996 109.117 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 145' ' ' THR . 20.6 ptmt -146.8 176.17 10.07 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.465 0.706 . . . . 63.409999999999997 111.877 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 134.32 -142.33 13.78 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 109.524 -1.43 . . . . 24.34 109.524 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.8 t -80.99 175.01 11.06 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.605 -0.887 . . . . 72.129999999999995 108.605 165.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.2 tp -57.65 -50.98 71.38 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.09 0.556 . . . . 55.539999999999999 111.452 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.5 mt-10 -71.67 -35.32 70.28 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.995 -1.002 . . . . 63.299999999999997 111.603 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.2 m -62.86 -49.9 73.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.462 0.705 . . . . 41.219999999999999 111.123 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.43 68.91 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.703 -1.135 . . . . 54.219999999999999 111.138 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.35 -50.4 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.735 0.814 . . . . 72.310000000000002 111.172 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 42.7 mt-10 -62.04 -42.06 98.78 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.236 -0.893 . . . . 73.120000000000005 110.891 -178.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.92 -34.91 71.99 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.623 -0.717 . . . . 54.509999999999998 111.775 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.09 -7.93 59.59 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.898 0.479 . . . . 62.539999999999999 111.328 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.6 21.04 77.84 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 116.324 -0.398 . . . . 73.099999999999994 113.734 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.69 156.1 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.491 1.116 . . . . 62.420000000000002 109.65 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 28' ' ' LYS . 53.5 t -65.84 106.53 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.392 0 N-CA-C 108.721 -0.844 . . . . 63.409999999999997 108.721 175.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 81.4 t -51.26 -52.78 17.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 113.694 -1.594 . . . . 64.230000000000004 111.116 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 28.2 t70 -54.2 -48.95 70.45 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.089 0.868 . . . . 70.140000000000001 111.247 -177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -55.97 -54.24 47.21 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.814 0.696 . . . . 75.329999999999998 111.866 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.3 pp -72.16 -24.55 61.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.016 0.747 . . . . 73.219999999999999 113.016 -177.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.3 t -69.03 -42.2 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 108.769 -0.826 . . . . 73.420000000000002 108.769 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 29.5 mm-40 -66.95 -41.77 86.36 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.85 0.719 . . . . 72.409999999999997 109.071 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 65.1 m -57.01 -47.52 80.66 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.576 -1.193 . . . . 73.120000000000005 111.709 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.1 t -82.22 -37.27 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.596 0.758 . . . . 72.450000000000003 111.636 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -74.45 -32.78 62.74 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 118.837 0.744 . . . . 62.409999999999997 110.981 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -82.47 -27.57 31.76 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.267 0.627 . . . . 75.319999999999993 109.544 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.522 ' HA ' ' CE2' ' A' ' 122' ' ' TYR . 84.1 t80 -55.27 -63.63 1.1 Allowed 'General case' 0 C--N 1.367 1.341 0 N-CA-C 108.063 -1.088 . . . . 75.010000000000005 108.063 167.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 124' ' ' GLN . 94.3 mt-30 -58.82 -30.26 67.51 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.113 -1.403 . . . . 73.099999999999994 111.769 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -62.17 -50.56 64.05 Favored Glycine 0 C--N 1.353 1.482 0 O-C-N 124.518 1.136 . . . . 43.240000000000002 112.336 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.522 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 4.4 p90 -78.81 -20.19 50.33 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 112.194 0.442 . . . . 74.239999999999995 112.194 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 138' ' ' LEU . 75.1 t -65.95 -51.93 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.099 0.559 . . . . 34.020000000000003 109.948 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 27.6 pt20 -75.69 -17.46 59.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.826 0.45 . . . . 74.450000000000003 111.216 178.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 122' ' ' TYR . 19.7 t70 -72.06 -28.03 63.07 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.495 0.497 . . . . 63.310000000000002 109.984 171.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.13 37.66 42.23 Favored Glycine 0 C--N 1.353 1.485 0 CA-C-N 115.935 -0.575 . . . . 45.240000000000002 112.855 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 77.8 t60 -155.19 136.47 14.0 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.0 0.52 . . . . 74.129999999999995 109.733 175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.69 151.61 45.65 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.762 0.825 . . . . 61.530000000000001 111.575 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.401 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . 37.3 m-70 -148.49 -26.03 0.32 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.38 0.672 . . . . 63.030000000000001 110.906 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -54.5 -60.34 3.48 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.212 1.005 . . . . 64.239999999999995 112.061 177.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -155.41 -51.16 0.09 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.507 1.523 . . . . 73.409999999999997 107.471 -168.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.36 25.15 0.02 OUTLIER Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.728 -0.669 . . . . 71.319999999999993 113.894 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.7 ttm-85 -82.59 104.65 13.01 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.098 0.949 . . . . 73.420000000000002 109.818 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -53.56 143.07 39.25 Favored Pre-proline 0 CA--C 1.564 1.499 0 C-N-CA 124.977 1.311 . . . . 75.239999999999995 112.212 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.514 ' HA ' HD12 ' A' ' 138' ' ' LEU . 3.2 Cg_exo -37.75 -34.89 0.3 Allowed 'Trans proline' 0 C--N 1.389 2.673 1 C-N-CA 125.727 4.285 . . . . 75.349999999999994 116.033 174.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -64.8 -28.44 69.57 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.855 0.462 . . . . 71.109999999999999 112.199 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -92.88 -15.9 25.86 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.715 0.806 . . . . 65.209999999999994 111.547 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 123' ' ' VAL . 90.8 mt -77.82 128.07 33.4 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.569 0.748 . . . . 74.430000000000007 112.376 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -147.37 139.43 24.35 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.413 -0.958 . . . . 65.25 108.413 168.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 24.2 mp0 -68.6 143.68 54.77 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.252 0.621 . . . . 73.349999999999994 110.571 177.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' HE1' ' HA ' ' A' ' 22' ' ' ALA . 56.5 m-85 -66.03 116.8 7.53 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.525 -0.917 . . . . 70.140000000000001 108.525 172.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.49 93.85 2.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 107.506 -1.294 . . . . 73.540000000000006 107.506 175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.85 60.91 4.75 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 114.729 -1.123 . . . . 73.140000000000001 114.013 -166.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -60.26 -46.17 90.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.106 -1.072 . . . . 61.219999999999999 108.106 166.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 95' ' ' LYS . 48.0 m -150.15 131.5 14.64 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 113.367 -1.742 . . . . 74.299999999999997 108.072 169.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.71 147.2 23.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.318 0.647 . . . . 43.210000000000001 110.181 174.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -124.33 138.35 54.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.798 1.239 . . . . 70.349999999999994 109.129 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 57' ' ' VAL . 51.0 mt -125.89 108.71 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 107.502 -1.296 . . . . 73.120000000000005 107.502 173.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.41 HD12 ' HD1' ' A' ' 93' ' ' PHE . 29.9 mm -95.79 124.04 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 109.175 -0.676 . . . . 75.109999999999999 109.175 -176.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -65.88 106.95 1.68 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.686 0.794 . . . . 65.319999999999993 109.539 176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -102.09 112.69 25.44 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.257 1.023 . . . . 72.129999999999995 110.422 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.84 176.93 5.12 Favored 'General case' 0 C--O 1.244 0.814 0 N-CA-C 108.67 -0.863 . . . . 74.120000000000005 108.67 167.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.78 164.61 23.22 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.841 -0.618 . . . . 62.340000000000003 109.744 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.98 -24.93 60.18 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.435 1.094 . . . . 70.030000000000001 113.47 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -105.07 106.48 16.99 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.328 0.651 . . . . 64.349999999999994 109.653 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -161.84 -42.59 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.454 0.702 . . . . 73.299999999999997 110.518 178.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -138.3 106.16 5.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.625 -0.879 . . . . 63.520000000000003 108.625 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -103.59 -161.9 0.87 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.59 0.756 . . . . 74.209999999999994 111.015 -172.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -62.21 154.68 26.75 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.459 1.104 . . . . 70.049999999999997 111.064 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 40.3 m80 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.596 -0.716 . . . . 74.530000000000001 109.24 -179.726 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tmm? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.512 -0.921 . . . . 62.229999999999997 108.512 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m 50.09 18.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 126.409 1.883 . . . . 74.409999999999997 113.272 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 63.9 146.55 0.09 OUTLIER Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 125.625 1.57 . . . . 64.340000000000003 112.385 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.68 22.9 0.75 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.371 2.714 . . . . 63.329999999999998 113.478 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.17 52.21 8.0 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.048 0.217 . . . . 71.099999999999994 112.862 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.85 -7.4 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 123.276 0.63 . . . . 41.43 112.382 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.58 100.69 0.7 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.102 0.561 . . . . 50.149999999999999 111.22 -177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.3 tmtp? -141.11 133.92 28.91 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.482 -1.303 . . . . 75.349999999999994 107.482 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.405 HD11 HD21 ' A' ' 70' ' ' LEU . 48.4 tp -79.35 135.19 36.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.127 0.571 . . . . 61.329999999999998 110.358 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -80.95 168.72 18.4 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.026 0.93 . . . . 65.030000000000001 111.613 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 21.8 p -75.24 -33.3 61.3 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.303 1.223 . . . . 72.340000000000003 114.303 -163.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -56.18 -34.26 66.04 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.731 0.696 . . . . 73.530000000000001 111.976 -176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' HB1' HG13 ' A' ' 66' ' ' VAL . . . -65.53 -42.94 91.41 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.301 1.04 . . . . 53.009999999999998 111.382 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -77.4 -31.77 54.37 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.661 -0.7 . . . . 74.239999999999995 111.416 -178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' THR . 74.6 mmtt -62.75 -50.73 69.92 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.531 0.732 . . . . 74.239999999999995 110.896 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -74.99 -25.79 59.1 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.666 -0.697 . . . . 65.019999999999996 112.065 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.61 -47.59 59.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.918 0.487 . . . . 63.350000000000001 110.695 177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -72.04 -31.36 66.08 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.127 0.571 . . . . 64.340000000000003 111.24 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.4 -37.82 82.02 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.242 1.017 . . . . 54.32 110.384 171.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.1 tpp -68.9 -35.02 76.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.892 -1.049 . . . . 64.140000000000001 110.326 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.51 17.06 1.43 Allowed Glycine 0 C--N 1.353 1.488 0 CA-C-N 116.252 -0.431 . . . . 43.399999999999999 113.467 178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.09 154.57 29.28 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.004 0.522 . . . . 73.200000000000003 110.91 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.548 HD12 ' NH2' ' A' ' 31' ' ' ARG . 30.3 pt -113.88 169.47 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.444 0.697 . . . . 73.109999999999999 111.04 -175.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -121.5 134.62 55.06 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.223 -0.898 . . . . 71.230000000000004 110.679 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.47 168.48 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.894 1.278 . . . . 72.340000000000003 109.82 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.667 HD21 ' HB2' ' A' ' 30' ' ' ASP . 7.1 p30 -103.67 -170.27 1.76 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.087 0.555 . . . . 74.040000000000006 109.607 172.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -70.03 -8.92 53.2 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.353 0.661 . . . . 72.329999999999998 112.122 -173.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -94.34 -46.9 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.223 -0.658 . . . . 62.530000000000001 109.223 172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.47 8.47 3.97 Favored Glycine 0 N--CA 1.473 1.125 0 CA-C-O 120.019 -0.323 . . . . 74.409999999999997 113.418 177.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.667 ' HB2' HD21 ' A' ' 26' ' ' ASN . 3.4 m-20 -83.75 164.15 19.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 72.420000000000002 110.275 176.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' NH2' HD12 ' A' ' 23' ' ' ILE . 16.3 mmp_? -55.4 138.34 46.14 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.185 0.594 . . . . 75.239999999999995 110.779 168.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 49' ' ' GLN . 42.0 pt -102.46 -42.99 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 109.144 -0.687 . . . . 73.129999999999995 109.144 166.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG12 HG13 ' A' ' 32' ' ' ILE . 10.1 p -146.09 163.93 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.364 1.066 . . . . 73.109999999999999 108.879 -171.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -50.27 73.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.893 0.877 . . . . 73.420000000000002 109.462 171.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -173.38 176.55 2.82 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.228 -1.351 . . . . 64.409999999999997 108.002 -175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 62.8 p -82.13 51.67 1.83 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.79 -0.569 . . . . 74.120000000000005 109.99 174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -60.96 -57.24 13.48 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.106 0.963 . . . . 73.409999999999997 110.273 -175.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' H ' ' A' ' 41' ' ' THR . 15.0 p -141.5 154.02 19.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 123.618 0.767 . . . . 74.25 108.977 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -55.19 -35.16 64.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.112 0.965 . . . . 74.209999999999994 111.283 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m -61.39 -59.12 5.76 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 123.86 0.725 . . . . 44.020000000000003 110.531 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.437 ' H ' HG13 ' A' ' 38' ' ' VAL . 22.7 m -64.11 -39.26 93.65 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.654 0.782 . . . . 70.299999999999997 111.423 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -68.33 -50.54 52.68 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.528 0.731 . . . . 73.519999999999996 111.629 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 21.5 ttt180 -64.12 -51.84 62.03 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.834 0.854 . . . . 54.530000000000001 110.193 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -59.73 -26.87 66.0 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.782 0.833 . . . . 72.140000000000001 111.809 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 49' ' ' GLN . . . -68.17 -40.83 82.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.253 0.621 . . . . 74.140000000000001 111.567 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mt -71.63 -35.78 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 121.345 0.593 . . . . 75.530000000000001 109.708 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 43' ' ' ARG . 58.2 mt -67.42 -33.71 75.74 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.312 -0.858 . . . . 72.319999999999993 110.368 174.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 45' ' ' ALA . 46.6 tttp -65.77 -36.2 82.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.392 1.477 . . . . 64.430000000000007 111.142 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.614 ' HG3' HG22 ' A' ' 32' ' ' ILE . 42.9 mm-40 -77.82 159.17 29.15 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.979 -0.749 . . . . 72.519999999999996 108.979 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.88 -34.05 75.92 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.551 0.532 . . . . 72.200000000000003 109.89 172.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -73.51 146.14 45.08 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.918 0.887 . . . . 63.439999999999998 110.544 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 26.7 mmtm -116.01 42.35 2.37 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.009 0.924 . . . . 70.209999999999994 110.352 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -155.47 139.34 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.621 -1.172 . . . . 61.140000000000001 110.019 179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.04 157.17 21.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.445 1.098 . . . . 74.099999999999994 109.986 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -138.28 122.44 18.04 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.665 0.786 . . . . 75.420000000000002 109.643 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 149' ' ' ILE . 34.7 tp -97.32 101.93 13.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.177 0.991 . . . . 55.25 109.269 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -89.25 124.54 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 108.535 -0.913 . . . . 65.010000000000005 108.535 -178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 25.0 ptp -142.54 176.65 8.86 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.739 0.816 . . . . 55.310000000000002 110.425 -175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.0 164.74 12.58 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.151 0.98 . . . . 43.439999999999998 109.07 170.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 145' ' ' THR . 32.7 tt0 -63.01 -37.21 86.29 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.149 0.58 . . . . 71.129999999999995 112.081 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.1 mtm180 -66.22 -29.48 69.75 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.59 0.356 . . . . 73.329999999999998 110.747 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 m -71.58 -39.5 70.51 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.481 0.713 . . . . 72.349999999999994 110.055 172.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.09 -34.67 78.58 Favored 'General case' 0 C--N 1.349 0.545 0 CA-C-N 115.592 -0.731 . . . . 74.310000000000002 111.041 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' HG2' ' A' ' 60' ' ' GLU . 70.3 mmtt -56.29 -36.92 69.17 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.074 0.397 . . . . 72.420000000000002 110.333 177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -71.05 -49.63 42.7 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 123.929 0.768 . . . . 72.510000000000005 110.745 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.498 HG13 ' HB1' ' A' ' 13' ' ' ALA . 97.7 t -60.72 -58.95 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.653 0.781 . . . . 74.329999999999998 111.006 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -47.99 -44.3 30.54 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.727 1.611 . . . . 73.010000000000005 112.415 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.41 -50.12 74.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.934 0.771 . . . . 64.049999999999997 110.244 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.88 -33.73 74.74 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.116 0.885 . . . . 74.540000000000006 111.881 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 66' ' ' VAL . 66.6 mt -60.08 -55.39 34.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.969 0.508 . . . . 63.109999999999999 109.935 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.5 mt -70.89 -28.63 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.305 -0.861 . . . . 75.349999999999994 110.879 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.35 -41.69 93.61 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.628 0.771 . . . . 74.540000000000006 109.692 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -83.36 -66.06 0.94 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 119.404 -0.332 . . . . 73.329999999999998 110.184 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.89 95.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.217 1.007 . . . . 72.519999999999996 109.943 -176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.83 135.59 2.8 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.218 -1.03 . . . . 53.539999999999999 108.218 174.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m -77.64 124.3 86.57 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 123.185 0.594 . . . . 74.340000000000003 109.602 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 76' ' ' THR . 11.7 Cg_endo -53.86 -37.45 85.16 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.069 2.513 . . . . 62.340000000000003 111.876 176.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.72 -39.73 89.66 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.587 1.18 . . . . 73.140000000000001 111.52 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -68.39 -44.53 74.89 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.5 0.32 . . . . 52.140000000000001 111.245 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 61.0 mt -58.6 -49.01 83.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.033 0.833 . . . . 73.109999999999999 110.854 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 11.2 ptmm? -72.32 -19.88 61.58 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.663 -0.699 . . . . 54.43 111.749 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -81.86 -22.18 37.08 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.797 0.439 . . . . 73.150000000000006 111.354 173.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -76.86 -2.8 35.26 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.793 0.437 . . . . 74.409999999999997 111.605 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' PHE . 81.0 m-85 -86.84 -11.46 50.8 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.484 0.714 . . . . 73.5 111.63 170.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -126.74 151.86 47.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.327 0.651 . . . . 61.119999999999997 109.647 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -163.85 152.02 13.11 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.033 -0.729 . . . . 61.530000000000001 109.033 170.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -95.95 -22.37 17.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.337 0.655 . . . . 75.319999999999993 111.824 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.04 -53.1 0.05 OUTLIER Glycine 0 C--N 1.347 1.149 0 N-CA-C 112.44 -0.264 . . . . 70.299999999999997 112.44 -175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.44 -171.37 2.42 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.42 0.688 . . . . 71.209999999999994 109.792 176.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -95.46 140.35 22.33 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.469 -0.787 . . . . 70.349999999999994 110.345 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.87 135.85 62.28 Favored 'Trans proline' 0 C--N 1.375 1.925 0 C-N-CA 122.485 2.123 . . . . 62.229999999999997 111.641 167.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.17 -50.28 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.28 0.632 . . . . 64.540000000000006 109.729 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 19.7 m-85 -99.96 124.38 45.24 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.833 -1.173 . . . . 73.120000000000005 107.833 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.58 149.69 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.143 0.577 . . . . 74.129999999999995 109.722 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -144.51 167.81 21.62 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.408 0.683 . . . . 61.25 111.374 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.63 -146.12 17.91 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.218 -0.901 . . . . 74.549999999999997 111.652 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 47.0 t -78.38 177.56 8.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.25 0.62 . . . . 72.400000000000006 109.63 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.9 tp -60.51 -48.18 82.9 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.83 0.452 . . . . 63.340000000000003 110.545 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 50.0 mt-10 -71.61 -43.98 65.24 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.501 -0.772 . . . . 74.049999999999997 111.468 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.5 m -60.73 -51.3 69.95 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.441 0.696 . . . . 74.450000000000003 111.599 -176.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.03 -26.08 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.105 -0.952 . . . . 55.149999999999999 111.221 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -68.49 -47.05 68.06 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.421 0.689 . . . . 62.100000000000001 111.088 176.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 38.6 mt-10 -65.35 -43.51 90.65 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.356 -0.838 . . . . 61.310000000000002 111.132 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -74.3 -25.83 59.81 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.753 -0.658 . . . . 55.329999999999998 111.0 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.26 -7.43 55.48 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.138 0.575 . . . . 64.239999999999995 111.462 173.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.26 23.0 78.55 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 113.953 0.341 . . . . 72.150000000000006 113.953 173.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.2 mt -91.57 144.31 9.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.368 -0.975 . . . . 64.340000000000003 108.368 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.2 t -64.1 109.98 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.94 0 N-CA-C 109.419 -0.586 . . . . 73.239999999999995 109.419 178.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 113' ' ' VAL . 74.0 t -53.74 -50.86 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.367 -1.288 . . . . 74.129999999999995 111.491 -172.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.57 -36.4 82.57 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.588 0.755 . . . . 74.319999999999993 111.768 -174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.14 -43.57 70.64 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.488 0.315 . . . . 74.329999999999998 111.125 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 102' ' ' ALA . 4.2 pp -75.29 -28.47 59.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 120.702 -0.399 . . . . 62.0 111.95 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 109' ' ' VAL . 39.7 t -59.1 -38.43 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.035 -0.728 . . . . 75.420000000000002 109.035 173.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -63.69 -55.7 21.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.392 -0.822 . . . . 71.329999999999998 110.58 173.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -65.14 -26.95 68.4 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.442 0.534 . . . . 72.329999999999998 112.442 -172.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.2 t -83.46 -42.41 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.708 0.803 . . . . 73.310000000000002 110.678 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -70.24 -34.2 72.56 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.887 0.312 . . . . 72.219999999999999 110.209 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -73.83 -37.42 64.85 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.218 0.607 . . . . 55.409999999999997 109.962 177.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.546 ' O ' HG23 ' A' ' 123' ' ' VAL . 61.4 t80 -56.22 -66.36 0.45 Allowed 'General case' 0 C--N 1.361 1.097 0 O-C-N 124.13 0.894 . . . . 62.310000000000002 109.362 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.498 HE21 ' H ' ' A' ' 141' ' ' PHE . 86.4 mt-30 -58.28 -28.25 64.78 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.095 0.872 . . . . 51.329999999999998 111.639 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -67.99 -50.94 37.16 Favored Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.432 -0.667 . . . . 62.109999999999999 111.432 178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -75.21 -20.41 59.28 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 111.887 0.328 . . . . 73.530000000000001 111.887 -177.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.634 HG22 ' HB3' ' A' ' 138' ' ' LEU . 56.0 t -61.96 -51.5 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.665 0.786 . . . . 63.420000000000002 110.148 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -75.44 -17.09 60.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.847 -0.615 . . . . 74.030000000000001 111.341 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -83.44 -17.54 41.74 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.025 0.53 . . . . 75.019999999999996 111.033 170.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.08 34.06 53.11 Favored Glycine 0 C--N 1.347 1.166 0 N-CA-C 114.326 0.49 . . . . 72.099999999999994 114.326 174.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 76.2 t60 -153.6 123.08 6.66 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.111 0.564 . . . . 73.120000000000005 110.072 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.0 141.16 43.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.776 0.431 . . . . 53.530000000000001 110.65 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -106.54 -57.5 2.05 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.771 0.828 . . . . 72.310000000000002 110.817 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.423 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 13.2 p30 -94.31 58.78 2.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 121.292 0.567 . . . . 63.119999999999997 110.666 -173.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.6 p90 41.84 61.61 1.85 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.656 1.582 . . . . 73.430000000000007 112.783 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -91.59 -147.43 20.05 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 114.879 -1.055 . . . . 62.399999999999999 111.149 175.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.9 -175.58 2.81 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.611 0.765 . . . . 63.420000000000002 110.012 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -65.04 143.17 98.84 Favored Pre-proline 0 N--CA 1.48 1.058 0 CA-C-O 118.145 -0.931 . . . . 75.549999999999997 110.198 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -38.51 -30.74 0.19 Allowed 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 125.138 3.892 . . . . 75.230000000000004 115.973 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -75.01 -35.86 61.97 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.4 0.28 . . . . 71.219999999999999 111.411 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -84.97 -27.04 26.77 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.173 0.589 . . . . 70.329999999999998 110.563 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.634 ' HB3' HG22 ' A' ' 123' ' ' VAL . 69.3 mt -61.47 102.17 0.22 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.659 0.784 . . . . 74.409999999999997 109.153 174.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -120.84 122.54 40.5 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.752 -0.833 . . . . 65.540000000000006 108.752 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -63.57 151.39 41.64 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.963 -0.754 . . . . 34.109999999999999 108.963 174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' H ' HE21 ' A' ' 120' ' ' GLN . 69.6 m-85 -64.99 88.93 0.07 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.495 0.664 . . . . 75.129999999999995 109.242 172.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.57 131.75 52.58 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.99 -1.115 . . . . 73.340000000000003 107.99 177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.64 -128.61 3.28 Favored Glycine 0 C--O 1.236 0.222 0 N-CA-C 109.424 -1.47 . . . . 42.310000000000002 109.424 -172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.23 -76.88 0.35 Allowed 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 117.86 0.83 . . . . 73.140000000000001 110.895 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.482 ' HB ' ' HB2' ' A' ' 60' ' ' GLU . 8.7 m -86.66 137.75 32.22 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 122.886 0.474 . . . . 70.400000000000006 111.437 -170.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -88.81 136.49 32.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.125 0.97 . . . . 71.329999999999998 109.529 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -124.06 117.4 24.62 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.07 0.948 . . . . 72.299999999999997 109.324 173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 50.8 mt -107.45 119.31 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.587 0.755 . . . . 74.030000000000001 108.981 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 35.6 mm -105.02 105.51 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 123.83 0.852 . . . . 70.219999999999999 109.849 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.26 133.34 44.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.997 0.519 . . . . 74.109999999999999 110.58 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.415 HE21 HG22 ' A' ' 149' ' ' ILE . 93.4 mm-40 -133.74 101.58 5.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.503 1.121 . . . . 65.439999999999998 109.444 175.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -77.0 150.51 35.83 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.835 -1.075 . . . . 75.439999999999998 109.048 173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.0 mt -70.38 177.75 3.23 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 112.773 0.657 . . . . 74.439999999999998 112.773 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -58.0 -35.61 71.48 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.242 -1.344 . . . . 63.43 111.74 -172.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -83.6 81.65 8.65 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.311 -0.996 . . . . 75.25 108.311 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -60.11 122.71 15.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 74.439999999999998 110.115 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -74.15 114.93 13.05 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.868 -0.605 . . . . 73.239999999999995 111.053 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -88.74 10.69 19.97 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.969 -1.014 . . . . 55.200000000000003 110.408 170.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -146.08 142.3 28.42 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.448 1.099 . . . . 74.310000000000002 108.839 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 123.373 0.669 . . . . 71.109999999999999 109.434 178.672 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.485 -0.561 . . . . 75.420000000000002 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -159.2 47.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 123.131 1.443 . . . . 75.049999999999997 108.599 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.12 156.75 83.83 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.184 -1.371 . . . . 74.019999999999996 110.316 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.49 -158.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.579 2.186 . . . . 74.120000000000005 112.225 175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.62 62.08 4.17 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 113.629 0.212 . . . . 50.340000000000003 113.629 -176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.0 m -81.08 -4.29 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.327 1.051 . . . . 73.540000000000006 112.03 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.14 122.53 25.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.19 0.996 . . . . 72.099999999999994 109.104 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -154.11 124.69 7.08 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.521 0.728 . . . . 71.040000000000006 109.806 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -81.22 95.67 7.0 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.979 -1.119 . . . . 73.420000000000002 107.979 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 11' ' ' THR . 1.6 m -110.67 175.34 5.46 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 123.422 0.689 . . . . 72.219999999999999 109.451 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.497 ' H ' HG22 ' A' ' 10' ' ' THR . 7.4 m -50.75 -32.59 20.17 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.195 1.798 . . . . 75.120000000000005 114.429 -170.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -54.53 -42.22 70.61 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.362 1.065 . . . . 74.409999999999997 112.424 -175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.42 -29.3 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.686 0.794 . . . . 64.010000000000005 111.719 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 m -84.25 -36.69 22.51 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.499 0.719 . . . . 70.519999999999996 111.498 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -75.75 -48.92 19.8 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.474 0.709 . . . . 73.340000000000003 111.413 -175.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.85 -25.51 68.2 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.894 0.478 . . . . 72.109999999999999 111.448 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.492 ' HB3' HD21 ' A' ' 56' ' ' LEU . . . -73.5 -47.1 43.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.558 0.743 . . . . 73.140000000000001 112.157 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' CE2' ' A' ' 24' ' ' TYR . 2.6 p -70.57 -33.7 71.4 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.806 0.442 . . . . 73.129999999999995 111.27 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -68.55 -27.91 66.5 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.0 0.92 . . . . 60.439999999999998 109.83 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 31.4 tpp -68.21 -35.29 77.75 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.844 0.858 . . . . 74.129999999999995 110.325 174.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.8 59.83 0.11 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.304 -0.718 . . . . 64.549999999999997 111.304 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -134.34 166.97 21.59 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.553 0.741 . . . . 60.420000000000002 110.554 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.2 pt -122.88 151.62 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.8 0.84 . . . . 74.25 110.554 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 18' ' ' THR . 51.2 m-85 -100.59 124.36 46.07 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.589 -0.893 . . . . 74.239999999999995 108.589 169.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.51 170.99 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.246 0.618 . . . . 71.430000000000007 109.953 171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 50' ' ' ALA . 26.4 p-10 -94.75 -172.42 2.72 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.007 0.523 . . . . 74.209999999999994 110.458 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.9 p -63.14 -13.41 36.46 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.216 1.007 . . . . 73.010000000000005 112.741 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -97.62 -37.89 9.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.429 0.691 . . . . 64.030000000000001 110.146 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.41 -5.0 9.42 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-O 119.669 -0.517 . . . . 73.030000000000001 114.016 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.48 147.96 52.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.076 0.95 . . . . 73.109999999999999 111.241 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.48 ' HG3' HG23 ' A' ' 115' ' ' THR . 0.1 OUTLIER -75.27 89.59 2.57 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.303 -0.629 . . . . 74.5 109.303 178.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.6 -33.62 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-O 121.182 0.515 . . . . 74.409999999999997 110.799 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 p -158.27 140.77 5.72 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 N-CA-C 108.028 -1.101 . . . . 74.400000000000006 108.028 168.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.729 HD22 ' HB2' ' A' ' 133' ' ' ARG . 24.4 p-10 -58.71 -43.17 90.01 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.526 1.131 . . . . 64.409999999999997 111.517 -175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -159.98 -157.55 0.57 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.132 1.373 . . . . 74.510000000000005 108.821 176.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.0 m -79.88 61.74 3.89 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.058 0.543 . . . . 44.5 110.442 176.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -68.57 -52.95 26.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.92 0.888 . . . . 62.140000000000001 109.444 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 40' ' ' THR . 7.1 p -161.45 142.62 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.335 -0.848 . . . . 64.019999999999996 109.427 173.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -62.03 -29.27 70.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.348 1.059 . . . . 73.530000000000001 112.143 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.428 ' H ' HG22 ' A' ' 38' ' ' VAL . 44.1 p -62.37 -57.61 10.66 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 122.876 0.47 . . . . 72.010000000000005 109.93 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.1 m -58.88 -43.54 90.96 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.554 0.742 . . . . 71.040000000000006 111.603 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -59.63 -60.74 3.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.609 0.764 . . . . 71.450000000000003 111.288 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -64.03 -43.42 95.61 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.859 0.864 . . . . 75.519999999999996 111.463 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 93.6 m-20 -65.15 -34.8 79.26 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.283 0.633 . . . . 72.340000000000003 111.286 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . . . -69.98 -26.25 64.0 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.425 0.29 . . . . 43.530000000000001 111.58 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.8 mt -74.36 -36.04 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 64.319999999999993 109.543 170.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.8 mt -73.25 -21.81 60.54 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.606 0.762 . . . . 63.229999999999997 111.501 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 27.6 mtpp -69.68 -37.84 76.82 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.332 0.653 . . . . 75.299999999999997 111.154 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -160.93 -110.27 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 108.846 -0.798 . . . . 74.340000000000003 108.846 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.557 ' HA ' ' HB2' ' A' ' 26' ' ' ASN . . . 58.65 -5.76 0.05 Allowed 'General case' 0 C--N 1.37 1.48 0 N-CA-C 115.645 1.72 . . . . 43.450000000000003 115.645 173.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 53.41 27.75 6.73 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.778 0.831 . . . . 74.450000000000003 111.137 -163.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp 62.58 31.21 16.99 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.895 1.278 . . . . 73.510000000000005 111.727 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -143.94 128.16 13.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-O 121.805 0.812 . . . . 71.409999999999997 110.152 175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.06 159.08 15.97 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.4 1.08 . . . . 33.020000000000003 108.891 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -135.98 106.71 6.57 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.008 0.923 . . . . 64.219999999999999 109.259 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' A' ' 17' ' ' ALA . 21.0 tp -76.76 105.86 8.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.193 0.997 . . . . 74.230000000000004 110.105 177.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.6 t -87.97 118.84 34.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.229 -1.026 . . . . 74.219999999999999 108.229 178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.7 ptp -136.14 177.28 7.96 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.692 1.197 . . . . 62.229999999999997 108.5 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -113.1 174.8 5.73 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.067 -1.086 . . . . 61.420000000000002 108.067 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 36.7 tt0 -63.66 -23.92 67.57 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.139 0.975 . . . . 74.209999999999994 112.129 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.6 -53.82 41.47 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.629 0.771 . . . . 61.240000000000002 109.394 172.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.7 m -65.34 -38.9 91.52 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 114.37 -1.286 . . . . 75.209999999999994 110.693 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 60' ' ' GLU . 75.4 t-105 -65.59 -36.61 84.26 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.962 0.727 . . . . 72.140000000000001 112.962 -175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 60' ' ' GLU . 71.4 mmtt -54.61 -31.67 57.53 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.77 0.714 . . . . 74.109999999999999 111.169 177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 31.1 mmmt -82.95 -48.99 10.08 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.064 -0.971 . . . . 73.540000000000006 110.673 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -61.8 -47.0 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 123.556 0.742 . . . . 71.439999999999998 111.254 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -53.48 -45.6 69.67 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.125 1.37 . . . . 73.219999999999999 110.933 175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.16 -46.13 82.13 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.82 -1.082 . . . . 71.099999999999994 110.565 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 82.7 mt -62.73 -37.32 86.06 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.455 0.702 . . . . 73.439999999999998 110.919 -178.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.29 -59.43 5.41 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.917 0.761 . . . . 75.239999999999995 109.912 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.5 mt -60.67 -33.88 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.821 0.848 . . . . 74.230000000000004 111.061 -177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -70.63 -49.67 45.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.123 0.969 . . . . 72.519999999999996 109.719 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -83.47 -65.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.83 -0.623 . . . . 60.039999999999999 109.85 -166.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -161.35 77.32 0.55 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.36 1.064 . . . . 73.420000000000002 109.466 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.33 179.85 1.74 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.197 0.999 . . . . 73.099999999999994 109.248 173.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.0 t -144.12 151.82 53.02 Favored Pre-proline 0 C--O 1.246 0.912 0 N-CA-C 107.83 -1.174 . . . . 64.230000000000004 107.83 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -53.23 -38.51 81.65 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.021 2.481 . . . . 73.5 112.058 178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 81' ' ' LYS . 44.3 mt-10 -61.31 -35.04 76.28 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.259 0.974 . . . . 73.129999999999995 112.977 -172.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -80.69 -43.73 19.87 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.492 0.317 . . . . 55.420000000000002 111.305 178.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.0 mt -61.07 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.663 0.785 . . . . 70.519999999999996 110.542 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.88 -32.57 72.01 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.254 -0.884 . . . . 74.209999999999994 110.919 178.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.9 t -69.55 -24.1 63.67 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.54 0.736 . . . . 64.540000000000006 111.323 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -71.79 -31.03 66.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.501 0.32 . . . . 72.519999999999996 111.05 172.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -76.65 -39.73 51.34 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 121.25 0.548 . . . . 75.299999999999997 110.232 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -90.48 17.61 7.18 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.545 1.138 . . . . 73.409999999999997 110.766 -177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 89' ' ' LYS . 58.7 t30 -74.16 95.54 2.6 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.468 1.107 . . . . 73.019999999999996 109.478 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -95.49 -38.16 10.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.716 0.806 . . . . 71.230000000000004 109.837 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.65 -35.4 91.98 Favored Glycine 0 C--N 1.354 1.583 0 CA-C-N 115.452 -0.794 . . . . 62.329999999999998 112.615 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' HB2' HD21 ' A' ' 86' ' ' ASN . 31.9 mmmt -123.54 -179.49 4.36 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.727 1.211 . . . . 72.129999999999995 108.436 172.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -87.55 131.93 42.3 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 110.084 -0.339 . . . . 64.540000000000006 110.084 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 94' ' ' VAL . 82.4 Cg_exo -51.06 126.59 19.27 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 124.333 3.355 . . . . 72.120000000000005 115.436 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.9 t -72.67 -43.86 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.892 -0.781 . . . . 73.109999999999999 108.892 171.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -99.38 114.35 27.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.89 -1.152 . . . . 74.219999999999999 107.89 172.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 91' ' ' PRO . 27.9 t -113.39 154.58 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.839 0.855 . . . . 73.329999999999998 109.555 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -151.48 172.67 15.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.529 0.732 . . . . 73.049999999999997 111.382 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 136.39 -140.04 11.18 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 114.582 -1.19 . . . . 73.239999999999995 110.412 175.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 m -78.84 173.04 12.92 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.243 -0.651 . . . . 72.010000000000005 109.243 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.09 -45.98 91.13 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.1 0.56 . . . . 74.129999999999995 110.509 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 103' ' ' GLU . 51.8 mt-10 -76.34 -38.8 55.42 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.198 -0.91 . . . . 70.450000000000003 111.278 -178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.3 m -63.18 -49.76 73.02 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.246 0.618 . . . . 70.430000000000007 111.108 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.54 -27.13 68.75 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.048 -0.978 . . . . 74.310000000000002 110.785 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -67.08 -46.64 73.66 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.872 0.869 . . . . 61.119999999999997 111.148 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 99' ' ' GLU . 39.9 mt-10 -65.05 -45.49 85.17 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 115.071 -0.968 . . . . 72.319999999999993 111.189 -178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.29 -24.23 60.39 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.771 0.828 . . . . 75.430000000000007 111.921 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.58 -26.31 32.46 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.832 0.453 . . . . 74.120000000000005 110.571 173.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 93.13 12.58 57.39 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 115.785 -0.643 . . . . 73.439999999999998 113.923 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.66 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.135 0.974 . . . . 71.219999999999999 109.669 -178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.16 107.79 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.299 0 N-CA-C 108.841 -0.799 . . . . 33.450000000000003 108.841 176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 113' ' ' VAL . 97.8 t -53.73 -53.83 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.283 1.433 . . . . 45.420000000000002 111.97 -171.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 23.2 t70 -60.39 -41.83 94.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 123.649 0.593 . . . . 74.219999999999999 110.918 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.54 -40.07 96.04 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.804 0.69 . . . . 74.340000000000003 111.97 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 4.3 pp -79.21 -25.72 42.64 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 112.072 0.397 . . . . 72.340000000000003 112.072 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 109' ' ' VAL . 43.1 t -65.25 -43.07 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.568 -0.901 . . . . 62.100000000000001 108.568 174.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 110' ' ' ASP . 28.0 mm-40 -62.16 -51.27 68.52 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 124.133 0.895 . . . . 71.430000000000007 109.007 176.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.522 ' HB ' ' HA ' ' A' ' 112' ' ' LEU . 2.9 m -49.05 -48.26 44.09 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.023 1.329 . . . . 70.420000000000002 112.998 177.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.1 t -77.56 -40.2 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 122.817 0.447 . . . . 75.420000000000002 110.902 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -30.87 62.03 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 118.389 0.541 . . . . 75.439999999999998 111.486 -175.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -81.41 -36.99 28.84 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.599 0.76 . . . . 53.299999999999997 109.193 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.489 ' O ' HG23 ' A' ' 123' ' ' VAL . 47.3 t80 -56.58 -64.18 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.112 0.883 . . . . 74.219999999999999 108.987 170.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -58.11 -24.99 60.76 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.5 1.12 . . . . 62.229999999999997 111.723 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' HA2' HE21 ' A' ' 124' ' ' GLN . . . -66.98 -56.31 13.09 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 124.127 0.892 . . . . 44.409999999999997 112.924 174.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 119' ' ' TYR . 10.3 p90 -74.18 -18.38 60.78 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 117.257 0.529 . . . . 74.400000000000006 111.391 -177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 138' ' ' LEU . 65.2 t -63.53 -57.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.985 0.514 . . . . 71.200000000000003 110.082 170.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.494 ' HB3' ' NE2' ' A' ' 140' ' ' GLN . 29.7 pt20 -70.92 -19.14 62.62 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.414 0.286 . . . . 63.43 111.491 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.63 -26.23 54.68 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.118 0.567 . . . . 71.340000000000003 110.249 173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 76.4 31.43 54.61 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.664 -0.698 . . . . 71.019999999999996 113.193 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -135.21 127.34 29.91 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.938 0.495 . . . . 74.109999999999999 110.013 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.34 150.45 48.19 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.253 1.021 . . . . 54.450000000000003 112.037 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.59 -66.68 0.53 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.319 0.648 . . . . 65.340000000000003 109.749 172.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -73.18 109.89 7.06 Favored 'General case' 0 C--O 1.246 0.886 0 C-N-CA 122.607 0.363 . . . . 51.130000000000003 111.352 -175.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 58.19 24.62 11.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.971 1.308 . . . . 72.340000000000003 111.816 172.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.47 41.65 97.22 Favored Glycine 0 C--N 1.352 1.442 0 CA-C-N 114.86 -1.064 . . . . 70.409999999999997 114.516 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.729 ' HB2' HD22 ' A' ' 34' ' ' ASN . 15.5 ttm180 -74.81 116.49 15.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.618 -0.882 . . . . 71.109999999999999 108.618 177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.94 147.2 55.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 123.872 0.869 . . . . 65.319999999999993 112.149 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.63 -25.12 19.08 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 124.088 3.192 . . . . 70.150000000000006 114.439 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -69.62 -31.29 69.32 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.172 0.589 . . . . 71.239999999999995 111.461 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -92.61 -15.64 26.63 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.117 0.967 . . . . 64.209999999999994 111.074 176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD23 ' HD2' ' A' ' 133' ' ' ARG . 68.5 mt -75.17 116.26 15.7 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.372 0.669 . . . . 73.219999999999999 110.215 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -146.81 136.2 22.8 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 73.430000000000007 108.417 176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' ' 124' ' ' GLN . 22.0 mp0 -77.76 153.37 32.97 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.68 0.392 . . . . 65.010000000000005 111.434 -177.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -66.18 104.47 1.18 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.631 -0.877 . . . . 64.450000000000003 108.631 168.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.52 97.53 0.78 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.971 -0.752 . . . . 52.109999999999999 108.971 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.87 114.13 5.13 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-N 114.224 -1.353 . . . . 73.5 114.876 -162.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.05 -55.02 2.37 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.326 -0.99 . . . . 75.049999999999997 108.326 163.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 86.2 m -151.3 123.34 8.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.148 0.979 . . . . 71.310000000000002 108.989 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.92 124.7 32.68 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.817 0.447 . . . . 75.019999999999996 110.095 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -107.53 125.2 50.99 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.484 1.114 . . . . 65.450000000000003 109.346 176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.2 mt -108.74 108.23 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.641 -0.874 . . . . 72.319999999999993 108.641 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 41.3 mm -93.97 128.18 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.918 0.887 . . . . 64.129999999999995 108.953 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.52 119.07 31.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 73.230000000000004 110.869 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.409 HE22 ' HB3' ' A' ' 56' ' ' LEU . 23.6 mp0 -108.43 100.99 10.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.56 -0.904 . . . . 72.310000000000002 108.56 171.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -84.83 145.98 27.57 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.416 -0.957 . . . . 61.329999999999998 108.416 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.38 152.51 21.14 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.576 0.547 . . . . 64.5 111.506 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.69 107.4 1.17 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.694 -1.139 . . . . 41.210000000000001 111.709 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.99 -12.02 34.18 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.346 1.058 . . . . 73.109999999999999 111.594 168.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -123.59 114.15 19.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.966 0.906 . . . . 75.450000000000003 108.661 169.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -63.44 131.86 49.56 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.403 -0.591 . . . . 70.519999999999996 109.403 173.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 122.052 -0.405 . . . . 71.319999999999993 110.607 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -103.66 74.58 1.25 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.144 -0.687 . . . . 74.0 109.144 169.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.247 0.953 0 N-CA-C 107.925 -1.139 . . . . 64.439999999999998 107.925 173.774 . . . . . . . . 0 0 . 1 stop_ save_